
<html lang="en"     class="pb-page"  data-request-id="ed7e6c64-1b70-4705-afd0-a067f71a3a31"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b00147;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein–Protein Interaction" /></meta><meta name="dc.Creator" content="Zhen  Wang" /></meta><meta name="dc.Creator" content="Min  Zhang" /></meta><meta name="dc.Creator" content="Jin  Wang" /></meta><meta name="dc.Creator" content="Haitao  Ji" /></meta><meta name="dc.Description" content="The β-catenin/T-cell factor (Tcf) protein–protein interaction (PPI) plays a critical role in the β-catenin signaling pathway which is hyperactivated in many cancers and fibroses. Based on compound ..." /></meta><meta name="Description" content="The β-catenin/T-cell factor (Tcf) protein–protein interaction (PPI) plays a critical role in the β-catenin signaling pathway which is hyperactivated in many cancers and fibroses. Based on compound ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 11, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00147" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00147" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00147" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00147" /></link>
        
    
    

<title>Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein–Protein Interaction | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00147" /></meta><meta property="og:title" content="Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein–Protein Interaction" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0016.jpeg" /></meta><meta property="og:description" content="The β-catenin/T-cell factor (Tcf) protein–protein interaction (PPI) plays a critical role in the β-catenin signaling pathway which is hyperactivated in many cancers and fibroses. Based on compound 1, which was designed to target the Tcf4 G13ANDE17 binding site of β-catenin, extensive structure–activity relationship studies have been conducted. As a result, compounds 53 and 57 were found to disrupt the β-catenin/Tcf PPI with the Ki values of 0.64 and 0.44 μM, respectively, and exhibit good selectivity for β-catenin/Tcf over β-catenin/E-cadherin and β-catenin/adenomatous polyposis coli (APC) PPIs. The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) cell viability assays revealed that 56, the ethyl ester of 53, was more potent than 53 in inhibiting viability of most of the Wnt/β-catenin hyperactive cancer cells. Further cell-based studies indicated that 56 disrupted the β-catenin/Tcf PPI without affecting the β-catenin/E-cadherin and β-catenin/APC PPIs, suppressed transactivation of Wnt/β-catenin signaling in dose-dependent manners, and inhibited migration and invasiveness of Wnt/β-catenin-dependent cancer cells." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00147"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00147">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00147&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00147&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00147&amp;href=/doi/10.1021/acs.jmedchem.9b00147" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3617-3635</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00090" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00157" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein–Protein Interaction</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Zhen Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhen Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612-9497, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhen++Wang">Zhen Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Min Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Min Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612-9497, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Min++Zhang">Min Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jin Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jin Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612-9497, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jin++Wang">Jin Wang</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Haitao Ji</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haitao Ji</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612-9497, United States</div><div class="loa-info-affiliations-info">Departments of Oncologic Sciences and Chemistry, University of South Florida, Tampa, Florida 33620-9497, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#4008212934212f6e0a29002d2f26262934346e2f3227"><span class="__cf_email__" data-cfemail="bdf5dcd4c9dcd293f7d4fdd0d2dbdbd4c9c993d2cfda">[email protected]</span></a>. Phone: (813) 745-8070. Fax: (813) 745-4506.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haitao++Ji">Haitao Ji</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5526-4503" title="Orcid link">http://orcid.org/0000-0001-5526-4503</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00147&amp;href=/doi/10.1021%2Facs.jmedchem.9b00147" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3617–3635</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 11, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 January 2019</li><li><span class="item_label"><b>Published</b> online</span>11 March 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 April 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00147" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00147</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3617%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhen%2BWang%252C%2BMin%2BZhang%252C%2BJin%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D7%26contentID%3Dacs.jmedchem.9b00147%26title%3DOptimization%2Bof%2BPeptidomimetics%2Bas%2BSelective%2BInhibitors%2Bfor%2Bthe%2B%25CE%25B2-Catenin%252FT-Cell%2BFactor%2BProtein%25E2%2580%2593Protein%2BInteraction%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3635%26publicationDate%3DApril%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00147"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1960</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00147" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein–Protein Interaction&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhen&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Haitao&quot;,&quot;last_name&quot;:&quot;Ji&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;3617-3635&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00147&quot;},&quot;abstract&quot;:&quot;The β-catenin/T-cell factor (Tcf) protein–protein interaction (PPI) plays a critical role in the β-catenin signaling pathway which is hyperactivated in many cancers and fibroses. Based on compound 1, which was designed to target the Tcf4 G13ANDE17 binding site of β-catenin, extensive structure–activity relationship studies have been conducted. As a result, compounds 53 and 57 were found to disrupt the β-catenin/Tcf PPI with the Ki values of 0.64 and 0.44 μM, respectively, and exhibit good selectivity for β-catenin/Tcf over β-catenin/E-cadherin and β-catenin/adenomatous polyposis coli (APC) PPIs. The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) cell viability assays revealed that 56, the ethyl ester of 53, was more potent than 53 in inhibiting viability of most of the Wnt/β-catenin hyperactive cancer cells. Further cell-based studies indicated that 56 disrupted the β-catenin/Tcf PPI without affecting the β-catenin/E-cadherin and β-catenin/APC PPIs, suppressed t&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00147&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00147" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00147&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00147" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00147&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00147" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00147&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00147&amp;href=/doi/10.1021/acs.jmedchem.9b00147" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00147" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00147" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00147%26sid%3Dliteratum%253Aachs%26pmid%3D30856332%26genre%3Darticle%26aulast%3DWang%26date%3D2019%26atitle%3DOptimization%2Bof%2BPeptidomimetics%2Bas%2BSelective%2BInhibitors%2Bfor%2Bthe%2B%25CE%25B2-Catenin%252FT-Cell%2BFactor%2BProtein%25E2%2580%2593Protein%2BInteraction%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D7%26spage%3D3617%26epage%3D3635%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/jmcmar.2019.62.issue-7/20190411/jmcmar.2019.62.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The β-catenin/T-cell factor (Tcf) protein–protein interaction (PPI) plays a critical role in the β-catenin signaling pathway which is hyperactivated in many cancers and fibroses. Based on compound <b>1</b>, which was designed to target the Tcf4 G<sup>13</sup>ANDE<sup>17</sup> binding site of β-catenin, extensive structure–activity relationship studies have been conducted. As a result, compounds <b>53</b> and <b>57</b> were found to disrupt the β-catenin/Tcf PPI with the <i>K</i><sub>i</sub> values of 0.64 and 0.44 μM, respectively, and exhibit good selectivity for β-catenin/Tcf over β-catenin/E-cadherin and β-catenin/adenomatous polyposis coli (APC) PPIs. The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium (MTS) cell viability assays revealed that <b>56</b>, the ethyl ester of <b>53</b>, was more potent than <b>53</b> in inhibiting viability of most of the Wnt/β-catenin hyperactive cancer cells. Further cell-based studies indicated that <b>56</b> disrupted the β-catenin/Tcf PPI without affecting the β-catenin/E-cadherin and β-catenin/APC PPIs, suppressed transactivation of Wnt/β-catenin signaling in dose-dependent manners, and inhibited migration and invasiveness of Wnt/β-catenin-dependent cancer cells.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Wnt/β-catenin signaling pathway plays a critical role in regulation of cell proliferation, differentiation, and survival.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> The aberrant activation of Wnt/β-catenin signaling has been implicated in initiation and progression of many cancers<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8 ref9">(4−9)</a> and fibroses.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> For instance, loss of adenomatous polyposis coli (APC) function can lead to the inappropriate stabilization of β-catenin and promote the formation of the constitutive complex between β-catenin and the T-cell factor (Tcf)/lymphoid enhancer-binding factor (Lef) family of transcriptional factors, which transcribes specific Wnt target genes that produce crypt progenitor-like cells in the surface intestinal epithelium, eventually causing sporadic colorectal cancer.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> The autocrine activation of Wnt ligands can stabilize β-catenin into the dephosphorylated state and result in an increased level of nuclear β-catenin to interact with Tcf/Lef to induce overexpression of Wnt target genes and cause initiation and progression of triple negative breast cancers (TNBCs).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Hyperactivation of β-catenin signaling was detected in cancer stem cells, which control tumor growth, seed metastases, and result in cancer recurrence after remission.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a> In addition, activation of β-catenin signaling was demonstrated to exclude CD8<sup>+</sup> T cells from the tumor microenvironment and promote intratumoral regulator T cell (Treg) survival and infiltration, thus impairing antitumor immunity.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18">(15−18)</a> Therefore, the suppression of this signaling pathway holds great promise for designing new targeted cancer therapy. Further biological studies indicated that the formation of the β-catenin/Tcf complex in the cell nucleus is the penultimate step of the Wnt/β-catenin signaling pathway and the activation of Wnt/β-catenin target genes is dependent on the formation of this complex.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19−21)</a> Therefore, the β-catenin/Tcf protein–protein interaction (PPI) has emerged as an appealing therapeutic target to suppress hyperactive β-catenin signaling.</div><div class="NLM_p last">Extensive efforts have been made to identify several small-molecule inhibitors for this PPI.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25 ref26 ref27 ref28 ref29">(22−29)</a> However, the binding mode of these compounds remains unknown, making it difficult for further optimization.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The large peptides or peptide-based macrocycles have also been designed as β-catenin/Tcf inhibitors.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34">(31−34)</a> Hydrocarbon-stapled peptide, aStAx-35, designed based on the Axin sequence and the phage display result, was reported to bind with the Axin-binding site of β-catenin and inhibit the β-catenin/Tcf PPI.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Further design offered a more cell-permeable derivative, NLS-StAx-h, by substituting all six arginine residues with homoarginine and introducing the nuclear localization sequence (NLS) to the N-terminus.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Recently, Logan, Kirshenbaum, and co-workers disclosed the design of peptoid–peptide macrocycles as β-catenin/Tcf inhibitors, which showed promising efficacy in prostate cancer models.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In the previous studies, our group reported small-molecule inhibitors for the β-catenin/Tcf PPI using different strategies.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35−37)</a> By targeting the Tcf4 G<sup>13</sup>ANDE<sup>17</sup> binding site, selective small-molecule inhibitors for β-catenin/Tcf PPI have been synthesized.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The best compound <b>1</b> (UU-T02) disrupted β-catenin/Tcf PPI with a <i>K</i><sub>i</sub> of 1.36 μM in the fluorescence polarization (FP) competitive inhibition assay and displayed 175- and 64-fold selectivity over β-catenin/E-cadherin and β-catenin/APC, respectively. However, this compound was almost inactive in cell-based assays unless converted into the ester form, including 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium (MTS) cell viability assays and TOPFlash/FOPFlash luciferase reporter assays. Herein, we report our further medicinal chemistry efforts on optimization, synthesis, and biological characterization of new derivatives.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Structure–Activity Relationship Studies</h3><div class="NLM_p">The indole scaffold represents one of the important privileged structures for the discovery of new drug candidates.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> However, its electron-rich nature renders the indole ring susceptible to metabolism, often by oxidation at the C-3 position of indole, which has the highest electron density.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Most of the reported indole-related drugs and probes contain substituents at indole 3-position to block this metabolically labile site.<a onclick="showRef(event, 'ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40">(38−40)</a> Therefore, to minimize the potential issue with indole in <b>1</b>, three different strategies were employed at the initial stage of our inhibitor optimization. As a direct approach, compounds <b>2</b> and <b>3</b> with indole C-3 position substitution were designed and synthesized. Both compounds showed a great loss of potency (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Alternatively, various electron-deficient heterocycles were introduced to replace the indole ring (<b>4–8</b>). While most compounds (<b>4</b>–<b>7</b>) in this series turned out to be inactive, compound <b>8</b> showed a <i>K</i><sub>i</sub> of 22 μM for the β-catenin/Tcf PPI. In addition, we designed <b>9</b> with the indole ring directly attaching to the amide group. This design is expected to reduce the electron density of the indole ring, thus increasing compound metabolic stability. Literature search revealed that this 1<i>H</i>-indole-2-carboxamido motif had been widely adopted in various medicinal chemistry programs.<a onclick="showRef(event, 'ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44">(41−44)</a> The FP competitive inhibition assay<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> showed that <b>9</b> inhibited the β-catenin/Tcf PPI with a promising <i>K</i><sub>i</sub> of 11 μM. Based on these results, we envisioned that compound <b>9</b> would represent a new starting point for further modification, and extensive structure–activity relationship (SAR) studies on this new scaffold were conducted.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. FP Competitive Inhibition Assay Results of Inhibitors <b>1</b>–<b>19</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0007.gif" alt="" id="GRAPHIC-d7e415-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0008.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Each set of data was expressed as mean ± standard deviation (<i>n</i> = 3). The <i>K</i><sub>i</sub> value for the parent peptide G<sup>13</sup>ANDE<sup>17</sup> was determined to be 290 ± 1.3 μM.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div></div><div></div></div><div class="NLM_p">Preliminary SAR studies on <b>9</b> suggested that a Cl substituent at the indole C-5 position is optimal among all monosubstitution analogues (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <b>9–17</b>). Switching the Cl substituent from the C-5 position to C-4 (<b>10</b>) or C-6 (<b>11</b>) led to decreased activity. Meanwhile, the derivatives in which the Cl atom at the C-5 position was replaced by the other groups, including both electron-withdrawing [F (<b>12</b>), Br (<b>13</b>), CF<sub>3</sub> (<b>16</b>), NO<sub>2</sub> (<b>17</b>)] and -donating [Me (<b>14</b>), OMe (<b>15</b>)] groups, were also made. The results revealed that the electron-withdrawing groups were more tolerated than the electron donating groups, while all of them were less potent than <b>9</b>. Two compounds with di-Cl substitutions (<b>18</b> and <b>19</b>) were synthesized, and both showed improved potency, especially <b>19</b>, which inhibited the β-catenin/Tcf PPI with a <i>K</i><sub>i</sub> of 4.3 μM, ∼3-fold potency improvement over <b>9</b>.</div><div class="NLM_p">Next, to increase the stability of the C-terminal ester group that tends to be hydrolyzed under relatively weak basic conditions (as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a> Note 1), a collection of derivatives with amides, instead of the methyl ester, was designed and synthesized. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, introduction of isobutyl (<b>20</b>) and phenyl (<b>21</b>) amides in replacement of the methyl ester resulted in the compounds with increased activities. For instance, compound <b>21</b> inhibited the β-catenin/Tcf PPI with a <i>K</i><sub>i</sub> of 3.3 μM, which is 3.4-fold more potent than <b>9</b>. Moreover, these more stable amides overcame the instability problem of the methyl ester in <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a> Note 1). Further substitution of the phenyl group in <b>21</b> with benzyl and phenylethyl groups as in <b>22</b> and <b>23</b>, respectively, showed decreased activities. Next, compounds <b>24</b>–<b>29</b> were designed and synthesized to explore the optimal substitution type on the phenyl group. As a result, compounds <b>24</b>–<b>26</b> with F-substitution showed similar activities, while <b>27</b> and <b>28</b> were 3- to 4-fold more potent than <b>29</b>, indicating the para- and meta-substitutions on the phenyl ring are preferable to the ortho derivatives. Therefore, more substituents were explored for these two positions. Compounds <b>33</b>–<b>38</b> were synthesized, and the results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. It was shown that most of these compounds displayed slight improvement of the inhibitory potency, when compared with <b>21</b>. Specifically, compounds <b>30</b> and <b>34</b>, featuring <i>para</i>-CF<sub>3</sub> and <i>para</i>-OCF<sub>3</sub> on the phenyl ring, respectively, were slightly more potent than the other compounds (the FP competitive inhibition assay curves of <b>30</b> and <b>34</b> are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a> Figure S3). Compounds with double substitutions (<b>36</b>–<b>38</b>) were also explored at these two positions, but they did not show potency improvement.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. FP Competitive Inhibition Assay Results of Inhibitors <b>20</b>–<b>38</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0009.gif" alt="" id="GRAPHIC-d7e628-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0010.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Each set of data was expressed as mean ± standard deviation (<i>n</i> = 3). The <i>K</i><sub>i</sub> value for the parent peptide G<sup>13</sup>ANDE<sup>17</sup> was determined to be 290 ± 1.3 μM.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div></div><div></div></div><div class="NLM_p">Further SAR studies on the naphthyl group were undertaken (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). It was shown that most of the synthesized compounds were less potent than <b>21</b>. Only compounds <b>40</b> and <b>46</b> exhibited comparable activity, indicating that the large hydrophobic moieties are critical for maintaining the activity at this site.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. FP Competitive Inhibition Assay Results of Inhibitors <b>39–46</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0011.gif" alt="" id="GRAPHIC-d7e675-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0012.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Each set of data is expressed as mean ± standard deviation (<i>n</i> = 3). The <i>K</i><sub>i</sub> value for the parent peptide G<sup>13</sup>ANDE<sup>17</sup> was determined to be 290 ± 1.3 μM.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div></div><div></div></div><div class="NLM_p">Our extensive SAR studies revealed that the primary configuration (S, S, S) was optimal for this series because individually reversing the configuration of each amino acid resulted in decreased activity (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Based on the inhibitory activity data, we can also conclude that the sensitivity of these three chiral amino acids to the configurational change was decreased following the order of glutamic acid (<b>47</b>), naphthyl-substituted amino acid (<b>49</b>), and aspartic acid (<b>48</b>), with glutamic acid being the most sensitive residue, when compared with those in <b>33</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. FP Competitive Inhibition Assay Results of Inhibitors <b>47–49</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0013.gif" alt="" id="GRAPHIC-d7e725-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">R, S</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> ± SD (μM)</th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>i</sub> ± SD (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">R, S, S</td><td class="colsep0 rowsep0" align="char" char="±">39 ± 2.9</td><td class="colsep0 rowsep0" align="char" char="±">10 ± 0.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">S, R, S</td><td class="colsep0 rowsep0" align="char" char="±">26 ± 1.6</td><td class="colsep0 rowsep0" align="char" char="±">6.6 ± 0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">S, S, R</td><td class="colsep0 rowsep0" align="char" char="±">31 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">8.0 ± 0.42</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Each set of data is expressed as mean ± standard deviation (<i>n</i> = 3). The <i>K</i><sub>i</sub> value for the parent peptide G<sup>13</sup>ANDE<sup>17</sup> was determined to be 290 ± 1.3 μM.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div></div></div><div class="NLM_p">Our next modification was focused on the two carboxylic acid groups, with the aim of improving both potency and cell permeability (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> One common bioisostere of carboxylic acid, amide, was first used to replace the carboxylic acids in <b>34</b> individually. The resulting compounds <b>50</b> and <b>51</b> showed decreased activities. To our delight, introduction of tetrazole, another common bioisostere of carboxylic acid, resulted in the derivatives with the improved potency. For instance, compound <b>53</b>, for the first time, displayed the submicromolar <i>K</i><sub>i</sub> (0.64 μM) for this challenging PPI target. In an attempt to eliminate both carboxylic acids in <b>34</b>, the amide was further introduced into the tetrazole derivatives <b>52</b> and <b>53</b>. However, the resulting compounds <b>54</b> and <b>55</b> displayed 3- to 6-fold potency loss. The ester derivative (<b>56</b>) of compound <b>53</b> was also synthesized to improve compound’s cell permeability. This compound inhibited the β-catenin/Tcf PPI with a <i>K</i><sub>i</sub> of 5.2 μM. In addition, compound <b>57</b> was synthesized based on the previous SAR results. This compound inhibited the β-catenin/Tcf PPI with a <i>K</i><sub>i</sub> of 0.44 μM, which was the most potent inhibitor of this series. The competitive FP inhibition assay curves of <b>52</b>–<b>57</b> are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S3.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. FP Competitive Inhibition Assay Results of Inhibitors <b>50–57</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0014.gif" alt="" id="GRAPHIC-d7e908-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0015.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Each set of data was expressed as mean ± standard deviation (<i>n</i> = 3). The <i>K</i><sub>i</sub> value for the parent peptide G<sup>13</sup>ANDE<sup>17</sup> was determined to be 290 ± 1.3 μM.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Inhibitor Selectivity between β-Catenin/Tcf, β-Catenin/E-Cadherin, and β-Catenin/APC PPIs</h3><div class="NLM_p">β-Catenin not only interacts with Tcf/Lef, BCL9/B9L, CREB-binding protein (CBP)/p300, and so forth to culminate Wnt/β-catenin signaling, but also forms the complexes with E-cadherin and APC to play specific roles in cellulo. The PPI between β-catenin and E-cadherin is essential for cell–cell adhesion, while the β-catenin/APC PPI is critical for β-catenin phosphorylation and degradation. The crystallographic analyses of β-catenin in complexes with Tcf, E-cadherin, and APC indicated that β-catenin uses the same armadillo repeats to bind Tcf/Lef,<a onclick="showRef(event, 'ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50">(47−50)</a> cadherin,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and APC.<a onclick="showRef(event, 'ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54">(52−54)</a> Biochemical analyses confirmed that the binding mode of Tcf, cadherin, and APC with β-catenin was identical and mutually exclusive.<a onclick="showRef(event, 'ref55 ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57 ref58">(55−58)</a> The selectivities of <b>53</b> and <b>57</b> between β-catenin/Tcf4, β-catenin/E-cadherin, and β-catenin/APC-R3 interactions were quantified using the FP selectivity assay.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> As shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, the selectivities of <b>53</b> for β-catenin/Tcf4 over β-catenin/E-cadherin and β-catenin/APC-R3 interactions are 50- and 137-fold, respectively. The selectivities of <b>57</b> for β-catenin/Tcf4 over β-catenin/E-cadherin and β-catenin/APC-R3 interactions are 30- and 395-fold.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Selectivities of <b>53</b> and <b>57</b> for β-Catenin/Tcf over β-Catenin/E-Cadherin and β-Catenin/APC Interactions<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±"><i>K</i><sub>i</sub> ± SD (μM)</th><th class="rowsep1 colsep0" colspan="2" align="center">selectivity</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center" char="±">β-catenin/Tcf</th><th class="colsep0 rowsep0" align="center" char="±">β-catenin/E-cadherin</th><th class="colsep0 rowsep0" align="center" char="±">β-catenin/APC</th><th class="colsep0 rowsep0" align="center">TCF/E-cadherin</th><th class="colsep0 rowsep0" align="center">TCF/APC</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="char" char="±">0.64 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">32 ± 2.8</td><td class="colsep0 rowsep0" align="char" char="±">88 ± 7.3</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">137</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="char" char="±">0.44 ± 0.098</td><td class="colsep0 rowsep0" align="char" char="±">13 ± 0.60</td><td class="colsep0 rowsep0" align="char" char="±">173 ± 15</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">395</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Each set of data was expressed as mean ± standard deviation (<i>n</i> = 3).</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Cell-Based Studies</h3><div class="NLM_p">MTS cell viability assays were performed to evaluate the effect of β-catenin/Tcf inhibitors on growth of different cancer cell lines with hyperactive Wnt signaling, including colorectal cancer cells (SW480 and HCT116) and TNBC cells (MDA-MB-231, MDA-MB-468, and BT-20), and one cancer cell line with normal Wnt signaling, A549. The half maximal inhibitory concentrations (IC<sub>50</sub>) of three representative compounds (<b>53</b>, <b>55</b>, and <b>56</b>) were determined. An inactive analogue (<b>Et</b>)-<b>15</b> (<i>K</i><sub>i</sub> > 100 μM, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) was also assessed in parallel. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a> Figure S4, compounds <b>53</b>, <b>55</b>, and <b>56</b> except (<b>Et</b>)-<b>15</b> inhibited viability of Wnt/β-catenin hyperactive cancer cells. Compound <b>56</b> is the most potent and selective inhibitor for most of the Wnt/β-catenin hyperactive cancer cells over Wnt/β-catenin normal cancer cells.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. MTS Assay to Monitor the Inhibitory Activities of (<b>Et</b>)-<b>15</b>, <b>53</b>, <b>55</b>, and <b>56</b> on Viability of Cancer Cells<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">MTS IC<sub>50</sub> ± SD (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">Wnt/β-catenin hyperactive</th><th class="rowsep1 colsep0" align="center">Wnt/β-catenin normal</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">no.</th><th class="colsep0 rowsep0" align="center">SW480</th><th class="colsep0 rowsep0" align="center">HCT116</th><th class="colsep0 rowsep0" align="center">MDA-MB-231</th><th class="colsep0 rowsep0" align="center">MDA-MB-468</th><th class="colsep0 rowsep0" align="center">BT-20</th><th class="colsep0 rowsep0" align="center">A549</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<b>Et</b>)-<b>15</b></td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">40.5 ± 1.78</td><td class="colsep0 rowsep0" align="left">45.8 ± 1.37</td><td class="colsep0 rowsep0" align="left">26.4 ± 0.74</td><td class="colsep0 rowsep0" align="left">20.6 ± 0.72</td><td class="colsep0 rowsep0" align="left">24.7 ± 1.00</td><td class="colsep0 rowsep0" align="left">71.7 ± 2.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">24.6 ± 1.01</td><td class="colsep0 rowsep0" align="left">57.8 ± 3.75</td><td class="colsep0 rowsep0" align="left">29.3 ± 2.15</td><td class="colsep0 rowsep0" align="left">26.9 ± 1.54</td><td class="colsep0 rowsep0" align="left">29.3 ± 2.20</td><td class="colsep0 rowsep0" align="left">47.5 ± 2.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">17.7 ± 0.54</td><td class="colsep0 rowsep0" align="left">60.6 ± 4.93</td><td class="colsep0 rowsep0" align="left">16.6 ± 1.16</td><td class="colsep0 rowsep0" align="left">10.6 ± 0.30</td><td class="colsep0 rowsep0" align="left">20.1 ± 0.52</td><td class="colsep0 rowsep0" align="left">67.9 ± 2.09</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Each set of data was expressed as mean ± standard deviation (<i>n</i> = 3).</p></div></div></div><div class="NLM_p">The suppressing effect of the inhibitors on transactivation of β-catenin signaling was evaluated by TOPFlash/FOPFlash luciferase reporter assays. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, the inactive compound (<b>Et</b>)-<b>15</b> did not inhibit the TOPFlash (in which the luciferase reporter has three wild-type Tcf4 binding sites) luciferase activity at the concentration of up to 200 μM. Compounds <b>55</b> and <b>56</b> suppressed the TOPFlash luciferase activities in dose-dependent manners, but did not inhibit the FOPFlash (with three mutant Tcf4 binding sites) luciferase reporter activities. However, it was noted that <b>56</b> did not show the sigmoidal curve at high concentrations. The cause of this result warrants further studies.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Wnt-responsive TOPFlash and FOPFlash luciferase reporter assay results of (<b>Et</b>)-<b>15</b> (negative control) and inhibitors <b>55</b> and <b>56</b> in β-catenin activated HEK293 cells. *<i>P</i> < 0.05, **<i>P</i> < 0.01, as determined by the unpaired, two-tailed Student <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Co-immunoprecipitation (co-IP) experiments were conducted to assess the effect of the inhibitors for disruption of the interaction between β-catenin and Tcf using SW480 cell lysates. The results are shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S5. Compound <b>53</b> can disrupt the interaction between full-length β-catenin and full-length Tcf in a dose-dependent manner after 4 h incubation with SW480 cell lysates. The effect of <b>56</b> on disruption of the β-catenin/Tcf PPI and on the selectivity between three PPIs in the cellular context was also evaluated by co-IP experiments using HCT116 cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a> Figure S5, compound <b>56</b> dose-dependently inhibited the β-catenin/Tcf PPI, but had no effect on the β-catenin/E-cadherin and β-catenin/APC PPIs at the concentrations that were sufficient to disrupt the β-catenin/Tcf PPI.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Co-IP experiments to evaluate the disruption of the β-catenin/TCF PPI by <b>53</b> in SW480 cell lysate. (B–D) Co-IP experiments to evaluate the disruption of the β-catenin/Tcf PPI by <b>56</b> and the inhibitory selectivity of <b>56</b> between β-catenin/Tcf, β-catenin/E-cadherin, and β-catenin/APC PPIs using HCT116 cells. IP, immunoprecipitation; IB, immunoblotting; input, 10% of cell lysate. Each experiment was performed in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">β-Catenin signaling induces and maintains migration, invasion, and metastasis of cancer cells, including TNBC cells.<a onclick="showRef(event, 'ref59 ref60 ref61 ref62 ref63 ref64 ref65 ref66 ref67 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref59 ref60 ref61 ref62 ref63 ref64 ref65 ref66 ref67 ref68 ref69 ref70">(59−70)</a> Scratch wound healing and Matrigel invasion assays using TNBC MDA-MB-231 cells were conducted. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, compound <b>56</b> can effectively inhibit TNBC cell migration (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A) and invasion (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B) at 10 μM. The effects are comparable with that of β-catenin/CBP inhibitor ICG-001<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> at 5 μM.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Wound-healing assays showed that <b>56</b> (10 μM) inhibited migration of human TNBC MDA-MB-231 cells induced by serum (10% in media). Control, 0.2% dimethyl sulfoxide (DMSO) in 10% fatal bovine serum (FBS). The β-catenin/CBP inhibitor ICG-001 (5 μM) was assessed in parallel. In all experiments, mitomycin (10 μg/mL) was added to inhibit cell proliferation and allow examination of the effects on cell migration. (B) Matrigel invasion assays showed that <b>56</b> (10 μM) inhibited invasion of human TNBC MDA-MB-231 cells. Control, 0.2% DMSO in 10% FBS. ICG-001 (5 μM) was assessed in parallel. **<i>P</i> < 0.01, as determined by the unpaired, two-tailed Student <i>t</i>-test. Each set of data is expressed as mean ± standard deviation (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3><div class="NLM_p">The synthetic routes for final products <b>20</b>–<b>21</b>, <b>30</b>–<b>38</b>, <b>53</b>, and <b>55–57</b> are shown in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The synthetic routes for the other final products and intermediates are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Informatio</a>n, Schemes S1–S14. The synthetic routes for <b>20</b>–<b>21</b> and <b>30</b>–<b>38</b> are shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, in which CH<sub>2</sub>Cl<sub>2</sub> was employed as the solvent for the amide coupling reactions. The amide bond coupling reaction between <i>N</i>-Cbz-<span class="smallcaps smallerCapital">l</span>-glutamic acid 5-<i>tert</i>-butyl ester and various amines generated intermediate <b>62</b>, which underwent the hydrogenation reaction to remove the Cbz-protecting group and then coupling with <i>N</i>-Cbz-<span class="smallcaps smallerCapital">l</span>-aspartic acid to yield <b>63</b>. Hydrogenation of <b>63</b> and coupling with <i>N</i>-Cbz-<span class="smallcaps smallerCapital">l</span>-2-naphthylalanine produced <b>64</b>. Removal of the Cbz-protecting group in <b>64</b> and then coupling with 5-chloroindole-2-carboxylic acid gave <b>65</b>, in which the <i>tert</i>-butyl ester-protecting group was removed by trifluoroacetic acid (TFA) in CH<sub>2</sub>Cl<sub>2</sub> solution to offer the final products.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>20</b>–<b>21</b> and <b>30</b>–<b>38</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>53</b>, <b>56</b>, and <b>57</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>55</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthetic routes for <b>53</b>, <b>56</b>, and <b>57</b> are shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, in which dimethylformamide (DMF) was used as the solvent for all the amide coupling reactions. The amide bond coupling reactions between <i>N</i>-Cbz-<span class="smallcaps smallerCapital">l</span>-glutamic acid 5-<i>tert</i>-butyl ester or <i>N</i>-Cbz-<span class="smallcaps smallerCapital">l</span>-glutamic acid 5-ethyl ester and various amines produced intermediate <b>62g</b> or <b>90</b>, which underwent the hydrogenation reaction to remove the Cbz-protecting group and then the coupling reaction with (<i>S</i>)-2-((((9<i>H</i>-fluoren-9-yl)methoxy)carbonyl)amino)-3-(2<i>H</i>-tetrazol-5-yl)propanoic acid to yield <b>91a,b</b>. Removal of the Fmoc-protecting group under the basic condition and then coupling with <b>68a,h</b> gave <b>92</b>, in which the Boc (and <i>tert</i>-butyl)-protecting group(s) was removed by TFA in CH<sub>2</sub>Cl<sub>2</sub> solution to offer the final products.</div><div class="NLM_p last">The synthetic route for <b>55</b> is shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The amide bond coupling reaction between <i>N</i>-Cbz-<span class="smallcaps smallerCapital">l</span>-glutamine and 4-(trifluoromethoxy)aniline and then the deprotection of the Cbz protecting group produced <b>95</b>, which was coupled with (<i>S</i>)-2-((((9<i>H</i>-fluoren-9-yl)methoxy)carbonyl)amino)-3-(2<i>H</i>-tetrazol-5-yl)propanoic acid to afford <b>96</b>. Removal of the Fmoc group in <b>96</b> and coupling with intermediate <b>86a</b> gave <b>97</b>. The Boc deprotection yielded final product <b>55</b>.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The β-catenin signaling pathway is frequently overactivated in many cancers and fibroses. The β-catenin/Tcf PPI represents an appealing therapeutic target to suppress this signaling pathway because the transcriptional overactivation of β-catenin signaling is dependent on the formation of the key downstream effector, the β-catenin/Tcf complex, in the cell nucleus. However, selective targeting of the β-catenin/Tcf PPI remains a great challenge. On one side, β-catenin and Tcf have a large contacting surface area and the tight binding affinity (<i>K</i><sub>d</sub> = 7–10 nM), which makes it challenging to achieve potent inhibition. On the other side, β-catenin uses the same armadillo repeats to bind Tcf, cadherin, and APC, and the crystallographic studies show that their binding mode is identical, indicating that the selectivity would be a major issue when designing β-catenin/Tcf inhibitors. In this work, the SAR studies on compound <b>1</b> has yielded inhibitors (compounds <b>53</b> and <b>57</b>) with improved activities for the β-catenin/Tcf PPI in this series. They also showed good selectivity for β-catenin/Tcf over β-catenin/E-cadherin and β-catenin/APC PPIs in the FP selectivity assay.</div><div class="NLM_p">The SAR is to study the correlation between the chemical structures of a series of derivatives and their biological activities. The SAR study has been widely used to facilitate step-by-step inhibitor optimization. Herein, extensive SAR studies on the structure of <b>1</b> were conducted. It not only yielded more potent inhibitors for the β-catenin/Tcf PPI, the SAR results obtained can also guide future inhibitor optimization. This is quite important given that no co-crystal structure of a small-molecule inhibitor with β-catenin has been reported. For instance, the study revealed the naphthyl group of <b>1</b> can only be substituted by the large hydrophobic groups. This gives us two directions to further investigate this site. One is to introduce larger moieties to examine whether the compound can further improve potency and selectivity. The other is to adopt nitrogen-containing benzoheterocyclic rings, which are large and hydrophobic enough, and at the same time might capture potential polar interactions with the protein and balance the physiochemical property of the inhibitors. This study revealed that the indole moiety was crucial for inhibitor potency. The feasible method to further optimize this substructure is to extensively modify the indole ring and the adjacent methylene group that connects indole with the amide group. In addition, the SAR results confirmed the importance of the two carboxylic acid groups, but they can be replaced by tetrazole, one of its bioisosteres, to improve the potency. This prompts us to try the other bioisosteres of carboxylic acid in the future optimization.</div><div class="NLM_p">The prodrug strategy was designed to address undesirable physicochemical properties of the drug and has been widely applied in contemporary drug design and development.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> In this work, we were interested whether this strategy could be applied to compound <b>53</b> to improve its cellular uptake because <b>53</b> has a carboxylic acid moiety, which could impair its cell permeability. Based on this hypothesis, compound <b>56</b> was synthesized. The preliminary cell-based studies indicated that <b>56</b> was indeed more potent and selective than <b>53</b> in inhibiting growth of most cancer cells with hyperactive Wnt/β-catenin signaling. Interestingly, the HPLC–MS based cell bioavailability assay<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> revealed that compound <b>56</b> did not transform into <b>53</b> after 24 h incubation with SW480 cells in 5 mL of Dulbecco’s modified Eagle’s medium (DMEM) media with 10% FBS, suggesting that <b>56</b> might not act as a prodrug of <b>53</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a> Note 2 and Figures S6–S8). Further analyses revealed that compound <b>56</b> did achieve a higher cell-bound concentration than <b>53</b>. For instance, the cell-bound concentration of <b>56</b> at 37 °C was determined to be 1.4 nmol/million SW480 cells, which is 8-fold higher than 0.17 nmol/million SW480 cells determined for <b>53</b>, for the 3 h incubation in 5 mL of DMEM media with 10% FBS, when the input concentration was set to 25 μM. The increased cell-bound concentration might explain why <b>56</b> exhibited the better cellular activity than <b>53</b>, although it showed the higher <i>K</i><sub>i</sub> value in FP assays. Further cell-based co-IP experiments indicated that compound <b>56</b> disrupted the β-catenin/Tcf PPI while leaving the β-catenin/E-cadherin and β-catenin/APC PPIs unaffected, demonstrating the selectivity of new inhibitors on the cell-based level. This compound also dose-dependently inhibited TOPFlash luciferase reporter activity without affecting FOPFlash luciferase reporter activity. In contrast, the negative control (<b>Et</b>)-<b>15</b> did not suppress Wnt specific TOPFlash luciferase reporter activity and did not inhibit growth of the cancer cells with hyperactive Wnt/β-catenin signaling.</div><div class="NLM_p last">In summary, the β-catenin/Tcf PPI has emerged as an appealing therapeutic target to suppress the overactivated β-catenin signaling for targeted cancer therapy. Extensive SAR studies were conducted based on compound <b>1</b>, which was designed to target the Tcf4 G<sup>13</sup>ANDE<sup>17</sup> binding site of β-catenin. Compounds <b>53</b> and <b>57</b> were found to disrupt the β-catenin/Tcf PPI with the <i>K</i><sub>i</sub> of 0.64 and 0.44 μM, respectively, and showed good selectivity for β-catenin/Tcf over β-catenin/E-cadherin and β-catenin/APC PPIs. Cell-based studies indicated that compound <b>56</b>, the ethyl ester derivative of <b>53</b>, disrupted the β-catenin/Tcf interaction without affecting the β-catenin/E-cadherin and β-catenin/APC interactions, dose-dependently suppressed transactivation of Wnt/β-catenin signaling, and inhibited viability, migration, and invasiveness of Wnt/β-catenin-dependent cancer cells. The extensive SAR results offered the directions for future inhibitor optimization.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78631" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78631" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemical Synthesis</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Methods, Reagents, and Materials</h4><div class="NLM_p last">All reagents were purchased from commercial sources and used without further purification unless stated otherwise. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on Bruker AVANCE III HD 500 (500 MHz) spectrometers (125.7 MHz for <sup>13</sup>C NMR spectra) in DMSO-<i>d</i><sub>6</sub>, <i>d</i><sub>6</sub>-acetone, <i>d</i><sub>4</sub>-methanol, and CDCl<sub>3</sub>. Chemical shifts were reported as values in parts per million (ppm), and the reference resonance peaks were set at 7.26 ppm (CHCl<sub>3</sub>), 3.31 ppm (CD<sub>2</sub>HOD), 2.50 ppm [(CD<sub>2</sub>H)<sub>2</sub>SO], and 2.05 ppm [(CD<sub>2</sub>H)<sub>2</sub>CO] for <sup>1</sup>H NMR spectra and 77.23 ppm (CDCl<sub>3</sub>), 49.00 ppm (CD<sub>3</sub>OD), 39.52 ppm (DMSO-<i>d</i><sub>6</sub>), and 29.84 ppm (<i>d</i><sub>6</sub>-acetone) for <sup>13</sup>C NMR spectra. Low-resolution mass spectra were determined on an Agilent 6120 single quadrupole mass spectrometer with a 1220 infinity LC system (HPLC–MS) and an ESI source. High-resolution mass spectra were determined on an Agilent G6230BA TOF LC–MS mass spectrometer with a TOF mass detector. Thin-layer chromatography (TLC) was carried out on E. Merck pre-coated silica gel 60 F254 plates with a UV–visible lamp. Column chromatography was performed with <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d083b9bcb9b3b196bcb1a3b890">[email protected]</a> F60 (230–400 mesh). The purity of final compounds <b>2</b>–<b>57</b> was determined by HPLC analyses with two different conditions (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a>). The instrument was an Agilent 1260 Infinity II HPLC system with a quaternary pump, a vial sampler, and a DAD detector. A Kromasil 300-5-C18 column (4.6 × 250 mm) was used. The DAD detector was set to 220, 254, and 280 nm. The purity of all tested compounds was >95%.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Peptide Coupling Procedure</h3><div class="NLM_p last">(a) CH<sub>2</sub>Cl<sub>2</sub> as the solvent: At 0 °C, to a suspension of carboxylic acid (1 mmol), amine (1 mmol), EDC·HCl (2 mmol), and HOAt (1.5 mmol) in 10 mL dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>) was added triethylamine (3 mmol) dropwise. The reaction mixture was warmed to room temperature and stirred overnight. After completion of the reaction, more CH<sub>2</sub>Cl<sub>2</sub> was added. The CH<sub>2</sub>Cl<sub>2</sub> phase was washed by 1 M HCl, saturated NaHCO<sub>3</sub>, and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. Column chromatography was used to purify the target compound. (b) DMF as the solvent: At 0 °C, to a suspension of carboxylic acid (1 mmol), amine (1 mmol) in 10 mL DMF were added EDC·HCl (2 mmol) and HOAt (2 mmol). The reaction mixture was warmed to room temperature and stirred overnight. The mixture was poured into water and the solid was collected. The pure compounds were obtained by recrystallization using the hexane and ethyl acetate mixture or CH<sub>2</sub>Cl<sub>2</sub>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for Deprotection of the Cbz-Protected Amines</h3><div class="NLM_p last">To the solution of the Cbz-protected amine (1 mmol) in 10 mL methanol was added 10% Pd/C (10% mmol) under Ar. The mixture was stirred overnight at room temperature under H<sub>2</sub>. The resulting product was collected by removal of the Pd/C catalyst and used directly in next step without further purification.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure for Deprotection of <i>tert</i>-Butyl Ester or Boc-Protected Indoles</h3><div class="NLM_p last">At 0 °C, to a solution of <i>tert</i>-butyl ester (1 mmol) or Boc-protected indole (1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added 5 mL TFA dropwise. The reaction was kept at 0 °C for 4 h. Upon completion, the solvent was removed under reduced pressure. TFA was completely removed by adding CH<sub>2</sub>Cl<sub>2</sub> three times to afford the desired product.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure for Deprotection of Fmoc-Protected Amines</h3><div class="NLM_p">At 0 °C, to a stirred solution of the Fmoc-protected amine (1 mmol) in dichloromethane (10 mL), diethylamine (10 mL) was added dropwise. The reaction was kept at 0 °C for 6 h until TLC showed no starting material left. Upon completion, the mixture was evaporated under reduced pressure. The diethyl amine residue was removed by adding dichloromethane at least three times. The residue was purified by a flash column, except Asn and Gln-containing compounds, which were recrystallized in dichloromethane.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i>)-4-((<i>S</i>)-3-Carboxy-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)propanamido)-5-(isopentylamino)-5-oxopentanoic Acid (<b>20</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.27 (s, 2H), 11.63 (d, <i>J</i> = 2.2 Hz, 1H), 8.80 (d, <i>J</i> = 8.5 Hz, 1H), 8.66 (d, <i>J</i> = 7.6 Hz, 1H), 7.92 (d, <i>J</i> = 8.0 Hz, 1H), 7.85 (d, <i>J</i> = 1.6 Hz, 1H), 7.83–7.73 (m, 4H), 7.70 (d, <i>J</i> = 2.1 Hz, 1H), 7.56 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.42 (pd, <i>J</i> = 6.8, 1.6 Hz, 2H), 7.36 (d, <i>J</i> = 8.7 Hz, 1H), 7.24–7.19 (m, 1H), 7.14 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 4.99–4.78 (m, 1H), 4.62 (q, <i>J</i> = 7.2 Hz, 1H), 4.21 (td, <i>J</i> = 8.3, 5.0 Hz, 1H), 3.27 (d, <i>J</i> = 3.6 Hz, 1H), 3.20–2.96 (m, 3H), 2.78 (dd, <i>J</i> = 16.6, 6.1 Hz, 1H), 2.60 (dd, <i>J</i> = 16.7, 7.4 Hz, 1H), 2.24 (dd, <i>J</i> = 9.6, 7.0 Hz, 2H), 2.05–1.89 (m, 1H), 1.84–1.69 (m, 1H), 1.55 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.29 (q, <i>J</i> = 7.2 Hz, 2H), 0.85 (d, <i>J</i> = 6.6 Hz, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.4, 172.4, 172.0, 170.9, 170.7, 161.0, 136.5, 135.2, 133.4, 133.1, 132.2, 128.5, 128.3, 127.91, 127.90, 127.84, 127.80, 126.4, 125.8, 124.6, 123.9, 121.1, 114.3, 103.3, 54.8, 52.5, 50.2, 38.4, 37.9, 37.3, 36.4, 30.5, 27.9, 25.5, 22.83, 22.80. HRMS (ESI) calcd for C<sub>36</sub>H<sub>40</sub>ClN<sub>5</sub>O<sub>8</sub> (M – H)<sup>−</sup>, 704.2487; found, 704.2492. HPLC purity 95.6%, <i>t</i><sub>R</sub> = 14.01 min (condition A2); 96.6%, <i>t</i><sub>R</sub> = 16.83 min (condition B2).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>S</i>)-4-((<i>S</i>)-3-Carboxy-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)propanamido)-5-oxo-5-(phenylamino)pentanoic Acid (<b>21</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.30 (s, 2H), 11.63 (d, <i>J</i> = 2.3 Hz, 1H), 9.86 (s, 1H), 8.81 (d, <i>J</i> = 8.5 Hz, 1H), 8.67 (d, <i>J</i> = 7.6 Hz, 1H), 8.13 (d, <i>J</i> = 7.8 Hz, 1H), 7.85 (d, <i>J</i> = 1.6 Hz, 1H), 7.83–7.75 (m, 3H), 7.70 (d, <i>J</i> = 2.1 Hz, 1H), 7.62 (d, <i>J</i> = 1.4 Hz, 1H), 7.60 (d, <i>J</i> = 1.2 Hz, 1H), 7.56 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.48–7.39 (m, 2H), 7.36 (d, <i>J</i> = 8.7 Hz, 1H), 7.33–7.27 (m, 2H), 7.21 (d, <i>J</i> = 2.0 Hz, 1H), 7.15 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.10–7.03 (m, 1H), 5.12–4.82 (m, 1H), 4.67 (td, <i>J</i> = 7.5, 6.0 Hz, 1H), 4.43 (td, <i>J</i> = 8.2, 5.0 Hz, 1H), 3.31 (d, <i>J</i> = 8.8 Hz, 1H), 3.16 (dd, <i>J</i> = 13.9, 11.0 Hz, 1H), 2.81 (dd, <i>J</i> = 16.7, 6.0 Hz, 1H), 2.63 (dd, <i>J</i> = 16.6, 7.6 Hz, 1H), 2.32 (td, <i>J</i> = 10.2, 6.2 Hz, 2H), 2.05 (ddt, <i>J</i> = 15.0, 9.9, 5.7 Hz, 1H), 1.89 (ddt, <i>J</i> = 13.6, 8.7, 4.7 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.3, 172.4, 172.1, 171.1, 170.3, 161.1, 139.1, 136.5, 135.2, 133.4, 133.1, 132.2, 129.2, 128.5, 128.3, 127.9, 127.89, 127.85, 127.7, 126.4, 125.8, 124.6, 123.99, 123.92, 121.1, 119.9, 114.3, 103.3, 54.8, 53.3, 50.2, 38.0, 36.4, 30.6, 27.8. HRMS (ESI) calcd for C<sub>37</sub>H<sub>34</sub>ClN<sub>5</sub>O<sub>8</sub> (M – H)<sup>−</sup>, 710.2018; found, 710.2024. HPLC purity 97.9%, <i>t</i><sub>R</sub> = 13.98 min (condition A2); 98.8%, <i>t</i><sub>R</sub> = 16.59 min (condition B2).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>S</i>)-4-((<i>S</i>)-3-Carboxy-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)propanamido)-5-oxo-5-((4-(trifluoromethyl)phenyl)amino)pentanoic Acid (<b>30</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.31 (s, 2H), 11.64 (s, 1H), 10.24 (s, 1H), 8.82 (d, <i>J</i> = 8.5 Hz, 1H), 8.67 (d, <i>J</i> = 7.6 Hz, 1H), 8.23 (d, <i>J</i> = 7.5 Hz, 1H), 7.98–7.74 (m, 6H), 7.74–7.59 (m, 3H), 7.56 (d, <i>J</i> = 8.4 Hz, 1H), 7.48–7.30 (m, 3H), 7.21 (s, 1H), 7.14 (d, <i>J</i> = 8.8 Hz, 1H), 4.90 (d, <i>J</i> = 8.1 Hz, 1H), 4.66 (q, <i>J</i> = 7.1 Hz, 1H), 4.42 (q, <i>J</i> = 7.1 Hz, 1H), 3.44–3.22 (m, 1H), 3.16 (t, <i>J</i> = 12.5 Hz, 1H), 2.80 (dd, <i>J</i> = 16.8, 5.9 Hz, 1H), 2.62 (dd, <i>J</i> = 16.6, 7.6 Hz, 1H), 2.33 (td, <i>J</i> = 10.2, 6.3 Hz, 2H), 2.11–2.03 (m, 1H), 1.95–1.80 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.3, 172.4, 172.0, 171.2, 171.0, 161.1, 142.7, 136.5, 135.2, 133.4, 133.1, 132.2, 128.4, 128.3, 127.9, 127.7, 126.45, 126.40, 125.8, 124.6, 123.9, 121.1, 119.8, 114.3, 103.3, 54.8, 53.6, 50.2, 38.0, 36.5, 30.6, 27.5. HRMS (ESI) calcd for C<sub>38</sub>H<sub>33</sub>ClF<sub>3</sub>N<sub>5</sub>O<sub>8</sub> (M – H)<sup>−</sup>, 778.1892; found, 778.1894. HPLC purity 95.1%, <i>t</i><sub>R</sub> = 14.58 min (condition A2); 97.5%, <i>t</i><sub>R</sub> = 17.13 min (condition B2).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i>)-4-((<i>S</i>)-3-Carboxy-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)propanamido)-5-oxo-5-((3-(trifluoromethyl)phenyl)amino)pentanoic Acid (<b>31</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.32 (s, 2H), 11.63 (s, 1H), 10.23 (s, 1H), 8.81 (d, <i>J</i> = 8.6 Hz, 1H), 8.66 (d, <i>J</i> = 7.6 Hz, 1H), 8.19 (d, <i>J</i> = 7.6 Hz, 1H), 8.12 (s, 1H), 7.93–7.73 (m, 5H), 7.70 (s, 1H), 7.55 (t, <i>J</i> = 7.7 Hz, 2H), 7.47–7.33 (m, 4H), 7.21 (s, 1H), 7.15 (d, <i>J</i> = 8.8 Hz, 1H), 4.97–4.86 (m, 1H), 4.75–4.59 (m, 1H), 4.42 (t, <i>J</i> = 7.0 Hz, 1H), 3.40–3.31 (m, 1H), 3.16 (t, <i>J</i> = 12.5 Hz, 1H), 2.80 (dd, <i>J</i> = 16.8, 5.8 Hz, 1H), 2.63 (dd, <i>J</i> = 16.7, 7.8 Hz, 1H), 2.34 (dt, <i>J</i> = 16.2, 7.7 Hz, 2H), 2.15–2.03 (m, 1H), 1.95–1.76 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.3, 172.3, 172.1, 171.2, 170.9, 161.1, 139.9, 136.5, 135.2, 133.4, 133.1, 132.2, 130.4, 128.5, 128.3, 127.9, 127.8, 127.7, 126.4, 125.8, 124.6, 123.9, 123.5, 121.1, 120.3, 115.9, 114.3, 103.3, 54.8, 53.5, 50.2, 38.0, 36.5, 30.5, 27.5. HRMS (ESI) calcd for C<sub>38</sub>H<sub>33</sub>ClF<sub>3</sub>N<sub>5</sub>O<sub>8</sub> (M – H)<sup>−</sup>, 778.1892; found, 778.1898. HPLC purity 96.5%, <i>t</i><sub>R</sub> = 14.56 min (condition A2); 96.5%, <i>t</i><sub>R</sub> = 17.11 min (condition B2).</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>S</i>)-4-((<i>S</i>)-3-Carboxy-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)propanamido)-5-((4-methoxyphenyl)amino)-5-oxopentanoic Acid (<b>32</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.31 (s, 2H), 11.63 (d, <i>J</i> = 2.2 Hz, 1H), 9.72 (s, 1H), 8.81 (d, <i>J</i> = 8.5 Hz, 1H), 8.69 (d, <i>J</i> = 7.5 Hz, 1H), 8.09 (d, <i>J</i> = 7.9 Hz, 1H), 7.93–7.73 (m, 4H), 7.70 (d, <i>J</i> = 2.1 Hz, 1H), 7.56 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.54–7.48 (m, 2H), 7.47–7.39 (m, 2H), 7.36 (d, <i>J</i> = 8.7 Hz, 1H), 7.21 (d, <i>J</i> = 2.2 Hz, 1H), 7.15 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 6.91–6.81 (m, 2H), 4.93–4.82 (m, 1H), 4.66 (q, <i>J</i> = 7.1 Hz, 1H), 4.40 (td, <i>J</i> = 8.3, 5.1 Hz, 1H), 3.71 (s, 3H), 3.30 (s, 1H), 3.16 (dd, <i>J</i> = 13.9, 11.0 Hz, 1H), 2.81 (dd, <i>J</i> = 16.6, 6.0 Hz, 1H), 2.63 (dd, <i>J</i> = 16.6, 7.6 Hz, 1H), 2.31 (dq, <i>J</i> = 16.6, 10.5 Hz, 2H), 2.11–1.99 (m, 1H), 1.87 (dq, <i>J</i> = 10.2, 5.3, 4.2 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.3, 172.4, 172.1, 171.0, 169.7, 161.1, 155.9, 136.5, 135.2, 133.4, 133.1, 132.23, 132.20, 128.5, 128.3, 127.9, 127.89, 127.85, 127.7, 126.4, 125.8, 124.6, 123.9, 121.5, 121.1, 114.3, 103.3, 55.6, 54.8, 53.2, 50.2, 38.0, 36.4, 30.5, 27.9. HRMS (ESI) calcd for C<sub>38</sub>H<sub>36</sub>ClN<sub>5</sub>O<sub>9</sub> (M – H)<sup>−</sup>, 740.2123; found, 740.2128. HPLC purity 96.1%, <i>t</i><sub>R</sub> = 13.87 min (condition A2); 95.8%, <i>t</i><sub>R</sub> = 16.47 min (condition B2).</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-4-((<i>S</i>)-3-Carboxy-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)propanamido)-5-((3-methoxyphenyl)amino)-5-oxopentanoic Acid (<b>33</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.31 (s, 2H), 11.63 (d, <i>J</i> = 2.2 Hz, 1H), 9.86 (s, 1H), 8.81 (d, <i>J</i> = 8.5 Hz, 1H), 8.68 (d, <i>J</i> = 7.5 Hz, 1H), 8.11 (d, <i>J</i> = 7.8 Hz, 1H), 7.94–7.73 (m, 4H), 7.70 (d, <i>J</i> = 2.1 Hz, 1H), 7.56 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.42 (pd, <i>J</i> = 6.9, 1.6 Hz, 2H), 7.37 (d, <i>J</i> = 8.7 Hz, 1H), 7.31 (t, <i>J</i> = 2.2 Hz, 1H), 7.25–7.18 (m, 2H), 7.17–7.10 (m, 2H), 6.65 (dd, <i>J</i> = 8.2, 2.5 Hz, 1H), 4.91 (ddd, <i>J</i> = 11.8, 8.6, 3.7 Hz, 1H), 4.67 (q, <i>J</i> = 7.1 Hz, 1H), 4.41 (td, <i>J</i> = 8.3, 5.1 Hz, 1H), 3.71 (s, 3H), 3.32 (s, 1H), 3.17 (dd, <i>J</i> = 13.9, 11.0 Hz, 1H), 2.81 (dd, <i>J</i> = 16.7, 5.9 Hz, 1H), 2.63 (dd, <i>J</i> = 16.7, 7.7 Hz, 1H), 2.31 (dq, <i>J</i> = 16.6, 10.4 Hz, 2H), 2.14–1.91 (m, 1H), 1.88 (dq, <i>J</i> = 10.3, 5.3, 4.3 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.3, 172.3, 172.1, 171.1, 170.3, 161.1, 159.9, 140.3, 136.5, 135.2, 133.4, 133.1, 132.2, 130.0, 128.5, 128.3, 127.9, 127.8, 127.7, 126.4, 125.8, 124.6, 123.9, 121.1, 114.3, 112.2, 109.5, 105.7, 103.3, 55.4, 54.9, 53.4, 50.2, 38.0, 36.4, 30.5, 27.8. HRMS (ESI) calcd for C<sub>38</sub>H<sub>36</sub>ClN<sub>5</sub>O<sub>9</sub> (M – H)<sup>−</sup>, 740.2123; found, 740.2127. HPLC purity 95.3%, <i>t</i><sub>R</sub> = 14.00 min (condition A2); 97.0%, <i>t</i><sub>R</sub> = 16.60 min (condition B2).</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>S</i>)-4-((<i>S</i>)-3-Carboxy-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)propanamido)-5-oxo-5-((4-(trifluoromethoxy)phenyl)amino)pentanoic Acid (<b>34</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.30 (s, 2H), 11.64 (s, 1H), 10.07 (s, 1H), 8.82 (d, <i>J</i> = 8.5 Hz, 1H), 8.67 (d, <i>J</i> = 7.5 Hz, 1H), 8.19 (d, <i>J</i> = 7.7 Hz, 1H), 7.97–7.65 (m, 7H), 7.56 (d, <i>J</i> = 8.4 Hz, 1H), 7.50–7.26 (m, 5H), 7.23–7.01 (m, 2H), 4.91 (ddd, <i>J</i> = 11.9, 8.4, 3.7 Hz, 1H), 4.66 (q, <i>J</i> = 7.1 Hz, 1H), 4.40 (td, <i>J</i> = 8.1, 5.0 Hz, 1H), 3.31 (s, 1H), 3.16 (dd, <i>J</i> = 13.9, 10.9 Hz, 1H), 2.80 (dd, <i>J</i> = 16.7, 6.0 Hz, 1H), 2.62 (dd, <i>J</i> = 16.6, 7.5 Hz, 1H), 2.32 (pd, <i>J</i> = 10.1, 3.2 Hz, 2H), 2.05 (ddt, <i>J</i> = 15.0, 11.1, 5.8 Hz, 1H), 1.89 (dt, <i>J</i> = 14.5, 4.3 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.3, 172.4, 172.1, 171.2, 170.5, 161.1, 138.3, 136.5, 135.2, 133.4, 133.1, 132.2, 128.5, 128.3, 127.9, 127.88, 127.85, 127.7, 126.4, 125.8, 124.6, 123.9, 122.1, 121.3, 121.1, 114.3, 103.3, 54.8, 53.4, 50.2, 38.0, 36.5, 30.5, 27.6. HRMS (ESI) calcd for C<sub>38</sub>H<sub>33</sub>ClF<sub>3</sub>N<sub>5</sub>O<sub>9</sub> (M – H)<sup>−</sup>, 794.1841; found, 794.1846. HPLC purity 100%, <i>t</i><sub>R</sub> = 10.24 min (condition A1); 100%, <i>t</i><sub>R</sub> = 12.59 min (condition B1).</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>S</i>)-4-((<i>S</i>)-3-Carboxy-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)propanamido)-5-oxo-5-((3-(trifluoromethoxy)phenyl)amino)pentanoic Acid (<b>35</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.30 (s, 2H), 11.62 (d, <i>J</i> = 2.2 Hz, 1H), 10.16 (s, 1H), 8.80 (d, <i>J</i> = 8.5 Hz, 1H), 8.66 (d, <i>J</i> = 7.5 Hz, 1H), 8.16 (d, <i>J</i> = 7.6 Hz, 1H), 7.97–7.76 (m, 5H), 7.70 (d, <i>J</i> = 2.1 Hz, 1H), 7.55 (ddd, <i>J</i> = 10.6, 8.3, 1.8 Hz, 2H), 7.48–7.34 (m, 4H), 7.21 (d, <i>J</i> = 2.2 Hz, 1H), 7.15 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.05 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 4.91 (ddd, <i>J</i> = 11.8, 8.6, 3.7 Hz, 1H), 4.67 (td, <i>J</i> = 7.6, 5.7 Hz, 1H), 4.41 (td, <i>J</i> = 8.3, 5.2 Hz, 1H), 3.46–3.27 (m, 1H), 3.16 (dd, <i>J</i> = 13.9, 10.9 Hz, 1H), 2.81 (dd, <i>J</i> = 16.7, 5.8 Hz, 1H), 2.63 (dd, <i>J</i> = 16.7, 7.8 Hz, 1H), 2.39–2.24 (m, 2H), 2.05 (td, <i>J</i> = 8.8, 4.5 Hz, 1H), 1.90 (ddt, <i>J</i> = 13.5, 8.7, 4.7 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.2, 172.3, 172.1, 171.2, 170.8, 161.1, 148.9, 140.7, 136.5, 135.2, 133.4, 133.1, 132.2, 130.9, 128.5, 128.3, 127.9, 127.87, 127.84, 127.7, 126.4, 125.8, 124.6, 123.9, 121.5, 121.1, 119.5, 118.5, 116.0, 114.3, 112.0, 103.3, 54.8, 53.5, 50.2, 38.0, 36.4, 30.5, 27.5. HRMS (ESI) calcd for C<sub>38</sub>H<sub>33</sub>ClF<sub>3</sub>N<sub>5</sub>O<sub>9</sub> (M – H)<sup>−</sup>, 794.1841; found, 794.1854. HPLC purity 98.2%, <i>t</i><sub>R</sub> = 14.67 min (condition A2); 100%, <i>t</i><sub>R</sub> = 17.23 min (condition B2).</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>S</i>)-4-((<i>S</i>)-3-Carboxy-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)propanamido)-5-((3,5-dimethoxyphenyl)amino)-5-oxopentanoic Acid (<b>36</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.30 (s, 2H), 11.62 (d, <i>J</i> = 2.2 Hz, 1H), 9.84 (s, 1H), 8.81 (d, <i>J</i> = 8.5 Hz, 1H), 8.68 (d, <i>J</i> = 7.5 Hz, 1H), 8.08 (d, <i>J</i> = 7.8 Hz, 1H), 7.94–7.74 (m, 4H), 7.70 (d, <i>J</i> = 2.0 Hz, 1H), 7.56 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.49–7.32 (m, 3H), 7.21 (dd, <i>J</i> = 2.1, 0.9 Hz, 1H), 7.15 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 6.87 (d, <i>J</i> = 2.3 Hz, 2H), 6.23 (t, <i>J</i> = 2.3 Hz, 1H), 5.01–4.83 (m, 1H), 4.66 (td, <i>J</i> = 7.6, 5.8 Hz, 1H), 4.40 (td, <i>J</i> = 8.3, 5.1 Hz, 1H), 3.70 (s, 6H), 3.30 (d, <i>J</i> = 3.7 Hz, 1H), 3.17 (dd, <i>J</i> = 13.9, 11.0 Hz, 1H), 2.80 (dd, <i>J</i> = 16.7, 5.8 Hz, 1H), 2.63 (dd, <i>J</i> = 16.7, 7.8 Hz, 1H), 2.38–2.23 (m, 2H), 2.11–1.96 (m, 1H), 1.87 (ddt, <i>J</i> = 13.6, 8.7, 4.8 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.3, 172.3, 172.1, 171.0, 170.3, 161.1, 160.9, 140.7, 136.5, 135.2, 133.4, 133.0, 132.2, 128.5, 128.3, 127.9, 127.88, 127.85, 127.7, 126.4, 125.8, 124.6, 123.9, 121.1, 114.3, 103.4, 98.2, 96.0, 55.5, 54.9, 53.4, 50.2, 38.0, 36.4, 30.5, 27.8. HRMS (ESI) calcd for C<sub>39</sub>H<sub>38</sub>ClN<sub>5</sub>O<sub>10</sub> (M – H)<sup>−</sup>, 770.2229; found, 770.2237. HPLC purity 98.1%, <i>t</i><sub>R</sub> = 14.08 min (condition A2); 97.6%, <i>t</i><sub>R</sub> = 16.69 min (condition B2).</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-4-((<i>S</i>)-3-Carboxy-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)propanamido)-5-((3-methoxy-5-(trifluoromethyl)phenyl)amino)-5-oxopentanoic Acid (<b>37</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.30 (s, 2H), 11.62 (s, 1H), 10.19 (s, 1H), 8.80 (d, <i>J</i> = 8.5 Hz, 1H), 8.66 (d, <i>J</i> = 7.6 Hz, 1H), 8.16 (d, <i>J</i> = 7.6 Hz, 1H), 7.92–7.75 (m, 4H), 7.74–7.68 (m, 1H), 7.66 (s, 1H), 7.55 (s, 1H), 7.51–7.35 (m, 4H), 7.31–7.19 (m, 1H), 7.15 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 6.95 (s, 1H), 4.99–4.82 (m, 1H), 4.67 (q, <i>J</i> = 7.1 Hz, 1H), 4.40 (q, <i>J</i> = 7.3 Hz, 1H), 3.80 (s, 3H), 3.42–3.28 (m, 1H), 3.25–3.05 (m, 1H), 2.81 (dd, <i>J</i> = 16.7, 5.7 Hz, 1H), 2.63 (dd, <i>J</i> = 16.6, 7.9 Hz, 1H), 2.33 (td, <i>J</i> = 9.9, 6.3 Hz, 2H), 2.06 (td, <i>J</i> = 11.2, 8.9, 5.3 Hz, 1H), 2.00–1.83 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.2, 172.3, 172.1, 171.2, 170.9, 161.1, 160.4, 141.1, 136.5, 135.2, 133.4, 133.0, 132.2, 130.9 (d, <i>J</i> = 31.8 Hz), 128.5, 128.3, 127.9, 127.87, 127.86, 127.7, 126.4, 125.8, 125.4, 124.6, 123.9, 123.3, 121.1, 114.3, 108.9, 108.4, 105.9, 103.4, 56.1, 54.9, 53.6, 50.2, 37.9, 36.4, 30.5, 27.5. HRMS (ESI) calcd for C<sub>39</sub>H<sub>35</sub>ClF<sub>3</sub>N<sub>5</sub>O<sub>9</sub> (M – H)<sup>−</sup>, 808.1997; found, 808.2004. HPLC purity 99.6%, <i>t</i><sub>R</sub> = 14.68 min (condition A2); 98.3%, <i>t</i><sub>R</sub> = 17.28 min (condition B2).</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>S</i>)-5-(Benzo[<i>d</i>][1,3]dioxol-5-ylamino)-4-((<i>S</i>)-3-carboxy-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)propanamido)-5-oxopentanoic Acid (<b>38</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.30 (s, 2H), 11.62 (s, 1H), 9.76 (s, 1H), 8.80 (d, <i>J</i> = 8.4 Hz, 1H), 8.67 (d, <i>J</i> = 7.5 Hz, 1H), 8.09 (d, <i>J</i> = 7.7 Hz, 1H), 7.93–7.74 (m, 4H), 7.70 (s, 1H), 7.56 (d, <i>J</i> = 8.4 Hz, 1H), 7.42 (p, <i>J</i> = 6.9 Hz, 2H), 7.37 (d, <i>J</i> = 8.7 Hz, 1H), 7.29 (s, 1H), 7.21 (s, 1H), 7.15 (d, <i>J</i> = 8.8 Hz, 1H), 7.00 (d, <i>J</i> = 8.4 Hz, 1H), 6.84 (d, <i>J</i> = 8.3 Hz, 1H), 5.98 (s, 2H), 5.00–4.79 (m, 1H), 4.66 (q, <i>J</i> = 7.1 Hz, 1H), 4.38 (q, <i>J</i> = 7.4 Hz, 1H), 3.31 (s, 1H), 3.16 (t, <i>J</i> = 12.5 Hz, 1H), 2.81 (dd, <i>J</i> = 16.8, 6.0 Hz, 1H), 2.63 (dd, <i>J</i> = 16.7, 7.5 Hz, 1H), 2.39–2.21 (m, 2H), 2.10–1.95 (m, 1H), 1.87 (dt, <i>J</i> = 15.3, 7.8 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.3, 172.4, 172.1, 171.0, 169.9, 161.1, 147.5, 143.6, 136.5, 135.2, 133.4, 133.3, 133.1, 132.2, 128.5, 128.3, 127.9, 127.88, 127.85, 127.7, 126.4, 125.8, 124.6, 123.9, 121.1, 114.3, 112.8, 108.5, 103.3, 102.1, 101.4, 54.8, 53.2, 50.2, 38.0, 36.4, 30.5, 27.8. HRMS (ESI) calcd for C<sub>38</sub>H<sub>34</sub>ClN<sub>5</sub>O<sub>10</sub> (M – H) 754.1916; found, 754.1924. HPLC purity 98.6%, <i>t</i><sub>R</sub> = 13.83 min (condition A2); 96.1%, <i>t</i><sub>R</sub> = 16.39 min (condition B2).</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>S</i>)-4-((<i>S</i>)-2-((<i>S</i>)-2-(5-Chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-3-(2<i>H</i>-tetrazol-5-yl)propanamido)-5-oxo-5-((4-(trifluoromethoxy)phenyl)amino)pentanoic Acid (<b>53</b>)</h4><div class="NLM_p last">Yield, 82%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.14 (s, 1H), 11.69–11.53 (m, 1H), 10.25 (s, 1H), 8.79 (d, <i>J</i> = 8.3 Hz, 1H), 8.69 (d, <i>J</i> = 7.5 Hz, 1H), 8.31 (d, <i>J</i> = 7.4 Hz, 1H), 7.90–7.64 (m, 8H), 7.53 (d, <i>J</i> = 8.4 Hz, 1H), 7.49–7.26 (m, 5H), 7.25–7.09 (m, 2H), 4.94–4.73 (m, 2H), 4.40 (td, <i>J</i> = 8.0, 5.1 Hz, 1H), 3.56–3.41 (m, 2H), 3.14 (dd, <i>J</i> = 13.9, 10.8 Hz, 2H), 2.39–2.22 (m, 2H), 2.04 (ddt, <i>J</i> = 15.1, 10.6, 5.7 Hz, 1H), 1.89 (dtd, <i>J</i> = 14.5, 9.0, 5.8 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.2, 172.1, 170.5, 170.4, 161.2, 144.3, 138.2, 136.3, 135.3, 133.4, 133.0, 132.2, 128.4, 128.2, 127.9, 127.8, 126.4, 125.8, 124.7, 124.0, 122.0, 121.5, 121.1, 114.3, 103.4, 55.0, 53.6, 51.7, 37.8, 30.5, 27.6. HRMS (ESI) calcd for C<sub>38</sub>H<sub>33</sub>ClF<sub>3</sub>N<sub>9</sub>O<sub>7</sub> (M – H)<sup>−</sup>, 818.2065; found, 818.2065. HPLC purity 98.5%, <i>t</i><sub>R</sub> = 10.44 min (condition A1); 100%, <i>t</i><sub>R</sub> = 12.85 min (condition B1).</div></div><div id="sec4_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>S</i>)-2-((<i>S</i>)-2-((<i>S</i>)-2-(5-Chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-3-(2<i>H</i>-tetrazol-5-yl)propanamido)-<i>N</i><sup>1</sup>-(4-(trifluoromethoxy)phenyl)pentanediamide (<b>55</b>)</h4><div class="NLM_p last">Yield, 75%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.65 (s, 1H), 10.27 (s, 1H), 8.81 (d, <i>J</i> = 8.1 Hz, 1H), 8.65 (d, <i>J</i> = 7.5 Hz, 1H), 8.29 (d, <i>J</i> = 7.1 Hz, 1H), 7.97–7.66 (m, 7H), 7.52 (d, <i>J</i> = 8.4 Hz, 1H), 7.49–7.26 (m, 6H), 7.21–7.07 (m, 2H), 6.85 (s, 1H), 4.83 (ddd, <i>J</i> = 21.3, 12.4, 5.4 Hz, 2H), 4.35 (q, <i>J</i> = 7.0 Hz, 1H), 3.44 (dd, <i>J</i> = 15.3, 6.0 Hz, 1H), 3.39–3.22 (m, 2H), 3.15 (dd, <i>J</i> = 13.9, 10.7 Hz, 1H), 2.18 (t, <i>J</i> = 8.0 Hz, 2H), 2.01 (p, <i>J</i> = 7.6 Hz, 1H), 1.92 (dq, <i>J</i> = 15.2, 8.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.1, 172.1, 170.7, 170.3, 161.3, 144.2, 138.3, 136.4, 135.3, 133.4, 132.9, 132.2, 128.4, 128.2, 127.9, 127.8, 127.7, 126.4, 125.9, 124.7, 124.0, 122.0, 121.4, 121.1, 120.6 (d, <i>J</i> = 255.0 Hz), 114.3, 103.4, 55.2, 54.0, 51.8, 37.7, 31.7, 28.1, 26.2. HRMS (ESI) calcd for C<sub>38</sub>H<sub>34</sub>ClF<sub>3</sub>N<sub>10</sub>O<sub>6</sub> (M – H)<sup>−</sup>, 817.2225; found, 817.2226. HPLC purity 98.3%, <i>t</i><sub>R</sub> = 14.29 min (condition A2); 100%, <i>t</i><sub>R</sub> = 12.78 min (condition B1).</div></div><div id="sec4_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Ethyl (<i>S</i>)-4-((<i>S</i>)-2-((<i>S</i>)-2-(5-Chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-3-(2<i>H</i>-tetrazol-5-yl)propanamido)-5-oxo-5-((4-(trifluoromethoxy)phenyl)amino)pentanoate (<b>56</b>)</h4><div class="NLM_p last">Yield, 67%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.76–11.50 (m, 1H), 10.26–10.22 (m, 1H), 8.91–8.63 (m, 2H), 8.37–8.33 (m, 1H), 8.01–7.61 (m, 7H), 7.55–7.25 (m, 6H), 7.23–7.05 (m, 2H), 4.85 (ddt, <i>J</i> = 29.7, 14.3, 5.9 Hz, 2H), 4.41 (tt, <i>J</i> = 8.7, 4.5 Hz, 1H), 4.13–3.86 (m, 2H), 3.62–2.91 (m, 4H), 2.38 (qd, <i>J</i> = 9.9, 9.3, 4.4 Hz, 2H), 2.07 (td, <i>J</i> = 8.7, 4.8 Hz, 1H), 1.91 (dtd, <i>J</i> = 14.3, 8.9, 5.8 Hz, 1H), 1.08 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.6, 172.1, 170.4, 161.2, 144.3, 138.2, 136.3, 135.3, 133.4, 133.0, 132.2, 128.4, 128.2, 127.9, 127.7, 126.4, 125.9, 124.7, 124.0, 122.0, 121.5, 121.4, 121.1, 119.6, 114.3, 103.4, 60.4, 55.0, 53.4, 51.7, 37.8, 30.4, 27.5, 14.4. HRMS (ESI) calcd for C<sub>40</sub>H<sub>37</sub>ClF<sub>3</sub>N<sub>9</sub>O<sub>7</sub> (M – H)<sup>−</sup>, 846.2378; found, 846.2375. HPLC purity 98.8%, <i>t</i><sub>R</sub> = 11.13 min (condition A1); 98.7%, <i>t</i><sub>R</sub> = 13.32 min (condition B1).</div></div><div id="sec4_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>S</i>)-4-((<i>S</i>)-2-((<i>S</i>)-2-(4,6-Dichloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-3-(2<i>H</i>-tetrazol-5-yl)propanamido)-5-oxo-5-((4-(trifluoromethoxy)phenyl)amino)pentanoic Acid (<b>57</b>)</h4><div class="NLM_p last">Yield, 83%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.90 (d, <i>J</i> = 36.1 Hz, 1H), 10.23 (d, <i>J</i> = 28.1 Hz, 1H), 8.95 (t, <i>J</i> = 7.8 Hz, 1H), 8.73 (dd, <i>J</i> = 28.2, 7.8 Hz, 1H), 8.35 (dd, <i>J</i> = 42.8, 7.3 Hz, 1H), 7.92–7.64 (m, 6H), 7.59–7.16 (m, 8H), 5.00–4.76 (m, 2H), 4.40 (p, <i>J</i> = 7.0 Hz, 1H), 3.31–2.97 (m, 4H), 2.33 (ttd, <i>J</i> = 16.5, 12.7, 9.8, 6.1 Hz, 2H), 2.06 (dt, <i>J</i> = 13.7, 6.2 Hz, 1H), 2.00–1.81 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.25, 174.22, 172.0, 171.8, 170.5, 170.4, 170.3, 160.7, 144.3, 138.2, 137.24, 137.20, 136.37, 136.34, 133.4, 133.2, 132.2, 128.25, 128.21, 127.9, 127.8, 127.7, 126.8, 126.4, 125.9, 125.1, 122.0, 121.9, 121.6, 121.5, 121.4, 119.9, 119.6, 111.5, 102.0, 55.0, 54.9, 53.7, 53.6, 51.7, 51.6, 37.8, 30.6, 30.5, 27.6, 27.5, 26.2. HRMS (ESI) calcd for C<sub>38</sub>H<sub>32</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>9</sub>O<sub>7</sub> (M – H)<sup>−</sup> 852.1676; found, 852.1686. HPLC purity 99.0%, <i>t</i><sub>R</sub> = 10.93 min (condition A1); 100%, <i>t</i><sub>R</sub> = 13.60 min (condition B1).</div></div><div id="sec4_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>tert</i>-Butyl (<i>S</i>)-4-(((Benzyloxy)carbonyl)amino)-5-(isopentylamino)-5-oxopentanoate (<b>62a</b>)</h4><div class="NLM_p last">Yield, 87%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 7.41–7.27 (m, 5H), 6.35 (t, <i>J</i> = 5.8 Hz, 1H), 5.76 (d, <i>J</i> = 7.9 Hz, 1H), 5.08 (s, 2H), 4.17 (q, <i>J</i> = 7.4 Hz, 1H), 3.30–3.16 (m, 2H), 2.40 (dt, <i>J</i> = 16.5, 7.1 Hz, 1H), 2.28 (dt, <i>J</i> = 16.6, 7.0 Hz, 1H), 2.05 (dtd, <i>J</i> = 14.3, 7.2, 5.5 Hz, 1H), 1.91 (dt, <i>J</i> = 14.4, 7.3 Hz, 1H), 1.66–1.51 (m, 1H), 1.43 (s, 11H), 0.89 (d, <i>J</i> = 6.6 Hz, 6H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.8, 171.0, 156.2, 136.2, 128.5, 128.2, 128.0, 81.0, 67.0, 54.4, 38.3, 37.9, 31.7, 28.2, 28.1, 25.8, 22.4 (d, <i>J</i> = 2.8 Hz). MS (ESI) <i>m</i>/<i>z</i>: 407.3 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 429.2 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>tert</i>-Butyl (<i>S</i>)-4-(((Benzyloxy)carbonyl)amino)-5-oxo-5-(phenylamino)pentanoate (<b>62b</b>)</h4><div class="NLM_p last">Yield, 82%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.60 (s, 1H), 7.42 (d, <i>J</i> = 8.0 Hz, 2H), 7.30–7.13 (m, 7H), 7.08–6.86 (m, 1H), 5.88 (d, <i>J</i> = 7.8 Hz, 1H), 5.11–4.94 (m, 2H), 4.32 (d, <i>J</i> = 6.9 Hz, 1H), 2.41 (dd, <i>J</i> = 16.5, 7.2 Hz, 1H), 2.29 (dt, <i>J</i> = 16.7, 6.9 Hz, 1H), 2.17–2.01 (m, 1H), 2.01–1.86 (m, 1H), 1.36 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.1, 169.7, 156.6, 137.6, 136.1, 128.9, 128.5, 128.2, 128.0, 124.5, 120.0, 81.3, 67.2, 55.0, 53.5, 31.9, 28.1. MS (ESI) <i>m</i>/<i>z</i>: 435.2 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>tert</i>-Butyl (<i>S</i>)-4-(((Benzyloxy)carbonyl)amino)-5-oxo-5-((4-(trifluoromethyl)phenyl)amino)pentanoate (<b>62c</b>)</h4><div class="NLM_p last">Yield, 79%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 9.01 (s, 1H), 7.48 (d, <i>J</i> = 8.4 Hz, 2H), 7.39 (d, <i>J</i> = 8.4 Hz, 2H), 7.23 (q, <i>J</i> = 4.1 Hz, 5H), 5.93 (d, <i>J</i> = 7.7 Hz, 1H), 5.14–4.94 (m, 2H), 4.32 (d, <i>J</i> = 7.0 Hz, 1H), 2.44 (dt, <i>J</i> = 16.5, 7.0 Hz, 1H), 2.32–2.24 (m, 1H), 2.08 (ddt, <i>J</i> = 13.8, 7.8, 6.0 Hz, 1H), 1.96–1.82 (m, 1H), 1.36 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.1, 170.2, 156.8, 140.7, 136.0, 128.6, 128.3, 128.0, 126.1 (d, <i>J</i> = 3.7 Hz), 125.9, 124.0 (d, <i>J</i> = 271.5 Hz), 119.4, 81.5, 67.4, 55.2, 31.9, 28.0, 27.8. MS (ESI) <i>m</i>/<i>z</i>: 503.2 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>tert</i>-Butyl (<i>S</i>)-4-(((Benzyloxy)carbonyl)amino)-5-oxo-5-((3-(trifluoromethyl)phenyl)amino)pentanoate (<b>62d</b>)</h4><div class="NLM_p last">Yield, 80%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 9.23 (s, 1H), 7.87 (s, 1H), 7.58 (s, 1H), 7.30 (t, <i>J</i> = 6.2 Hz, 7H), 6.23 (d, <i>J</i> = 12.1 Hz, 1H), 5.10 (q, <i>J</i> = 12.4 Hz, 2H), 4.48 (d, <i>J</i> = 9.3 Hz, 1H), 2.51–2.30 (m, 2H), 2.17 (p, <i>J</i> = 7.4 Hz, 1H), 2.09–1.94 (m, 1H), 1.43 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.8, 170.4, 156.9, 138.3 (d, <i>J</i> = 2.5 Hz), 136.0, 131.2 (q, <i>J</i> = 32.1 Hz), 129.4, 128.5, 128.2, 127.9, 123.8 (q, <i>J</i> = 271.2 Hz), 122.8, 120.8, 116.5 (d, <i>J</i> = 4.1 Hz), 81.3, 67.3, 55.1, 31.7, 28.0, 27.8. MS (ESI) <i>m</i>/<i>z</i>: 503.2 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>tert</i>-Butyl (<i>S</i>)-4-(((Benzyloxy)carbonyl)amino)-5-((4-methoxyphenyl)amino)-5-oxopentanoate (<b>62e</b>)</h4><div class="NLM_p last">Yield, 85%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.48 (s, 1H), 7.39 (d, <i>J</i> = 8.5 Hz, 2H), 7.35–7.28 (m, 5H), 6.90–6.73 (m, 2H), 5.92 (d, <i>J</i> = 7.8 Hz, 1H), 5.29–4.96 (m, 2H), 4.49–4.25 (m, 1H), 3.77 (s, 3H), 2.58–2.42 (m, 1H), 2.36 (dt, <i>J</i> = 16.6, 6.9 Hz, 1H), 2.15 (dq, <i>J</i> = 13.4, 6.3 Hz, 1H), 2.06–1.93 (m, 1H), 1.45 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.1, 169.4, 156.5, 136.1, 130.7, 128.5, 128.2, 128.0, 121.7, 114.1, 81.2, 67.2, 55.5, 54.9, 31.9, 28.2, 28.1. MS (ESI) <i>m</i>/<i>z</i>: 443.1 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 465.2 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>tert</i>-Butyl (<i>S</i>)-4-(((Benzyloxy)carbonyl)amino)-5-((3-methoxyphenyl)amino)-5-oxopentanoate (<b>62f</b>)</h4><div class="NLM_p last">Yield, 87%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.75 (s, 1H), 7.28–7.14 (m, 6H), 7.05 (t, <i>J</i> = 8.1 Hz, 1H), 6.96–6.74 (m, 1H), 6.54 (dd, <i>J</i> = 8.3, 2.5 Hz, 1H), 5.98 (d, <i>J</i> = 8.2 Hz, 1H), 5.05–4.89 (m, 2H), 4.33 (d, <i>J</i> = 8.4 Hz, 1H), 3.64 (s, 3H), 2.44–2.33 (m, 1H), 2.28 (dt, <i>J</i> = 16.8, 7.0 Hz, 1H), 2.10–2.04 (m, 1H), 1.96–1.83 (m, 1H), 1.34 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.9, 169.9, 160.1, 156.6, 138.9, 136.1, 129.6, 128.5, 128.2, 128.0, 112.1, 110.5, 105.5, 81.1, 67.2, 55.2, 55.1, 38.6, 31.8, 28.1. MS (ESI) <i>m</i>/<i>z</i>: 465.2 [M + Na]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 907.4 [2M + Na]<sup>+</sup>.</div></div><div id="sec4_5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>tert</i>-Butyl (<i>S</i>)-4-(((Benzyloxy)carbonyl)amino)-5-oxo-5-((4-(trifluoromethoxy)phenyl)amino)pentanoate (<b>62g</b>)</h4><div class="NLM_p last">Yield, 82%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.97 (s, 1H), 7.75–7.40 (m, 2H), 7.31 (d, <i>J</i> = 4.1 Hz, 5H), 7.09 (d, <i>J</i> = 8.6 Hz, 2H), 6.03 (d, <i>J</i> = 7.8 Hz, 1H), 5.10 (d, <i>J</i> = 5.2 Hz, 2H), 4.39 (t, <i>J</i> = 7.2 Hz, 1H), 2.50 (dt, <i>J</i> = 16.6, 7.1 Hz, 1H), 2.38 (dt, <i>J</i> = 16.8, 6.8 Hz, 1H), 2.15 (ddt, <i>J</i> = 13.9, 7.4, 5.9 Hz, 1H), 2.02 (dt, <i>J</i> = 14.4, 7.2 Hz, 1H), 1.44 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.1, 169.9, 156.7, 145.3, 136.3, 136.0, 128.6, 128.3, 128.0, 121.6, 121.0, 120.5 (q, <i>J</i> = 190 Hz), 81.4, 67.3, 55.1, 31.8, 28.0, 27.9. MS (ESI) <i>m</i>/<i>z</i>: 519.2 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>tert</i>-Butyl (<i>S</i>)-4-(((Benzyloxy)carbonyl)amino)-5-oxo-5-((3-(trifluoromethoxy)phenyl)amino)pentanoate (<b>62h</b>)</h4><div class="NLM_p last">Yield, 80%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 9.10 (s, 1H), 7.50 (s, 1H), 7.24–7.13 (m, 6H), 7.09 (t, <i>J</i> = 8.2 Hz, 1H), 6.80 (d, <i>J</i> = 8.2 Hz, 1H), 6.10 (d, <i>J</i> = 7.9 Hz, 1H), 4.98 (q, <i>J</i> = 12.3 Hz, 2H), 4.34 (t, <i>J</i> = 7.3 Hz, 1H), 2.36 (dt, <i>J</i> = 16.7, 7.3 Hz, 1H), 2.28 (dt, <i>J</i> = 16.8, 6.9 Hz, 1H), 2.06 (dtd, <i>J</i> = 14.5, 7.2, 5.5 Hz, 1H), 1.97–1.85 (m, 1H), 1.33 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.9, 170.3, 156.8, 149.4 (d, <i>J</i> = 1.9 Hz), 139.2, 136.0, 129.8, 128.5, 128.2, 127.9, 120.4 (d, <i>J</i> = 257.2 Hz), 117.9, 116.3, 112.6, 81.3, 67.3, 55.1, 31.7, 28.0, 27.8. MS (ESI) <i>m</i>/<i>z</i>: 519.2 [M + Na]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 495.3 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>tert</i>-Butyl (<i>S</i>)-4-(((Benzyloxy)carbonyl)amino)-5-((3,5-dimethoxyphenyl)amino)-5-oxopentanoate (<b>62i</b>)</h4><div class="NLM_p last">Yield, 85%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.62 (s, 1H), 7.33 (d, <i>J</i> = 4.0 Hz, 5H), 6.77 (d, <i>J</i> = 2.3 Hz, 2H), 6.23 (t, <i>J</i> = 2.2 Hz, 1H), 5.88 (d, <i>J</i> = 7.7 Hz, 1H), 5.27–4.84 (m, 2H), 4.55–4.22 (m, 1H), 3.75 (s, 6H), 2.51 (dt, <i>J</i> = 14.7, 6.8 Hz, 1H), 2.42–2.31 (m, 1H), 2.15 (ddt, <i>J</i> = 13.8, 7.5, 6.0 Hz, 1H), 2.01 (dt, <i>J</i> = 14.4, 7.2 Hz, 1H), 1.45 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.1, 169.7, 161.0, 156.6, 139.3, 136.0, 128.5, 128.2, 128.0, 98.1, 97.0, 81.3, 67.2, 55.4, 55.1, 31.9, 28.1. MS (ESI) <i>m</i>/<i>z</i>: 473.3 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 495.3 [M + Na]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 967.4 [2M + Na]<sup>+</sup>.</div></div><div id="sec4_5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>tert</i>-Butyl (<i>S</i>)-4-(((Benzyloxy)carbonyl)amino)-5-((3-methoxy-5-(trifluoromethyl)phenyl)amino)-5-oxopentanoate (<b>62j</b>)</h4><div class="NLM_p last">Yield, 81%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 9.06 (s, 1H), 7.39–7.11 (m, 7H), 6.72 (s, 1H), 6.02 (d, <i>J</i> = 7.8 Hz, 1H), 5.01 (q, <i>J</i> = 12.2 Hz, 2H), 4.34 (d, <i>J</i> = 7.1 Hz, 1H), 3.65 (s, 3H), 2.49–2.34 (m, 1H), 2.29 (dt, <i>J</i> = 16.7, 6.9 Hz, 1H), 2.11–2.00 (m, 1H), 2.02–1.88 (m, 1H), 1.34 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.9, 170.3, 160.2, 156.8, 139.5, 135.9, 131.9 (q, <i>J</i> = 32.6 Hz), 128.5, 128.3, 128.0, 123.7 (q, <i>J</i> = 272.5 Hz), 108.7, 108.3, 106.9 (d, <i>J</i> = 4.0 Hz), 81.3, 67.4, 55.5, 55.2, 31.7, 28.0, 27.8. MS (ESI) <i>m</i>/<i>z</i>: 533.2 [M + Na]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 509.2 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>tert</i>-Butyl (<i>S</i>)-5-(Benzo[<i>d</i>][1,3]dioxol-5-ylamino)-4-(((benzyloxy)carbonyl)amino)-5-oxopentanoate (<b>62k</b>)</h4><div class="NLM_p last">Yield, 85%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.75 (s, 1H), 7.27–7.13 (m, 5H), 7.07 (d, <i>J</i> = 2.2 Hz, 1H), 6.65 (dd, <i>J</i> = 8.4, 2.1 Hz, 1H), 6.52 (d, <i>J</i> = 8.3 Hz, 1H), 6.13 (d, <i>J</i> = 8.0 Hz, 1H), 5.77 (s, 2H), 5.10–4.78 (m, 2H), 4.32 (d, <i>J</i> = 7.3 Hz, 1H), 2.30 (qt, <i>J</i> = 16.6, 7.3 Hz, 2H), 2.11–1.99 (m, 1H), 1.92 (dt, <i>J</i> = 14.4, 7.4 Hz, 1H), 1.33 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.7, 169.8, 156.7, 147.6, 144.2, 136.1, 131.9, 128.5, 128.1, 127.9, 113.3, 107.9, 102.8, 101.2, 81.0, 67.1, 55.0, 31.8, 28.1. MS (ESI) <i>m</i>/<i>z</i>: 457.3 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 479.2 [M + Na]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 935.4 [2M + Na]<sup>+</sup>.</div></div><div id="sec4_5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanamido)-5-(isopentylamino)-5-oxopentanoate (<b>63a</b>)</h4><div class="NLM_p last">Yield, 86%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 7.46–7.28 (m, 6H), 6.57 (d, <i>J</i> = 5.9 Hz, 1H), 5.86 (d, <i>J</i> = 8.3 Hz, 1H), 5.12 (q, <i>J</i> = 12.2 Hz, 2H), 4.46 (dt, <i>J</i> = 8.5, 5.4 Hz, 1H), 4.35 (td, <i>J</i> = 8.1, 4.7 Hz, 1H), 3.31–3.15 (m, 2H), 2.89 (dd, <i>J</i> = 16.9, 4.7 Hz, 1H), 2.70 (dd, <i>J</i> = 16.9, 6.1 Hz, 1H), 2.43–2.34 (m, 1H), 2.33–2.23 (m, 1H), 2.17–2.05 (m, 1H), 1.95 (dq, <i>J</i> = 14.5, 7.1 Hz, 1H), 1.58 (td, <i>J</i> = 13.3, 6.6 Hz, 1H), 1.42 (d, <i>J</i> = 5.0 Hz, 20H), 0.89 (dd, <i>J</i> = 6.6, 0.9 Hz, 6H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.6, 170.9, 170.7, 170.4, 156.1, 136.0, 128.6, 128.3, 128.1, 81.9, 81.0, 67.3, 53.3, 51.67, 38.3, 37.9, 37.3, 31.7, 28.05, 28.03, 27.1, 25.8, 22.4. MS (ESI) <i>m</i>/<i>z</i>: 600.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanamido)-5-oxo-5-(phenylamino)pentanoate (<b>63b</b>)</h4><div class="NLM_p last">Yield, 83%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.69 (s, 1H), 7.60 (t, <i>J</i> = 8.9 Hz, 3H), 7.46–7.22 (m, 7H), 7.15–6.99 (m, 1H), 5.91 (d, <i>J</i> = 8.2 Hz, 1H), 5.24–5.02 (m, 2H), 4.53 (tt, <i>J</i> = 10.3, 5.3 Hz, 2H), 2.92 (dd, <i>J</i> = 16.9, 4.8 Hz, 1H), 2.73 (dd, <i>J</i> = 16.9, 6.1 Hz, 1H), 2.51 (ddd, <i>J</i> = 17.1, 8.2, 5.6 Hz, 1H), 2.36 (ddd, <i>J</i> = 17.1, 7.3, 5.6 Hz, 1H), 2.25–2.16 (m, 1H), 2.05 (dt, <i>J</i> = 14.5, 7.4 Hz, 1H), 1.44 (s, 9H), 1.41 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.8, 171.1, 170.9, 168.9, 156.2, 137.8, 136.0, 128.8, 128.6, 128.3, 128.2, 124.3, 120.1, 82.1, 81.3, 67.4, 53.9, 51.8, 37.3, 31.8, 28.1, 28.0, 26.9. MS (ESI) <i>m</i>/<i>z</i>: 606.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanamido)-5-oxo-5-((4-(trifluoromethyl)phenyl)amino)pentanoate (<b>63c</b>)</h4><div class="NLM_p last">Yield, 82%. <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>): δ 9.50 (s, 1H), 7.94 (d, <i>J</i> = 8.4 Hz, 2H), 7.84 (d, <i>J</i> = 8.0 Hz, 1H), 7.65 (d, <i>J</i> = 8.5 Hz, 2H), 7.44–7.17 (m, 5H), 6.91 (d, <i>J</i> = 7.6 Hz, 1H), 5.23–4.97 (m, 2H), 4.77–4.37 (m, 2H), 2.95–2.83 (m, 1H), 2.76 (dd, <i>J</i> = 16.5, 6.8 Hz, 1H), 2.38 (ddd, <i>J</i> = 11.3, 9.1, 6.3 Hz, 2H), 2.28–2.18 (m, 1H), 2.00–1.83 (m, 1H), 1.41 (s, 9H), 1.41 (s, 9H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>): δ 171.8, 171.0, 170.2, 170.0, 156.5, 142.3, 136.9, 128.4, 127.9, 127.8, 125.9 (q, <i>J</i> = 3.8 Hz), 124.7 (d, <i>J</i> = 32.5 Hz), 124.5 (d, <i>J</i> = 268.7 Hz), 119.5, 119.4, 80.7, 79.7, 66.3, 53.5, 52.2, 37.0, 31.2, 27.4, 27.3, 26.8. MS (ESI) <i>m</i>/<i>z</i>: 674.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanamido)-5-oxo-5-((3-(trifluoromethyl)phenyl)amino)pentanoate (<b>63d</b>)</h4><div class="NLM_p last">Yield, 83%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 9.06 (s, 1H), 7.84 (s, 1H), 7.78–7.59 (m, 2H), 7.41–6.94 (m, 7H), 6.04 (d, <i>J</i> = 9.7 Hz, 1H), 5.23–4.85 (m, 2H), 4.60–4.33 (m, 2H), 2.85–2.66 (m, 2H), 2.42–2.21 (m, 2H), 2.18–2.06 (m, 1H), 1.99–1.88 (m, 1H), 1.40–1.32 (m, 9H), 1.30 (d, <i>J</i> = 2.3 Hz, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.4, 171.4, 170.8, 169.6, 156.3, 138.5, 136.0, 131.0 (q, <i>J</i> = 32.5 Hz), 129.3, 128.5, 128.2, 128.0, 123.9 (q, <i>J</i> = 271.2 Hz), 123.2, 120.7 (d, <i>J</i> = 4.0 Hz), 116.8 (d, <i>J</i> = 4.3 Hz), 82.1, 81.2, 67.3, 53.9, 51.9, 37.3, 31.7, 28.0, 27.9, 26.7. MS (ESI) <i>m</i>/<i>z</i>: 674.2 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanamido)-5-((4-methoxyphenyl)amino)-5-oxopentanoate (<b>63e</b>)</h4><div class="NLM_p last">Yield, 82%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.56 (s, 1H), 7.59 (d, <i>J</i> = 7.4 Hz, 1H), 7.48 (d, <i>J</i> = 8.6 Hz, 2H), 7.37–7.27 (m, 5H), 6.90–6.65 (m, 2H), 5.92 (d, <i>J</i> = 8.1 Hz, 1H), 5.13 (q, <i>J</i> = 12.2 Hz, 2H), 4.52 (tt, <i>J</i> = 10.3, 5.3 Hz, 2H), 3.77 (s, 3H), 2.90 (dd, <i>J</i> = 16.9, 4.9 Hz, 1H), 2.73 (dd, <i>J</i> = 16.8, 6.1 Hz, 1H), 2.48 (ddd, <i>J</i> = 17.0, 8.0, 5.9 Hz, 1H), 2.40–2.29 (m, 1H), 2.23–2.12 (m, 1H), 2.04 (d, <i>J</i> = 2.7 Hz, 1H), 1.43 (s, 9H), 1.40 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.7, 171.0, 170.9, 168.7, 156.4, 156.2, 136.0, 131.0, 128.6, 128.3, 128.1, 121.8, 114.0, 82.1, 81.2, 67.4, 55.5, 53.7, 51.8, 37.3, 31.8, 28.1, 28.0, 26.9. MS (ESI) <i>m</i>/<i>z</i>: 614.3 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 636.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanamido)-5-((3-methoxyphenyl)amino)-5-oxopentanoate (<b>63f</b>)</h4><div class="NLM_p last">Yield, 88%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.79 (s, 1H), 7.61 (d, <i>J</i> = 7.6 Hz, 1H), 7.33–7.13 (m, 6H), 7.08–6.92 (m, 2H), 6.53 (ddd, <i>J</i> = 8.1, 2.5, 1.0 Hz, 1H), 6.05 (d, <i>J</i> = 8.2 Hz, 1H), 5.18–4.94 (m, 2H), 4.61–4.41 (m, 2H), 3.65 (s, 3H), 2.77 (dd, <i>J</i> = 16.8, 5.3 Hz, 1H), 2.65 (dd, <i>J</i> = 16.8, 6.2 Hz, 1H), 2.39–2.30 (m, 1H), 2.26 (dt, <i>J</i> = 16.8, 6.8 Hz, 1H), 2.11 (dt, <i>J</i> = 13.4, 6.9 Hz, 1H), 1.94 (q, <i>J</i> = 5.7, 4.2 Hz, 1H), 1.33 (s, 9H), 1.30 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.2, 171.3, 170.7, 169.2, 160.0, 156.2, 139.1, 136.0, 129.4, 128.5, 128.2, 128.1, 112.4, 110.3, 105.7, 81.9, 81.0, 67.3, 55.2, 53.7, 51.8, 37.4, 31.7, 28.0, 27.9, 27.1. MS (ESI) <i>m</i>/<i>z</i>: 636.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanamido)-5-oxo-5-((4-(trifluoromethoxy)phenyl)amino)pentanoate (<b>63g</b>)</h4><div class="NLM_p last">Yield, 87%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.95 (s, 1H), 7.70 (d, <i>J</i> = 7.4 Hz, 1H), 7.54 (d, <i>J</i> = 8.6 Hz, 2H), 7.38–7.15 (m, 5H), 7.08–6.87 (m, 2H), 6.04 (d, <i>J</i> = 8.0 Hz, 1H), 5.36–4.93 (m, 2H), 4.49 (dp, <i>J</i> = 18.7, 6.4, 5.7 Hz, 2H), 2.77 (dd, <i>J</i> = 16.9, 5.2 Hz, 1H), 2.70 (d, <i>J</i> = 6.3 Hz, 1H), 2.51–2.31 (m, 1H), 2.27 (dt, <i>J</i> = 16.9, 6.6 Hz, 1H), 2.18–2.10 (m, 1H), 1.95 (q, <i>J</i> = 7.3, 6.9 Hz, 1H), 1.33 (s, 9H), 1.30 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.4, 171.4, 170.8, 169.3, 156.3, 145.2 (d, <i>J</i> = 2.0 Hz), 136.6, 136.0, 128.5, 128.2, 128.0, 121.4, 121.2, 119.4, 82.0, 81.2, 67.3, 53.9, 51.8, 37.3, 31.7, 28.0, 27.9, 26.8. MS (ESI) <i>m</i>/<i>z</i>: 690.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanamido)-5-oxo-5-((3-(trifluoromethoxy)phenyl)amino)pentanoate (<b>63h</b>)</h4><div class="NLM_p last">Yield, 84%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.87 (s, 1H), 7.60 (d, <i>J</i> = 19.4 Hz, 2H), 7.51–7.40 (m, 1H), 7.31–7.13 (m, 6H), 6.87 (ddt, <i>J</i> = 8.2, 2.3, 1.1 Hz, 1H), 5.83 (d, <i>J</i> = 7.7 Hz, 1H), 5.33–4.95 (m, 2H), 4.66–4.29 (m, 2H), 2.82 (dd, <i>J</i> = 16.8, 4.9 Hz, 1H), 2.70 (dd, <i>J</i> = 16.8, 6.2 Hz, 1H), 2.43 (ddd, <i>J</i> = 17.2, 8.4, 5.3 Hz, 1H), 2.32–2.24 (m, 1H), 2.13 (ddd, <i>J</i> = 13.8, 8.4, 4.3 Hz, 1H), 1.99 (dd, <i>J</i> = 14.0, 6.6 Hz, 1H), 1.37 (s, 9H), 1.34 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 174.0, 171.2, 170.9, 169.2, 156.3, 149.4, 139.3, 135.9, 129.8, 128.6, 128.3, 128.1, 120.4 (d, <i>J</i> = 257.3 Hz), 118.1, 116.3, 112.9, 82.3, 81.5, 67.4, 54.0, 51.9, 37.2, 31.8, 28.0, 27.9, 26.5. MS (ESI) <i>m</i>/<i>z</i>: 668.3 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 690.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanamido)-5-((3,5-dimethoxyphenyl)amino)-5-oxopentanoate (<b>63i</b>)</h4><div class="NLM_p last">Yield, 87%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.64 (s, 1H), 7.59 (d, <i>J</i> = 7.4 Hz, 1H), 7.40–7.27 (m, 5H), 6.86 (d, <i>J</i> = 2.3 Hz, 2H), 6.22 (t, <i>J</i> = 2.3 Hz, 1H), 5.91 (d, <i>J</i> = 8.1 Hz, 1H), 5.31–5.03 (m, 2H), 4.51 (td, <i>J</i> = 7.8, 4.7 Hz, 2H), 3.76 (s, 6H), 2.92 (dd, <i>J</i> = 16.9, 4.9 Hz, 1H), 2.72 (dd, <i>J</i> = 16.9, 6.0 Hz, 1H), 2.50 (ddd, <i>J</i> = 17.1, 8.2, 5.6 Hz, 1H), 2.35 (ddd, <i>J</i> = 17.1, 7.2, 5.5 Hz, 1H), 2.23–2.09 (m, 1H), 2.11–1.96 (m, 1H), 1.44 (s, 9H), 1.41 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.8, 171.2, 170.8, 169.0, 160.9, 156.2, 139.5, 135.9, 128.6, 128.3, 128.1, 98.3, 97.0, 82.1, 81.3, 67.4, 55.4, 53.9, 51.8, 37.2, 31.8, 28.1, 28.0, 26.9. MS (ESI) <i>m</i>/<i>z</i>: 644.3 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 666.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-(((Benzyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanamido)-5-((3-methoxy-5-(trifluoromethyl)phenyl)amino)-5-oxopentanoate (<b>63j</b>)</h4><div class="NLM_p last">Yield, 86%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.98–8.91 (m, 1H), 7.71 (d, <i>J</i> = 7.2 Hz, 1H), 7.63 (s, 1H), 7.43–7.27 (m, 6H), 6.94–6.80 (m, 1H), 6.00–5.76 (m, 1H), 5.30–5.06 (m, 2H), 4.66–4.35 (m, 2H), 3.82 (d, <i>J</i> = 0.9 Hz, 3H), 2.95–2.84 (m, 1H), 2.79 (dd, <i>J</i> = 16.8, 6.2 Hz, 1H), 2.50 (dtd, <i>J</i> = 17.3, 5.9, 5.3, 2.9 Hz, 1H), 2.37 (ddd, <i>J</i> = 17.2, 7.4, 5.2 Hz, 1H), 2.20 (ddd, <i>J</i> = 13.4, 9.1, 4.5 Hz, 1H), 2.08 (dt, <i>J</i> = 14.6, 7.4 Hz, 1H), 1.44 (s, 9H), 1.41 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 174.0 (d, <i>J</i> = 3.1 Hz), 171.2, 170.9, 169.4, 160.2, 156.3, 139.7, 135.9, 131.9 (d, <i>J</i> = 32.5 Hz), 128.6, 128.1, 123.8 (d, <i>J</i> = 272.5 Hz), 109.1, 108.6, 106.9 (d, <i>J</i> = 3.9 Hz), 82.3, 81.5, 67.4, 55.6, 54.1, 51.9, 37.2, 31.8, 28.0, 27.9, 26.4. MS (ESI) <i>m</i>/<i>z</i>: 682.3 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 704.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>tert</i>-Butyl (<i>S</i>)-5-(Benzo[<i>d</i>][1,3]dioxol-5-ylamino)-4-((<i>S</i>)-2-(((benzyloxy)carbonyl)amino)-4-(<i>tert</i>-butoxy)-4-oxobutanamido)-5-oxopentanoate (<b>63k</b>)</h4><div class="NLM_p last">Yield, 88%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.61 (q, <i>J</i> = 5.9, 4.6 Hz, 1H), 7.54 (d, <i>J</i> = 7.4 Hz, 1H), 7.38–7.10 (m, 6H), 6.84 (d, <i>J</i> = 8.4 Hz, 1H), 6.61 (dq, <i>J</i> = 8.5, 1.7 Hz, 1H), 5.91 (d, <i>J</i> = 8.8 Hz, 1H), 5.83 (q, <i>J</i> = 1.6 Hz, 2H), 5.05 (q, <i>J</i> = 12.4 Hz, 2H), 4.45 (q, <i>J</i> = 6.8, 6.2 Hz, 2H), 2.79 (d, <i>J</i> = 3.7 Hz, 1H), 2.67 (dd, <i>J</i> = 16.9, 6.2 Hz, 1H), 2.48–2.31 (m, 1H), 2.27 (dt, <i>J</i> = 16.8, 6.6 Hz, 1H), 2.16–2.05 (m, 1H), 2.04–1.84 (m, 1H), 1.35 (d, <i>J</i> = 1.6 Hz, 9H), 1.33 (d, <i>J</i> = 1.5 Hz, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.5, 171.1, 170.8, 168.8, 156.2, 147.6, 144.2, 136.0, 132.1, 128.5, 128.3, 128.1, 113.3, 107.9, 102.8, 101.1, 82.0, 81.2, 67.3, 53.7, 51.8, 37.3, 31.8, 28.1, 28.0, 27.0. MS (ESI) <i>m</i>/<i>z</i>: 628.3 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 650.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>tert</i>-Butyl (5<i>S</i>,8<i>S</i>,11<i>S</i>)-8-(2-(<i>tert</i>-Butoxy)-2-oxoethyl)-11-(isopentylcarbamoyl)-5-(naphthalen-2-ylmethyl)-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazatetradecan-14-oate (<b>64a</b>)</h4><div class="NLM_p last">Yield, 81%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 7.75–7.59 (m, 3H), 7.58–7.52 (m, 2H), 7.44 (d, <i>J</i> = 8.1 Hz, 1H), 7.40–7.28 (m, 2H), 7.26–7.01 (m, 6H), 6.67 (t, <i>J</i> = 5.6 Hz, 1H), 5.54 (d, <i>J</i> = 5.7 Hz, 1H), 4.94 (s, 2H), 4.61 (ddd, <i>J</i> = 7.9, 6.4, 4.5 Hz, 1H), 4.54–4.41 (m, 1H), 4.33 (td, <i>J</i> = 8.6, 4.5 Hz, 1H), 3.27 (dd, <i>J</i> = 14.2, 5.0 Hz, 1H), 3.19–3.00 (m, 3H), 2.80 (dd, <i>J</i> = 16.9, 4.4 Hz, 1H), 2.53 (dd, <i>J</i> = 16.9, 6.5 Hz, 1H), 2.24–2.04 (m, 3H), 1.90–1.76 (m, 1H), 1.52 (dp, <i>J</i> = 13.3, 6.6 Hz, 1H), 1.30 (s, 9H), 1.28 (s, 11H), 0.81 (dd, <i>J</i> = 6.7, 3.0 Hz, 6H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.6, 171.6, 171.0, 170.5, 170.2, 156.7, 135.7, 133.4, 132.5, 128.6, 128.5, 128.3, 128.2, 128.0, 127.7, 127.6, 127.0, 126.3, 125.9, 82.0, 80.5, 67.5, 56.7, 53.1, 50.2, 38.2, 38.0, 36.5, 31.9, 28.1, 28.0, 27.1, 22.52, 22.50. MS (ESI) <i>m</i>/<i>z</i>: 775.2 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 797.2 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>tert</i>-Butyl (5<i>S</i>,8<i>S</i>,11<i>S</i>)-8-(2-(<i>tert</i>-Butoxy)-2-oxoethyl)-5-(naphthalen-2-ylmethyl)-3,6,9-trioxo-1-phenyl-11-(phenylcarbamoyl)-2-oxa-4,7,10-triazatetradecan-14-oate (<b>64b</b>)</h4><div class="NLM_p last">Yield, 85%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.92 (s, 1H), 8.55 (d, <i>J</i> = 7.9 Hz, 1H), 8.07 (d, <i>J</i> = 7.9 Hz, 1H), 7.88 (dd, <i>J</i> = 6.9, 2.2 Hz, 1H), 7.86–7.75 (m, 3H), 7.69–7.58 (m, 3H), 7.56–7.41 (m, 3H), 7.37–7.27 (m, 2H), 7.27–7.11 (m, 5H), 7.09–6.98 (m, 1H), 4.90 (d, <i>J</i> = 2.3 Hz, 2H), 4.66 (td, <i>J</i> = 7.8, 6.1 Hz, 1H), 4.43 (tdd, <i>J</i> = 10.9, 7.9, 4.3 Hz, 2H), 3.19 (dd, <i>J</i> = 13.9, 3.7 Hz, 1H), 2.94 (dd, <i>J</i> = 13.8, 10.9 Hz, 1H), 2.77 (dd, <i>J</i> = 16.2, 6.0 Hz, 1H), 2.56 (dd, <i>J</i> = 16.2, 7.8 Hz, 1H), 2.37–2.20 (m, 2H), 2.01 (ddd, <i>J</i> = 14.0, 6.8, 3.4 Hz, 1H), 1.90–1.73 (m, 1H), 1.38 (s, 9H), 1.32 (s, 9H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.2, 172.0, 170.7, 170.1, 169.9, 156.3, 139.1, 137.4, 136.3, 133.4, 132.3, 129.2, 128.6, 128.3, 128.1, 127.99, 127.97, 127.91, 127.80, 127.7, 126.4, 125.9, 124.0, 119.8, 80.8, 80.2, 65.6, 56.6, 53.2, 50.1, 38.1, 37.6, 31.6, 28.13, 28.11, 27.8. MS (ESI) <i>m</i>/<i>z</i>: 781.1 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 803.1 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>tert</i>-Butyl (5<i>S</i>,8<i>S</i>,11<i>S</i>)-8-(2-(<i>tert</i>-Butoxy)-2-oxoethyl)-5-(naphthalen-2-ylmethyl)-3,6,9-trioxo-1-phenyl-11-((4-(trifluoromethyl)phenyl)carbamoyl)-2-oxa-4,7,10-triazatetradecan-14-oate (<b>64c</b>)</h4><div class="NLM_p last">Yield, 74%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.81 (d, <i>J</i> = 7.1 Hz, 1H), 7.88 (d, <i>J</i> = 8.2 Hz, 2H), 7.85–7.62 (m, 6H), 7.59–7.51 (m, 2H), 7.51–7.43 (m, 2H), 7.35–7.12 (m, 6H), 5.33 (t, <i>J</i> = 9.6 Hz, 1H), 5.14–4.93 (m, 2H), 4.71–4.62 (m, 1H), 4.55 (d, <i>J</i> = 8.6 Hz, 1H), 4.48 (q, <i>J</i> = 5.1, 4.5 Hz, 1H), 3.43 (dd, <i>J</i> = 14.5, 4.9 Hz, 1H), 3.15 (dd, <i>J</i> = 14.2, 8.9 Hz, 1H), 3.00 (dd, <i>J</i> = 17.2, 4.4 Hz, 1H), 2.70–2.56 (m, 1H), 2.33 (p, <i>J</i> = 4.1 Hz, 3H), 2.01–1.91 (m, 1H), 1.41 (s, 9H), 1.36 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.4, 172.2, 171.2, 170.5, 169.6, 157.1, 141.3, 135.3, 133.4, 132.8, 132.6, 129.0, 128.6, 128.5, 128.3, 127.9, 127.8, 127.6, 126.6, 126.5, 126.2, 126.02, 125.96, 125.90, 125.6, 125.3, 123.2, 119.7, 82.5, 80.7, 68.0, 57.2, 53.9, 50.8, 37.7, 35.7, 32.1, 28.0, 27.9, 26.5. MS (ESI) <i>m</i>/<i>z</i>: 871.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>tert</i>-Butyl (5<i>S</i>,8<i>S</i>,11<i>S</i>)-8-(2-(<i>tert</i>-Butoxy)-2-oxoethyl)-5-(naphthalen-2-ylmethyl)-3,6,9-trioxo-1-phenyl-11-((3-(trifluoromethyl)phenyl)carbamoyl)-2-oxa-4,7,10-triazatetradecan-14-oate (<b>64d</b>)</h4><div class="NLM_p last">Yield, 76%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.95 (s, 1H), 7.95 (s, 1H), 7.89–7.70 (m, 3H), 7.65–7.53 (m, 3H), 7.48 (d, <i>J</i> = 1.6 Hz, 1H), 7.28 (dd, <i>J</i> = 6.2, 3.3 Hz, 2H), 7.22–7.14 (m, 3H), 7.14–6.99 (m, 5H), 5.85 (d, <i>J</i> = 6.2 Hz, 1H), 4.89 (q, <i>J</i> = 12.3 Hz, 2H), 4.78–4.69 (m, 1H), 4.66–4.56 (m, 1H), 4.51 (q, <i>J</i> = 8.3, 5.8 Hz, 1H), 3.23 (dd, <i>J</i> = 14.3, 4.9 Hz, 1H), 3.04 (dd, <i>J</i> = 14.1, 8.8 Hz, 1H), 2.75 (dd, <i>J</i> = 17.1, 4.6 Hz, 1H), 2.61 (dd, <i>J</i> = 16.9, 7.0 Hz, 1H), 2.37–2.11 (m, 3H), 1.95–1.81 (m, 1H), 1.25 (s, 9H), 1.24 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.4, 172.2, 170.9 (d, <i>J</i> = 3.1 Hz), 169.7, 156.9, 138.8, 135.7, 133.5, 132.5, 131.0 (d, <i>J</i> = 32.2 Hz), 129.3, 128.55, 128.51, 128.4, 128.3, 128.1, 127.7, 127.6, 127.0, 126.3, 125.9, 125.1, 123.2, 123.0, 120.6, 116.9 (d, <i>J</i> = 4.0 Hz), 82.2, 80.8, 67.5, 56.8, 53.8, 50.4, 38.4, 36.7, 31.8, 28.0, 27.9, 26.9. MS (ESI) <i>m</i>/<i>z</i>: 871.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>tert</i>-Butyl (5<i>S</i>,8<i>S</i>,11<i>S</i>)-8-(2-(<i>tert</i>-Butoxy)-2-oxoethyl)-11-((4-methoxyphenyl)carbamoyl)-5-(naphthalen-2-ylmethyl)-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazatetradecan-14-oate (<b>64e</b>)</h4><div class="NLM_p last">Yield, 83%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.46 (s, 1H), 7.77–7.62 (m, 3H), 7.58–7.48 (m, 5H), 7.38–7.34 (m, 2H), 7.26–7.11 (m, 6H), 6.74 (d, <i>J</i> = 9.0 Hz, 2H), 5.42 (d, <i>J</i> = 5.5 Hz, 1H), 4.95 (d, <i>J</i> = 2.7 Hz, 2H), 4.63 (ddd, <i>J</i> = 7.7, 6.2, 4.4 Hz, 1H), 4.46 (q, <i>J</i> = 5.5, 4.8 Hz, 2H), 3.68 (s, 3H), 3.40–3.20 (m, 1H), 3.07 (dd, <i>J</i> = 14.2, 8.6 Hz, 1H), 2.85 (dd, <i>J</i> = 17.2, 4.4 Hz, 1H), 2.54 (dd, <i>J</i> = 17.0, 6.3 Hz, 1H), 2.31–2.15 (m, 3H), 1.90 (dt, <i>J</i> = 11.9, 3.7 Hz, 1H), 1.29 (s, 9H), 1.28 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.6, 171.9, 171.1, 170.4, 168.8, 156.8, 156.3, 135.6, 133.4, 133.2, 132.6, 131.3, 128.7, 128.5, 128.3, 128.2, 128.0, 127.7, 127.6, 126.9, 126.4, 126.0, 121.7, 113.9, 82.2, 80.6, 67.6, 56.9, 55.4, 53.7, 50.4, 37.9, 36.2, 32.0, 28.0, 27.9, 26.9. MS (ESI) <i>m</i>/<i>z</i>: 833.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>tert</i>-Butyl (5<i>S</i>,8<i>S</i>,11<i>S</i>)-8-(2-(<i>tert</i>-Butoxy)-2-oxoethyl)-11-((3-methoxyphenyl)carbamoyl)-5-(naphthalen-2-ylmethyl)-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazatetradecan-14-oate (<b>64f</b>)</h4><div class="NLM_p last">Yield, 80%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.65 (s, 1H), 7.81–7.55 (m, 5H), 7.54–7.47 (m, 1H), 7.37 (t, <i>J</i> = 2.2 Hz, 1H), 7.32 (dd, <i>J</i> = 6.2, 3.2 Hz, 2H), 7.23–6.99 (m, 8H), 6.58–6.45 (m, 1H), 5.64 (d, <i>J</i> = 5.8 Hz, 1H), 4.92 (s, 2H), 4.73–4.63 (m, 1H), 4.51 (ddd, <i>J</i> = 21.6, 10.8, 5.9 Hz, 2H), 3.63 (s, 3H), 3.26 (dd, <i>J</i> = 14.2, 5.0 Hz, 1H), 3.05 (dd, <i>J</i> = 14.1, 8.7 Hz, 1H), 2.80 (dd, <i>J</i> = 17.2, 4.4 Hz, 1H), 2.55 (dd, <i>J</i> = 17.0, 6.6 Hz, 1H), 2.30–2.11 (m, 3H), 1.91–1.77 (m, 1H), 1.27 (s, 9H), 1.27 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.5, 171.9, 171.0, 170.7, 169.3, 160.0, 156.8, 139.3, 135.7, 133.4 (d, <i>J</i> = 2.6 Hz), 132.5, 129.5, 128.6, 128.5, 128.3, 128.2, 128.0, 127.7, 127.6, 127.0, 126.3, 125.9, 112.4, 110.3, 105.6, 82.2, 80.6, 67.5, 56.8, 55.2, 53.8, 50.3, 38.2, 36.5, 31.9, 28.1, 28.0, 27.0. MS (ESI) <i>m</i>/<i>z</i>: 833.4 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>tert</i>-Butyl (5<i>S</i>,8<i>S</i>,11<i>S</i>)-8-(2-(<i>tert</i>-Butoxy)-2-oxoethyl)-5-(naphthalen-2-ylmethyl)-3,6,9-trioxo-1-phenyl-11-((4-(trifluoromethoxy)phenyl)carbamoyl)-2-oxa-4,7,10-triazatetradecan-14-oate (<b>64g</b>)</h4><div class="NLM_p last">Yield, 79%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.64 (dd, <i>J</i> = 11.5, 4.6 Hz, 1H), 7.84–7.64 (m, 5H), 7.59 (d, <i>J</i> = 26.7 Hz, 3H), 7.44–7.32 (m, 2H), 7.25–7.13 (m, 6H), 7.07 (dd, <i>J</i> = 8.9, 3.3 Hz, 2H), 5.30 (d, <i>J</i> = 28.7 Hz, 1H), 5.11–4.84 (m, 2H), 4.68–4.54 (m, 1H), 4.50–4.25 (m, 2H), 3.44–3.26 (m, 1H), 3.07 (dd, <i>J</i> = 14.2, 8.8 Hz, 1H), 2.90 (d, <i>J</i> = 17.1 Hz, 1H), 2.54 (ddd, <i>J</i> = 17.0, 5.9, 2.3 Hz, 1H), 2.32–2.16 (m, 2H), 1.96–1.81 (m, 2H), 1.32 (s, 9H), 1.28 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.5, 172.2, 171.2, 170.4, 169.3, 157.0, 145.1, 136.9, 135.3, 133.4, 132.9, 132.6, 128.9, 128.6, 128.5, 128.3, 128.0, 127.7, 127.6, 126.7, 126.5, 126.1, 121.5, 121.2, 82.4, 80.7, 67.9, 57.2, 53.8, 50.7, 37.7, 35.7, 32.1, 28.0, 27.9, 26.6. MS (ESI) <i>m</i>/<i>z</i>: 887.4 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>tert</i>-Butyl (5<i>S</i>,8<i>S</i>,11<i>S</i>)-8-(2-(<i>tert</i>-Butoxy)-2-oxoethyl)-5-(naphthalen-2-ylmethyl)-3,6,9-trioxo-1-phenyl-11-((3-(trifluoromethoxy)phenyl)carbamoyl)-2-oxa-4,7,10-triazatetradecan-14-oate (<b>64h</b>)</h4><div class="NLM_p last">Yield, 80%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.89 (s, 1H), 7.88 (d, <i>J</i> = 7.6 Hz, 1H), 7.80 (d, <i>J</i> = 8.1 Hz, 1H), 7.68–7.53 (m, 4H), 7.47 (dd, <i>J</i> = 15.1, 5.0 Hz, 2H), 7.28 (dd, <i>J</i> = 6.2, 3.2 Hz, 2H), 7.22–7.17 (m, 1H), 7.14–7.04 (m, 6H), 6.89–6.63 (m, 1H), 5.84 (d, <i>J</i> = 6.2 Hz, 1H), 4.89 (q, <i>J</i> = 12.3 Hz, 2H), 4.77–4.67 (m, 1H), 4.62–4.59 (m, 1H), 4.52–4.46 (m, 1H), 3.25 (dd, <i>J</i> = 14.2, 4.8 Hz, 1H), 3.05 (dd, <i>J</i> = 14.1, 8.8 Hz, 1H), 2.76 (dd, <i>J</i> = 17.1, 4.6 Hz, 1H), 2.60 (dd, <i>J</i> = 16.9, 6.9 Hz, 1H), 2.30–2.11 (m, 3H), 1.89 (s, 1H), 1.25 (s, 18H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.3, 172.1, 170.87, 170.86, 169.6, 156.9, 149.43, 149.41, 139.7, 135.7, 133.5, 133.4, 132.5, 129.8, 128.55, 128.50, 128.3, 128.1 (d, <i>J</i> = 2.2 Hz), 127.7, 127.6, 127.0, 126.3, 125.9, 120.5 (d, <i>J</i> = 257.1 Hz), 118.2, 116.1, 112.9, 82.2, 80.7, 67.5, 56.8, 53.8, 50.3, 38.4, 36.7, 31.8, 28.0, 27.9, 26.9. MS (ESI) <i>m</i>/<i>z</i>: 887.4 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>tert</i>-Butyl (5<i>S</i>,8<i>S</i>,11<i>S</i>)-8-(2-(<i>tert</i>-Butoxy)-2-oxoethyl)-11-((3,5-dimethoxyphenyl)carbamoyl)-5-(naphthalen-2-ylmethyl)-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazatetradecan-14-oate (<b>64i</b>)</h4><div class="NLM_p last">Yield, 81%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.55 (s, 1H), 7.84–7.55 (m, 5H), 7.52 (d, <i>J</i> = 1.6 Hz, 1H), 7.38–7.29 (m, 2H), 7.21–7.11 (m, 6H), 6.92 (s, 2H), 6.13 (t, <i>J</i> = 2.3 Hz, 1H), 5.49 (d, <i>J</i> = 5.4 Hz, 1H), 4.94 (s, 2H), 4.63 (ddd, <i>J</i> = 7.6, 6.1, 4.4 Hz, 1H), 4.47 (h, <i>J</i> = 4.8 Hz, 2H), 3.64 (s, 6H), 3.27 (dd, <i>J</i> = 14.1, 5.1 Hz, 1H), 3.05 (dd, <i>J</i> = 14.2, 8.6 Hz, 1H), 2.84 (dd, <i>J</i> = 17.6, 4.2 Hz, 1H), 2.53 (dd, <i>J</i> = 17.3, 6.4 Hz, 1H), 2.29–2.13 (m, 3H), 1.91 (d, <i>J</i> = 24.4 Hz, 1H), 1.29 (s, 9H), 1.27 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.5, 171.9, 171.1, 170.6, 169.2, 160.9, 156.9, 139.9, 135.6, 133.4, 133.3, 132.6, 128.7, 128.5, 128.3, 128.2, 128.0, 127.7, 127.6, 126.9, 126.4, 126.0, 98.3, 97.0, 82.2, 80.6, 67.7, 56.9, 55.3, 53.8, 50.5, 38.0, 36.2, 32.0, 28.0, 27.9, 26.9. MS (ESI) <i>m</i>/<i>z</i>: 863.4 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> <i>tert</i>-Butyl (5<i>S</i>,8<i>S</i>,11<i>S</i>)-8-(2-(<i>tert</i>-Butoxy)-2-oxoethyl)-11-((3-methoxy-5-(trifluoromethyl)phenyl)carbamoyl)-5-(naphthalen-2-ylmethyl)-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazatetradecan-14-oate (<b>64j</b>)</h4><div class="NLM_p last">Yield, 82%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.82 (s, 1H), 7.75–7.54 (m, 6H), 7.50 (t, <i>J</i> = 2.5 Hz, 2H), 7.40–7.24 (m, 2H), 7.24–7.02 (m, 6H), 6.75 (t, <i>J</i> = 1.8 Hz, 1H), 5.58 (d, <i>J</i> = 5.6 Hz, 1H), 4.92 (s, 2H), 4.62 (td, <i>J</i> = 7.0, 4.8 Hz, 1H), 4.55–4.36 (m, 2H), 3.65 (s, 3H), 3.27 (dd, <i>J</i> = 14.2, 5.0 Hz, 1H), 3.04 (dd, <i>J</i> = 14.2, 8.7 Hz, 1H), 2.81 (dd, <i>J</i> = 17.1, 4.4 Hz, 1H), 2.58 (dd, <i>J</i> = 17.0, 6.5 Hz, 1H), 2.26–2.11 (m, 3H), 1.92 (s, 1H), 1.28 (s, 9H), 1.26 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.4, 172.2, 171.0, 170.7, 169.6, 160.2, 157.0, 140.0, 135.5, 133.4, 133.2, 132.6, 131.8 (q, <i>J</i> = 32.3 Hz), 128.7, 128.5, 128.4, 128.2, 128.0, 127.7, 127.6, 126.8, 126.4, 126.0, 125.0, 122.8, 109.1 (d, <i>J</i> = 4.3 Hz), 108.6, 106.9 (d, <i>J</i> = 4.1 Hz), 82.4, 80.7, 67.7, 57.0, 55.5, 53.8, 50.6, 38.0, 36.2, 31.9, 28.0, 27.9, 26.7. MS (ESI) <i>m</i>/<i>z</i>: 901.4 [M + Na]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 877.2 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> <i>tert</i>-Butyl (5<i>S</i>,8<i>S</i>,11<i>S</i>)-11-(Benzo[<i>d</i>][1,3]dioxol-5-ylcarbamoyl)-8-(2-(<i>tert</i>-butoxy)-2-oxoethyl)-5-(naphthalen-2-ylmethyl)-3,6,9-trioxo-1-phenyl-2-oxa-4,7,10-triazatetradecan-14-oate (<b>64k</b>)</h4><div class="NLM_p last">Yield, 80%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 8.54 (s, 1H), 7.65 (ddt, <i>J</i> = 17.6, 13.4, 5.0 Hz, 5H), 7.52 (d, <i>J</i> = 1.7 Hz, 1H), 7.43–7.31 (m, 2H), 7.30–7.26 (m, 1H), 7.22–7.09 (m, 6H), 6.93–6.85 (m, 1H), 6.59 (d, <i>J</i> = 8.4 Hz, 1H), 5.79 (s, 2H), 5.58 (d, <i>J</i> = 5.7 Hz, 1H), 4.93 (s, 2H), 4.76–4.58 (m, 1H), 4.48 (ddd, <i>J</i> = 19.7, 9.4, 5.0 Hz, 2H), 3.36–3.21 (m, 1H), 3.05 (dd, <i>J</i> = 14.2, 8.7 Hz, 1H), 2.81 (dd, <i>J</i> = 17.1, 4.5 Hz, 1H), 2.62–2.46 (m, 1H), 2.33–2.14 (m, 3H), 1.90 (dd, <i>J</i> = 14.9, 8.6 Hz, 1H), 1.28 (s, 9H), 1.27 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.5, 171.9, 171.0, 170.5, 168.9, 156.8, 147.5, 144.0, 135.7, 133.4, 133.3, 132.5, 132.4, 128.6, 128.5, 128.3, 128.2, 128.0, 127.7, 127.6, 127.0, 126.3, 125.9, 113.3, 107.9, 102.8, 101.1, 82.2, 80.6, 67.6, 56.8, 53.7, 53.5, 50.4, 38.1, 36.4, 32.0, 28.1, 28.0, 27.0. MS (ESI) <i>m</i>/<i>z</i>: 825.3 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 847.4 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-4-(<i>tert</i>-Butoxy)-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-4-oxobutanamido)-5-(isopentylamino)-5-oxopentanoate (<b>65a</b>)</h4><div class="NLM_p last">Yield, 89%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 7.76–7.61 (m, 3H), 7.59–7.50 (m, 2H), 7.44 (d, <i>J</i> = 8.1 Hz, 1H), 7.39–7.31 (m, 2H), 7.26–7.08 (m, 6H), 6.67 (t, <i>J</i> = 5.6 Hz, 1H), 5.54 (d, <i>J</i> = 5.7 Hz, 1H), 4.94 (s, 2H), 4.61 (ddd, <i>J</i> = 7.9, 6.4, 4.5 Hz, 1H), 4.53–4.42 (m, 1H), 4.33 (td, <i>J</i> = 8.6, 4.5 Hz, 1H), 3.27 (dd, <i>J</i> = 14.2, 5.0 Hz, 1H), 3.20–2.92 (m, 3H), 2.80 (dd, <i>J</i> = 16.9, 4.4 Hz, 1H), 2.53 (dd, <i>J</i> = 16.9, 6.5 Hz, 1H), 2.28–2.00 (m, 3H), 1.84 (tt, <i>J</i> = 15.7, 7.0 Hz, 1H), 1.52 (dt, <i>J</i> = 13.4, 6.7 Hz, 1H), 1.30 (s, 9H), 1.28 (s, 9H), 0.81 (dd, <i>J</i> = 6.7, 3.0 Hz, 6H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 172.6, 171.6, 171.0, 170.5, 170.2, 156.7, 135.7, 133.4, 132.5, 128.6, 128.5, 128.3, 128.2, 128.0, 127.7, 127.6, 127.0, 126.3, 125.9, 82.0, 80.5, 67.5, 56.7, 53.1, 50.2, 38.2, 38.1, 38.0, 36.5, 31.9, 28.0, 27.9, 27.1, 25.8, 22.5. MS (ESI) <i>m</i>/<i>z</i>: 775.2 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 797.2 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-4-(<i>tert</i>-Butoxy)-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-4-oxobutanamido)-5-oxo-5-(phenylamino)pentanoate (<b>65b</b>)</h4><div class="NLM_p last">Yield, 84%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.92 (s, 1H), 8.55 (d, <i>J</i> = 7.9 Hz, 1H), 8.07 (d, <i>J</i> = 7.9 Hz, 1H), 7.88 (dd, <i>J</i> = 6.9, 2.2 Hz, 1H), 7.86–7.75 (m, 3H), 7.73–7.56 (m, 3H), 7.55–7.35 (m, 3H), 7.36–7.27 (m, 2H), 7.27–7.19 (m, 3H), 7.19–7.13 (m, 2H), 7.12–6.92 (m, 1H), 5.00–4.81 (m, 2H), 4.66 (td, <i>J</i> = 7.8, 6.1 Hz, 1H), 4.43 (tdd, <i>J</i> = 10.9, 7.9, 4.3 Hz, 2H), 3.23–3.09 (m, 1H), 2.94 (dd, <i>J</i> = 13.8, 10.9 Hz, 1H), 2.77 (dd, <i>J</i> = 16.2, 6.0 Hz, 1H), 2.56 (dd, <i>J</i> = 16.2, 7.8 Hz, 1H), 2.38–2.18 (m, 2H), 2.11–1.97 (m, 1H), 1.86 (ddt, <i>J</i> = 10.6, 5.2, 2.9 Hz, 1H), 1.38 (s, 9H), 1.32 (s, 9H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.2, 172.0, 170.7, 170.1, 169.9, 156.3, 139.1, 137.4, 136.3, 133.4, 132.3, 129.2, 128.6, 128.3, 128.1, 127.99, 127.97, 127.91, 127.8, 126.4, 125.9, 119.8, 80.8, 80.2, 65.6, 56.6, 53.2, 50.1, 38.1, 37.6, 31.6, 28.13, 28.11, 27.8. MS (ESI) <i>m</i>/<i>z</i>: 781.1 [M + H]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 803.1 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-4-(<i>tert</i>-Butoxy)-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-4-oxobutanamido)-5-oxo-5-((4-(trifluoromethyl)phenyl)amino)pentanoate (<b>65c</b>)</h4><div class="NLM_p last">Yield, 72%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 11.05–10.69 (m, 1H), 8.90 (s, 1H), 8.10 (d, <i>J</i> = 7.5 Hz, 1H), 8.00 (d, <i>J</i> = 7.5 Hz, 1H), 7.89 (d, <i>J</i> = 8.5 Hz, 2H), 7.84–7.69 (m, 4H), 7.59–7.49 (m, 3H), 7.49–7.43 (m, 2H), 7.40–7.33 (m, 2H), 7.18 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 6.87 (d, <i>J</i> = 4.5 Hz, 1H), 6.62 (d, <i>J</i> = 2.2 Hz, 1H), 4.87 (dd, <i>J</i> = 9.5, 4.9 Hz, 1H), 4.69 (ddd, <i>J</i> = 7.6, 6.0, 4.5 Hz, 1H), 4.44 (ddd, <i>J</i> = 11.0, 7.3, 3.5 Hz, 1H), 3.56 (dd, <i>J</i> = 14.2, 5.3 Hz, 1H), 3.28 (dd, <i>J</i> = 14.2, 9.1 Hz, 1H), 2.96 (dd, <i>J</i> = 16.9, 4.5 Hz, 1H), 2.82–2.58 (m, 1H), 2.53–2.32 (m, 3H), 2.30–2.21 (m, 1H), 1.49 (s, 9H), 1.20 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 174.3, 172.1, 170.9, 170.8, 169.8, 163.1, 141.1, 135.8, 133.5, 132.8, 132.7, 129.9, 129.2, 128.0, 127.78, 127.77, 127.5, 126.7, 126.5, 126.3, 126.2, 125.9 (d, <i>J</i> = 3.9 Hz), 125.8, 125.5, 125.3, 123.1, 121.0, 119.8, 113.7, 103.0, 82.5, 81.7, 56.4, 54.4, 51.0, 37.7, 35.7, 33.3, 28.1, 27.7, 27.5. MS (ESI) <i>m</i>/<i>z</i>: 914.3 [M + Na]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 890.3 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-4-(<i>tert</i>-Butoxy)-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-4-oxobutanamido)-5-oxo-5-((3-(trifluoromethyl)phenyl)amino)pentanoate (<b>65d</b>)</h4><div class="NLM_p last">Yield, 70%. <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>): δ 11.18–10.69 (m, 1H), 9.28 (s, 1H), 8.26 (dd, <i>J</i> = 7.2, 4.4 Hz, 2H), 8.10 (d, <i>J</i> = 2.0 Hz, 1H), 7.99–7.73 (m, 2H), 7.64 (d, <i>J</i> = 1.7 Hz, 1H), 7.61–7.49 (m, 3H), 7.47 (d, <i>J</i> = 2.0 Hz, 1H), 7.42–7.28 (m, 3H), 7.28–7.16 (m, 3H), 7.14–6.85 (m, 2H), 4.96 (ddd, <i>J</i> = 8.9, 6.9, 5.7 Hz, 1H), 4.66 (q, <i>J</i> = 6.8 Hz, 1H), 4.38 (ddd, <i>J</i> = 9.5, 7.7, 4.8 Hz, 1H), 3.33 (dd, <i>J</i> = 14.0, 5.7 Hz, 1H), 3.23 (dd, <i>J</i> = 14.0, 9.0 Hz, 1H), 2.75 (dd, <i>J</i> = 16.5, 6.5 Hz, 1H), 2.59 (dd, <i>J</i> = 16.5, 6.6 Hz, 1H), 2.27 (td, <i>J</i> = 9.3, 6.1 Hz, 2H), 2.21–2.08 (m, 1H), 1.98–1.87 (m, 1H), 1.25 (s, 9H), 1.17 (s, 9H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>): δ 172.3, 172.1, 170.9, 170.14, 170.10, 162.0, 139.6, 135.3, 135.0, 133.6, 132.4, 132.0, 130.4 (q, <i>J</i> = 31.9 Hz), 129.6, 128.6, 127.9, 127.8, 127.5, 127.48, 127.47, 125.9, 125.5, 125.4, 125.3, 124.2, 123.2, 123.1, 120.0 (q, <i>J</i> = 3.8 Hz), 116.0 (q, <i>J</i> = 4.1 Hz), 113.8, 103.1, 80.9, 80.0, 55.9, 53.8, 50.8, 37.4, 36.8, 31.7, 27.4, 27.3, 27.0. MS (ESI) <i>m</i>/<i>z</i>: 914.3 [M + Na]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 890.3 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-4-(<i>tert</i>-Butoxy)-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-4-oxobutanamido)-5-((4-methoxyphenyl)amino)-5-oxopentanoate (<b>65e</b>)</h4><div class="NLM_p last">Yield, 86%. <sup>1</sup>H NMR (500 MHz, acetone-<i>d</i><sub>6</sub>): δ 11.13–10.78 (m, 1H), 9.00 (s, 1H), 8.29 (t, <i>J</i> = 7.0 Hz, 2H), 7.88 (d, <i>J</i> = 8.0 Hz, 1H), 7.68 (d, <i>J</i> = 1.6 Hz, 1H), 7.62–7.43 (m, 3H), 7.38–7.31 (m, 3H), 7.24 (dd, <i>J</i> = 6.3, 3.2 Hz, 2H), 7.16–6.97 (m, 2H), 6.92–6.56 (m, 2H), 5.17–4.93 (m, 1H), 4.76 (q, <i>J</i> = 6.9 Hz, 1H), 4.59–4.29 (m, 1H), 3.63 (s, 3H), 3.38 (dd, <i>J</i> = 14.0, 5.7 Hz, 1H), 3.27 (dd, <i>J</i> = 14.0, 9.0 Hz, 1H), 2.79 (dd, <i>J</i> = 16.4, 6.6 Hz, 1H), 2.62 (dd, <i>J</i> = 16.4, 6.6 Hz, 1H), 2.38–2.25 (m, 2H), 2.23–2.12 (m, 1H), 2.00–1.90 (m, 1H), 1.29 (s, 9H), 1.21 (s, 9H). <sup>13</sup>C NMR (126 MHz, acetone-<i>d</i><sub>6</sub>): δ 172.3, 171.8, 170.8, 170.0, 169.1, 161.9, 156.2, 135.3, 135.1, 133.6, 132.4, 132.1, 131.9, 128.7, 127.9, 127.8, 127.6, 127.5, 127.4, 125.8, 125.4, 125.2, 124.2, 121.3, 120.9, 113.8, 113.7, 103.0, 80.8, 79.9, 55.7, 54.8, 53.6, 50.6, 37.6, 37.1, 31.7, 27.5, 27.4, 27.3. MS (ESI) <i>m</i>/<i>z</i>: 876.2 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-4-(<i>tert</i>-Butoxy)-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-4-oxobutanamido)-5-((3-methoxyphenyl)amino)-5-oxopentanoate (<b>65f</b>)</h4><div class="NLM_p last">Yield, 81%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 10.75 (s, 1H), 8.76 (s, 1H), 8.61 (s, 1H), 8.31 (s, 1H), 7.62 (s, 1H), 7.49–7.35 (m, 5H), 7.33–7.26 (m, 1H), 7.24–7.08 (m, 4H), 7.08–6.93 (m, 3H), 6.87 (s, 1H), 6.50 (dt, <i>J</i> = 5.8, 2.7 Hz, 1H), 5.38 (s, 1H), 4.98 (s, 1H), 4.38 (s, 1H), 3.56 (s, 3H), 3.31 (t, <i>J</i> = 7.1 Hz, 1H), 3.23 (dd, <i>J</i> = 14.0, 7.8 Hz, 1H), 2.70 (qd, <i>J</i> = 17.1, 6.6 Hz, 2H), 2.42–2.07 (m, 3H), 1.94 (s, 1H), 1.33 (s, 9H), 1.05 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.4, 171.5, 171.2, 170.3, 169.6, 162.0, 160.0, 138.8, 135.5, 133.6, 133.3, 132.3, 130.9, 129.5, 128.3, 128.2, 127.9, 127.5, 127.4, 127.1, 126.0, 125.9, 125.6, 125.0, 121.1, 113.7, 112.9, 110.3, 106.5, 103.6, 81.9, 81.3, 55.2, 54.9, 54.2, 50.0, 38.9, 37.6, 32.2, 28.1, 27.7, 27.5. MS (ESI) <i>m</i>/<i>z</i>: 876.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-4-(<i>tert</i>-Butoxy)-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-4-oxobutanamido)-5-oxo-5-((4-(trifluoromethoxy)phenyl)amino)pentanoate (<b>65g</b>)</h4><div class="NLM_p last">Yield, 86%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 10.99 (s, 1H), 8.76 (s, 1H), 8.07 (d, <i>J</i> = 7.6 Hz, 1H), 7.90–7.69 (m, 7H), 7.52 (dt, <i>J</i> = 5.4, 2.9 Hz, 3H), 7.45–7.35 (m, 2H), 7.23–7.02 (m, 3H), 6.69 (d, <i>J</i> = 4.9 Hz, 1H), 6.55 (d, <i>J</i> = 2.6 Hz, 1H), 4.76 (s, 1H), 4.70–4.60 (m, 1H), 4.45 (ddd, <i>J</i> = 10.7, 7.6, 3.6 Hz, 1H), 3.61 (dd, <i>J</i> = 14.3, 4.9 Hz, 1H), 3.28 (dd, <i>J</i> = 14.3, 9.4 Hz, 1H), 3.00 (dd, <i>J</i> = 17.0, 4.4 Hz, 1H), 2.62–2.55 (m, 1H), 2.54–2.44 (m, 1H), 2.44–2.24 (m, 3H), 1.49 (s, 9H), 1.18 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 174.5, 172.2, 171.0, 170.6, 169.5, 163.3, 145.2, 136.9, 135.8, 133.5, 132.74, 132.70, 129.8, 129.4, 127.9, 127.8, 127.7, 127.5, 126.9, 126.4, 126.3, 125.6, 121.5, 121.2, 121.0, 119.5, 113.7, 102.9, 82.6, 81.7, 56.6, 54.3, 51.1, 37.5, 35.3, 33.5, 29.3, 28.1, 27.7. MS (ESI) <i>m</i>/<i>z</i>: 930.3 [M + Na]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 906.2 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-4-(<i>tert</i>-Butoxy)-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-4-oxobutanamido)-5-oxo-5-((3-(trifluoromethoxy)phenyl)amino)pentanoate (<b>65h</b>)</h4><div class="NLM_p last">Yield, 76%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 10.93 (d, <i>J</i> = 8.7 Hz, 1H), 8.96–8.75 (m, 1H), 8.13–7.98 (m, 2H), 7.90–7.62 (m, 6H), 7.53 (q, <i>J</i> = 2.1 Hz, 1H), 7.48–7.31 (m, 4H), 7.31–7.24 (m, 1H), 7.17 (dt, <i>J</i> = 8.8, 2.3 Hz, 1H), 6.94 (d, <i>J</i> = 8.3 Hz, 2H), 6.68 (s, 1H), 4.99 (s, 1H), 4.77–4.61 (m, 1H), 4.43 (t, <i>J</i> = 8.0 Hz, 1H), 3.54 (d, <i>J</i> = 15.1 Hz, 1H), 3.34–3.20 (m, 1H), 2.92 (d, <i>J</i> = 17.6 Hz, 1H), 2.67 (dd, <i>J</i> = 20.8, 12.6 Hz, 1H), 2.49–2.31 (m, 3H), 2.23 (d, <i>J</i> = 9.1 Hz, 1H), 1.48 (d, <i>J</i> = 2.4 Hz, 9H), 1.20 (d, <i>J</i> = 3.3 Hz, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 174.2, 171.9, 170.9, 170.8, 169.6, 162.8, 149.4, 139.5, 135.8, 133.5, 133.0, 132.6, 130.1, 129.7, 129.0, 128.0, 127.8, 127.4, 126.6, 126.2, 125.5, 121.5, 121.0, 119.5, 118.2, 116.2, 113.7, 112.9, 103.0, 82.5, 81.6, 56.2, 54.3, 50.9, 38.0, 36.1, 33.0, 28.1, 27.7, 27.4. MS (ESI) <i>m</i>/<i>z</i>: 930.3 [M + Na]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 906.3 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-4-(<i>tert</i>-Butoxy)-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-4-oxobutanamido)-5-((3,5-dimethoxyphenyl)amino)-5-oxopentanoate (<b>65i</b>)</h4><div class="NLM_p last">Yield, 83%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 10.86 (s, 1H), 8.73 (s, 1H), 8.40 (s, 1H), 8.22 (s, 1H), 7.61 (q, <i>J</i> = 11.7, 9.7 Hz, 4H), 7.51 (d, <i>J</i> = 2.0 Hz, 1H), 7.31 (t, <i>J</i> = 8.3 Hz, 5H), 7.15 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 6.95 (d, <i>J</i> = 2.2 Hz, 2H), 6.85 (s, 1H), 6.19 (t, <i>J</i> = 2.2 Hz, 1H), 5.28 (s, 1H), 4.93 (s, 1H), 4.45 (s, 1H), 3.67 (s, 6H), 3.44 (dd, <i>J</i> = 14.0, 6.1 Hz, 1H), 3.31 (dd, <i>J</i> = 14.0, 8.1 Hz, 1H), 2.84 (dd, <i>J</i> = 16.7, 4.9 Hz, 1H), 2.74 (dd, <i>J</i> = 16.7, 7.4 Hz, 1H), 2.48–2.24 (m, 3H), 2.18–2.07 (m, 1H), 1.45 (s, 9H), 1.19 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.7, 171.5, 171.0, 170.5, 169.5, 162.3, 160.9, 139.5, 135.6, 133.38, 133.36, 132.4, 130.6, 128.5, 128.2, 127.9, 127.5, 127.4, 127.0, 126.2, 126.0, 125.8, 125.1, 121.0, 113.7, 103.3, 98.7, 96.9, 82.1, 81.4, 55.3, 55.3, 54.3, 50.3, 38.6, 37.0, 32.5, 28.1, 27.7, 27.5. MS (ESI) <i>m</i>/<i>z</i>: 906.4 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-4-(<i>tert</i>-Butoxy)-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-4-oxobutanamido)-5-((3-methoxy-5-(trifluoromethyl)phenyl)amino)-5-oxopentanoate (<b>65j</b>)</h4><div class="NLM_p last">Yield, 80%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 10.86 (s, 1H), 8.92 (s, 1H), 8.31 (s, 1H), 8.14 (d, <i>J</i> = 7.3 Hz, 1H), 7.73–7.58 (m, 5H), 7.54 (d, <i>J</i> = 2.0 Hz, 1H), 7.50 (s, 1H), 7.42–7.27 (m, 4H), 7.16 (dd, <i>J</i> = 8.7, 2.0 Hz, 2H), 6.88–6.52 (m, 2H), 5.15 (d, <i>J</i> = 8.6 Hz, 1H), 4.80 (td, <i>J</i> = 7.5, 4.6 Hz, 1H), 4.49–4.30 (m, 1H), 3.74 (s, 3H), 3.46 (dd, <i>J</i> = 14.0, 6.1 Hz, 1H), 3.28 (dd, <i>J</i> = 14.0, 8.4 Hz, 1H), 2.92–2.78 (m, 1H), 2.81–2.69 (m, 1H), 2.48–2.28 (m, 3H), 2.17 (d, <i>J</i> = 6.1 Hz, 1H), 1.48 (s, 9H), 1.20 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 174.1, 171.8, 170.9, 170.8, 169.7, 162.5, 160.1, 139.7, 135.6, 133.4, 133.1, 132.5, 131.7 (d, <i>J</i> = 32.3 Hz), 130.3, 128.7, 128.1, 127.8, 127.6, 127.4, 126.7, 126.4, 126.1, 126.0, 125.3, 123.8 (q, <i>J</i> = 272.5 Hz), 121.0, 113.7, 109.2 (d, <i>J</i> = 4.1 Hz), 108.9, 106.8, 103.0, 82.4, 81.6, 55.6, 55.5, 54.4, 50.6, 38.4, 36.6, 32.7, 28.1, 27.7, 27.2. MS (ESI) <i>m</i>/<i>z</i>: 944.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_5_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>tert</i>-Butyl (<i>S</i>)-5-(Benzo[<i>d</i>][1,3]dioxol-5-ylamino)-4-((<i>S</i>)-4-(<i>tert</i>-butoxy)-2-((<i>S</i>)-2-(5-chloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-4-oxobutanamido)-5-oxopentanoate (<b>65k</b>)</h4><div class="NLM_p last">Yield, 88%. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>): δ 10.75 (s, 1H), 8.73 (s, 1H), 8.63 (s, 1H), 8.36 (s, 1H), 7.65 (s, 1H), 7.49–7.33 (m, 5H), 7.27–7.09 (m, 5H), 7.05 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 6.88 (s, 1H), 6.82 (dd, <i>J</i> = 8.4, 2.1 Hz, 1H), 6.51 (d, <i>J</i> = 8.3 Hz, 1H), 5.75 (d, <i>J</i> = 1.5 Hz, 1H), 5.70 (s, 1H), 5.39 (s, 1H), 5.01 (s, 1H), 4.40 (s, 1H), 3.33 (dd, <i>J</i> = 14.2, 6.3 Hz, 1H), 3.23 (d, <i>J</i> = 14.1 Hz, 1H), 2.76 (dd, <i>J</i> = 16.7, 8.0 Hz, 1H), 2.66 (d, <i>J</i> = 13.0 Hz, 1H), 2.42–2.10 (m, 3H), 1.94 (s, 1H), 1.33 (s, 9H), 1.05 (s, 9H). <sup>13</sup>C NMR (126 MHz, chloroform-<i>d</i>): δ 173.3, 171.5, 171.1, 170.3, 169.5, 161.9, 147.6, 144.4, 135.5, 133.6, 133.3, 132.3, 131.8, 130.9, 128.3, 128.2, 127.9, 127.4, 127.3, 127.1, 126.0, 125.9, 125.6, 125.0, 121.0, 114.0, 113.7, 107.8, 103.8, 103.3, 101.2, 81.8, 81.2, 54.9, 53.9, 49.9, 38.9, 37.7, 32.1, 28.1, 27.7, 27.4. MS (ESI) <i>m</i>/<i>z</i>: 890.3 [M + Na]<sup>+</sup>, MS (ESI) <i>m</i>/<i>z</i>: 866.3 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Ethyl (<i>S</i>)-4-(((Benzyloxy)carbonyl)amino)-5-oxo-5-((4(trifluoromethoxy)phenyl)amino)pentanoate (<b>90</b>)</h4><div class="NLM_p last">Yield, 76%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.25 (s, 1H), 8.09–7.58 (m, 3H), 7.53–7.15 (m, 6H), 5.33–4.85 (m, 2H), 4.16 (td, <i>J</i> = 8.3, 5.6 Hz, 1H), 4.02 (qd, <i>J</i> = 7.1, 1.3 Hz, 2H), 2.38 (ddd, <i>J</i> = 8.5, 6.6, 3.8 Hz, 2H), 1.98 (pd, <i>J</i> = 6.1, 2.4 Hz, 1H), 1.94–1.78 (m, 1H), 1.14 (t, <i>J</i> = 7.1 Hz, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.5, 171.1, 156.5, 144.1, 138.5, 137.4, 128.8, 128.3, 128.2, 122.1, 121.6, 121.1, 119.6, 66.0, 60.4, 55.2, 30.6, 27.4, 14.5. MS (ESI) <i>m</i>/<i>z</i>: 469.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_5_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2<i>H</i>-tetrazol-5-yl)propanamido)-5-oxo-5-((4-(trifluoromethoxy)phenyl)amino)pentanoate (<b>91a</b>)</h4><div class="NLM_p last">Yield, 60%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.26 (s, 1H), 8.35 (d, <i>J</i> = 7.5 Hz, 1H), 7.88 (d, <i>J</i> = 7.5 Hz, 2H), 7.80 (d, <i>J</i> = 8.2 Hz, 1H), 7.75–7.69 (m, 2H), 7.66 (t, <i>J</i> = 8.4 Hz, 2H), 7.41 (tt, <i>J</i> = 7.5, 1.5 Hz, 2H), 7.31 (tt, <i>J</i> = 7.4, 1.3 Hz, 4H), 4.58 (td, <i>J</i> = 8.6, 5.3 Hz, 1H), 4.39 (td, <i>J</i> = 8.1, 5.1 Hz, 1H), 4.29–4.15 (m, 3H), 3.39–3.34 (m, 1H), 3.23 (dd, <i>J</i> = 15.3, 9.1 Hz, 1H), 2.37–2.18 (m, 2H), 1.99 (ddd, <i>J</i> = 9.9, 8.4, 5.2 Hz, 1H), 1.86 (dtd, <i>J</i> = 14.1, 9.2, 5.7 Hz, 1H), 1.33 (s, 9H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 171.9, 170.8, 170.5, 156.2, 144.2, 141.1, 138.3, 128.1, 127.6, 127.5, 125.8, 125.7, 122.1, 121.6, 121.3, 120.6, 119.6, 80.2, 66.4, 55.4, 53.5, 53.3, 47.0, 31.6, 28.1, 27.5. MS (ESI) <i>m</i>/<i>z</i>: 724.3 [M + H]<sup>+</sup>, 746.2 [M + Na]<sup>+</sup>, 722.3 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Ethyl (<i>S</i>)-4-((<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2<i>H</i>-tetrazol-5-yl)propanamido)-5-oxo-5-((4-(trifluoromethoxy)phenyl)amino)pentanoate (<b>91b</b>)</h4><div class="NLM_p last">Yield, 69%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.23 (s, 1H), 8.34 (d, <i>J</i> = 7.5 Hz, 1H), 7.88 (d, <i>J</i> = 7.5 Hz, 2H), 7.78 (d, <i>J</i> = 8.1 Hz, 1H), 7.74–7.69 (m, 2H), 7.66 (t, <i>J</i> = 8.4 Hz, 2H), 7.40 (tt, <i>J</i> = 7.6, 1.5 Hz, 2H), 7.31 (tt, <i>J</i> = 7.4, 1.4 Hz, 5H), 4.57 (td, <i>J</i> = 8.5, 5.4 Hz, 1H), 4.39 (td, <i>J</i> = 8.2, 5.4 Hz, 1H), 4.31–4.13 (m, 3H), 3.98 (qd, <i>J</i> = 7.1, 1.8 Hz, 2H), 3.22 (dd, <i>J</i> = 15.3, 9.0 Hz, 2H), 2.41–2.25 (m, 2H), 2.04 (ddt, <i>J</i> = 14.9, 9.8, 5.8 Hz, 1H), 1.95–1.82 (m, 1H), 1.10 (t, <i>J</i> = 7.1 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i>: 696.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_5_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>tert</i>-Butyl 2-(((<i>S</i>)-1-(((<i>S</i>)-1-(((<i>S</i>)-5-(<i>tert</i>-Butoxy)-1,5-dioxo-1-((4-(trifluoromethoxy)phenyl)amino)pentan-2-yl)amino)-1-oxo-3-(2<i>H</i>-tetrazol-5-yl)propan-2-yl)amino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)carbamoyl)-5-chloro-1<i>H</i>-indole-1-carboxylate (<b>92a</b>)</h4><div class="NLM_p last">Yield, 56%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.34 (s, 1H), 9.02 (d, <i>J</i> = 8.3 Hz, 1H), 8.65 (d, <i>J</i> = 7.7 Hz, 1H), 8.34 (d, <i>J</i> = 7.5 Hz, 1H), 7.84 (td, <i>J</i> = 41.5, 40.5, 8.7 Hz, 8H), 7.60–7.18 (m, 6H), 6.78 (s, 1H), 5.00–4.72 (m, 2H), 4.40 (q, <i>J</i> = 7.3 Hz, 1H), 3.31–2.87 (m, 4H), 2.28 (ddt, <i>J</i> = 20.7, 15.7, 7.7 Hz, 2H), 2.01 (p, <i>J</i> = 7.4, 6.9 Hz, 1H), 1.85 (h, <i>J</i> = 6.8, 6.2 Hz, 1H), 1.31 (s, 9H), 1.26 (s, 9H).</div></div><div id="sec4_5_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>tert</i>-Butyl 5-Chloro-2-(((<i>S</i>)-1-(((<i>S</i>)-1-(((<i>S</i>)-5-ethoxy-1,5-dioxo-1-((4-(trifluoromethoxy)phenyl)amino)pentan-2-yl)amino)-1-oxo-3-(2<i>H</i>-tetrazol-5-yl)propan-2-yl)amino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)carbamoyl)-1<i>H</i>-indole-1-carboxylate (<b>92b</b>)</h4><div class="NLM_p last">Yield, 58%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.39 (d, <i>J</i> = 35.1 Hz, 1H), 9.00 (dd, <i>J</i> = 30.5, 8.3 Hz, 1H), 8.70 (dd, <i>J</i> = 48.7, 7.8 Hz, 1H), 8.39 (dd, <i>J</i> = 36.7, 7.4 Hz, 1H), 8.08–7.61 (m, 8H), 7.61–7.22 (m, 6H), 6.76 (d, <i>J</i> = 25.8 Hz, 1H), 4.99–4.70 (m, 2H), 4.40 (qd, <i>J</i> = 7.9, 4.9 Hz, 1H), 4.15–3.81 (m, 2H), 3.32–2.86 (m, 4H), 2.37 (qd, <i>J</i> = 9.5, 8.7, 4.3 Hz, 2H), 2.05 (d, <i>J</i> = 10.5 Hz, 1H), 1.98–1.77 (m, 1H), 1.26 (s, 9H), 1.17–0.91 (m, 3H). MS (ESI) <i>m</i>/<i>z</i>: 948.3 [M + H]<sup>+</sup>, 970.3 [M + H]<sup>+</sup>, 946.3 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> <i>tert</i>-Butyl (<i>S</i>)-4-((<i>S</i>)-2-((<i>S</i>)-2-(4,6-Dichloro-1<i>H</i>-indole-2-carboxamido)-3-(naphthalen-2-yl)propanamido)-3-(2<i>H</i>-tetrazol-5-yl)propanamido)-5-oxo-5-((4-(trifluoromethoxy)phenyl)amino)pentanoate (<b>92c</b>)</h4><div class="NLM_p last">Yield, 53%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.94 (d, <i>J</i> = 2.3 Hz, 1H), 10.29 (s, 1H), 8.97 (d, <i>J</i> = 8.4 Hz, 1H), 8.71 (d, <i>J</i> = 7.6 Hz, 1H), 8.31 (d, <i>J</i> = 7.5 Hz, 1H), 7.96–7.63 (m, 4H), 7.53 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 7.48–7.25 (m, 4H), 7.21 (dd, <i>J</i> = 4.7, 1.7 Hz, 1H), 4.98–4.67 (m, 2H), 4.41 (td, <i>J</i> = 8.1, 5.1 Hz, 1H), 3.44 (dd, <i>J</i> = 15.3, 6.3 Hz, 1H), 3.30–3.28 (m, 2H), 3.14 (dd, <i>J</i> = 13.9, 11.0 Hz, 1H), 2.29 (qdd, <i>J</i> = 16.2, 11.8, 3.9 Hz, 2H), 2.02 (ddd, <i>J</i> = 15.2, 10.2, 5.4 Hz, 1H), 1.94–1.74 (m, 1H), 1.31 (d, <i>J</i> = 1.8 Hz, 9H).</div></div><div id="sec4_5_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> (<i>S</i>)-2-Amino-<i>N</i><sup>1</sup>-(4-(trifluoromethoxy)phenyl)pentanediamide (<b>95</b>)</h4><div class="NLM_p last">Yield, 75%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.91–7.62 (m, 2H), 7.43–7.12 (m, 3H), 6.71 (s, 1H), 3.45–3.15 (m, 3H), 2.26–2.05 (m, 2H), 1.86 (dddd, <i>J</i> = 13.4, 9.3, 6.6, 5.4 Hz, 1H), 1.75–1.58 (m, 1H). MS (ESI) <i>m</i>/<i>z</i>: 306.1 [M + H]<sup>+</sup>, 304.2 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> (9<i>H</i>-Fluoren-9-yl)methyl ((<i>S</i>)-1-(((<i>S</i>)-5-Amino-1,5-dioxo-1-((4-(trifluoromethoxy)phenyl)amino)pentan-2-yl)amino)-1-oxo-3-(2<i>H</i>-tetrazol-5-yl)propan-2-yl)carbamate (<b>96</b>)</h4><div class="NLM_p last">Yield, 71%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.34 (s, 1H), 8.36 (d, <i>J</i> = 7.3 Hz, 1H), 7.88 (d, <i>J</i> = 7.6 Hz, 2H), 7.74 (dd, <i>J</i> = 8.5, 6.2 Hz, 3H), 7.67 (t, <i>J</i> = 8.2 Hz, 2H), 7.53–7.37 (m, 2H), 7.37–7.07 (m, 5H), 7.01–6.61 (m, 1H), 4.55 (td, <i>J</i> = 8.4, 5.4 Hz, 1H), 4.40–4.14 (m, 4H), 3.22 (dd, <i>J</i> = 15.3, 8.9 Hz, 2H), 2.15 (dt, <i>J</i> = 9.3, 6.3 Hz, 2H), 1.99 (s, 1H), 1.87–1.73 (m, 1H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 173.9, 170.9, 170.8, 156.2, 144.2, 141.1, 138.4, 128.11, 127.6, 127.5, 125.8, 125.7, 122.0, 121.6, 121.4, 120.6, 119.6, 66.4, 60.2, 53.4, 47.0, 31.7, 28.0. MS (ESI) <i>m</i>/<i>z</i>: 667.3 [M + H]<sup>+</sup>, 665.3 [M – H]<sup>−</sup>.</div></div><div id="sec4_5_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>tert</i>-Butyl 2-(((<i>S</i>)-1-(((<i>S</i>)-1-(((<i>S</i>)-5-Amino-1,5-dioxo-1-((4-(trifluoromethoxy)phenyl)amino)pentan-2-yl)amino)-1-oxo-3-(2<i>H</i>-tetrazol-5-yl)propan-2-yl)amino)-3-(naphthalen-2-yl)-1-oxopropan-2-yl)carbamoyl)-5-chloro-1<i>H</i>-indole-1-carboxylate (<b>97</b>)</h4><div class="NLM_p last">Yield, 65%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.33 (s, 1H), 9.01 (d, <i>J</i> = 8.4 Hz, 1H), 8.63 (d, <i>J</i> = 7.6 Hz, 1H), 8.39 (d, <i>J</i> = 7.3 Hz, 1H), 7.99–7.62 (m, 8H), 7.56–7.20 (m, 7H), 6.93–6.62 (m, 2H), 4.81 (dt, <i>J</i> = 7.6, 4.2 Hz, 2H), 4.37 (td, <i>J</i> = 7.8, 5.6 Hz, 1H), 3.43–3.03 (m, 4H), 2.30–2.12 (m, 2H), 2.03–1.99 (m, 1H), 1.88 (ddt, <i>J</i> = 11.8, 8.0, 3.6 Hz, 1H), 1.25 (s, 9H). MS (ESI) <i>m</i>/<i>z</i>: 919.3 [M + H]<sup>+</sup>, 917.2 [M – H]<sup>−</sup>.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Peptides, and Protein Expression and Purification<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a></h3><div class="NLM_p">Wild-type human β-catenin (residues 138–781) were cloned into a pET-28b vector carrying a C-terminal 6× histidine (Novagen) and transformed into <i>Escherichia coli</i> BL21 DE3 (Novagen). Cells were cultured in LB medium with 30 μg/mL kanamycin until the OD<sub>600</sub> was approximately 0.8. The protein expression was then induced with 400 μM IPTG at 16 °C overnight. Cells were lysed by sonication. The proteins were purified by two steps of chromatography, including Ni-NTA affinity chromatography (30210, Qiagen) and size-exclusion chromatography with a HiLoad 26/600 Superdex 200 pg column (28-9893-36, GE Healthcare Life Science) using an AKTA Pure FPLC system (GE Healthcare Life Science). Protein was eluted in the buffer containing 20 mM Tris (pH 8.5), 100 mM NaCl, and 2 mM DTT. The purity of β-catenin was greater than 95% as determined by SDS-PAGE gel analysis. Thermal-shift assay was performed on a CFX96 Real Time System (Bio-Rad) to monitor protein stability and detect protein aggregation. Protein unfolding was evaluated through measuring the fluorescence changes of fluorescent dye SYPRO Orange when interacting with wild-type or mutant β-catenin proteins. A temperature increment of 1°/min was applied. All proteins were stable, and no aggregation was observed under storage or assay conditions. Proteins were aliquoted and stored at −80 °C. The SDS-PAGE result of the purified β-catenin is shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a> Figure S1.</div><div class="NLM_p last">C-terminally fluorescein-labeled human Tcf4 (residues 7–51), C-terminally fluorescein-labeled human E-cadherin (residues 819–873), and C-terminally fluorescein-labeled human APC-R3 (residues 1477–1519) were synthesized by InnoPep, Inc. (<a href="http://www.innopep.com/" class="extLink">http://www.innopep.com/</a>) and HPLC purified with purity > 95%. The structures were validated by LC–MS (liquid chromatography–mass spectrometry). The sequences of these peptides were reported previously<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a> Table S1.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> FP Competitive Inhibition Assays<a onclick="showRef(event, 'ref29 ref45'); return false;" href="javascript:void(0);" class="ref ref29 ref45">(29,45)</a></h3><div class="NLM_p last">Experiments were performed in 96-well Microfluor 2 black plates on a Synergy 2 plate reader (Biotek). The polarization was measured at room temperature with an excitation wavelength at 485 nm and an emission wavelength at 535 nm. The FP experiments were performed in an assay buffer of 25 mM Hepes (pH 7.4), 100 mM NaCl, 0.01% Triton X-100, and 100 μg/mL γ-globulin. The final reaction volume was set to 100 μL. For the β-catenin/Tcf assay, 10 nM human β-catenin (residues 138–781) was incubated with 2.5 nM C-terminally fluorescein-labeled human Tcf4 (residues 7–51) for 30 min at 4 °C, and then different concentrations of the compound in assay buffer were added. The negative control (equivalent to 0% inhibition) refers to 2.5 nM Tcf4 fluorescence tracer and 10 nM β-catenin in assay buffer without the tested compound. The positive control (equivalent to 100% inhibition) refers to only 2.5 nM Tcf4 fluorescence tracer in assay buffer. For the β-catenin/cadherin assay, 150 nM human β-catenin (residues 138–781) was incubated with 5 nM C-terminally fluorescent-labeled human E-cadherin (residues 819–873) in assay buffer for 30 min at 4 °C. The negative control refers to a 5 nM E-cadherin fluorescence tracer and 150 nM β-catenin in assay buffer with no inhibitor presenting. The positive control refers to a 5 nM E-cadherin fluorescence tracer in assay buffer. For the β-catenin/APC-R3 assay, 2000 nM human β-catenin (residues 138–781) was incubated with 5 nM of C-terminally fluorescent-labeled human APC-R3 (residues 1477–1519) in assay buffer for 30 min at 4 °C. The negative control refers to a 5 nM APC-R3 fluorescence tracer and 2000 nM β-catenin in assay buffer without the tested compound. The positive control refers to a 5 nM APC-R3 fluorescence tracer in assay buffer. Each assay plate was covered black and gently mixed on an orbital shaker at 4 °C for 2.5 h to reach equilibrium before the polarization values were read. The background of the tested inhibitors was corrected by subtracting the raw intensity values of the sample background well (all components except probe) from the raw intensity values of the corresponding test wells (all components). The IC<sub>50</sub> values were determined by GraphPad Prism 5.0. The <i>K</i><sub>i</sub> values were derived from the IC<sub>50</sub> values.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The equation used is <i>K</i><sub>i</sub> = [I]<sub>50</sub>/([L]<sub>50</sub>/<i>K</i><sub>d</sub> + [P]<sub>0</sub>/<i>K</i><sub>d</sub> + 1) (where [I]<sub>50</sub> denotes the concentration of the free inhibitor at 50% inhibition, [L]<sub>50</sub> is the concentration of the free labeled ligand at 50% inhibition, [P]<sub>0</sub> is the concentration of the free protein at 0% inhibition, and <i>K</i><sub>d</sub> is the dissociation constant of the protein–ligand complex). All of the experiments were performed in triplicate and carried out in the presence of 1% DMSO for small-molecule inhibitors. Each compound was assayed at least by two independent experiments. The results were expressed as mean ± standard deviation. The Tcf/cadherin selectivity ratio was calculated on the basis of the respective <i>K</i><sub>i</sub> value of the β-catenin/E-cadherin interaction over that of the β-catenin/Tcf4 interaction. The Tcf/APC selectivity ratio was calculated on the basis of the respective <i>K</i><sub>i</sub> value of the β-catenin/APC-R3 interaction over that of the β-catenin/Tcf4 interaction. The FP saturation binding assay curves and the <i>K</i><sub>d</sub>’s of the β-catenin/Tcf, β-catenin/E-cadherin, and β-catenin/APC interactions are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">Supporting Information</a> Figure S2.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> MTS Cell Viability Assay</h3><div class="NLM_p last">Colorectal cancer cells (SW480 and HCT116), TNBC cells (MDA-MB-231, MDA-MB-468, and BT-20), and lung cancer A549 cells were seeded in 96-well plates at 5 × 10<sup>3</sup> cells/well, maintained overnight at 37 °C, and incubated with the tested compounds at various concentrations. Cell viability was monitored after 72 h using a freshly prepared mixture of 1 part phenazine methosulfate (Sigma) solution (0.92 mg/mL) and 19 parts MTS (Promega) solution (2 mg/mL). Cells were incubated in 10 μL of this solution at 37 °C for 3 h, and <i>A</i><sub>490</sub> was measured. The effect of each compound is expressed as the concentration required to reduce <i>A</i><sub>490</sub> by 50% (IC<sub>50</sub>) relative to DMSO-treated cells. Experiments were performed in triplicate.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Cell Transfection and Luciferase Assay</h3><div class="NLM_p last">FuGENE 6 (E2962, Promega) in the 96-well plate format was used for the transfection of HEK293 cells according to the manufacturer’s instructions. HEK293 cells were co-transfected with 45 ng of the TOPFlash or FOPFlash reporter gene and 135 ng of pcDNA3.1−β-catenin. Cells were cultured in DMEM and 10% FBS at 37 °C for 24 h, and different concentrations of inhibitors were then added. After 24 h, the luciferase reporter activity was measured using the Dual-Glo system (E2940, Promega). Normalized luciferase activity in response to the treatment with the inhibitors was compared with that obtained from the cells treated with DMSO. Experiments were performed in triplicate.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Co-IP Experiments</h3><div class="NLM_p last">Two sets of co-IP experiments were conducted: one where the inhibitor was added onto the cell lysates and the second where the inhibitor was added onto the live cells. For the cell lysate co-IP experiments, SW480 cells were lysed in buffer A containing 50 mM Tris, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 2 mM ethylenediaminetetraacetic acid (EDTA), and protease inhibitors. Different concentrations of the inhibitor were incubated with the SW480 cell lysates at 4 °C for 4 h. For the whole cell co-IP experiments, HCT116 cells at 1 × 10<sup>6</sup>/mL were treated with different concentrations of the inhibitor for 24 h. Cells were then lysed in buffer containing 50 mM Tris, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 2 mM EDTA, and protease inhibitors. For both cell lysate and whole cell co-IP experiments, the lysates were preadsorbed to A/G plus agarose (sc-2003, Santa Cruz Biotechnology, Inc.) at 4 °C for 1 h. Preadsorbed lysates were incubated with a specific primary antibody overnight at 4 °C. A/G plus agarose was then added to the lysates mixture and incubated for 3 h. The beads were washed 5 times with the lysis buffer at 4 °C. The bound protein was eluted by boiling in the SDS sample buffer and loaded onto 8% SDS polyacrylamide gel for electrophoretic analysis. Separated proteins were transferred onto nitrocellulose membranes for immunoblot analysis. The primary antibodies were against β-catenin (610153, BD Biosciences) and Tcf4 (05-511, Millipore), E-cadherin (610404, BD Biosciences), and APC (MAB3785, Millipore). IRDye 680LT goat antimouse IgG (827-11080, LiCOR) was used as the secondary antibody. The images were detected by the Odyssey infrared imaging system (LiCOR). Experiments were performed in duplicate.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Scratch Wound Healing Assay</h3><div class="NLM_p last">To the ∼70–80% confluent monolayer of MDA-MB-231 cells in 24-well plates, wounds will be made by scraping a sterile 200 μL pipette tip. Cells were maintained in DMEM containing 10% FBS with 10 μg/mL mitomycin to inhibit cell proliferation. Images of wounds were taken immediately and 14 h after wounding.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Matrigel Invasion Assay</h3><div class="NLM_p last">MDA-MB-231 cells (5 × 10<sup>4</sup>) suspended in 200 μL starvation medium were added to the upper chamber of a Matrigel coated insert (6.5 mm diameter, 8 mm pore size; Corning 353097), and the insert was placed in a 24-well plate containing 600 μL DMEM medium with 10% FBS. Inhibitors were added to both upper and the lower chambers. Invasion assays were performed for 24 h, and the cells were fixed with 3.7% formaldehyde. Cells were then stained with crystal violet staining solution. The cells on the upper side of the insert were removed with a cotton swab. Five randomly selected fields (×10 objectives) on the lower side of the insert were photographed, and the invaded cells were counted. Experiments were performed in triplicate.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00147" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00147" class="ext-link">10.1021/acs.jmedchem.9b00147</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Supplemental procedures, chemical stability of <b>1</b> and <b>21</b>, determination of the intracellular concentrations of <b>53</b> and <b>56</b>, FP and MTS cell viability assay curves of β-catenin/Tcf inhibitors, sequences of the fluorescence tracers, SDS-PAGE result of the purified β-catenin (residue 138–781), full western blot images of co-IP experiments, supplementary synthetic schemes S1–S14, HPLC conditions and chromatograms, NMR spectra, and the supplementary references (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf">jm9b00147_si_001.pdf (13.74 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_002.csv">jm9b00147_si_002.csv (7.7 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00147" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15818" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15818" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haitao Ji</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Department, H. Lee Moffitt Cancer
Center and Research Institute, Tampa, Florida 33612-9497, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments
of Oncologic Sciences and Chemistry, University
of South Florida, Tampa, Florida 33620-9497, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5526-4503" title="Orcid link">http://orcid.org/0000-0001-5526-4503</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e8a089819c8987c6a281a885878e8e819c9cc6879a8f"><span class="__cf_email__" data-cfemail="276f464e534648096d4e674a4841414e535309485540">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhen Wang</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Department, H. Lee Moffitt Cancer
Center and Research Institute, Tampa, Florida 33612-9497, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Zhang</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Department, H. Lee Moffitt Cancer
Center and Research Institute, Tampa, Florida 33612-9497, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Wang</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Department, H. Lee Moffitt Cancer
Center and Research Institute, Tampa, Florida 33612-9497, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Z.W. and M.Z. contribute equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): a provisional patent application has been filed based on these results.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56055" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56055" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Susan G. Komen Career Catalyst Research Grant CCR16380693. The H. Lee Moffitt Cancer Center & Research Institute is a NCI-designated Comprehensive Cancer Center, supported under NIH grant P30-CA76292.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">TCF</td><td class="NLM_def"><p class="first last">T-cell factor</p></td></tr><tr><td class="NLM_term">Lef</td><td class="NLM_def"><p class="first last">lymphoid enhancer-binding factor</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">adenomatous polyposis coli</p></td></tr><tr><td class="NLM_term">Treg</td><td class="NLM_def"><p class="first last">regulator T cell</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">inhibition constant</p></td></tr><tr><td class="NLM_term">BCL9</td><td class="NLM_def"><p class="first last">B-cell lymphoma 9</p></td></tr><tr><td class="NLM_term">B9L</td><td class="NLM_def"><p class="first last">BCL9-like</p></td></tr><tr><td class="NLM_term">CBP</td><td class="NLM_def"><p class="first last">CREB-binding protein</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">co-IP</td><td class="NLM_def"><p class="first last">co-immunoprecipitation</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i105">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 73 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span> <span> </span><span class="NLM_article-title">Wnt/β-catenin signaling and disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.cell.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=22682243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1192-1205&author=H.+Cleversauthor=R.+Nusse&title=Wnt%2F%CE%B2-catenin+signaling+and+disease&doi=10.1016%2Fj.cell.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling and disease</span></div><div class="casAuthors">Clevers, Hans; Nusse, Roel</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1192-1205</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade controls myriad biol. phenomena throughout development and adult life of all animals.  In parallel, aberrant Wnt signaling underlies a wide range of pathologies in humans.  In this Review, we provide an update of the core Wnt/β-catenin signaling pathway, discuss how its various components contribute to disease, and pose outstanding questions to be addressed in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDPj3TZSiR1rVg90H21EOLACvtfcHk0ljgZwWUPZr_lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D&md5=441540f5c9e168b2a4e657a19bbe31c7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DClevers%26aufirst%3DH.%26aulast%3DNusse%26aufirst%3DR.%26atitle%3DWnt%252F%25CE%25B2-catenin%2520signaling%2520and%2520disease%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1192%26epage%3D1205%26doi%3D10.1016%2Fj.cell.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Wnt/β-catenin signaling, disease, and emerging therapeutic modalities</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.cell.2017.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=28575679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2017&pages=985-999&author=R.+Nusseauthor=H.+Clevers&title=Wnt%2F%CE%B2-catenin+signaling%2C+disease%2C+and+emerging+therapeutic+modalities&doi=10.1016%2Fj.cell.2017.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling, disease, and emerging therapeutic modalities</span></div><div class="casAuthors">Nusse, Roel; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">985-999</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade is a main regulator of development throughout the animal kingdom.  Wnts are also key drivers of most types of tissue stem cells in adult mammals.  Unsurprisingly, mutated Wnt pathway components are causative to multiple growth-related pathologies and to cancer.  Here, we describe the core Wnt/β-catenin signaling pathway, how it controls stem cells, and contributes to disease.  Finally, we discuss strategies for Wnt-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnL11nCbSs8LVg90H21EOLACvtfcHk0ljgZwWUPZr_lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D&md5=869cc558296677481527ac138f68fbb0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DWnt%252F%25CE%25B2-catenin%2520signaling%252C%2520disease%252C%2520and%2520emerging%2520therapeutic%2520modalities%26jtitle%3DCell%26date%3D2017%26volume%3D169%26spage%3D985%26epage%3D999%26doi%3D10.1016%2Fj.cell.2017.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akhmetshina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dees, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venalis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kireva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwerina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riener, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDougald, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, J. H.</span></span> <span> </span><span class="NLM_article-title">Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1038/ncomms1734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fncomms1734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=22415826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A280%3ADC%252BC38zhtVKmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=735-746&author=A.+Akhmetshinaauthor=K.+Palumboauthor=C.+Deesauthor=C.+Bergmannauthor=P.+Venalisauthor=P.+Zerrauthor=A.+Hornauthor=T.+Kirevaauthor=C.+Beyerauthor=J.+Zwerinaauthor=H.+Schneiderauthor=A.+Sadowskiauthor=M.+O.+Rienerauthor=O.+A.+MacDougaldauthor=O.+Distlerauthor=G.+Schettauthor=J.+H.+Distler&title=Activation+of+canonical+Wnt+signalling+is+required+for+TGF-beta-mediated+fibrosis&doi=10.1038%2Fncomms1734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis</span></div><div class="casAuthors">Akhmetshina Alfiya; Palumbo Katrin; Dees Clara; Bergmann Christina; Venalis Paulius; Zerr Pawel; Horn Angelika; Kireva Trayana; Beyer Christian; Zwerina Jochen; Schneider Holm; Sadowski Anika; Riener Marc-Oliver; MacDougald Ormond A; Distler Oliver; Schett Georg; Distler Jorg H W</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">735</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The transforming growth factor-β (TGF-β) signalling pathway is a key mediator of fibroblast activation that drives the aberrant synthesis of extracellular matrix in fibrotic diseases.  Here we demonstrate a novel link between transforming growth factor-β and the canonical Wnt pathway.  TGF-β stimulates canonical Wnt signalling in a p38-dependent manner by decreasing the expression of the Wnt antagonist Dickkopf-1.  Tissue samples from human fibrotic diseases show enhanced expression of Wnt proteins and decreased expression of Dickkopf-1.  Activation of the canonical Wnt pathway stimulates fibroblasts in vitro and induces fibrosis in vivo.  Transgenic overexpression of Dickkopf-1 ameliorates skin fibrosis induced by constitutively active TGF-β receptor type I signalling and also prevents fibrosis in other TGF-β-dependent animal models.  These findings demonstrate that canonical Wnt signalling is necessary for TGF-β-mediated fibrosis and highlight a key role for the interaction of both pathways in the pathogenesis of fibrotic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoEJ29yVOUW02yPDyEFiigfW6udTcc2eaA2se4E4sGerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zhtVKmuw%253D%253D&md5=9d10b3b0c90e2c1b72b71e43deb93765</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fncomms1734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1734%26sid%3Dliteratum%253Aachs%26aulast%3DAkhmetshina%26aufirst%3DA.%26aulast%3DPalumbo%26aufirst%3DK.%26aulast%3DDees%26aufirst%3DC.%26aulast%3DBergmann%26aufirst%3DC.%26aulast%3DVenalis%26aufirst%3DP.%26aulast%3DZerr%26aufirst%3DP.%26aulast%3DHorn%26aufirst%3DA.%26aulast%3DKireva%26aufirst%3DT.%26aulast%3DBeyer%26aufirst%3DC.%26aulast%3DZwerina%26aufirst%3DJ.%26aulast%3DSchneider%26aufirst%3DH.%26aulast%3DSadowski%26aufirst%3DA.%26aulast%3DRiener%26aufirst%3DM.%2BO.%26aulast%3DMacDougald%26aufirst%3DO.%2BA.%26aulast%3DDistler%26aufirst%3DO.%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DDistler%26aufirst%3DJ.%2BH.%26atitle%3DActivation%2520of%2520canonical%2520Wnt%2520signalling%2520is%2520required%2520for%2520TGF-beta-mediated%2520fibrosis%26jtitle%3DNat.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D735%26epage%3D746%26doi%3D10.1038%2Fncomms1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
de Wetering, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sancho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lau, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oving, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurlstone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Horn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batlle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudreuse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haramis, A.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjon-Pon-Fong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moerer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Born, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soete, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pals, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1016/s0092-8674(02)01014-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fs0092-8674%2802%2901014-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=12408868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotlahsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2002&pages=241-250&author=M.+van%0Ade+Weteringauthor=E.+Sanchoauthor=C.+Verweijauthor=W.+de+Lauauthor=I.+Ovingauthor=A.+Hurlstoneauthor=K.+van+der+Hornauthor=E.+Batlleauthor=D.+Coudreuseauthor=A.-P.+Haramisauthor=M.+Tjon-Pon-Fongauthor=P.+Moererauthor=M.+van+den+Bornauthor=G.+Soeteauthor=S.+Palsauthor=M.+Eilersauthor=R.+Medemaauthor=H.+Clevers&title=The+%CE%B2-catenin%2FTCF-4+complex+imposes+a+crypt+progenitor+phenotype+on+colorectal+cancer+cells&doi=10.1016%2Fs0092-8674%2802%2901014-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells</span></div><div class="casAuthors">Van de Wetering, Marc; Sancho, Elena; Verweij, Cornelis; De Lau, Wim; Oving, Irma; Hurlstone, Adam; Van der Horn, Karin; Batlle, Eduard; Coudreuse, Damien; Haramis, Anna-Pavlina; Tjon-Pon-Fong, Menno; Moerer, Petra; Van den Born, Maaike; Soete, Gwen; Pals, Steven; Eilers, Martin; Medema, Rene; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-250</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The transactivation of TCF target genes induced by Wnt pathway mutations constitutes the primary transforming event in colorectal cancer (CRC).  The authors show that disruption of β-catenin/TCF-4 activity in CRC cells induces a rapid G1 arrest and blocks a genetic program that is physiol. active in the proliferative compartment of colon crypts.  Coincidently, an intestinal differentiation program is induced.  The TCF-4 target gene c-MYC plays a central role in this switch by direct repression of the p21CIP1/WAF1 promoter.  Following disruption of β-catenin/TCF-4 activity, the decreased expression of c-MYC releases p21CIP1/WAF1 transcription, which in turn mediates G1 arrest and differentiation.  Thus, the β-catenin/TCF-4 complex constitutes the master switch that controls proliferation vs. differentiation in healthy and malignant intestinal epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVqLagkm3jcLVg90H21EOLACvtfcHk0ljc9CIyz9nDiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotlahsrg%253D&md5=d3b611aa88ba8ea40d333774f844038e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fs0092-8674%2802%2901014-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0092-8674%252802%252901014-0%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BWetering%26aufirst%3DM.%26aulast%3DSancho%26aufirst%3DE.%26aulast%3DVerweij%26aufirst%3DC.%26aulast%3Dde%2BLau%26aufirst%3DW.%26aulast%3DOving%26aufirst%3DI.%26aulast%3DHurlstone%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BHorn%26aufirst%3DK.%26aulast%3DBatlle%26aufirst%3DE.%26aulast%3DCoudreuse%26aufirst%3DD.%26aulast%3DHaramis%26aufirst%3DA.-P.%26aulast%3DTjon-Pon-Fong%26aufirst%3DM.%26aulast%3DMoerer%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BBorn%26aufirst%3DM.%26aulast%3DSoete%26aufirst%3DG.%26aulast%3DPals%26aufirst%3DS.%26aulast%3DEilers%26aufirst%3DM.%26aulast%3DMedema%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DThe%2520%25CE%25B2-catenin%252FTCF-4%2520complex%2520imposes%2520a%2520crypt%2520progenitor%2520phenotype%2520on%2520colorectal%2520cancer%2520cells%26jtitle%3DCell%26date%3D2002%26volume%3D111%26spage%3D241%26epage%3D250%26doi%3D10.1016%2Fs0092-8674%2802%2901014-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Rourke, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschaharganeh, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Es, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span> <span> </span><span class="NLM_article-title">Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1539</span>– <span class="NLM_lpage">1552</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.cell.2015.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=26091037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Squ7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2015&pages=1539-1552&author=L.+E.+Dowauthor=K.+P.+O%E2%80%99Rourkeauthor=J.+Simonauthor=D.+F.+Tschaharganehauthor=J.+H.+van+Esauthor=H.+Cleversauthor=S.+W.+Lowe&title=Apc+restoration+promotes+cellular+differentiation+and+reestablishes+crypt+homeostasis+in+colorectal+cancer&doi=10.1016%2Fj.cell.2015.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer</span></div><div class="casAuthors">Dow, Lukas E.; O'Rourke, Kevin P.; Simon, Janelle; Tschaharganeh, Darjus F.; van Es, Johan H.; Clevers, Hans; Lowe, Scott W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1539-1552</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The adenomatous polyposis coli (APC) tumor suppressor is mutated in the vast majority of human colorectal cancers (CRC) and leads to deregulated Wnt signaling.  To det. whether Apc disruption is required for tumor maintenance, we developed a mouse model of CRC whereby Apc can be conditionally suppressed using a doxycycline-regulated shRNA.  Apc suppression produces adenomas in both the small intestine and colon that, in the presence of Kras and p53 mutations, can progress to invasive carcinoma.  In established tumors, Apc restoration drives rapid and widespread tumor-cell differentiation and sustained regression without relapse.  Tumor regression is accompanied by the re-establishment of normal crypt-villus homeostasis, such that once aberrantly proliferating cells reacquire self-renewal and multi-lineage differentiation capability.  Our study reveals that CRC cells can revert to functioning normal cells given appropriate signals and provide compelling in vivo validation of the Wnt pathway as a therapeutic target for treatment of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOJhLhIEo70LVg90H21EOLACvtfcHk0ljc9CIyz9nDiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Squ7zF&md5=c5bdedbcfb89050521a0316438327b5a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DL.%2BE.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DK.%2BP.%26aulast%3DSimon%26aufirst%3DJ.%26aulast%3DTschaharganeh%26aufirst%3DD.%2BF.%26aulast%3Dvan%2BEs%26aufirst%3DJ.%2BH.%26aulast%3DClevers%26aufirst%3DH.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DApc%2520restoration%2520promotes%2520cellular%2520differentiation%2520and%2520reestablishes%2520crypt%2520homeostasis%2520in%2520colorectal%2520cancer%26jtitle%3DCell%26date%3D2015%26volume%3D161%26spage%3D1539%26epage%3D1552%26doi%3D10.1016%2Fj.cell.2015.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawatao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leoni, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipps, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. A.</span></span> <span> </span><span class="NLM_article-title">Activation of the Wnt signaling pathway in chronic lymphocytic leukemia</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">3118</span>– <span class="NLM_lpage">3123</span>, <span class="refDoi"> DOI: 10.1073/pnas.0308648100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.0308648100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=14973184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlWhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=3118-3123&author=D.+Luauthor=Y.+Zhaoauthor=R.+Tawataoauthor=H.+B.+Cottamauthor=M.+Senauthor=L.+M.+Leoniauthor=T.+J.+Kippsauthor=M.+Corrauthor=D.+A.+Carson&title=Activation+of+the+Wnt+signaling+pathway+in+chronic+lymphocytic+leukemia&doi=10.1073%2Fpnas.0308648100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the Wnt signaling pathway in chronic lymphocytic leukemia</span></div><div class="casAuthors">Lu, Desheng; Zhao, Yandong; Tawatao, Rommel; Cottam, Howard B.; Sen, Malini; Leoni, Lorenzo M.; Kipps, Thomas J.; Corr, Maripat; Carson, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3118-3123</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">B cell chronic lymphocytic leukemia (CLL) is characterized by an accumulation of mature, functionally incompetent B cells.  Wnts are a large family of secreted glycoproteins involved in cell proliferation, differentiation, and oncogenesis.  The classical Wnt signaling cascade inhibits the activity of the enzyme glycogen synthase kinase-3β, augmenting β-catenin translocation to the nucleus, and the transcription of target genes.  Little is known about the potential roles of Wnt signaling in CLL.  In this study, the authors quantified the gene expression profiles of the Wnt family, and their cognate frizzled (Fzd) receptors in primary CLL cells, and detd. the role of Wnt signaling in promoting CLL cell survival.  Wnt3, Wnt5b, Wnt6, Wnt10a, Wnt14, and Wnt16, as well as the Wnt receptor Fzd3, were highly expressed in CLL, compared with normal B cells.  Three lines of evidence suggested that the Wnt signaling pathway was active in CLL.  First, the Wnt/β-catenin-regulated transcription factor lymphoid-enhancing factor-1, and its downstream target cyclin D1, were overexpressed in CLL.  Second, a pharmacol. inhibitor of glycogen synthase kinase-3β, SB-216763, activated β-catenin-mediated transcription, and enhanced the survival of CLL lymphocytes.  Third, Wnt/β-catenin signaling was diminished by an analog of a nonsteroidal antiinflammatory drug (R-etodolac), at concns. that increased apoptosis of CLL cells.  Taken together, these results indicate that Wnt signaling genes are overexpressed and are active in CLL.  Uncontrolled Wnt signaling may contribute to the defect in apoptosis that characterizes this malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV-46cT9ujIrVg90H21EOLACvtfcHk0lgIDf_0Kp3pgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlWhtL8%253D&md5=6cccf8814aa66e9db8ab83e7a11f6553</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0308648100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0308648100%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DTawatao%26aufirst%3DR.%26aulast%3DCottam%26aufirst%3DH.%2BB.%26aulast%3DSen%26aufirst%3DM.%26aulast%3DLeoni%26aufirst%3DL.%2BM.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DCorr%26aufirst%3DM.%26aulast%3DCarson%26aufirst%3DD.%2BA.%26atitle%3DActivation%2520of%2520the%2520Wnt%2520signaling%2520pathway%2520in%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D3118%26epage%3D3123%26doi%3D10.1073%2Fpnas.0308648100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sukhdeo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, D. R.</span></span> <span> </span><span class="NLM_article-title">Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">7516</span>– <span class="NLM_lpage">7521</span>, <span class="refDoi"> DOI: 10.1073/pnas.0610299104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.0610299104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=17452641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A280%3ADC%252BD2s3nt1Wnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=7516-7521&author=K.+Sukhdeoauthor=M.+Maniauthor=Y.+Zhangauthor=J.+Duttaauthor=H.+Yasuiauthor=M.+D.+Rooneyauthor=D.+E.+Carrascoauthor=M.+Zhengauthor=H.+Heauthor=Y.-T.+Taiauthor=C.+Mitsiadesauthor=K.+C.+Andersonauthor=D.+R.+Carrasco&title=Targeting+the+%CE%B2-catenin%2FTCF+transcriptional+complex+in+the+treatment+of+multiple+myeloma&doi=10.1073%2Fpnas.0610299104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma</span></div><div class="casAuthors">Sukhdeo Kumar; Mani Mala; Zhang Yunyu; Dutta Jui; Yasui Hiroshi; Rooney Melissa D; Carrasco Daniel E; Zheng Mei; He Haiying; Tai Yu-Tzu; Mitsiades Constantine; Anderson Kenneth C; Carrasco Daniel R</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7516-21</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Multiple myeloma (MM) is an invariably fatal form of cancer characterized by clonal proliferation of malignant plasma cells in the bone marrow.  The canonical Wnt signaling pathway is activated in MM cells through constitutively active beta-catenin, a messenger molecule relevant to growth, survival, and migration of MM cells.  The identification of a number of small molecular compounds, such as PKF115-584, which disrupt the interaction of the transcriptionally active beta-catenin/TCF protein complex, provides valuable new therapeutic tools to target an alternative pathway in MM independent of the proteasome.  Here we evaluated the transcriptional, proteomic, signaling changes, and biological sequelae associated with the inhibition of Wnt signaling in MM by PKF115-584.  The compound blocks expression of Wnt target genes and induces cytotoxicity in both patient MM cells and MM cell lines without a significant effect in normal plasma cells.  In xenograft models of human MM, PKF115-584 inhibits tumor growth and prolongs survival.  Taken together, these data demonstrate the efficacy of disrupting the beta-catenin/TCF transcriptional complex to exploit tumor dependence on Wnt signaling as a therapeutic approach in the treatment of MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfuM4ZEOdZFjAyhZbj3lKdfW6udTcc2ebzjxIwBynfgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3nt1Wnug%253D%253D&md5=6bd5a012f7fdb1227f3042ace84063af</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0610299104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0610299104%26sid%3Dliteratum%253Aachs%26aulast%3DSukhdeo%26aufirst%3DK.%26aulast%3DMani%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDutta%26aufirst%3DJ.%26aulast%3DYasui%26aufirst%3DH.%26aulast%3DRooney%26aufirst%3DM.%2BD.%26aulast%3DCarrasco%26aufirst%3DD.%2BE.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DTai%26aufirst%3DY.-T.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DCarrasco%26aufirst%3DD.%2BR.%26atitle%3DTargeting%2520the%2520%25CE%25B2-catenin%252FTCF%2520transcriptional%2520complex%2520in%2520the%2520treatment%2520of%2520multiple%2520myeloma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D7516%26epage%3D7521%26doi%3D10.1073%2Fpnas.0610299104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bafico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, S. A.</span></span> <span> </span><span class="NLM_article-title">An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2004.09.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ccr.2004.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=15542433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGlurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=497-506&author=A.+Baficoauthor=G.+Liuauthor=L.+Goldinauthor=V.+Harrisauthor=S.+A.+Aaronson&title=An+autocrine+mechanism+for+constitutive+Wnt+pathway+activation+in+human+cancer+cells&doi=10.1016%2Fj.ccr.2004.09.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells</span></div><div class="casAuthors">Bafico, Anna; Liu, Guizhong; Goldin, Luba; Harris, Violaine; Aaronson, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autocrine Wnt signaling in the mouse mammary tumor virus model was the first identified mechanism of canonical pathway activation in cancer.  In search of this transformation mechanism in human cancer cells, we identified breast and ovarian tumor lines with upregulation of the uncomplexed transcriptionally active form of β-catenin without mutations afflicting downstream components.  Extracellular Wnt antagonists FRP1 and DKK1 caused a dramatic downregulation of β-catenin levels in these tumor cells assocd. with alteration of biol. properties and increased expression of epithelial differentiation markers.  Colorectal carcinoma cells with knockout of the mutant β-catenin allele retained upregulated β-catenin levels, which also could be inhibited by these Wnt antagonists.  Together, these findings establish the involvement of autocrine Wnt signaling in human cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXPoqwc2vXarVg90H21EOLACvtfcHk0lgIDf_0Kp3pgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGlurjO&md5=d120566809d1ee0f6474a22eff99630d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DBafico%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGoldin%26aufirst%3DL.%26aulast%3DHarris%26aufirst%3DV.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26atitle%3DAn%2520autocrine%2520mechanism%2520for%2520constitutive%2520Wnt%2520pathway%2520activation%2520in%2520human%2520cancer%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D497%26epage%3D506%26doi%3D10.1016%2Fj.ccr.2004.09.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaffer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhardt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kah, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.04.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.cell.2011.04.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21663795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVOkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2011&pages=926-940&author=C.+Scheelauthor=E.+N.+Eatonauthor=S.+H.-J.+Liauthor=C.+L.+Chafferauthor=F.+Reinhardtauthor=K.-J.+Kahauthor=G.+Bellauthor=W.+Guoauthor=J.+Rubinauthor=A.+L.+Richardsonauthor=R.+A.+Weinberg&title=Paracrine+and+autocrine+signals+induce+and+maintain+mesenchymal+and+stem+cell+states+in+the+breast&doi=10.1016%2Fj.cell.2011.04.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast</span></div><div class="casAuthors">Scheel, Christina; Ng Eaton, Elinor; Li, Sophia Hsin-Jung; Chaffer, Christine L.; Reinhardt, Ferenc; Kah, Kong-Jie; Bell, George; Guo, Wenjun; Rubin, Jeffrey; Richardson, Andrea L.; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">926-940</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The epithelial-mesenchymal transition (EMT) has been assocd. with the acquisition of motility, invasiveness, and self-renewal traits.  During both normal development and tumor pathogenesis, this change in cell phenotype is induced by contextual signals that epithelial cells receive from their microenvironment.  The signals that are responsible for inducing an EMT and maintaining the resulting cellular state have been unclear.  We describe three signaling pathways, involving transforming growth factor (TGF)-β and canonical and noncanonical Wnt signaling, that collaborate to induce activation of the EMT program and thereafter function in an autocrine fashion to maintain the resulting mesenchymal state.  Downregulation of endogenously synthesized inhibitors of autocrine signals in epithelial cells enables the induction of the EMT program.  Conversely, disruption of autocrine signaling by added inhibitors of these pathways inhibits migration and self-renewal in primary mammary epithelial cells and reduces tumorigenicity and metastasis by their transformed derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQlb4blu5l8rVg90H21EOLACvtfcHk0li90xne5cNgfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVOkt7s%253D&md5=b3478b773e87b5b98ace6f6172cbfa29</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.04.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.04.029%26sid%3Dliteratum%253Aachs%26aulast%3DScheel%26aufirst%3DC.%26aulast%3DEaton%26aufirst%3DE.%2BN.%26aulast%3DLi%26aufirst%3DS.%2BH.-J.%26aulast%3DChaffer%26aufirst%3DC.%2BL.%26aulast%3DReinhardt%26aufirst%3DF.%26aulast%3DKah%26aufirst%3DK.-J.%26aulast%3DBell%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DRubin%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DA.%2BL.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DParacrine%2520and%2520autocrine%2520signals%2520induce%2520and%2520maintain%2520mesenchymal%2520and%2520stem%2520cell%2520states%2520in%2520the%2520breast%26jtitle%3DCell%26date%3D2011%26volume%3D145%26spage%3D926%26epage%3D940%26doi%3D10.1016%2Fj.cell.2011.04.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brack, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conboy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rando, T. A.</span></span> <span> </span><span class="NLM_article-title">Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1126/science.1144090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1126%2Fscience.1144090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=17690295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVWjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=807-810&author=A.+S.+Brackauthor=M.+J.+Conboyauthor=S.+Royauthor=M.+Leeauthor=C.+J.+Kuoauthor=C.+Kellerauthor=T.+A.+Rando&title=Increased+Wnt+signaling+during+aging+alters+muscle+stem+cell+fate+and+increases+fibrosis&doi=10.1126%2Fscience.1144090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Wnt Signaling During Aging Alters Muscle Stem Cell Fate and Increases Fibrosis</span></div><div class="casAuthors">Brack, Andrew S.; Conboy, Michael J.; Roy, Sudeep; Lee, Mark; Kuo, Calvin J.; Keller, Charles; Rando, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5839</span>),
    <span class="NLM_cas:pages">807-810</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The regenerative potential of skeletal muscle declines with age, and this impairment is assocd. with an increase in tissue fibrosis.  We show that muscle stem cells (satellite cells) from aged mice tend to convert from a myogenic to a fibrogenic lineage as they begin to proliferate and that this conversion is mediated by factors in the systemic environment of the old animals.  We also show that this lineage conversion is assocd. with an activation of the canonical Wnt signaling pathway in aged myogenic progenitors and can be suppressed by Wnt inhibitors.  Furthermore, components of serum from aged mice that bind to the Frizzled family of proteins, which are Wnt receptors, may account for the elevated Wnt signaling in aged cells.  These results indicate that the Wnt signaling pathway may play a crit. role in tissue-specific stem cell aging and an increase in tissue fibrosis with age.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1GnKCzo1JrVg90H21EOLACvtfcHk0li90xne5cNgfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVWjt7g%253D&md5=59532d0206c12d84177212acee85dbe3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.1144090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1144090%26sid%3Dliteratum%253Aachs%26aulast%3DBrack%26aufirst%3DA.%2BS.%26aulast%3DConboy%26aufirst%3DM.%2BJ.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DKuo%26aufirst%3DC.%2BJ.%26aulast%3DKeller%26aufirst%3DC.%26aulast%3DRando%26aufirst%3DT.%2BA.%26atitle%3DIncreased%2520Wnt%2520signaling%2520during%2520aging%2520alters%2520muscle%2520stem%2520cell%2520fate%2520and%2520increases%2520fibrosis%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D807%26epage%3D810%26doi%3D10.1126%2Fscience.1144090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lancaster, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silhavy, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sintasath, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decambre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nigam, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, J. G.</span></span> <span> </span><span class="NLM_article-title">Impaired Wnt-β-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1054</span>, <span class="refDoi"> DOI: 10.1038/nm.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnm.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=19718039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKhs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1046-1054&author=M.+A.+Lancasterauthor=C.+M.+Louieauthor=J.+L.+Silhavyauthor=L.+Sintasathauthor=M.+Decambreauthor=S.+K.+Nigamauthor=K.+Willertauthor=J.+G.+Gleeson&title=Impaired+Wnt-%CE%B2-catenin+signaling+disrupts+adult+renal+homeostasis+and+leads+to+cystic+kidney+ciliopathy&doi=10.1038%2Fnm.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired Wnt-β-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy</span></div><div class="casAuthors">Lancaster, Madeline A.; Louie, Carrie M.; Silhavy, Jennifer L.; Sintasath, Louis; DeCambre, Marvalyn; Nigam, Sanjay K.; Willert, Karl; Gleeson, Joseph G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1046-1054</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cystic kidney disease represents a major cause of end-stage renal disease, yet the mol. mechanisms of pathogenesis remain largely unclear.  Recent emphasis has been placed on a potential role for canonical Wnt signaling, but investigation of this pathway in adult renal homeostasis is lacking.  Here we provide evidence of a previously unidentified canonical Wnt activity in adult mammalian kidney homeostasis, the loss of which leads to cystic kidney disease.  Loss of the Jouberin (Jbn) protein in mouse leads to the cystic kidney disease nephronophthisis, owing to an unexpected decrease in endogenous Wnt activity.  Jbn interacts with and facilitates β-catenin nuclear accumulation, resulting in pos. modulation of downstream transcription.  Finally, we show that Jbn is required in vivo for a Wnt response to injury and renal tubule repair, the absence of which triggers cystogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr717LRBx5i1bVg90H21EOLACvtfcHk0li90xne5cNgfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKhs7jI&md5=a4bd6a8cd2af68f2aa7ad8143603a78f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2010%26sid%3Dliteratum%253Aachs%26aulast%3DLancaster%26aufirst%3DM.%2BA.%26aulast%3DLouie%26aufirst%3DC.%2BM.%26aulast%3DSilhavy%26aufirst%3DJ.%2BL.%26aulast%3DSintasath%26aufirst%3DL.%26aulast%3DDecambre%26aufirst%3DM.%26aulast%3DNigam%26aufirst%3DS.%2BK.%26aulast%3DWillert%26aufirst%3DK.%26aulast%3DGleeson%26aufirst%3DJ.%2BG.%26atitle%3DImpaired%2520Wnt-%25CE%25B2-catenin%2520signaling%2520disrupts%2520adult%2520renal%2520homeostasis%2520and%2520leads%2520to%2520cystic%2520kidney%2520ciliopathy%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D1046%26epage%3D1054%26doi%3D10.1038%2Fnm.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malanchi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peinado, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussenet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huelsken, J.</span></span> <span> </span><span class="NLM_article-title">Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>452</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1038/nature06835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnature06835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=18385740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFCgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2008&pages=650-653&author=I.+Malanchiauthor=H.+Peinadoauthor=D.+Kassenauthor=T.+Hussenetauthor=D.+Metzgerauthor=P.+Chambonauthor=M.+Huberauthor=D.+Hohlauthor=A.+Canoauthor=W.+Birchmeierauthor=J.+Huelsken&title=Cutaneous+cancer+stem+cell+maintenance+is+dependent+on+%CE%B2-catenin+signalling&doi=10.1038%2Fnature06835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cutaneous cancer stem cell maintenance is dependent on β-catenin signaling</span></div><div class="casAuthors">Malanchi, Ilaria; Peinado, Hector; Kassen, Deepika; Hussenet, Thomas; Metzger, Daniel; Chambon, Pierre; Huber, Marcel; Hohl, Daniel; Cano, Amparo; Birchmeier, Walter; Huelsken, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">452</span>
        (<span class="NLM_cas:issue">7187</span>),
    <span class="NLM_cas:pages">650-653</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Continuous turnover of epithelia is ensured by the extensive self-renewal capacity of tissue-specific stem cells.  Similarly, epithelial tumor maintenance relies on cancer stem cells (CSCs), which co-opt stem cell properties.  For most tumors, the cellular origin of these CSCs and regulatory pathways essential for sustaining stemness have not been identified.  In murine skin, follicular morphogenesis is driven by bulge stem cells that specifically express CD34.  Here we identify a population of cells in early epidermal tumors characterized by phenotypic and functional similarities to normal bulge skin stem cells.  This population contains CSCs, which are the only cells with tumor initiation properties.  Transplants derived from these CSCs preserve the hierarchical organization of the primary tumor.  We describe β-catenin signaling as being essential in sustaining the CSC phenotype.  Ablation of the β-catenin gene results in the loss of CSCs and complete tumor regression.  In addn., we provide evidence for the involvement of increased β-catenin signaling in malignant human squamous cell carcinomas.  Because Wnt/β-catenin signaling is not essential for normal epidermal homeostasis, such a mechanistic difference may thus be targeted to eliminate CSCs and consequently eradicate squamous cell carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrZ5OBtyG5wrVg90H21EOLACvtfcHk0li0Xy-2YDg2eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFCgsLY%253D&md5=39a4f10d273ba7dd51b507365bf15ff0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature06835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06835%26sid%3Dliteratum%253Aachs%26aulast%3DMalanchi%26aufirst%3DI.%26aulast%3DPeinado%26aufirst%3DH.%26aulast%3DKassen%26aufirst%3DD.%26aulast%3DHussenet%26aufirst%3DT.%26aulast%3DMetzger%26aufirst%3DD.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3DHuber%26aufirst%3DM.%26aulast%3DHohl%26aufirst%3DD.%26aulast%3DCano%26aufirst%3DA.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DHuelsken%26aufirst%3DJ.%26atitle%3DCutaneous%2520cancer%2520stem%2520cell%2520maintenance%2520is%2520dependent%2520on%2520%25CE%25B2-catenin%2520signalling%26jtitle%3DNature%26date%3D2008%26volume%3D452%26spage%3D650%26epage%3D653%26doi%3D10.1038%2Fnature06835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridgway, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Es, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Wetering, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begthel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Born, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Crypt stem cells as the cells-of-origin of intestinal cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>457</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">611</span>, <span class="refDoi"> DOI: 10.1038/nature07602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnature07602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=19092804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2009&pages=608-611&author=N.+Barkerauthor=R.+A.+Ridgwayauthor=J.+H.+van+Esauthor=M.+van+de+Weteringauthor=H.+Begthelauthor=M.+van+den+Bornauthor=E.+Danenbergauthor=A.+R.+Clarkeauthor=O.+J.+Sansomauthor=H.+Clevers&title=Crypt+stem+cells+as+the+cells-of-origin+of+intestinal+cancer&doi=10.1038%2Fnature07602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Crypt stem cells as the cells-of-origin of intestinal cancer</span></div><div class="casAuthors">Barker, Nick; Ridgway, Rachel A.; van Es, Johan H.; van de Wetering, Marc; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; Clarke, Alan R.; Sansom, Owen J.; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">7229</span>),
    <span class="NLM_cas:pages">608-611</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Intestinal cancer is initiated by Wnt-pathway-activating mutations in genes such as adenomatous polyposis coli (APC).  As in most cancers, the cell of origin has remained elusive.  In a previously established Lgr5 (leucine-rich-repeat contg. G-protein-coupled receptor 5) knockin mouse model, a tamoxifen-inducible Cre recombinase is expressed in long-lived intestinal stem cells.  Here it is shown that deletion of Apc in these stem cells leads to their transformation within days.  Transformed stem cells remain located at crypt bottoms, while fueling a growing microadenoma.  These microadenomas show unimpeded growth and develop into macroscopic adenomas within 3-5 wk.  The distribution of Lgr5+ cells within stem-cell-derived adenomas indicates that a stem cell/progenitor cell hierarchy is maintained in early neoplastic lesions.  When Apc is deleted in short-lived transit-amplifying cells using a different cre mouse, the growth of the induced microadenomas rapidly stalls.  Even after 30 wk, large adenomas are very rare in these mice.  It is concluded that stem-cell-specific loss of Apc results in progressively growing neoplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6qLpNRIIFTbVg90H21EOLACvtfcHk0li0Xy-2YDg2eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOmsbg%253D&md5=2e0febacce6faf1eeafea138c22be101</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature07602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07602%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DN.%26aulast%3DRidgway%26aufirst%3DR.%2BA.%26aulast%3Dvan%2BEs%26aufirst%3DJ.%2BH.%26aulast%3Dvan%2Bde%2BWetering%26aufirst%3DM.%26aulast%3DBegthel%26aufirst%3DH.%26aulast%3Dvan%2Bden%2BBorn%26aufirst%3DM.%26aulast%3DDanenberg%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DA.%2BR.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DCrypt%2520stem%2520cells%2520as%2520the%2520cells-of-origin%2520of%2520intestinal%2520cancer%26jtitle%3DNature%26date%3D2009%26volume%3D457%26spage%3D608%26epage%3D611%26doi%3D10.1038%2Fnature07602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandillet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeisig, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griessinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, C. W. E.</span></span> <span> </span><span class="NLM_article-title">β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2010.10.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ccr.2010.10.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21156284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=606-618&author=J.+Yeungauthor=M.+T.+Espositoauthor=A.+Gandilletauthor=B.+B.+Zeisigauthor=E.+Griessingerauthor=D.+Bonnetauthor=C.+W.+E.+So&title=%CE%B2-Catenin+mediates+the+establishment+and+drug+resistance+of+MLL+leukemic+stem+cells&doi=10.1016%2Fj.ccr.2010.10.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">β-catenin mediates the establishment and drug resistance of MLL leukemic stem cells</span></div><div class="casAuthors">Yeung, Jenny; Esposito, Maria Teresa; Gandillet, Arnaud; Zeisig, Bernd B.; Griessinger, Emmanuel; Bonnet, Dominique; So, Chi Wai Eric</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">606-618</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Identification of mol. pathways essential for cancer stem cells is crit. for understanding the underlying biol. and designing effective cancer therapeutics.  Here, we demonstrated that β-catenin was activated during development of MLL leukemic stem cells (LSCs).  Suppression of β-catenin reversed LSCs to a pre-LSC-like stage and significantly reduced the growth of human MLL leukemic cells.  Conditional deletion of β-catenin completely abolished the oncogenic potential of MLL-transformed cells.  In addn., established MLL LSCs that have acquired resistance against GSK3 inhibitors could be resensitized by suppression of β-catenin expression.  These results unveil previously unrecognized multifaceted functions of β-catenin in the establishment and drug-resistant properties of MLL stem cells, highlighting it as a potential therapeutic target for an important subset of AMLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Xe1nJS3857Vg90H21EOLACvtfcHk0li0Xy-2YDg2eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvF&md5=22f418917d697374b30bec1d91dffbfc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.10.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.10.032%26sid%3Dliteratum%253Aachs%26aulast%3DYeung%26aufirst%3DJ.%26aulast%3DEsposito%26aufirst%3DM.%2BT.%26aulast%3DGandillet%26aufirst%3DA.%26aulast%3DZeisig%26aufirst%3DB.%2BB.%26aulast%3DGriessinger%26aufirst%3DE.%26aulast%3DBonnet%26aufirst%3DD.%26aulast%3DSo%26aufirst%3DC.%2BW.%2BE.%26atitle%3D%25CE%25B2-Catenin%2520mediates%2520the%2520establishment%2520and%2520drug%2520resistance%2520of%2520MLL%2520leukemic%2520stem%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D606%26epage%3D618%26doi%3D10.1016%2Fj.ccr.2010.10.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spranger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, T. F.</span></span> <span> </span><span class="NLM_article-title">Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>523</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1038/nature14404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnature14404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=25970248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFaitrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2015&pages=231-235&author=S.+Sprangerauthor=R.+Baoauthor=T.+F.+Gajewski&title=Melanoma-intrinsic+%CE%B2-catenin+signalling+prevents+anti-tumour+immunity&doi=10.1038%2Fnature14404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity</span></div><div class="casAuthors">Spranger, Stefani; Bao, Riyue; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">523</span>
        (<span class="NLM_cas:issue">7559</span>),
    <span class="NLM_cas:pages">231-235</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanoma treatment is being revolutionized by the development of effective immunotherapeutic approaches.  These strategies include blockade of immune-inhibitory receptors on activated T cells; for example, using monoclonal antibodies against CTLA-4, PD-1, and PD-L1 (refs 3, 4, 5).  However, only a subset of patients responds to these treatments, and data suggest that therapeutic benefit is preferentially achieved in patients with a pre-existing T-cell response against their tumor, as evidenced by a baseline CD8+ T-cell infiltration within the tumor microenvironment.  Understanding the mol. mechanisms that underlie the presence or absence of a spontaneous anti-tumor T-cell response in subsets of cases, therefore, should enable the development of therapeutic solns. for patients lacking a T-cell infiltrate.  Here the authors identify a melanoma-cell-intrinsic oncogenic pathway that contributes to a lack of T-cell infiltration in melanoma.  Mol. anal. of human metastatic melanoma samples revealed a correlation between activation of the WNT/β-catenin signaling pathway and absence of a T-cell gene expression signature.  Using autochthonous mouse melanoma models the authors identified the mechanism by which tumor-intrinsic active β-catenin signaling results in T-cell exclusion and resistance to anti-PD-L1/anti-CTLA-4 monoclonal antibody therapy.  Specific oncogenic signals, therefore, can mediate cancer immune evasion and resistance to immunotherapies, pointing to new candidate targets for immune potentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXZ3KSCsvVbVg90H21EOLACvtfcHk0lgZcHIjVd5QCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFaitrrL&md5=ff32a95e2614e76cf9f9167e35bf015e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature14404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14404%26sid%3Dliteratum%253Aachs%26aulast%3DSpranger%26aufirst%3DS.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DMelanoma-intrinsic%2520%25CE%25B2-catenin%2520signalling%2520prevents%2520anti-tumour%2520immunity%26jtitle%3DNature%26date%3D2015%26volume%3D523%26spage%3D231%26epage%3D235%26doi%3D10.1038%2Fnature14404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spranger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, T. F.</span></span> <span> </span><span class="NLM_article-title">Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2017.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ccell.2017.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=28486109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsVanurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=711-723&author=S.+Sprangerauthor=D.+Daiauthor=B.+Hortonauthor=T.+F.+Gajewski&title=Tumor-residing+Batf3+dendritic+cells+are+required+for+effector+T+cell+trafficking+and+adoptive+T+cell+therapy&doi=10.1016%2Fj.ccell.2017.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy</span></div><div class="casAuthors">Spranger, Stefani; Dai, Daisy; Horton, Brendan; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">711-723.e4</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Effector T cells have the capability of recognizing and killing cancer cells.  However, whether tumors can become immune resistant through exclusion of effector T cells from the tumor microenvironment is not known.  By using a tumor model resembling non-T cell-inflamed human tumors, we assessed whether adoptive T cell transfer might overcome failed spontaneous priming.  Flow cytometric assays combined with intra-vital imaging indicated failed trafficking of effector T cells into tumors.  Mechanistically, this was due to the absence of CXCL9/10, which we found to be produced by CD103+ dendritic cells (DCs) in T cell-inflamed tumors.  Our data indicate that lack of CD103+ DCs within the tumor microenvironment dominantly resists the effector phase of an anti-tumor T cell response, contributing to immune escape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7fiCVbCdG17Vg90H21EOLACvtfcHk0lgZcHIjVd5QCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsVanurY%253D&md5=dec11abf8411306202decf48235b2eac</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DSpranger%26aufirst%3DS.%26aulast%3DDai%26aufirst%3DD.%26aulast%3DHorton%26aufirst%3DB.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DTumor-residing%2520Batf3%2520dendritic%2520cells%2520are%2520required%2520for%2520effector%2520T%2520cell%2520trafficking%2520and%2520adoptive%2520T%2520cell%2520therapy%26jtitle%3DCancer%2520Cell%26date%3D2017%26volume%3D31%26spage%3D711%26epage%3D723%26doi%3D10.1016%2Fj.ccell.2017.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lino, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curotto de Lafaille, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span> <span> </span><span class="NLM_article-title">β-Catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1038/nm1707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnm1707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=18246080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1KhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=162-169&author=Y.+Dingauthor=S.+Shenauthor=A.+C.+Linoauthor=M.+A.+Curotto+de+Lafailleauthor=J.+J.+Lafaille&title=%CE%B2-Catenin+stabilization+extends+regulatory+T+cell+survival+and+induces+anergy+in+nonregulatory+T+cells&doi=10.1038%2Fnm1707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells</span></div><div class="casAuthors">Ding, Yi; Shen, Shiqian; Lino, Andreia C.; Curotto de Lafaille, Maria A.; Lafaille, Juan J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">162-169</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Catenin is a central mol. in the Wnt pathway.  Expression of a stable form of β-catenin on CD4+CD25+ regulatory T (Treg) cells resulted in a marked enhancement of survival of these cells in vitro.  Furthermore, stable β-catenin-expressing CD4+CD25+ Treg cells outcompeted control Treg cells in vivo, and the no. of Treg cells necessary for protection against inflammatory bowel disease could be substantially reduced when stable β-catenin-expressing CD4+CD25+ Treg cells were used instead of control Treg cells.  Expression of stable β-catenin on potentially pathogenic CD4+CD25- T cells rendered these cells anergic, and the β-catenin-mediated induction of anergy occurred even in Foxp3-deficient T cells.  Thus, through enhanced survival of existing regulatory T cells, and through induction of unresponsiveness in precursors of T effector cells, β-catenin stabilization has a powerful effect on the prevention of inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUx840IceVx7Vg90H21EOLACvtfcHk0lgZcHIjVd5QCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1KhsLk%253D&md5=6f7c3c53195015f78e01057f16fb1940</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnm1707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1707%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DLino%26aufirst%3DA.%2BC.%26aulast%3DCurotto%2Bde%2BLafaille%26aufirst%3DM.%2BA.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26atitle%3D%25CE%25B2-Catenin%2520stabilization%2520extends%2520regulatory%2520T%2520cell%2520survival%2520and%2520induces%2520anergy%2520in%2520nonregulatory%2520T%2520cells%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D162%26epage%3D169%26doi%3D10.1038%2Fnm1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keerthivasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghajani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkateswaran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmanuel, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentrem, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keshavarzian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khazaie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gounari, F.</span></span> <span> </span><span class="NLM_article-title">β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">225ra28</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3007607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1126%2Fscitranslmed.3007607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=24574339" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=225ra28&author=S.+Keerthivasanauthor=K.+Aghajaniauthor=M.+Doseauthor=L.+Molineroauthor=M.+W.+Khanauthor=V.+Venkateswaranauthor=C.+Weberauthor=A.+O.+Emmanuelauthor=T.+Sunauthor=D.+J.+Bentremauthor=M.+Mulcahyauthor=A.+Keshavarzianauthor=E.+M.+Ramosauthor=N.+Blatnerauthor=K.+Khazaieauthor=F.+Gounari&title=%CE%B2-Catenin+promotes+colitis+and+colon+cancer+through+imprinting+of+proinflammatory+properties+in+T+cells&doi=10.1126%2Fscitranslmed.3007607"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3007607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3007607%26sid%3Dliteratum%253Aachs%26aulast%3DKeerthivasan%26aufirst%3DS.%26aulast%3DAghajani%26aufirst%3DK.%26aulast%3DDose%26aufirst%3DM.%26aulast%3DMolinero%26aufirst%3DL.%26aulast%3DKhan%26aufirst%3DM.%2BW.%26aulast%3DVenkateswaran%26aufirst%3DV.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DEmmanuel%26aufirst%3DA.%2BO.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DBentrem%26aufirst%3DD.%2BJ.%26aulast%3DMulcahy%26aufirst%3DM.%26aulast%3DKeshavarzian%26aufirst%3DA.%26aulast%3DRamos%26aufirst%3DE.%2BM.%26aulast%3DBlatner%26aufirst%3DN.%26aulast%3DKhazaie%26aufirst%3DK.%26aulast%3DGounari%26aufirst%3DF.%26atitle%3D%25CE%25B2-Catenin%2520promotes%2520colitis%2520and%2520colon%2520cancer%2520through%2520imprinting%2520of%2520proinflammatory%2520properties%2520in%2520T%2520cells%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D225ra28%26doi%3D10.1126%2Fscitranslmed.3007607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foxworth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldman, T.</span></span> <span> </span><span class="NLM_article-title">Proof-of-principle: oncogenic β-catenin is a valid molecular target for the development of pharmacological inhibitors</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=12516970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFaksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=1355-1359&author=J.+S.+Kimauthor=H.+Crooksauthor=A.+Foxworthauthor=T.+Waldman&title=Proof-of-principle%3A+oncogenic+%CE%B2-catenin+is+a+valid+molecular+target+for+the+development+of+pharmacological+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Proof-of-principle: oncogenic β-catenin is a valid molecular target for the development of pharmacological inhibitors</span></div><div class="casAuthors">Kim, Jung-Sik; Crooks, Heather; Foxworth, Aaron; Waldman, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1355-1359</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activation of β-catenin is a crit. step in the pathogenesis of many common human cancers and is the initiating event in adenocarcinoma of the colon.  Because activation of β-catenin provides a gain-of-function, it is tempting to speculate that specific pharmacol. inhibition of activated β-catenin might reverse the tumorigenic properties of human cancer cells and therefore form the basis of an effective anticancer strategy.  In an effort to provide proof-of-principle for such a strategy, we used a novel clonal growth assay based on human somatic cell gene targeting to det. whether activated β-catenin remains a necessary oncogenic stimulus in advanced human cancer cells.  Using this approach, we demonstrate that β-catenin is a necessary oncogene in human SW48 and DLD1 colon cancer cells but not in HCT116 cells.  These data indicate that activated β-catenin can remain a crit. oncogenic stimulus throughout the progression of human colon cancer and suggest that the small mol. inhibitors of activated β-catenin currently under development will be effective anticancer therapeutics in a subset of malignant colon cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXo_mVzWbq8bVg90H21EOLACvtfcHk0ljL16KYgwNOKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFaksA%253D%253D&md5=59287e5934c147053f390b147e9df20d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DCrooks%26aufirst%3DH.%26aulast%3DFoxworth%26aufirst%3DA.%26aulast%3DWaldman%26aufirst%3DT.%26atitle%3DProof-of-principle%253A%2520oncogenic%2520%25CE%25B2-catenin%2520is%2520a%2520valid%2520molecular%2520target%2520for%2520the%2520development%2520of%2520pharmacological%2520inhibitors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D1355%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashihara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimazaski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamitsuji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniwaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maekawa, T.</span></span> <span> </span><span class="NLM_article-title">β-Catenin small interfering RNA successfully suppressed progression of multiple myeloma in a mouse model</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2731</span>– <span class="NLM_lpage">2738</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-08-1350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1158%2F1078-0432.ccr-08-1350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=19351774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksV2nsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=2731-2738&author=E.+Ashiharaauthor=E.+Kawataauthor=Y.+Nakagawaauthor=C.+Shimazaskiauthor=J.+Kurodaauthor=K.+Taniguchiauthor=H.+Uchiyamaauthor=R.+Tanakaauthor=A.+Yokotaauthor=M.+Takeuchiauthor=Y.+Kamitsujiauthor=T.+Inabaauthor=M.+Taniwakiauthor=S.+Kimuraauthor=T.+Maekawa&title=%CE%B2-Catenin+small+interfering+RNA+successfully+suppressed+progression+of+multiple+myeloma+in+a+mouse+model&doi=10.1158%2F1078-0432.ccr-08-1350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">β-Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse Model</span></div><div class="casAuthors">Ashihara, Eishi; Kawata, Eri; Nakagawa, Yoko; Shimazaski, Chihiro; Kuroda, Junya; Taniguchi, Kyoko; Uchiyama, Hitoji; Tanaka, Ruriko; Yokota, Asumi; Takeuchi, Miki; Kamitsuji, Yuri; Inaba, Tohru; Taniwaki, Masafumi; Kimura, Shinya; Maekawa, Taira</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2731-2738</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: β-catenin is the downstream effector of the Wnt signaling pathway, and it regulates cell proliferation. β-catenin overexpression correlates pos. with prognosis in several types of malignancies.  We herein assessed its effects on growth of multiple myeloma cells using a xenograft model.  Exptl. Design: We first investigated the expression of β-catenin in multiple myeloma cell lines and multiple myeloma cells obtained from patients.  Next, we investigated the growth inhibitory effects of β-catenin small interfering RNA on the growth of multiple myeloma cells in vivo.  Six-week-old male BALB/c nu/nu mice were inoculated s.c. in the right flank with 5 x 106 RPMI8226 cells, followed by s.c. injections of β-catenin small interfering RNA, scramble small interfering RNA, or PBS/atelocollagen complex twice a week for a total of eight injections.  RESULTS: Significantly higher levels of β-catenin expression were obsd. in multiple myeloma cell lines and in samples from patients with multiple myeloma than those found in mononuclear cells obtained from healthy volunteers.  In in vivo expts., no inhibitory effects were obsd. following treatment with scramble small interfering RNA or PBS/atelocollagen complexes, whereas treatment with β-catenin small interfering RNA/atelocollagen complex significantly inhibited growth of multiple myeloma tumors (P < 0.05).  CONCLUSIONS: β-catenin small interfering RNA treatment inhibited the growth of multiple myeloma tumors in a xenograft model.  To our knowledge, this is the first report showing that the treatment with β-catenin small interfering RNA produces an inhibitory effects on growth of hematol. malignancies in vivo.  Because treatment with β-catenin small interfering RNA inhibited growth of multiple myeloma cells, β-catenin is the attractive novel target for treating multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqizwMA0oxKDrVg90H21EOLACvtfcHk0ljL16KYgwNOKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksV2nsbs%253D&md5=4d277be3cf4990ad216b725fc302e60f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.ccr-08-1350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.ccr-08-1350%26sid%3Dliteratum%253Aachs%26aulast%3DAshihara%26aufirst%3DE.%26aulast%3DKawata%26aufirst%3DE.%26aulast%3DNakagawa%26aufirst%3DY.%26aulast%3DShimazaski%26aufirst%3DC.%26aulast%3DKuroda%26aufirst%3DJ.%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DUchiyama%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DYokota%26aufirst%3DA.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DKamitsuji%26aufirst%3DY.%26aulast%3DInaba%26aufirst%3DT.%26aulast%3DTaniwaki%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DMaekawa%26aufirst%3DT.%26atitle%3D%25CE%25B2-Catenin%2520small%2520interfering%2520RNA%2520successfully%2520suppressed%2520progression%2520of%2520multiple%2520myeloma%2520in%2520a%2520mouse%2520model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D2731%26epage%3D2738%26doi%3D10.1158%2F1078-0432.ccr-08-1350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scholer-Dahirel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlabach, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagdasarian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolfenden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonkin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosher, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, M. E.</span></span> <span> </span><span class="NLM_article-title">Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/β-catenin signaling</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">17135</span>– <span class="NLM_lpage">17140</span>, <span class="refDoi"> DOI: 10.1073/pnas.1104182108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.1104182108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=17135-17140&author=A.+Scholer-Dahirelauthor=M.+R.+Schlabachauthor=A.+Looauthor=L.+Bagdasarianauthor=R.+Meyerauthor=R.+Guoauthor=S.+Woolfendenauthor=K.+K.+Yuauthor=J.+Markovitsauthor=K.+Killaryauthor=D.+Sonkinauthor=Y.-M.+Yaoauthor=M.+Warmuthauthor=W.+R.+Sellersauthor=R.+Schlegelauthor=F.+Stegmeierauthor=R.+E.+Mosherauthor=M.+E.+McLaughlin&title=Maintenance+of+adenomatous+polyposis+coli+%28APC%29-mutant+colorectal+cancer+is+dependent+on+Wnt%2F%CE%B2-catenin+signaling&doi=10.1073%2Fpnas.1104182108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1104182108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1104182108%26sid%3Dliteratum%253Aachs%26aulast%3DScholer-Dahirel%26aufirst%3DA.%26aulast%3DSchlabach%26aufirst%3DM.%2BR.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DBagdasarian%26aufirst%3DL.%26aulast%3DMeyer%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DWoolfenden%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DK.%2BK.%26aulast%3DMarkovits%26aufirst%3DJ.%26aulast%3DKillary%26aufirst%3DK.%26aulast%3DSonkin%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DY.-M.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DSchlegel%26aufirst%3DR.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMosher%26aufirst%3DR.%2BE.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BE.%26atitle%3DMaintenance%2520of%2520adenomatous%2520polyposis%2520coli%2520%2528APC%2529-mutant%2520colorectal%2520cancer%2520is%2520dependent%2520on%2520Wnt%252F%25CE%25B2-catenin%2520signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D17135%26epage%3D17140%26doi%3D10.1073%2Fpnas.1104182108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lepourcelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruseo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivdasani, R. A.</span></span> <span> </span><span class="NLM_article-title">Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/s1535-6108(03)00334-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fs1535-6108%2803%2900334-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=14749129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGrsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=91-102&author=M.+Lepourceletauthor=Y.-N.+P.+Chenauthor=D.+S.+Franceauthor=H.+Wangauthor=P.+Crewsauthor=F.+Petersenauthor=C.+Bruseoauthor=A.+W.+Woodauthor=R.+A.+Shivdasani&title=Small-molecule+antagonists+of+the+oncogenic+Tcf%2F%CE%B2-catenin+protein+complex&doi=10.1016%2Fs1535-6108%2803%2900334-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex</span></div><div class="casAuthors">Lepourcelet, Maina; Chen, Ying-Nan P.; France, Dennis S.; Wang, Huisheng; Crews, Phillip; Petersen, Frank; Bruseo, Charles; Wood, Alexander W.; Shivdasani, Ramesh A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-102</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Key mol. lesions in colorectal and other cancers cause β-catenin-dependent transactivation of T cell factor (Tcf)-dependent genes.  Disruption of this signal represents an opportunity for rational cancer therapy.  To identify compds. that inhibit assocn. between Tcf4 and β-catenin, we screened libraries of natural compds. in a high-throughput assay for immunoenzymic detection of the protein-protein interaction.  Selected compds. disrupt Tcf/β-catenin complexes in several independent in vitro assays and potently antagonize cellular effects of β-catenin-dependent activities, including reporter gene activation, c-myc or cyclin D1 expression, cell proliferation, and duplication of the Xenopus embryonic dorsal axis.  These compds. thus meet predicted criteria for disrupting Tcf/β-catenin complexes and define a general std. to establish mechanism-based activity of small mol. inhibitors of this pathogenic protein-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGHpdE0U0vA7Vg90H21EOLACvtfcHk0ljnDgvTptqz6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGrsbw%253D&md5=ddf90ca6f63e3d11421138f5e2bccc17</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fs1535-6108%2803%2900334-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1535-6108%252803%252900334-9%26sid%3Dliteratum%253Aachs%26aulast%3DLepourcelet%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.-N.%2BP.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCrews%26aufirst%3DP.%26aulast%3DPetersen%26aufirst%3DF.%26aulast%3DBruseo%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DA.%2BW.%26aulast%3DShivdasani%26aufirst%3DR.%2BA.%26atitle%3DSmall-molecule%2520antagonists%2520of%2520the%2520oncogenic%2520Tcf%252F%25CE%25B2-catenin%2520protein%2520complex%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D91%26epage%3D102%26doi%3D10.1016%2Fs1535-6108%2803%2900334-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trosset, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantegani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianellini, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stouten, P. F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, J. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of protein-protein interactions: the discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1002/prot.20955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1002%2Fprot.20955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=16568448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFahs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2006&pages=60-67&author=J.-Y.+Trossetauthor=C.+Dalvitauthor=S.+Knappauthor=M.+Fasoliniauthor=M.+Veronesiauthor=S.+Manteganiauthor=L.+M.+Gianelliniauthor=C.+Catanaauthor=M.+Sundstr%C3%B6mauthor=P.+F.+W.+Stoutenauthor=J.+K.+Moll&title=Inhibition+of+protein-protein+interactions%3A+the+discovery+of+druglike+%CE%B2-catenin+inhibitors+by+combining+virtual+and+biophysical+screening&doi=10.1002%2Fprot.20955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein-protein interactions: the discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening</span></div><div class="casAuthors">Trosset, Jean-Yves; Dalvit, Claudio; Knapp, Stefan; Fasolini, Marina; Veronesi, Marina; Mantegani, Sergio; Gianellini, Laura M.; Catana, Cornel; Sundstrom, Michael; Stouten, Pieter F. W.; Moll, Jurgen K.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-67</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The interaction between β-catenin and Tcf family members is crucial for the Wnt signal transduction pathway, which is commonly mutated in cancer.  This interaction extends over a very large surface area (4800 Å2), and inhibiting such interactions using low mol. wt. inhibitors is a challenge.  However, protein surfaces frequently contain "hot spots," small patches that are the main mediators of binding affinity.  By making tight interactions with a hot spot, a small mol. can compete with a protein.  The Tcf3/Tcf4-binding surface on β-catenin contains a well-defined hot spot around residues K435 and R469.  A 17,700 compds. subset of the Pharmacia corporate collection was docked to this hot spot with the QXP program; 22 of the best scoring compds. were put into a biophys. (NMR and ITC) screening funnel, where specific binding to β-catenin, competition with Tcf4 and finally binding consts. were detd.  This process led to the discovery of three druglike, low mol. wt. Tcf4-competitive compds. with the tightest binder having a KD of 450 nM.  Our approach can be used in several situations (e.g., when selecting compds. from external collections, when no biochem. functional assay is available, or when no HTS is envisioned), and it may be generally applicable to the identification of inhibitors of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDI5V3CAoiWLVg90H21EOLACvtfcHk0ljnDgvTptqz6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFahs7k%253D&md5=eb5afb4ac9d4f2be85fec32de9e95c26</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fprot.20955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20955%26sid%3Dliteratum%253Aachs%26aulast%3DTrosset%26aufirst%3DJ.-Y.%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DFasolini%26aufirst%3DM.%26aulast%3DVeronesi%26aufirst%3DM.%26aulast%3DMantegani%26aufirst%3DS.%26aulast%3DGianellini%26aufirst%3DL.%2BM.%26aulast%3DCatana%26aufirst%3DC.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DStouten%26aufirst%3DP.%2BF.%2BW.%26aulast%3DMoll%26aufirst%3DJ.%2BK.%26atitle%3DInhibition%2520of%2520protein-protein%2520interactions%253A%2520the%2520discovery%2520of%2520druglike%2520%25CE%25B2-catenin%2520inhibitors%2520by%2520combining%2520virtual%2520and%2520biophysical%2520screening%26jtitle%3DProteins%26date%3D2006%26volume%3D64%26spage%3D60%26epage%3D67%26doi%3D10.1002%2Fprot.20955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonsalves, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekas, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagourney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DasGupta, R.</span></span> <span> </span><span class="NLM_article-title">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">5954</span>– <span class="NLM_lpage">5963</span>, <span class="refDoi"> DOI: 10.1073/pnas.1017496108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.1017496108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21393571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5954-5963&author=F.+C.+Gonsalvesauthor=K.+Kleinauthor=B.+B.+Carsonauthor=S.+Katzauthor=L.+A.+Ekasauthor=S.+Evansauthor=R.+Nagourneyauthor=T.+Cardozoauthor=A.+M.+C.+Brownauthor=R.+DasGupta&title=An+RNAi-based+chemical+genetic+screen+identifies+three+small-molecule+inhibitors+of+the+Wnt%2Fwingless+signaling+pathway&doi=10.1073%2Fpnas.1017496108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span></div><div class="casAuthors">Gonsalves, Foster C.; Klein, Keren; Carson, Brittany B.; Katz, Shauna; Ekas, Laura A.; Evans, Steve; Nagourney, Robert; Cardozo, Timothy; Brown, Anthony M. C.; Das Gupta, Ramanuj</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5954-5963, S5954/1-S5954/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Misregulated β-catenin responsive transcription (CRT) has been implicated in the genesis of various malignancies, including colorectal carcinomas, and it is a key therapeutic target in combating various cancers.  Despite significant effort, successful clin. implementation of CRT inhibitory therapeutics remains a challenging goal.  This is, in part, because of the challenge of identifying inhibitory compds. that specifically modulate the nuclear transcriptional activity of β-catenin while not affecting its cytoskeletal function in stabilizing adherens junctions at the cell membrane.  Here, we report an RNAi-based modifier screening strategy for the identification of CRT inhibitors.  Our data provide support for the specificity of these inhibitory compds. in antagonizing the transcriptional function of nuclear β-catenin.  We show that these inhibitors efficiently block Wnt/β-catenin-induced target genes and phenotypes in various mammalian and cancer cell lines.  Importantly, these Wnt inhibitors are specifically cytotoxic to human colon tumor biopsy cultures as well as colon cancer cell lines that exhibit deregulated Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94ZMZYTd807Vg90H21EOLACvtfcHk0ljnDgvTptqz6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D&md5=566aa3c22ccee9ae88aeda4e523699db</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1017496108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1017496108%26sid%3Dliteratum%253Aachs%26aulast%3DGonsalves%26aufirst%3DF.%2BC.%26aulast%3DKlein%26aufirst%3DK.%26aulast%3DCarson%26aufirst%3DB.%2BB.%26aulast%3DKatz%26aufirst%3DS.%26aulast%3DEkas%26aufirst%3DL.%2BA.%26aulast%3DEvans%26aufirst%3DS.%26aulast%3DNagourney%26aufirst%3DR.%26aulast%3DCardozo%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DA.%2BM.%2BC.%26aulast%3DDasGupta%26aufirst%3DR.%26atitle%3DAn%2520RNAi-based%2520chemical%2520genetic%2520screen%2520identifies%2520three%2520small-molecule%2520inhibitors%2520of%2520the%2520Wnt%252Fwingless%2520signaling%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D5954%26epage%3D5963%26doi%3D10.1073%2Fpnas.1017496108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggineni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, J.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1021/bi201428h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201428h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OjtLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=724-731&author=W.+Tianauthor=X.+Hanauthor=M.+Yanauthor=Y.+Xuauthor=S.+Duggineniauthor=N.+Linauthor=G.+Luoauthor=Y.+M.+Liauthor=X.+Hanauthor=Z.+Huangauthor=J.+An&title=Structure-based+discovery+of+a+novel+inhibitor+targeting+the+%CE%B2-catenin%2FTcf4+interaction&doi=10.1021%2Fbi201428h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of a Novel Inhibitor Targeting the β-Catenin/Tcf4 Interaction</span></div><div class="casAuthors">Tian, Wang; Han, Xiaofeng; Yan, Maocai; Xu, Yan; Duggineni, Srinivas; Lin, Nan; Luo, Guifen; Li, Yan Michael; Han, Xiaobing; Huang, Ziwei; An, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">724-731</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overactivation or overexpression of β-catenin in the Wnt (wingless) signaling pathway plays an important role in tumorigenesis.  Interaction of β-catenin with T-cell factor (Tcf) DNA binding proteins is a key step in the activation of the proliferative genes in response to upstream signals of this Wnt/β-catenin pathway.  Recently, we identified a new small mol. inhibitor, named BC21 (C32H36Cl2Cu2N2O2), which effectively inhibits the binding of β-catenin with Tcf4-derived peptide and suppresses β-catenin/Tcf4 driven reporter gene activity.  This inhibitor decreases the viability of β-catenin overexpressing HCT116 colon cancer cells that harbor the β-catenin mutation, and more significantly, it inhibits the clonogenic activity of these cells.  Down-regulation of c-Myc and cyclin D1 expression, the two important effectors of the Wnt/β-catenin signaling, is confirmed by treating HCT116 cells with BC21.  This compd. represents a new and modifiable potential anticancer candidate that targets β-catenin/Tcf-4 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64BkaTOeZErVg90H21EOLACvtfcHk0lg2274LD-t83Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OjtLfM&md5=21392f27d240f4625f2ff0e77b1afe30</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi201428h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201428h%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DDuggineni%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DN.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAn%26aufirst%3DJ.%26atitle%3DStructure-based%2520discovery%2520of%2520a%2520novel%2520inhibitor%2520targeting%2520the%2520%25CE%25B2-catenin%252FTcf4%2520interaction%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D724%26epage%3D731%26doi%3D10.1021%2Fbi201428h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">740</span>, <span class="refDoi"> DOI: 10.1038/cr.2011.30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fcr.2011.30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21321609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVGjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=730-740&author=W.+Wangauthor=H.+Liuauthor=S.+Wangauthor=X.+Haoauthor=L.+Li&title=A+diterpenoid+derivative+15-oxospiramilactone+inhibits+Wnt%2F%CE%B2-catenin+signaling+and+colon+cancer+cell+tumorigenesis&doi=10.1038%2Fcr.2011.30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis</span></div><div class="casAuthors">Wang, Wei; Liu, Haiyang; Wang, Sheng; Hao, Xiaojiang; Li, Lin</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">730-740</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">The Wnt/β-catenin signaling pathway is a highly conserved pathway in organism evolution and regulates many biol. processes.  Aberrant activation of the Wnt/β-catenin signaling pathway is closely related to tumorigenesis.  In order to identify potent small mols. to treat the over-activated Wnt signaling-mediated cancer, such as colon cancer, we established a mammalian cell line-based reporter gene screening system.  The screen revealed a diterpenoid deriv., 15-oxospiramilactone (NC043) that inhibits Wnt3a or LiCl-stimulated Top-flash reporter activity in HEK293T cells and growth of colon cancer cells, SW480 and Caco-2.  Treatment of SW480 cells with NC043 led to decreases in the mRNA and/or protein expression of Wnt target genes Axin2, Cyclin D1 and Survivin , as well as decreases in the protein levels of Cdc25c and Cdc2.  NC043 did not affect the cytosol-nuclear distribution and protein level of sol. β-catenin, but decreased β-catenin/TCF4 assocn. in SW480 cells.  Moreover, NC043 inhibited anchorage-independent growth and xenograft tumorigenesis of SW480 cells.  Collectively these results demonstrate that NC043 is a novel small mol. that inhibits canonical Wnt signaling downstream of β-catenin stability and may be a potential compd. for treating colorectal cancer.  Cell Research (2011) 21:730-740. doi:10.1038/cr.2011.30; published online 15 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMfekvifh107Vg90H21EOLACvtfcHk0lg2274LD-t83Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVGjtrk%253D&md5=8bdcb5ea06a60672fc2fd86c76147524</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fcr.2011.30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2011.30%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DA%2520diterpenoid%2520derivative%252015-oxospiramilactone%2520inhibits%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520and%2520colon%2520cancer%2520cell%2520tumorigenesis%26jtitle%3DCell%2520Res.%26date%3D2011%26volume%3D21%26spage%3D730%26epage%3D740%26doi%3D10.1038%2Fcr.2011.30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuenschwander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulf-Goldenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span> <span> </span><span class="NLM_article-title">A small-molecule antagonist of the β-catenin/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">901</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-15-1519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1158%2F0008-5472.can-15-1519" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=891-901&author=L.+Fangauthor=Q.+Zhuauthor=M.+Neuenschwanderauthor=E.+Speckerauthor=A.+Wulf-Goldenbergauthor=W.+I.+Weisauthor=J.+P.+von+Kriesauthor=W.+Birchmeier&title=A+small-molecule+antagonist+of+the+%CE%B2-catenin%2FTCF4+interaction+blocks+the+self-renewal+of+cancer+stem+cells+and+suppresses+tumorigenesis&doi=10.1158%2F0008-5472.can-15-1519"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-15-1519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-15-1519%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DNeuenschwander%26aufirst%3DM.%26aulast%3DSpecker%26aufirst%3DE.%26aulast%3DWulf-Goldenberg%26aufirst%3DA.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DA%2520small-molecule%2520antagonist%2520of%2520the%2520%25CE%25B2-catenin%252FTCF4%2520interaction%2520blocks%2520the%2520self-renewal%2520of%2520cancer%2520stem%2520cells%2520and%2520suppresses%2520tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D891%26epage%3D901%26doi%3D10.1158%2F0008-5472.can-15-1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malakhova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibitor of the β-catenin-TCF4 interaction suppresses colorectal cancer growth in vitro and in vivo</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2017.09.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ebiom.2017.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=29033371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A280%3ADC%252BC1M7gvVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=22-31&author=S.+H.+Shinauthor=D.+Y.+Limauthor=K.+Reddyauthor=M.+Malakhovaauthor=F.+Liuauthor=T.+Wangauthor=M.+Songauthor=H.+Chenauthor=K.+B.+Baeauthor=J.+Ryuauthor=K.+Liuauthor=M.-H.+Leeauthor=A.+M.+Bodeauthor=Z.+Dong&title=A+small+molecule+inhibitor+of+the+%CE%B2-catenin-TCF4+interaction+suppresses+colorectal+cancer+growth+in+vitro+and+in+vivo&doi=10.1016%2Fj.ebiom.2017.09.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo</span></div><div class="casAuthors">Shin Seung Ho; Bode Ann M; Lim Do Young; Reddy Kanamata; Malakhova Margarita; Chen Hanyong; Bae Ki Beom; Ryu Joohyun; Liu Fangfang; Song Mengqiu; Wang Ting; Lee Mee-Hyun; Liu Kangdong; Dong Zigang</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colorectal cancer is associated with aberrant activation of the Wnt pathway. β-Catenin plays essential roles in the Wnt pathway by interacting with T-cell factor 4 (TCF4) to transcribe oncogenes.  We synthesized a small molecule, referred to as HI-B1, and evaluated signaling changes and biological consequences induced by the compound.  HI-B1 inhibited β-catenin/TCF4 luciferase activity and preferentially caused apoptosis of cancer cells in which the survival is dependent on β-catenin.  The formation of the β-catenin/TCF4 complex was disrupted by HI-B1 due to the direct interaction of HI-B1 with β-catenin.  Colon cancer patient-derived xenograft (PDX) studies showed that a tumor with higher levels of β-catenin expression was more sensitive to HI-B1 treatment, compared to a tumor with lower expression levels of β-catenin.  The different sensitivities of PDX tumors to HI-B1 were dependent on the β-catenin expression level and potentially could be further exploited for biomarker development and therapeutic applications against colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqN5OgHz-tvNenUz0lpNqnfW6udTcc2eYC-GQSl72GIrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7gvVeitQ%253D%253D&md5=c0b3f84100f9d17a0f8df4f5c7f6d0eb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2017.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2017.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DS.%2BH.%26aulast%3DLim%26aufirst%3DD.%2BY.%26aulast%3DReddy%26aufirst%3DK.%26aulast%3DMalakhova%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DBae%26aufirst%3DK.%2BB.%26aulast%3DRyu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.-H.%26aulast%3DBode%26aufirst%3DA.%2BM.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520the%2520%25CE%25B2-catenin-TCF4%2520interaction%2520suppresses%2520colorectal%2520cancer%2520growth%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DEBioMedicine%26date%3D2017%26volume%3D25%26spage%3D22%26epage%3D31%26doi%3D10.1016%2Fj.ebiom.2017.09.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catrow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">High-throughput selectivity assays for small-molecule inhibitors of β-catenin/T-cell factor protein-protein interactions</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1021/ml300367f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300367f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=306-311&author=M.+Zhangauthor=J.+L.+Catrowauthor=H.+Ji&title=High-throughput+selectivity+assays+for+small-molecule+inhibitors+of+%CE%B2-catenin%2FT-cell+factor+protein-protein+interactions&doi=10.1021%2Fml300367f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fml300367f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300367f%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DCatrow%26aufirst%3DJ.%2BL.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DHigh-throughput%2520selectivity%2520assays%2520for%2520small-molecule%2520inhibitors%2520of%2520%25CE%25B2-catenin%252FT-cell%2520factor%2520protein-protein%2520interactions%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D306%26epage%3D311%26doi%3D10.1021%2Fml300367f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halbedl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratzer, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zippert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bräse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel inhibitors blocking Wnt signaling downstream of β-catenin</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>587</i></span>,  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2013.01.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.febslet.2013.01.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=2013&pages=522-527&author=S.+Halbedlauthor=M.-C.+Kratzerauthor=K.+Rahmauthor=N.+Crostaauthor=K.-S.+Mastersauthor=J.+Zippertauthor=S.+Br%C3%A4seauthor=D.+Gradl&title=Synthesis+of+novel+inhibitors+blocking+Wnt+signaling+downstream+of+%CE%B2-catenin&doi=10.1016%2Fj.febslet.2013.01.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2013.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2013.01.034%26sid%3Dliteratum%253Aachs%26aulast%3DHalbedl%26aufirst%3DS.%26aulast%3DKratzer%26aufirst%3DM.-C.%26aulast%3DRahm%26aufirst%3DK.%26aulast%3DCrosta%26aufirst%3DN.%26aulast%3DMasters%26aufirst%3DK.-S.%26aulast%3DZippert%26aufirst%3DJ.%26aulast%3DBr%25C3%25A4se%26aufirst%3DS.%26aulast%3DGradl%26aufirst%3DD.%26atitle%3DSynthesis%2520of%2520novel%2520inhibitors%2520blocking%2520Wnt%2520signaling%2520downstream%2520of%2520%25CE%25B2-catenin%26jtitle%3DFEBS%2520Lett.%26date%3D2013%26volume%3D587%26spage%3D522%26epage%3D527%26doi%3D10.1016%2Fj.febslet.2013.01.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, J. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moellering, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdine, G. L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">17942</span>– <span class="NLM_lpage">17947</span>, <span class="refDoi"> DOI: 10.1073/pnas.1208396109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.1208396109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=23071338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsl2ktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=17942-17947&author=T.+N.+Grossmannauthor=J.+T.+H.+Yehauthor=B.+R.+Bowmanauthor=Q.+Chuauthor=R.+E.+Moelleringauthor=G.+L.+Verdine&title=Inhibition+of+oncogenic+Wnt+signaling+through+direct+targeting+of+%CE%B2-catenin&doi=10.1073%2Fpnas.1208396109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin</span></div><div class="casAuthors">Grossmann, Tom N.; Yeh, Johannes T.-H.; Bowman, Brian R.; Chu, Qian; Moellering, Raymond E.; Verdine, Gregory L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">17942-17947, S17942/1-S17942/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant activation of signaling by the Wnt pathway is strongly implicated in the onset and progression of numerous types of cancer.  Owing to the persistent dependence of these tumors on Wnt signaling for growth and survival, inhibition of this pathway is considered an attractive mechanism-based therapeutic approach.  Oncogenic activation of Wnt signaling can ensue from a variety of distinct aberrations in the signaling pathway, but most share the common feature of causing increased cellular levels of β-catenin by interfering with its constitutive degrdn.  β-Catenin serves as a central hub in Wnt signaling by engaging in crucial protein-protein interactions with both neg. and pos. effectors of the pathway.  Direct interference with these protein-protein interactions is a biol. compelling approach toward suppression of β-catenin hyperactivity, but such interactions have proven intransigent with respect to small-mol. targeting.  Hence β-catenin remains an elusive target for translational cancer therapy.  Here the authors report the discovery of a hydrocarbon-stapled peptide that directly targets β-catenin and interferes with its ability to serve as a transcriptional coactivator for T-cell factor (TCF) proteins, the downstream transcriptional regulators of the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD9Q6Y8-IAI7Vg90H21EOLACvtfcHk0lja_qkEGFORwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsl2ktbvI&md5=3f2fc0f4f616ef057317639fe7c465c6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1208396109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1208396109%26sid%3Dliteratum%253Aachs%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26aulast%3DYeh%26aufirst%3DJ.%2BT.%2BH.%26aulast%3DBowman%26aufirst%3DB.%2BR.%26aulast%3DChu%26aufirst%3DQ.%26aulast%3DMoellering%26aufirst%3DR.%2BE.%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26atitle%3DInhibition%2520of%2520oncogenic%2520Wnt%2520signaling%2520through%2520direct%2520targeting%2520of%2520%25CE%25B2-catenin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D17942%26epage%3D17947%26doi%3D10.1073%2Fpnas.1208396109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, E. M.</span></span> <span> </span><span class="NLM_article-title">A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19156</span>– <span class="NLM_lpage">19167</span>, <span class="refDoi"> DOI: 10.1038/srep19156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fsrep19156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=26750754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=19156-19167&author=T.-H.+Hsiehauthor=C.+Y.+Hsuauthor=C.+F.+Tsaiauthor=C.+C.+Chiuauthor=S.+S.+Liangauthor=T.+N.+Wangauthor=P.+L.+Kuoauthor=C.+Y.+Longauthor=E.+M.+Tsai&title=A+novel+cell-penetrating+peptide+suppresses+breast+tumorigenesis+by+inhibiting+%CE%B2-catenin%2FLEF-1+signaling&doi=10.1038%2Fsrep19156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling</span></div><div class="casAuthors">Hsieh, Tsung-Hua; Hsu, Chia-Yi; Tsai, Cheng-Fang; Chiu, Chien-Chih; Liang, Shih-Shin; Wang, Tsu-Nai; Kuo, Po-Lin; Long, Cheng-Yu; Tsai, Eing-Mei</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19156</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibition of β-catenin/LEF-1 signaling is an emerging strategy in cancer therapy.  However, clin. targeted treatment of the β-catenin/LEF-1 complex remains relatively ineffective.  Therefore, development of specific mol. targets is a key approach for identifying new cancer therapeutics.  Thus, we attempted to synthesize a peptide (TAT-NLS-BLBD-6) that could interfere with the interaction of β-catenin and LEF-1 at nuclei in human breast cancer cells.  TAT-NLS-BLBD-6 directly interacted with β-catenin and inhibited breast cancer cell growth, invasion, migration, and colony formation as well as increased arrest of sub-G1 phase and apoptosis; it also suppressed breast tumor growth in nude mouse and zebrafish xenotransplantation models, showed no signs of toxicity, and did not affect body wt.  Furthermore, the human global gene expression profiles and Ingenuity Pathway Anal. software showed that the TAT-NLS-BLBD-6 downstream target genes were assocd. with the HER-2 and IL-9 signaling pathways.  TAT-NLS-BLBD-6 commonly down-regulated 27 candidate genes in MCF-7 and MDA-MB-231 cells, which are concurrent with Wnt downstream target genes in human breast cancer.  Our study suggests that TAT-NLS-BLBD-6 is a promising drug candidate for the development of effective therapeutics specific for Wnt/β-catenin signaling inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_8qz-srDyV7Vg90H21EOLACvtfcHk0lja_qkEGFORwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFOguw%253D%253D&md5=b1d48f8e3788cd3b4e05601357ce7fa4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fsrep19156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep19156%26sid%3Dliteratum%253Aachs%26aulast%3DHsieh%26aufirst%3DT.-H.%26aulast%3DHsu%26aufirst%3DC.%2BY.%26aulast%3DTsai%26aufirst%3DC.%2BF.%26aulast%3DChiu%26aufirst%3DC.%2BC.%26aulast%3DLiang%26aufirst%3DS.%2BS.%26aulast%3DWang%26aufirst%3DT.%2BN.%26aulast%3DKuo%26aufirst%3DP.%2BL.%26aulast%3DLong%26aufirst%3DC.%2BY.%26aulast%3DTsai%26aufirst%3DE.%2BM.%26atitle%3DA%2520novel%2520cell-penetrating%2520peptide%2520suppresses%2520breast%2520tumorigenesis%2520by%2520inhibiting%2520%25CE%25B2-catenin%252FLEF-1%2520signaling%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D19156%26epage%3D19167%26doi%3D10.1038%2Fsrep19156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathmer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bange, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schade, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span> <span> </span><span class="NLM_article-title">Cell permeable stapled peptide inhibitor of Wnt signaling that targets β-catenin protein-protein interactions</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.chembiol.2017.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=28757184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1CksrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=958-968&author=L.+Dietrichauthor=B.+Rathmerauthor=K.+Ewanauthor=T.+Bangeauthor=S.+Heinrichsauthor=T.+C.+Daleauthor=D.+Schadeauthor=T.+N.+Grossmann&title=Cell+permeable+stapled+peptide+inhibitor+of+Wnt+signaling+that+targets+%CE%B2-catenin+protein-protein+interactions&doi=10.1016%2Fj.chembiol.2017.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Cell permeable stapled peptide inhibitor of wnt signaling that targets β-catenin protein-protein interactions</span></div><div class="casAuthors">Dietrich, Laura; Rathmer, Bernd; Ewan, Kenneth; Bange, Tanja; Heinrichs, Stefan; Dale, Trevor C.; Schade, Dennis; Grossmann, Tom N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">958-968.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Wnt signaling pathway plays a crit. role in cell proliferation and differentiation, thus it is often assocd. with diseases such as cancers.  Unfortunately, although attractive, developing anti-cancer strategy targeting Wnt signaling has been challenging given that the most attractive targets are involved in protein-protein interactions (PPIs).  Here, we develop a stapled peptide inhibitor that targets the interaction between β-catenin and T cell factor/lymphoid enhancer-binding factor transcription factors, which are crucially involved in Wnt signaling.  Our integrative approach combines peptide stapling to optimize proteolytic stability, with lessons learned from cell-penetrating peptide (CPP) design to maximize cellular uptake resulting in NLS-StAx-h, a selective, cell permeable, stapled peptide inhibitor of oncogenic Wnt signaling that efficiently inhibits β-catenin-transcription factor interactions.  We expect that this type of integrative strategy that endows stapled peptides with CPP features will be generally useful for developing inhibitors of intracellular PPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4mcl8B_B0B7Vg90H21EOLACvtfcHk0lhr1abPu0BiCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1CksrjK&md5=cbf0b96aab1e21c298b9a6d22b7f05d1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DDietrich%26aufirst%3DL.%26aulast%3DRathmer%26aufirst%3DB.%26aulast%3DEwan%26aufirst%3DK.%26aulast%3DBange%26aufirst%3DT.%26aulast%3DHeinrichs%26aufirst%3DS.%26aulast%3DDale%26aufirst%3DT.%2BC.%26aulast%3DSchade%26aufirst%3DD.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26atitle%3DCell%2520permeable%2520stapled%2520peptide%2520inhibitor%2520of%2520Wnt%2520signaling%2520that%2520targets%2520%25CE%25B2-catenin%2520protein-protein%2520interactions%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D958%26epage%3D968%26doi%3D10.1016%2Fj.chembiol.2017.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craven, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugbro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svetlov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaut, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garabedian, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirshenbaum, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, S. K.</span></span> <span> </span><span class="NLM_article-title">Design of peptoid-peptide macrocycles to inhibit the β-catenin TCF interaction in prostate cancer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4396</span>– <span class="NLM_lpage">4405</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06845-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fs41467-018-06845-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=30352998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A280%3ADC%252BB3cvisFSlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4396-4405&author=J.+A.+Schneiderauthor=T.+W.+Cravenauthor=A.+C.+Kasperauthor=C.+Yunauthor=M.+Haugbroauthor=E.+M.+Briggsauthor=V.+Svetlovauthor=E.+Nudlerauthor=H.+Knautauthor=R.+Bonneauauthor=M.+J.+Garabedianauthor=K.+Kirshenbaumauthor=S.+K.+Logan&title=Design+of+peptoid-peptide+macrocycles+to+inhibit+the+%CE%B2-catenin+TCF+interaction+in+prostate+cancer&doi=10.1038%2Fs41467-018-06845-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer</span></div><div class="casAuthors">Schneider Jeffrey A; Briggs Erica M; Garabedian Michael J; Logan Susan K; Craven Timothy W; Kasper Amanda C; Haugbro Michael; Kirshenbaum Kent; Craven Timothy W; Bonneau Richard; Yun Chi; Knaut Holger; Briggs Erica M; Svetlov Vladimir; Nudler Evgeny; Logan Susan K; Svetlov Vladimir; Nudler Evgeny; Garabedian Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4396</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">New chemical inhibitors of protein-protein interactions are needed to propel advances in molecular pharmacology.  Peptoids are peptidomimetic oligomers with the capability to inhibit protein-protein interactions by mimicking protein secondary structure motifs.  Here we report the in silico design of a macrocycle primarily composed of peptoid subunits that targets the β-catenin:TCF interaction.  The β-catenin:TCF interaction plays a critical role in the Wnt signaling pathway which is over-activated in multiple cancers, including prostate cancer.  Using the Rosetta suite of protein design algorithms, we evaluate how different macrocycle structures can bind a pocket on β-catenin that associates with TCF.  The in silico designed macrocycles are screened in vitro using luciferase reporters to identify promising compounds.  The most active macrocycle inhibits both Wnt and AR-signaling in prostate cancer cell lines, and markedly diminishes their proliferation.  In vivo potential is demonstrated through a zebrafish model, in which Wnt signaling is potently inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScmbQ8u9AhUDToTC3aBaesfW6udTcc2eZt2Qk1-Ax99Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvisFSlug%253D%253D&md5=1c04088452bbaf704ced21bf03541253</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06845-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06845-3%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DCraven%26aufirst%3DT.%2BW.%26aulast%3DKasper%26aufirst%3DA.%2BC.%26aulast%3DYun%26aufirst%3DC.%26aulast%3DHaugbro%26aufirst%3DM.%26aulast%3DBriggs%26aufirst%3DE.%2BM.%26aulast%3DSvetlov%26aufirst%3DV.%26aulast%3DNudler%26aufirst%3DE.%26aulast%3DKnaut%26aufirst%3DH.%26aulast%3DBonneau%26aufirst%3DR.%26aulast%3DGarabedian%26aufirst%3DM.%2BJ.%26aulast%3DKirshenbaum%26aufirst%3DK.%26aulast%3DLogan%26aufirst%3DS.%2BK.%26atitle%3DDesign%2520of%2520peptoid-peptide%2520macrocycles%2520to%2520inhibit%2520the%2520%25CE%25B2-catenin%2520TCF%2520interaction%2520in%2520prostate%2520cancer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D4396%26epage%3D4405%26doi%3D10.1038%2Fs41467-018-06845-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Rational design of small-molecule inhibitors for β-catenin/T-cell factor protein-protein interactions by bioisostere replacement</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1021/cb300564v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300564v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=524-529&author=B.+Yuauthor=Z.+Huangauthor=M.+Zhangauthor=D.+R.+Dillardauthor=H.+Ji&title=Rational+design+of+small-molecule+inhibitors+for+%CE%B2-catenin%2FT-cell+factor+protein-protein+interactions+by+bioisostere+replacement&doi=10.1021%2Fcb300564v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcb300564v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300564v%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DDillard%26aufirst%3DD.%2BR.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DRational%2520design%2520of%2520small-molecule%2520inhibitors%2520for%2520%25CE%25B2-catenin%252FT-cell%2520factor%2520protein-protein%2520interactions%2520by%2520bioisostere%2520replacement%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D524%26epage%3D529%26doi%3D10.1021%2Fcb300564v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsakhyan, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Targeting the Tcf4 G<sup>13</sup>ANDE<sup>17</sup> binding site to selectively disrupt β-catenin/T-cell factor protein-protein interactions</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1021/cb400795x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400795x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=193-201&author=Z.+Huangauthor=M.+Zhangauthor=S.+D.+Burtonauthor=L.+N.+Katsakhyanauthor=H.+Ji&title=Targeting+the+Tcf4+G13ANDE17+binding+site+to+selectively+disrupt+%CE%B2-catenin%2FT-cell+factor+protein-protein+interactions&doi=10.1021%2Fcb400795x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Tcf4 G13ANDE17 Binding Site To Selectively Disrupt β-Catenin/T-Cell Factor Protein-Protein Interactions</span></div><div class="casAuthors">Huang, Zheng; Zhang, Min; Burton, Shawn D.; Katsakhyan, Levon N.; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-201</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective disruption of protein-protein interactions by small mols. is important for probing the structure and dynamic aspects of cellular network.  It can also provide new therapeutic targets. β-Catenin of the canonical Wnt signaling pathway uses the same pos. charged groove to bind with T-cell factor (Tcf), cadherin, and adenomatous polysis coli (APC).  The extravagant formation of β-catenin/Tcf interactions drives the initiation and progression of many cancers and fibroses, while β-catenin/cadherin and β-catenin/APC interactions are essential for cell-cell adhesion and β-catenin degrdn.  In this study, a selective binding site that can differentiate β-catenin/Tcf, β-catenin/cadherin, and β-catenin/APC interactions was identified by alanine scanning and biochem. assays.  A new peptidomimetic strategy that incorporates SiteMap and multiple-copy simultaneous search was used to design selective small-mol. inhibitors for β-catenin/Tcf interactions.  A potent inhibitor was discovered to bind with β-catenin and completely disrupt β-catenin/Tcf interactions.  It also exhibits dual selectivity for β-catenin/Tcf over β-catenin/cadherin and β-catenin/APC interactions in both biochem. and cell-based assays.  This study provides a proof of concept for designing selective inhibitors for β-catenin/Tcf interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNcaw5jsvhZbVg90H21EOLACvtfcHk0lhr1abPu0BiCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrtb%252FN&md5=9f59f92f44e5b6cd486d351bd0bf77c6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcb400795x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400795x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DS.%2BD.%26aulast%3DKatsakhyan%26aufirst%3DL.%2BN.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DTargeting%2520the%2520Tcf4%2520G13ANDE17%2520binding%2520site%2520to%2520selectively%2520disrupt%2520%25CE%25B2-catenin%252FT-cell%2520factor%2520protein-protein%2520interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D193%26epage%3D201%26doi%3D10.1021%2Fcb400795x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catrow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective small-molecule inhibitors for the β-catenin/T-cell factor protein-protein interaction through the optimization of the acyl hydrazone moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4678</span>– <span class="NLM_lpage">4692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00223</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00223" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFakt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4678-4692&author=J.+L.+Catrowauthor=Y.+Zhangauthor=M.+Zhangauthor=H.+Ji&title=Discovery+of+selective+small-molecule+inhibitors+for+the+%CE%B2-catenin%2FT-cell+factor+protein-protein+interaction+through+the+optimization+of+the+acyl+hydrazone+moiety&doi=10.1021%2Facs.jmedchem.5b00223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety</span></div><div class="casAuthors">Catrow, J. Leon; Zhang, Yongqiang; Zhang, Min; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4678-4692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl hydrazone is an important functional group for the discovery of bioactive small mols.  This functional group is also recognized as a pan assay interference structure.  In this study, a new small-mol. inhibitor for the β-catenin/Tcf protein-protein interaction (PPI), ZINC02092166, was identified through AlphaScreen and FP assays.  This compd. contains an acyl hydrazone group and exhibits higher inhibitory activities in cell-based assays than biochem. assays.  Inhibitor optimization resulted in chem. stable derivs. that disrupt the β-catenin/Tcf PPI.  The binding mode of new inhibitors was characterized by site-directed mutagenesis and structure-activity relationship studies.  This series of inhibitors with a new scaffold exhibits dual selectivity for β-catenin/Tcf over β-catenin/cadherin and β-catenin/APC PPIs.  One deriv. of this series suppresses canonical Wnt signaling, downregulates the expression of Wnt target genes, and inhibits the growth of cancer cells.  This compd. represents a solid starting point for the development of potent and selective β-catenin/Tcf inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqusdU2c6KIQLVg90H21EOLACvtfcHk0lha3-zfJmB4KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFakt7o%253D&md5=11aa0209009144341d692c4cf6966790</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00223%26sid%3Dliteratum%253Aachs%26aulast%3DCatrow%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520selective%2520small-molecule%2520inhibitors%2520for%2520the%2520%25CE%25B2-catenin%252FT-cell%2520factor%2520protein-protein%2520interaction%2520through%2520the%2520optimization%2520of%2520the%2520acyl%2520hydrazone%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4678%26epage%3D4692%26doi%3D10.1021%2Facs.jmedchem.5b00223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Sa Alves, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manssour Fraga, C.</span></span> <span> </span><span class="NLM_article-title">From nature to drug discovery: the indole scaffold as a “privileged structure”</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.2174/138955709788452649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.2174%2F138955709788452649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=19519503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A280%3ADC%252BD1MvhtlymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=782-793&author=F.+de%0ASa+Alvesauthor=E.+Barreiroauthor=C.+Manssour+Fraga&title=From+nature+to+drug+discovery%3A+the+indole+scaffold+as+a+%E2%80%9Cprivileged+structure%E2%80%9D&doi=10.2174%2F138955709788452649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">From nature to drug discovery: the indole scaffold as a 'privileged structure'</span></div><div class="casAuthors">de Sa Alves Fernando Rodrigues; Barreiro Eliezer J; Fraga Carlos Alberto Manssour</div><div class="citationInfo"><span class="NLM_cas:title">Mini reviews in medicinal chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">782-93</span>
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    </div><div class="casAbstract">The indole scaffold probably represents one of the most important structural subunits for the discovery of new drug candidates.  The demonstration that many alkaloids contain the indole nucleus, the recognition of the importance of essential amino acid tryptophan in human nutrition and the discovery of plant hormones served to bring about a massive search on indole chemistry, giving rise to a vast number of biologically active natural and synthetic products, with a wide range of therapeutic targets, such as anti-inflammatories, phosphodiesterase inhibitors, 5-hydroxytryptamine receptor agonists and antagonists, cannabinoid receptors agonists and HMG-CoA reductase inhibitors.  Many of these target-receptors belong to the class of GPCRs (integral membrane G-protein coupled receptors) and possess a conserved binding pocket that is recognized by the indole scaffold in a "common" complementary binding domain, explaining the great number of drugs that contain the indole substructure, such as indomethacin, ergotamine, frovatriptan, ondansetron, tadalafil, among many others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBKUu7YDCtEQWRJ3OJdH_qfW6udTcc2ebUf_aJEi4lGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvhtlymtQ%253D%253D&md5=34fa9e3785856259b4486d57af2e75ee</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F138955709788452649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955709788452649%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BSa%2BAlves%26aufirst%3DF.%26aulast%3DBarreiro%26aufirst%3DE.%26aulast%3DManssour%2BFraga%26aufirst%3DC.%26atitle%3DFrom%2520nature%2520to%2520drug%2520discovery%253A%2520the%2520indole%2520scaffold%2520as%2520a%2520%25E2%2580%259Cprivileged%2520structure%25E2%2580%259D%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D782%26epage%3D793%26doi%3D10.2174%2F138955709788452649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sravanthi, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manju, S. L.</span></span> <span> </span><span class="NLM_article-title">Indoles - a promising scaffold for drug development</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2016.05.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ejps.2016.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=27237590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1ShsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2016&pages=1-10&author=T.+V.+Sravanthiauthor=S.+L.+Manju&title=Indoles+-+a+promising+scaffold+for+drug+development&doi=10.1016%2Fj.ejps.2016.05.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Indoles - A promising scaffold for drug development</span></div><div class="casAuthors">Sravanthi, T. V.; Manju, S. L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Generally, heterocycles occupy a prominent place in chem. due to their wide range of applications in the fields of drug design, photochem., agrochems., dyes and so on.  Among them, indole scaffolds have been found in most of the important synthetic drug mols. and paved a faithful way to develop effective targets.  Privileged structures bind to multiple receptors with high affinity, thus aiding the development of novel biol. active compds.  Among the indole class of compds., 2-arylindoles appear to be a most promising lead for drug development.  The derivs. of 2-arylindoles exhibits antibacterial, anticancer, anti-oxidants, anti-inflammatory, anti-diabetic, antiviral, antiproliferative, antituberculosis activity, etc.  This article would provide a clear knowledge on the wide-ranging biol. activities of 2-arylindoles over the past two decades, which would be beneficial for the designing of more potent drug targets in order to compete with the existing drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHUcvfxzoNJ7Vg90H21EOLACvtfcHk0lha3-zfJmB4KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1ShsL0%253D&md5=b32d3300238020d5b95dbf5fbcab7509</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2016.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2016.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DSravanthi%26aufirst%3DT.%2BV.%26aulast%3DManju%26aufirst%3DS.%2BL.%26atitle%3DIndoles%2520-%2520a%2520promising%2520scaffold%2520for%2520drug%2520development%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D91%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.ejps.2016.05.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banoglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, R. S.</span></span> <span> </span><span class="NLM_article-title">Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1007/bf03226377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1007%2Fbf03226377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=11808865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtlKmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2001&pages=235-240&author=E.+Banogluauthor=G.+G.+Jhaauthor=R.+S.+King&title=Hepatic+microsomal+metabolism+of+indole+to+indoxyl%2C+a+precursor+of+indoxyl+sulfate&doi=10.1007%2Fbf03226377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate</span></div><div class="casAuthors">Banoglu, Erden; Jha, Gautam G.; King, Roberta S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-240</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Medecine et Hygiene</span>)
        </div><div class="casAbstract">The aim of our study was to det. which microsomal cytochrome P 450 isoenzyme(s) were responsible for the microsomal oxidn. of indole to indoxyl, an important intermediate in the information of the uremic toxin indoxyl sulfate.  Indole was incubated together with an NADPH - generating system and rat liver microsomes.  Formation of indigo, an auto-oxidn. product of indoxyl, was used to det. the indole-3-hydroxylation activity.  Apparent Km and Vmax values of 0.85 mM and 1152 pmol min-1 mg-1 were calcd. for the formation of indoxyl from indole using rat liver microsomes.  The effects of various potential inducers and inhibitors on the metab. of indole to indoxyl by rat liver microsomes were studied to elucidate the enzymes responsible for metab.  Studies with general and isoenzyme-specific P 450 inhibitors demonstrated that P 450 enzymes and not FMO are responsible for the formation of indoxyl.  In the induction studies, rate of indoxyl formation in the microsomes from untreated vs. induced rats correlated nearly exactly with the CYP2E1 activity (4-nitrophenol 2-hydroxylation).  These results suggests that CYP2E1 is the major isoform for the microsomal oxidn. of indole to indoxyl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobdrwvJ8pFf7Vg90H21EOLACvtfcHk0ljr_HD0bXSTmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtlKmt7w%253D&md5=b09209999ef01cf1fd48393cb4992119</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fbf03226377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fbf03226377%26sid%3Dliteratum%253Aachs%26aulast%3DBanoglu%26aufirst%3DE.%26aulast%3DJha%26aufirst%3DG.%2BG.%26aulast%3DKing%26aufirst%3DR.%2BS.%26atitle%3DHepatic%2520microsomal%2520metabolism%2520of%2520indole%2520to%2520indoxyl%252C%2520a%2520precursor%2520of%2520indoxyl%2520sulfate%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2001%26volume%3D26%26spage%3D235%26epage%3D240%26doi%3D10.1007%2Fbf03226377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kondreddi, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bifani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8849</span>– <span class="NLM_lpage">8859</span>, <span class="refDoi"> DOI: 10.1021/jm4012774</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4012774" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOisLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8849-8859&author=R.+R.+Kondreddiauthor=J.+Jiricekauthor=S.+P.+S.+Raoauthor=S.+B.+Lakshminarayanaauthor=L.+R.+Camachoauthor=R.+Raoauthor=M.+Herveauthor=P.+Bifaniauthor=N.+L.+Maauthor=K.+Kuhenauthor=A.+Gohauthor=A.+K.+Chatterjeeauthor=T.+Dickauthor=T.+T.+Diaganaauthor=U.+H.+Manjunathaauthor=P.+W.+Smith&title=Design%2C+synthesis%2C+and+biological+evaluation+of+indole-2-carboxamides%3A+a+promising+class+of+antituberculosis+agents&doi=10.1021%2Fjm4012774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides: A Promising Class of Antituberculosis Agents</span></div><div class="casAuthors">Kondreddi, Ravinder Reddy; Jiricek, Jan; Rao, Srinivasa P. S.; Lakshminarayana, Suresh B.; Camacho, Luis R.; Rao, Ranga; Herve, Maxime; Bifani, Pablo; Ma, Ngai Ling; Kuhen, Kelli; Goh, Anne; Chatterjee, Arnab K.; Dick, Thomas; Diagana, Thierry T.; Manjunatha, Ujjini H.; Smith, Paul W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8849-8859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indole-2-carboxamides have been identified as a promising class of antituberculosis agents from phenotypic screening against mycobacteria.  One of the hits, indole-2-carboxamide analog (I), had low micromolar potency against Mycobacterium tuberculosis (Mtb), high mouse liver microsomal clearance, and low aq. soly.  Structure-activity relationship studies revealed that attaching alkyl groups to the cyclohexyl ring significantly improved Mtb activity but reduced soly.  Furthermore, chloro, fluoro, or cyano substitutions on the 4- and 6-positions of the indole ring as well as Me substitution on the cyclohexyl ring significantly improved metabolic stability.  II and III, the lead candidates, displayed improved in vitro activity compared to most of the current std. TB drugs.  The low aq. soly. could not be mitigated because of the pos. correlation of lipophilicity with Mtb potency.  However, both compds. displayed favorable oral pharmacokinetic properties in rodents and demonstrated in vivo efficacy.  Thus, indole-2-carboxamides represent a promising new class of antituberculosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4KW8om-6fZ7Vg90H21EOLACvtfcHk0ljr_HD0bXSTmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOisLjL&md5=ab732bc84632b1f9f364e45610bcbc1b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm4012774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4012774%26sid%3Dliteratum%253Aachs%26aulast%3DKondreddi%26aufirst%3DR.%2BR.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DCamacho%26aufirst%3DL.%2BR.%26aulast%3DRao%26aufirst%3DR.%26aulast%3DHerve%26aufirst%3DM.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DN.%2BL.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520indole-2-carboxamides%253A%2520a%2520promising%2520class%2520of%2520antituberculosis%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8849%26epage%3D8859%26doi%3D10.1021%2Fjm4012774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piscitelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Regina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coluccia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allarà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestri, R.</span></span> <span> </span><span class="NLM_article-title">Indole-2-carboxamides as allosteric modulators of the cannabinoid CB(1) receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5627</span>– <span class="NLM_lpage">5631</span>, <span class="refDoi"> DOI: 10.1021/jm201485c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201485c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5627-5631&author=F.+Piscitelliauthor=A.+Ligrestiauthor=G.+La+Reginaauthor=A.+Colucciaauthor=L.+Moreraauthor=M.+Allar%C3%A0author=E.+Novellinoauthor=V.+Di+Marzoauthor=R.+Silvestri&title=Indole-2-carboxamides+as+allosteric+modulators+of+the+cannabinoid+CB%281%29+receptor&doi=10.1021%2Fjm201485c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm201485c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201485c%26sid%3Dliteratum%253Aachs%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DLa%2BRegina%26aufirst%3DG.%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DMorera%26aufirst%3DL.%26aulast%3DAllar%25C3%25A0%26aufirst%3DM.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DIndole-2-carboxamides%2520as%2520allosteric%2520modulators%2520of%2520the%2520cannabinoid%2520CB%25281%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5627%26epage%3D5631%26doi%3D10.1021%2Fjm201485c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ban, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munuganti, R. S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frewin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rennie, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherkasov, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1H-indole-2-carboxamides as novel inhibitors of the androgen receptor binding function 3 (BF3)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6867</span>– <span class="NLM_lpage">6872</span>, <span class="refDoi"> DOI: 10.1021/jm500684r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500684r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6867-6872&author=F.+Banauthor=E.+Leblancauthor=H.+Liauthor=R.+S.+N.+Munugantiauthor=K.+Frewinauthor=P.+S.+Rennieauthor=A.+Cherkasov&title=Discovery+of+1H-indole-2-carboxamides+as+novel+inhibitors+of+the+androgen+receptor+binding+function+3+%28BF3%29&doi=10.1021%2Fjm500684r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1H-Indole-2-carboxamides as Novel Inhibitors of the Androgen Receptor Binding Function 3 (BF3)</span></div><div class="casAuthors">Ban, Fuqiang; Leblanc, Eric; Li, Huifang; Munuganti, Ravi S. N.; Frewin, Kate; Rennie, Paul S.; Cherkasov, Artem</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6867-6872</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To overcome resistance to conventional antiandrogens of human androgen receptor (AR), the allosteric site of the AR binding function 3 (BF3) was investigated as an alternative target for small mol. therapeutics.  A library of 1H-indole-2-carboxamides were discovered as BF3 inhibitors and exhibited strong antiproliferative activity against LNCaP and enzalutamide-resistant prostate cancer cell lines.  Several of the lead compds. may prove of particular benefit as a novel alternative treatment for castration-resistant prostate cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTICfYB_78jbVg90H21EOLACvtfcHk0ljr_HD0bXSTmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtLrN&md5=e19e2284afd93d3957e77a63a8f0f146</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm500684r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500684r%26sid%3Dliteratum%253Aachs%26aulast%3DBan%26aufirst%3DF.%26aulast%3DLeblanc%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMunuganti%26aufirst%3DR.%2BS.%2BN.%26aulast%3DFrewin%26aufirst%3DK.%26aulast%3DRennie%26aufirst%3DP.%2BS.%26aulast%3DCherkasov%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25201H-indole-2-carboxamides%2520as%2520novel%2520inhibitors%2520of%2520the%2520androgen%2520receptor%2520binding%2520function%25203%2520%2528BF3%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6867%26epage%3D6872%26doi%3D10.1021%2Fjm500684r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stec, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onajole, O. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merenbloom, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishai, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Indole-2-carboxamide-based MmpL3 inhibitors show exceptional antitubercular activity in an animal model of tuberculosis infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6232</span>– <span class="NLM_lpage">6247</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00415</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00415" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsVCltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6232-6247&author=J.+Stecauthor=O.+K.+Onajoleauthor=S.+Lunauthor=H.+Guoauthor=B.+Merenbloomauthor=G.+Vistoliauthor=W.+R.+Bishaiauthor=A.+P.+Kozikowski&title=Indole-2-carboxamide-based+MmpL3+inhibitors+show+exceptional+antitubercular+activity+in+an+animal+model+of+tuberculosis+infection&doi=10.1021%2Facs.jmedchem.6b00415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection</span></div><div class="casAuthors">Stec, Jozef; Onajole, Oluseye K.; Lun, Shichun; Guo, Haidan; Merenbloom, Benjamin; Vistoli, Giulio; Bishai, William R.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6232-6247</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our team had previously identified certain indolecarboxamides that represented a new chem. scaffold that showed promising anti-TB activity at both an in vitro and in vivo level.  Based on mutational anal. using bacteria found resistant to one of these indolecarboxamides, we identified the trehalose monomycolate transporter MmpL3 as the likely target of these compds.  In the present work, we now further elaborate on the SAR of these compds., which has led in turn to the identification of a new analog, 4,6-difluoro-N-((1R,2R,3R,5S)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)-1H-indole-2-carboxamide (26), that shows excellent activity against drug-sensitive (MIC = 0.012 μM; SI ≥ 16000), multidrug-resistant (MDR), and extensively drug-resistant (XDR) Mycobacterium tuberculosis strains, has superior ADMET properties, and shows excellent activity in the TB aerosol lung infection model.  Compd. 26 is also shown to work in synergy with rifampin.  Because of these properties, we believe that indolecarboxamide 26 is a possible candidate for advancement to human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg0h9TR-VL5rVg90H21EOLACvtfcHk0lhJoY9D4l5oog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsVCltb8%253D&md5=f9e3d545a65f85deb3f97054dca77c1f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00415%26sid%3Dliteratum%253Aachs%26aulast%3DStec%26aufirst%3DJ.%26aulast%3DOnajole%26aufirst%3DO.%2BK.%26aulast%3DLun%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DMerenbloom%26aufirst%3DB.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIndole-2-carboxamide-based%2520MmpL3%2520inhibitors%2520show%2520exceptional%2520antitubercular%2520activity%2520in%2520an%2520animal%2520model%2520of%2520tuberculosis%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6232%26epage%3D6247%26doi%3D10.1021%2Facs.jmedchem.6b00415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">New homogeneous high-throughput assays for inhibitors of β-catenin/Tcf protein-protein interactions</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>424</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2012.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ab.2012.02.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2012&pages=57-63&author=M.+Zhangauthor=Z.+Huangauthor=B.+Yuauthor=H.+Ji&title=New+homogeneous+high-throughput+assays+for+inhibitors+of+%CE%B2-catenin%2FTcf+protein-protein+interactions&doi=10.1016%2Fj.ab.2012.02.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2012.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2012.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DNew%2520homogeneous%2520high-throughput%2520assays%2520for%2520inhibitors%2520of%2520%25CE%25B2-catenin%252FTcf%2520protein-protein%2520interactions%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D424%26spage%3D57%26epage%3D63%26doi%3D10.1016%2Fj.ab.2012.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liljebris, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazuk, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleasdale, J. E.</span></span> <span> </span><span class="NLM_article-title">Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: identification of a tetrazole-containing inhibitor with cellular activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1785</span>– <span class="NLM_lpage">1798</span>, <span class="refDoi"> DOI: 10.1021/jm011100y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011100y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1785-1798&author=C.+Liljebrisauthor=S.+D.+Larsenauthor=D.+Oggauthor=B.+J.+Palazukauthor=J.+E.+Bleasdale&title=Investigation+of+potential+bioisosteric+replacements+for+the+carboxyl+groups+of+peptidomimetic+inhibitors+of+protein+tyrosine+phosphatase+1B%3A+identification+of+a+tetrazole-containing+inhibitor+with+cellular+activity&doi=10.1021%2Fjm011100y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm011100y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011100y%26sid%3Dliteratum%253Aachs%26aulast%3DLiljebris%26aufirst%3DC.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DOgg%26aufirst%3DD.%26aulast%3DPalazuk%26aufirst%3DB.%2BJ.%26aulast%3DBleasdale%26aufirst%3DJ.%2BE.%26atitle%3DInvestigation%2520of%2520potential%2520bioisosteric%2520replacements%2520for%2520the%2520carboxyl%2520groups%2520of%2520peptidomimetic%2520inhibitors%2520of%2520protein%2520tyrosine%2520phosphatase%25201B%253A%2520identification%2520of%2520a%2520tetrazole-containing%2520inhibitor%2520with%2520cellular%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1785%26epage%3D1798%26doi%3D10.1021%2Fjm011100y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepourcelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivdasani, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span> <span> </span><span class="NLM_article-title">Structure of a human Tcf4-β-catenin complex</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1053</span>– <span class="NLM_lpage">1057</span>, <span class="refDoi"> DOI: 10.1038/nsb720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnsb720" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=1053-1057&author=F.+Poyauthor=M.+Lepourceletauthor=R.+A.+Shivdasaniauthor=M.+J.+Eck&title=Structure+of+a+human+Tcf4-%CE%B2-catenin+complex&doi=10.1038%2Fnsb720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnsb720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb720%26sid%3Dliteratum%253Aachs%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DLepourcelet%26aufirst%3DM.%26aulast%3DShivdasani%26aufirst%3DR.%2BA.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DStructure%2520of%2520a%2520human%2520Tcf4-%25CE%25B2-catenin%2520complex%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D1053%26epage%3D1057%26doi%3D10.1038%2Fnsb720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graham, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferkey, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimelman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span> <span> </span><span class="NLM_article-title">Tcf4 can specifically recognize β-catenin using alternative conformations</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1048</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1038/nsb718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnsb718" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=1048-1052&author=T.+A.+Grahamauthor=D.+M.+Ferkeyauthor=F.+Maoauthor=D.+Kimelmanauthor=W.+Xu&title=Tcf4+can+specifically+recognize+%CE%B2-catenin+using+alternative+conformations&doi=10.1038%2Fnsb718"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnsb718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb718%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DT.%2BA.%26aulast%3DFerkey%26aufirst%3DD.%2BM.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DKimelman%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DTcf4%2520can%2520specifically%2520recognize%2520%25CE%25B2-catenin%2520using%2520alternative%2520conformations%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D1048%26epage%3D1052%26doi%3D10.1038%2Fnsb718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sampietro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlberg, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimelman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a β-catenin/BCL9/Tcf4 complex</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2006.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.molcel.2006.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=17052462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2rs7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=293-300&author=J.+Sampietroauthor=C.+L.+Dahlbergauthor=U.+S.+Choauthor=T.+R.+Hindsauthor=D.+Kimelmanauthor=W.+Xu&title=Crystal+structure+of+a+%CE%B2-catenin%2FBCL9%2FTcf4+complex&doi=10.1016%2Fj.molcel.2006.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a β-catenin/BCL9/Tcf4 complex</span></div><div class="casAuthors">Sampietro, James; Dahlberg, Caroline L.; Cho, Uhn Soo; Hinds, Thomas R.; Kimelman, David; Xu, Wenqing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">293-300</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The canonical Wnt pathway plays crit. roles in embryonic development, stem cell growth, and tumorigenesis.  Stimulation of the Wnt pathway leads to the assocn. of β-catenin with Tcf and BCL9 in the nucleus, resulting in the transactivation of Wnt target genes.  We have detd. the crystal structure of a β-catenin/BCL9/Tcf-4 triple complex at 2.6 Å resoln.  Our studies reveal that the β-catenin binding site of BCL9 is distinct from that of most other β-catenin partners and forms a good target for developing drugs that block canonical Wnt/β-catenin signaling.  The BCL9 β-catenin binding domain (CBD) forms an α helix that binds to the first armadillo repeat of β-catenin, which can be mutated to prevent β-catenin binding to BCL9 without affecting cadherin or α-catenin binding.  We also demonstrate that β-catenin Y142 phosphorylation, which has been proposed to regulate BCL9-2 binding, does not directly affect the interaction of β-catenin with either BCL9 or BCL9-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyhIEzcTKHQbVg90H21EOLACvtfcHk0li2YuZZGtWb4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2rs7%252FF&md5=493e9271912b304915e8371b87d2a9b9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DSampietro%26aufirst%3DJ.%26aulast%3DDahlberg%26aufirst%3DC.%2BL.%26aulast%3DCho%26aufirst%3DU.%2BS.%26aulast%3DHinds%26aufirst%3DT.%2BR.%26aulast%3DKimelman%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DCrystal%2520structure%2520of%2520a%2520%25CE%25B2-catenin%252FBCL9%252FTcf4%2520complex%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D24%26spage%3D293%26epage%3D300%26doi%3D10.1016%2Fj.molcel.2006.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">Biochemical and structural characterization of β-catenin interactions with nonphosphorylated and CK2-phosphorylated Lef-1</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>405</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.jmb.2010.11.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2011&pages=519-530&author=J.+Sunauthor=W.+I.+Weis&title=Biochemical+and+structural+characterization+of+%CE%B2-catenin+interactions+with+nonphosphorylated+and+CK2-phosphorylated+Lef-1&doi=10.1016%2Fj.jmb.2010.11.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DBiochemical%2520and%2520structural%2520characterization%2520of%2520%25CE%25B2-catenin%2520interactions%2520with%2520nonphosphorylated%2520and%2520CK2-phosphorylated%2520Lef-1%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D405%26spage%3D519%26epage%3D530%26doi%3D10.1016%2Fj.jmb.2010.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1016/s0092-8674(01)00330-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fs0092-8674%2801%2900330-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=11348595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1ait74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2001&pages=391-402&author=A.+H.+Huberauthor=W.+I.+Weis&title=The+structure+of+the+%CE%B2-catenin%2FE-cadherin+complex+and+the+molecular+basis+of+diverse+ligand+recognition+by+beta-catenin&doi=10.1016%2Fs0092-8674%2801%2900330-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin</span></div><div class="casAuthors">Huber, Andrew H.; Weis, William I.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">391-402</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">As a component of adherens junctions and the Wnt signaling pathway, β-catenin binds cadherins, Tcf family transcription factors, and the tumor suppressor APC.  We have detd. the crystal structures of both unphosphorylated and phosphorylated E-cadherin cytoplasmic domain complexed with the arm repeat region of β-catenin.  The interaction spans all 12 arm repeats, and features quasi-independent binding regions that include helixes which interact with both ends of the arm repeat domain and an extended stretch of 14 residues which closely resembles a portion of XTcf-3.  Phosphorylation of E-cadherin results in interactions with a hydrophobic patch of β-catenin that mimics the binding of an amphipathic XTcf-3 helix.  APC contains sequences homologous to the phosphorylated region of cadherin, and is likely to bind similarly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3EHT0byAbaLVg90H21EOLACvtfcHk0li2YuZZGtWb4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1ait74%253D&md5=e1264790de237cd912acbece8621c7d0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fs0092-8674%2801%2900330-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0092-8674%252801%252900330-0%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DA.%2BH.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DThe%2520structure%2520of%2520the%2520%25CE%25B2-catenin%252FE-cadherin%2520complex%2520and%2520the%2520molecular%2520basis%2520of%2520diverse%2520ligand%2520recognition%2520by%2520beta-catenin%26jtitle%3DCell%26date%3D2001%26volume%3D105%26spage%3D391%26epage%3D402%26doi%3D10.1016%2Fs0092-8674%2801%2900330-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spink, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of β-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-β-catenin complex</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6203</span>– <span class="NLM_lpage">6212</span>, <span class="refDoi"> DOI: 10.1093/emboj/20.22.6203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1093%2Femboj%2F20.22.6203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=6203-6212&author=K.+E.+Spinkauthor=S.+G.+Fridmanauthor=W.+I.+Weis&title=Molecular+mechanisms+of+%CE%B2-catenin+recognition+by+adenomatous+polyposis+coli+revealed+by+the+structure+of+an+APC-%CE%B2-catenin+complex&doi=10.1093%2Femboj%2F20.22.6203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.22.6203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.22.6203%26sid%3Dliteratum%253Aachs%26aulast%3DSpink%26aufirst%3DK.%2BE.%26aulast%3DFridman%26aufirst%3DS.%2BG.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DMolecular%2520mechanisms%2520of%2520%25CE%25B2-catenin%2520recognition%2520by%2520adenomatous%2520polyposis%2520coli%2520revealed%2520by%2520the%2520structure%2520of%2520an%2520APC-%25CE%25B2-catenin%2520complex%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D6203%26epage%3D6212%26doi%3D10.1093%2Femboj%2F20.22.6203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ha, N.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonozuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">Mechanism of phosphorylation-dependent binding of APC to β-catenin and its role in β-catenin degradation</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2004.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.molcel.2004.08.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=511-521&author=N.-C.+Haauthor=T.+Tonozukaauthor=J.+L.+Stamosauthor=H.-J.+Choiauthor=W.+I.+Weis&title=Mechanism+of+phosphorylation-dependent+binding+of+APC+to+%CE%B2-catenin+and+its+role+in+%CE%B2-catenin+degradation&doi=10.1016%2Fj.molcel.2004.08.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DHa%26aufirst%3DN.-C.%26aulast%3DTonozuka%26aufirst%3DT.%26aulast%3DStamos%26aufirst%3DJ.%2BL.%26aulast%3DChoi%26aufirst%3DH.-J.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DMechanism%2520of%2520phosphorylation-dependent%2520binding%2520of%2520APC%2520to%2520%25CE%25B2-catenin%2520and%2520its%2520role%2520in%2520%25CE%25B2-catenin%2520degradation%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D15%26spage%3D511%26epage%3D521%26doi%3D10.1016%2Fj.molcel.2004.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Trong, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenkamp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimelman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a β-catenin/APC complex reveals a critical role for APC phosphorylation in APC function</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2004.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.molcel.2004.08.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=523-533&author=Y.+Xingauthor=W.+K.+Clementsauthor=I.+Le+Trongauthor=T.+R.+Hindsauthor=R.+Stenkampauthor=D.+Kimelmanauthor=W.+Xu&title=Crystal+structure+of+a+%CE%B2-catenin%2FAPC+complex+reveals+a+critical+role+for+APC+phosphorylation+in+APC+function&doi=10.1016%2Fj.molcel.2004.08.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DY.%26aulast%3DClements%26aufirst%3DW.%2BK.%26aulast%3DLe%2BTrong%26aufirst%3DI.%26aulast%3DHinds%26aufirst%3DT.%2BR.%26aulast%3DStenkamp%26aufirst%3DR.%26aulast%3DKimelman%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DCrystal%2520structure%2520of%2520a%2520%25CE%25B2-catenin%252FAPC%2520complex%2520reveals%2520a%2520critical%2520role%2520for%2520APC%2520phosphorylation%2520in%2520APC%2520function%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D15%26spage%3D523%26epage%3D533%26doi%3D10.1016%2Fj.molcel.2004.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hulsken, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, J.</span></span> <span> </span><span class="NLM_article-title">E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">2061</span>– <span class="NLM_lpage">2069</span>, <span class="refDoi"> DOI: 10.1083/jcb.127.6.2061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1083%2Fjcb.127.6.2061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1994&pages=2061-2069&author=J.+Hulskenauthor=W.+Birchmeierauthor=J.+Behrens&title=E-cadherin+and+APC+compete+for+the+interaction+with+%CE%B2-catenin+and+the+cytoskeleton&doi=10.1083%2Fjcb.127.6.2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1083%2Fjcb.127.6.2061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.127.6.2061%26sid%3Dliteratum%253Aachs%26aulast%3DHulsken%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DBehrens%26aufirst%3DJ.%26atitle%3DE-cadherin%2520and%2520APC%2520compete%2520for%2520the%2520interaction%2520with%2520%25CE%25B2-catenin%2520and%2520the%2520cytoskeleton%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1994%26volume%3D127%26spage%3D2061%26epage%3D2069%26doi%3D10.1083%2Fjcb.127.6.2061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kral, A. M.</span></span> <span> </span><span class="NLM_article-title">Identification of Tcf4 residues involved in high-affinity β-catenin binding</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1999.0379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1006%2Fbbrc.1999.0379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10080941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVahurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1999&pages=584-590&author=C.+A.+Omerauthor=P.+J.+Millerauthor=R.+E.+Diehlauthor=A.+M.+Kral&title=Identification+of+Tcf4+residues+involved+in+high-affinity+%CE%B2-catenin+binding&doi=10.1006%2Fbbrc.1999.0379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Tcf4 Residues Involved in High-Affinity β-Catenin Binding</span></div><div class="casAuthors">Omer, Charles A.; Miller, Patricia J.; Diehl, Ronald E.; Kral, Astrid M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">584-590</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The N-termini of members of the T-cell factor (Tcf) and lymphocyte-enhancement factor (Lef) protein families bind to β-catenin, forming bipartite transcription factors which regulate expression of genes involved in organismal development and the growth of normal and malignant colon epithelium.  Elevated levels of Tcf4:β-catenin are found in colon tumor cells with mutations in the adenomatous polyposis coli (APC) gene.  The elevated levels of Tcf4:β-catenin result in increased transcription of genes, including c-myc, important for the growth of these tumor cells.  Here we analyze the interaction between β-catenin and Tcf4 and show that the N-terminal 53 amino acids of Tcf4 bind with high affinity to β-catenin.  We show that this high-affinity interaction involves multiple contact points including Tcf4 Asp-16, which is essential for β-catenin binding.  In addn. to Tcf/Lef family members, β-catenin binds to APC and cadherins.  We found that the binding of β-catenin to Tcf4, APC, or E-cadherin was mutually exclusive.  These results are discussed with regard to how β-catenin interacts with its binding partners and to the potential for identifying specific, small mol. inhibitors of these interactions.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0x1TFhpevbVg90H21EOLACvtfcHk0liyW8AQCmhUeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVahurw%253D&md5=fba757520faae5a84dc51abc0baba7e0</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1999.0379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1999.0379%26sid%3Dliteratum%253Aachs%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DMiller%26aufirst%3DP.%2BJ.%26aulast%3DDiehl%26aufirst%3DR.%2BE.%26aulast%3DKral%26aufirst%3DA.%2BM.%26atitle%3DIdentification%2520of%2520Tcf4%2520residues%2520involved%2520in%2520high-affinity%2520%25CE%25B2-catenin%2520binding%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1999%26volume%3D256%26spage%3D584%26epage%3D590%26doi%3D10.1006%2Fbbrc.1999.0379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orsulic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemler, R.</span></span> <span> </span><span class="NLM_article-title">E-cadherin binding prevents β-catenin nuclear localization and β-catenin/LEF-1-mediated transactivation</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1237</span>– <span class="NLM_lpage">1245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10085258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADyaK1MXjtFGhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1999&pages=1237-1245&author=S.+Orsulicauthor=O.+Huberauthor=H.+Aberleauthor=S.+Arnoldauthor=R.+Kemler&title=E-cadherin+binding+prevents+%CE%B2-catenin+nuclear+localization+and+%CE%B2-catenin%2FLEF-1-mediated+transactivation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">E-cadherin binding prevents β-catenin nuclear localization and β-catenin/LEF-1-mediated transactivation</span></div><div class="casAuthors">Orsulic, Sandra; Huber, Otmar; Aberle, Hermann; Arnold, Sebastian; Kemler, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1237-1245</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">β-Catenin is a multifunctional protein found in three cell compartments: the plasma membrane, the cytoplasm and the nucleus.  The cell has developed elaborate ways of regulating the level and localization of β-catenin to assure its specific function in each compartment.  One aspect of this regulation is inherent in the structural organization of β-catenin itself; most of its protein-interacting motifs overlap so that interaction with one partner can block binding of another at the same time.  Using recombinant proteins, we found that E-cadherin and lymphocyte-enhancer factor-1 (LEF-1) form mutually exclusive complexes with β-catenin; the assocn. of β-catenin with LEF-1 was competed out by the E-cadherin cytoplasmic domain.  Similarly, LEF-1 and adenomatous polyposis coli (APC) formed sep., mutually exclusive complexes with β-catenin.  In Wnt-1-transfected C57MG cells, free β-catenin accumulated and was able to assoc. with LEF-1.  The absence of E-cadherin in E-cadherin-/- embryonic stem (ES) cells also led to an accumulation of free β-catenin and its assocn. with LEF-1, thereby mimicking Wnt signaling.  β-Catenin/LEF-1-mediated transactivation in these cells was antagonized by transient expression of wild-type E-cadherin, but not of E-cadherin lacking the β-catenin binding site.  The potent ability of E-cadherin to recruit β-catenin to the cell membrane and prevent its nuclear localization and transactivation was also demonstrated using SW480 colon carcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVI5JKvvBRzrVg90H21EOLACvtfcHk0liyW8AQCmhUeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtFGhsLk%253D&md5=f57e374bf552d6e1d413826e8c5c53b0</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrsulic%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DO.%26aulast%3DAberle%26aufirst%3DH.%26aulast%3DArnold%26aufirst%3DS.%26aulast%3DKemler%26aufirst%3DR.%26atitle%3DE-cadherin%2520binding%2520prevents%2520%25CE%25B2-catenin%2520nuclear%2520localization%2520and%2520%25CE%25B2-catenin%252FLEF-1-mediated%2520transactivation%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D1999%26volume%3D112%26spage%3D1237%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">Thermodynamics of β-Catenin-Ligand Interactions</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1038</span>, <span class="refDoi"> DOI: 10.1074/jbc.m511338200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1074%2Fjbc.m511338200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=1027-1038&author=H.-J.+Choiauthor=A.+H.+Huberauthor=W.+I.+Weis&title=Thermodynamics+of+%CE%B2-Catenin-Ligand+Interactions&doi=10.1074%2Fjbc.m511338200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m511338200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m511338200%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.-J.%26aulast%3DHuber%26aufirst%3DA.%2BH.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DThermodynamics%2520of%2520%25CE%25B2-Catenin-Ligand%2520Interactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D1027%26epage%3D1038%26doi%3D10.1074%2Fjbc.m511338200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiendlmeyer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabletz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hlubek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, A.</span></span> <span> </span><span class="NLM_article-title">β-Catenin regulates the expression of tenascin-C in human colorectal tumors</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">8200</span>– <span class="NLM_lpage">8204</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1208960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fsj.onc.1208960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=16091738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=8200-8204&author=K.+Beiterauthor=E.+Hiendlmeyerauthor=T.+Brabletzauthor=F.+Hlubekauthor=A.+Haynlauthor=C.+Knollauthor=T.+Kirchnerauthor=A.+Jung&title=%CE%B2-Catenin+regulates+the+expression+of+tenascin-C+in+human+colorectal+tumors&doi=10.1038%2Fsj.onc.1208960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">β-Catenin regulates the expression of tenascin-C in human colorectal tumors</span></div><div class="casAuthors">Beiter, Katharina; Hiendlmeyer, Elke; Brabletz, Thomas; Hlubek, Falk; Haynl, Angela; Knoll, Claudia; Kirchner, Thomas; Jung, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">55</span>),
    <span class="NLM_cas:pages">8200-8204</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tenascin-C (TN-C) is a component of the extracellular matrix (ECM).  It is expressed during development and re-expressed in many types of cancers, where it is involved in the modulation of adhesion and proliferation.  TN-C expression is esp. high at sites of epithelial mesenchymal transition (EMT), which are found frequently at the invasion front of well-differentiated human colorectal adenocarcinomas.  Tumor cells in this compartment are characterized by a strong nuclear expression of the oncogenic transcription factor β-catenin.  Here, we demonstrate that TN-C is a β-catenin target gene in human colorectal tumors.  Thus, by far the most common mutations in colorectal tumors, found in the Wnt-signaling pathway and leading to the stabilizing of β-catenin, might influence invasion by altering adhesive properties and EMT of tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP7S_zSxaDkLVg90H21EOLACvtfcHk0liyW8AQCmhUeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktbfE&md5=cc223d0407d4eaaf3fe23b8c195f71c5</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1208960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1208960%26sid%3Dliteratum%253Aachs%26aulast%3DBeiter%26aufirst%3DK.%26aulast%3DHiendlmeyer%26aufirst%3DE.%26aulast%3DBrabletz%26aufirst%3DT.%26aulast%3DHlubek%26aufirst%3DF.%26aulast%3DHaynl%26aufirst%3DA.%26aulast%3DKnoll%26aufirst%3DC.%26aulast%3DKirchner%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DA.%26atitle%3D%25CE%25B2-Catenin%2520regulates%2520the%2520expression%2520of%2520tenascin-C%2520in%2520human%2520colorectal%2520tumors%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D8200%26epage%3D8204%26doi%3D10.1038%2Fsj.onc.1208960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oskarsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharyya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. H.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanharanta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavazoie, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manova-Todorova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massagué, J.</span></span> <span> </span><span class="NLM_article-title">Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1038/nm.2379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnm.2379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21706029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotV2hsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=867-874&author=T.+Oskarssonauthor=S.+Acharyyaauthor=X.+H.-F.+Zhangauthor=S.+Vanharantaauthor=S.+F.+Tavazoieauthor=P.+G.+Morrisauthor=R.+J.+Downeyauthor=K.+Manova-Todorovaauthor=E.+Brogiauthor=J.+Massagu%C3%A9&title=Breast+cancer+cells+produce+tenascin+C+as+a+metastatic+niche+component+to+colonize+the+lungs&doi=10.1038%2Fnm.2379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs</span></div><div class="casAuthors">Oskarsson, Thordur; Acharyya, Swarnali; Zhang, Xiang H.-F.; Vanharanta, Sakari; Tavazoie, Sohail F.; Morris, Patrick G.; Downey, Robert J.; Manova-Todorova, Katia; Brogi, Edi; Massague, Joan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">867-874</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report that breast cancer cells that infiltrate the lungs support their own metastasis-initiating ability by expressing tenascin C (TNC).  We find that the expression of TNC, an extracellular matrix protein of stem cell niches, is assocd. with the aggressiveness of pulmonary metastasis.  Cancer cell-derived TNC promotes the survival and outgrowth of pulmonary micrometastases.  TNC enhances the expression of stem cell signaling components, musashi homolog 1 (MSI1) and leucine-rich repeat-contg. G protein-coupled receptor 5 (LGR5).  MSI1 is a pos. regulator of NOTCH signaling, whereas LGR5 is a target gene of the WNT pathway.  TNC modulation of stem cell signaling occurs without affecting the expression of transcriptional enforcers of the stem cell phenotype and pluripotency, namely nanog homeobox (NANOG), POU class 5 homeobox 1 (POU5F1), also known as OCT4, and SRY-box 2 (SOX2).  TNC protects MSI1-dependent NOTCH signaling from inhibition by signal transducer and activator of transcription 5 (STAT5), and selectively enhances the expression of LGR5 as a WNT target gene.  Cancer cell-derived TNC remains essential for metastasis outgrowth until the tumor stroma takes over as a source of TNC.  These findings link TNC to pathways that support the fitness of metastasis-initiating breast cancer cells and highlight the relevance of TNC as an extracellular matrix component of the metastatic niche.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOdMMNxDI7srVg90H21EOLACvtfcHk0lhp8Ho2gGI8pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotV2hsLg%253D&md5=eaca74c63536b025cadbbb0a641524d2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnm.2379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2379%26sid%3Dliteratum%253Aachs%26aulast%3DOskarsson%26aufirst%3DT.%26aulast%3DAcharyya%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%2BH.-F.%26aulast%3DVanharanta%26aufirst%3DS.%26aulast%3DTavazoie%26aufirst%3DS.%2BF.%26aulast%3DMorris%26aufirst%3DP.%2BG.%26aulast%3DDowney%26aufirst%3DR.%2BJ.%26aulast%3DManova-Todorova%26aufirst%3DK.%26aulast%3DBrogi%26aufirst%3DE.%26aulast%3DMassagu%25C3%25A9%26aufirst%3DJ.%26atitle%3DBreast%2520cancer%2520cells%2520produce%2520tenascin%2520C%2520as%2520a%2520metastatic%2520niche%2520component%2520to%2520colonize%2520the%2520lungs%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D867%26epage%3D874%26doi%3D10.1038%2Fnm.2379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walther, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertins, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heizmann, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlag, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span> <span> </span><span class="NLM_article-title">The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">1486</span>– <span class="NLM_lpage">1500</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2006.08.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1053%2Fj.gastro.2006.08.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=17101323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlantrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=1486-1500&author=U.+Steinauthor=F.+Arltauthor=W.+Waltherauthor=J.+Smithauthor=T.+Waldmanauthor=E.+D.+Harrisauthor=S.+D.+Mertinsauthor=C.+W.+Heizmannauthor=D.+Allardauthor=W.+Birchmeierauthor=P.+M.+Schlagauthor=R.+H.+Shoemaker&title=The+metastasis-associated+gene+S100A4+is+a+novel+target+of+beta-catenin%2FT-cell+factor+signaling+in+colon+cancer&doi=10.1053%2Fj.gastro.2006.08.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The metastasis-associated gene S100A4 is a novel target of β-catenin/T-cell factor signaling in colon cancer</span></div><div class="casAuthors">Stein, Ulrike; Arlt, Franziska; Walther, Wolfgang; Smith, Janice; Waldman, Todd; Harris, Erik D.; Mertins, Susan D.; Heizmann, Claus W.; Allard, David; Birchmeier, Walter; Schlag, Peter M.; Shoemaker, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1486-1500</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background & Aims: Activation of the Wnt/β-catenin pathway is frequently obsd. in colorectal cancers.  Our aim was to elucidate the impact of gain-of-function β-catenin on the metastasis-assocd. gene S100A4 in human colon cancer cell lines and tumors.  Methods: We analyzed cell lines heterozygous for gain-of-function and wild-type β-catenin, and variants homozygous for gain- or loss-of-function mutation in β-catenin, for S100A4 expression, cell motility, and in vivo metastasis.  β-Catenin-mediated S100A4 promoter activation was tested by reporter assays.  For human colon carcinomas, S100A4 expression, β-catenin genotype, and metachronous metastasis were correlated.  Results: We identified S100A4 as the most regulated gene by gain-of-function β-catenin using a 10K microarray.  Cell lines with gain-of-function β-catenin expressed up to 60-fold elevated S100A4 levels, displayed strongly increased migration and invasion in vitro, and induced metastasis in mice.  S100A4 small interfering RNA, β-catenin small interfering RNA, or dominant neg. T-cell factor (TCF) knocked down S100A4 and blocked biol. effects.  S100A4 complementary DNA transfection increased migration and invasion.  We identified a TCF binding site within the S100A4 promoter and demonstrated the direct binding of heterodimeric β-catenin/TCF complexes.  Reporter assays confirmed the β-catenin-induced S100A4 promoter activity.  Furthermore, S100A4 mRNA expression was increased in primary colon cancers, which later developed distant metastases, compared to non-metastasizing tumors.  Colon tumors heterozygous for gain-of-function β-catenin showed concomitant nuclear β-catenin localization, high S100A4 expression, and metastases.  Conclusions: S100A4 is a direct β-catenin/TCF target, induces migration and invasion in vitro and metastasis in vivo, and has value for prognosis of metastasis formation in colon cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSIYEwlk_9X7Vg90H21EOLACvtfcHk0lhp8Ho2gGI8pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlantrfJ&md5=a521ea31e8c81809d09d143991717619</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2006.08.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2006.08.041%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DU.%26aulast%3DArlt%26aufirst%3DF.%26aulast%3DWalther%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DWaldman%26aufirst%3DT.%26aulast%3DHarris%26aufirst%3DE.%2BD.%26aulast%3DMertins%26aufirst%3DS.%2BD.%26aulast%3DHeizmann%26aufirst%3DC.%2BW.%26aulast%3DAllard%26aufirst%3DD.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DSchlag%26aufirst%3DP.%2BM.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26atitle%3DThe%2520metastasis-associated%2520gene%2520S100A4%2520is%2520a%2520novel%2520target%2520of%2520beta-catenin%252FT-cell%2520factor%2520signaling%2520in%2520colon%2520cancer%26jtitle%3DGastroenterology%26date%3D2006%26volume%3D131%26spage%3D1486%26epage%3D1500%26doi%3D10.1053%2Fj.gastro.2006.08.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barraclough, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudland, P. S.</span></span> <span> </span><span class="NLM_article-title">S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6601483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fsj.bjc.6601483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=14710237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFKntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=253-262&author=S.+R.+Jenkinsonauthor=R.+Barracloughauthor=C.+R.+Westauthor=P.+S.+Rudland&title=S100A4+regulates+cell+motility+and+invasion+in+an+in+vitro+model+for+breast+cancer+metastasis&doi=10.1038%2Fsj.bjc.6601483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis</span></div><div class="casAuthors">Jenkinson, S. R.; Barraclough, R.; West, C. R.; Rudland, P. S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">253-262</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Elevated levels of the calcium-binding protein S100A4 are assocd. with poor patient survival in breast cancer patients and induce metastasis in rodent models.  To investigate the effects of S100A4 on different components of the metastatic process, epithelial cells lines have been isolated from nonmalignant tumors in neu transgenic mice and from malignant tumors in neu/S100A4 double transgenic mice.  Addnl. cell lines expressing both Neu and S100A4 have also been derived by transfection of rat S100A4 cDNA into tumor cell lines cloned from neu single transgenic mice.  Using these cells in transfilter migration assays, it has been shown that increases in either motility or invasive properties correlate with each other and with the level of S100A4 protein.  Injection of three of the cell lines sep. into the mammary fat pads of nude mice showed that elevated levels of S100A4 correlated with the degree of metastasis to the lungs.  In contrast, changes in cell proliferation and cell-substrate adhesion did not correlate with S100A4 levels.  Neither motility nor invasiveness correlated with proteolytic degrdn. of gelatin as measured by zymog.  Thus, the results suggest that the main effect of increases in S100A4 levels in metastasis is to generate increased cell motility and invasion and that this latter change is not dependent upon an increased ability to degrade the intercellular matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ_2NcKfUPYrVg90H21EOLACvtfcHk0lhp8Ho2gGI8pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFKntA%253D%253D&md5=7cf5ff170472eb292b9ee58a6a18dc57</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601483%26sid%3Dliteratum%253Aachs%26aulast%3DJenkinson%26aufirst%3DS.%2BR.%26aulast%3DBarraclough%26aufirst%3DR.%26aulast%3DWest%26aufirst%3DC.%2BR.%26aulast%3DRudland%26aufirst%3DP.%2BS.%26atitle%3DS100A4%2520regulates%2520cell%2520motility%2520and%2520invasion%2520in%2520an%2520in%2520vitro%2520model%2520for%2520breast%2520cancer%2520metastasis%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D90%26spage%3D253%26epage%3D262%26doi%3D10.1038%2Fsj.bjc.6601483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ambartsumian, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grigorian, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstrøm, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidenius, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rygaard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiev, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukanidin, E.</span></span> <span> </span><span class="NLM_article-title">Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1621</span>– <span class="NLM_lpage">1630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=8895507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADyaK28XmvVShtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=1621-1630&author=N.+S.+Ambartsumianauthor=M.+S.+Grigorianauthor=I.+F.+Larsenauthor=O.+Karlstr%C3%B8mauthor=N.+Sideniusauthor=J.+Rygaardauthor=G.+Georgievauthor=E.+Lukanidin&title=Metastasis+of+mammary+carcinomas+in+GRS%2FA+hybrid+mice+transgenic+for+the+mts1+gene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene</span></div><div class="casAuthors">Ambartsumian, Noona S.; Grigorian, Mariam S.; Larsen, Ingrid Fossar; Karlstroem, Olle; Sidenius, Nicolai; Rygaard, Joergen; Georgiev, Georgii; Lukanidin, Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1621-1630</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">Transgenic mice, carrying the mts1 gene, one of the genes involved in the acquisition of the metastatic phenotype, were generated.  The mts1 gene was placed under the control of the mouse mammary tumor virus (MMTV) long terminal repeat (LTR) promoter leading to overexpression in the lactating mammary gland of transgenic animals.  Animals bearing the transgene appear phenotypically normal.  Animals of two transgenic lines (Tg463 and Tg507) were crossed with the GRS/A mice.  The GRS/A strain is characterized by high incidence of mammary tumors which rarely metastasize.  Some 40% of the tumor bearing hybrid GRS/A mts1 females were found to develop secondary tumors in the lungs.  The Mts1 protein was detected in the transgene primary tumor cells as well as in the corresponding metastases.  Nontransgenic littermates expressed the Mts1 protein only in the stromal cells surrounding the tumor but not in tumor cells by itself.  Thus, overexpression of the mts1 gene in the mouse mammary carcinoma cells gives rise to more aggressive tumors which are able to metastasize.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfG1SSuBCa8rVg90H21EOLACvtfcHk0lg5lCoi3rs22Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVShtr4%253D&md5=57499dec46b70c7389ea2b90f4ed2c6b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmbartsumian%26aufirst%3DN.%2BS.%26aulast%3DGrigorian%26aufirst%3DM.%2BS.%26aulast%3DLarsen%26aufirst%3DI.%2BF.%26aulast%3DKarlstr%25C3%25B8m%26aufirst%3DO.%26aulast%3DSidenius%26aufirst%3DN.%26aulast%3DRygaard%26aufirst%3DJ.%26aulast%3DGeorgiev%26aufirst%3DG.%26aulast%3DLukanidin%26aufirst%3DE.%26atitle%3DMetastasis%2520of%2520mammary%2520carcinomas%2520in%2520GRS%252FA%2520hybrid%2520mice%2520transgenic%2520for%2520the%2520mts1%2520gene%26jtitle%3DOncogene%26date%3D1996%26volume%3D13%26spage%3D1621%26epage%3D1630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudland, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolicoeur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barraclough, R.</span></span> <span> </span><span class="NLM_article-title">Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1631</span>– <span class="NLM_lpage">1637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=8895508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADyaK28XmvVShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=1631-1637&author=M.+P.+Daviesauthor=P.+S.+Rudlandauthor=L.+Robertsonauthor=E.+W.+Parryauthor=P.+Jolicoeurauthor=R.+Barraclough&title=Expression+of+the+calcium-binding+protein+S100A4+%28p9Ka%29+in+MMTV-neu+transgenic+mice+induces+metastasis+of+mammary+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumors</span></div><div class="casAuthors">Davies, Michael P. A.; Rudland, Philip S.; Robertson, Lynne; Parry, E. Wyn; Jolicoeur, Paul; Barraclough, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1631-1637</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">Increased levels of S100A4 (p9Ka) confer metastatic ability on a normally non-metastatic epithelial cell line.  To find out whether S100A4 can induce metastasis in vivo, transgenic mice expressing high levels of S100A4, but which show no phenotypic effect, have been mated with MMTV-neu transgenic mice which succumb to stochastic mammary neoplasia related to expression of the MMTV-neu transgene.  Resulting bitransgenic, multi-parous, female progeny expressing both S100A4 and Neu have a slightly earlier incidence of palpable mammary tumors than the MMTV-neu offspring and specifically exhibit macroscopic metastatic lesions in the lungs.  The S100A4 transgene is expressed in primary and secondary lesions of bitransgenic offspring and its expression its particularly assocd. with regions of invasion of primary lesions and metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWU4IbRc-SmLVg90H21EOLACvtfcHk0lg5lCoi3rs22Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVShtr8%253D&md5=492ba973da5d85f262547241c75a3d61</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DM.%2BP.%26aulast%3DRudland%26aufirst%3DP.%2BS.%26aulast%3DRobertson%26aufirst%3DL.%26aulast%3DParry%26aufirst%3DE.%2BW.%26aulast%3DJolicoeur%26aufirst%3DP.%26aulast%3DBarraclough%26aufirst%3DR.%26atitle%3DExpression%2520of%2520the%2520calcium-binding%2520protein%2520S100A4%2520%2528p9Ka%2529%2520in%2520MMTV-neu%2520transgenic%2520mice%2520induces%2520metastasis%2520of%2520mammary%2520tumours%26jtitle%3DOncogene%26date%3D1996%26volume%3D13%26spage%3D1631%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platt-Higgins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudland, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barraclough, R.</span></span> <span> </span><span class="NLM_article-title">Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1201948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fsj.onc.1201948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=9696040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVWlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=465-473&author=B.+H.+Lloydauthor=A.+Platt-Higginsauthor=P.+S.+Rudlandauthor=R.+Barraclough&title=Human+S100A4+%28p9Ka%29+induces+the+metastatic+phenotype+upon+benign+tumour+cells&doi=10.1038%2Fsj.onc.1201948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumor cells</span></div><div class="casAuthors">Lloyd, Bryony H.; Platt-Higgins, Angela; Rudland, Philip S.; Barraclough, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-473</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The rodent S100-related calcium-binding protein, S100A4 induces metastasis in non-metastatic rat and mouse benign mammary cells and cooperates with benign-tumor-inducing changes in two transgenic mouse models, to yield metastatic mammary tumors.  Co-transfection of the human gene for S100A4 with pSV2neo into the benign rat mammary cell line, Rama 37, yielded cells which expressed a low level of the endogenous S100A4 mRNA, and either high or undetectable levels of human S100A4 mRNA.  The cells which expressed a high level of human S100A4 mRNA induced metastasis in the benign rat mammary cell line Rama 37 in an in vivo assay, whereas the cells which expressed an undetectable level of human S100A4 did not induce any detectable metastases.  The primary tumors arising from the S100A4-expressing cells contained high levels of immunocytochem.-detected S100A4 and this high level of S100A4 and the metastatic potential were maintained when cells from a metastasis were re-injected into syngeneic rats.  The results show that the human S100A4 possesses metastasis-inducing capabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa9Fd7JjzxgbVg90H21EOLACvtfcHk0lg5lCoi3rs22Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVWlurY%253D&md5=1fdd72f7d0bfa497abddbce6d62e4c45</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1201948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1201948%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DB.%2BH.%26aulast%3DPlatt-Higgins%26aufirst%3DA.%26aulast%3DRudland%26aufirst%3DP.%2BS.%26aulast%3DBarraclough%26aufirst%3DR.%26atitle%3DHuman%2520S100A4%2520%2528p9Ka%2529%2520induces%2520the%2520metastatic%2520phenotype%2520upon%2520benign%2520tumour%2520cells%26jtitle%3DOncogene%26date%3D1998%26volume%3D17%26spage%3D465%26epage%3D473%26doi%3D10.1038%2Fsj.onc.1201948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravindranath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, H.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grills, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappin, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tanani, M.</span></span> <span> </span><span class="NLM_article-title">Wnt-β-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1038/bjc.2011.269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fbjc.2011.269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21772333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFygsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2011&pages=542-551&author=A.+Ravindranathauthor=H.-F.+Yuenauthor=K.-K.+Chanauthor=C.+Grillsauthor=D.+A.+Fennellauthor=T.+R.+Lappinauthor=M.+El-Tanani&title=Wnt-%CE%B2-catenin-Tcf-4+signalling-modulated+invasiveness+is+dependent+on+osteopontin+expression+in+breast+cancer&doi=10.1038%2Fbjc.2011.269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt-β-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer</span></div><div class="casAuthors">Ravindranath, A.; Yuen, H.-F.; Chan, K.-K.; Grills, C.; Fennell, D. A.; Lappin, T. R.; El-Tanani, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">542-551</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: We have previously demonstrated that Tcf-4 regulates osteopontin (OPN) in rat breast epithelial cells, Rama37.  In this report, we have examd. the importance of this regulation in human breast cancer.  Methods: The regulatory roles of Tcf-4 on cell invasion and OPN expression were investigated.  The mRNA expression of Tcf-4 and OPN, and survival of breast cancer patients were correlated.  Results: Tcf-4 enhanced cell invasion in both MCF10AT and MDA MB 231 breast cancer cells by transcriptionally activating OPN expression.  Osteopontin was activated by Wnt signaling in MDA MB 231 cells.  Paradoxical results on Tcf-4-regulated OPN expression in MCF10AT (activation) and Rama37 (repression) cells were shown to be a result of differential Wnt signaling competency in MCF10AT and Rama37 cells.  High levels of OPN and Tcf-4 mRNA expression were significantly assocd. with survival in breast cancer patients.  Most importantly, Tcf-4-pos. patients had a poorer prognosis when OPN was overexpressed, while OPN-neg. patients had a better prognosis when Tcf-4 was overexpressed.  Conclusion: Our results suggest that Tcf-4 can act as a repressor or activator of breast cancer progression by regulating OPN expression in a Wnt-dependent manner and that Tcf-4 and OPN together may be a novel prognostic indicator for breast cancer progression.  British Journal of Cancer (2011) 105, 542-551; doi:10.1038/bjc.2011.269 www. bjcancer. com. published online 19 July 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWbYcLI9kxLLVg90H21EOLACvtfcHk0lg5lCoi3rs22Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFygsLs%253D&md5=82407baaedb6d96489723ae8e602320a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2011.269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2011.269%26sid%3Dliteratum%253Aachs%26aulast%3DRavindranath%26aufirst%3DA.%26aulast%3DYuen%26aufirst%3DH.-F.%26aulast%3DChan%26aufirst%3DK.-K.%26aulast%3DGrills%26aufirst%3DC.%26aulast%3DFennell%26aufirst%3DD.%2BA.%26aulast%3DLappin%26aufirst%3DT.%2BR.%26aulast%3DEl-Tanani%26aufirst%3DM.%26atitle%3DWnt-%25CE%25B2-catenin-Tcf-4%2520signalling-modulated%2520invasiveness%2520is%2520dependent%2520on%2520osteopontin%2520expression%2520in%2520breast%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2011%26volume%3D105%26spage%3D542%26epage%3D551%26doi%3D10.1038%2Fbjc.2011.269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howe, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span> <span> </span><span class="NLM_article-title">Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1906</span>– <span class="NLM_lpage">1913</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1906-1913&author=L.+R.+Howeauthor=O.+Watanabeauthor=J.+Leonardauthor=A.+M.+Brown&title=Twist+is+up-regulated+in+response+to+Wnt1+and+inhibits+mouse+mammary+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowe%26aufirst%3DL.%2BR.%26aulast%3DWatanabe%26aufirst%3DO.%26aulast%3DLeonard%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26atitle%3DTwist%2520is%2520up-regulated%2520in%2520response%2520to%2520Wnt1%2520and%2520inhibits%2520mouse%2520mammary%2520cell%2520differentiation%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D1906%26epage%3D1913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yook, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. J.</span></span> <span> </span><span class="NLM_article-title">Wnt-dependent regulation of the E-cadherin repressor snail</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">11740</span>– <span class="NLM_lpage">11748</span>, <span class="refDoi"> DOI: 10.1074/jbc.m413878200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1074%2Fjbc.m413878200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=11740-11748&author=J.+I.+Yookauthor=X.-Y.+Liauthor=I.+Otaauthor=E.+R.+Fearonauthor=S.+J.+Weiss&title=Wnt-dependent+regulation+of+the+E-cadherin+repressor+snail&doi=10.1074%2Fjbc.m413878200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m413878200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m413878200%26sid%3Dliteratum%253Aachs%26aulast%3DYook%26aufirst%3DJ.%2BI.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DOta%26aufirst%3DI.%26aulast%3DFearon%26aufirst%3DE.%2BR.%26aulast%3DWeiss%26aufirst%3DS.%2BJ.%26atitle%3DWnt-dependent%2520regulation%2520of%2520the%2520E-cadherin%2520repressor%2520snail%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D11740%26epage%3D11748%26doi%3D10.1074%2Fjbc.m413878200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yook, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. J.</span></span> <span> </span><span class="NLM_article-title">A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1398</span>– <span class="NLM_lpage">1406</span>, <span class="refDoi"> DOI: 10.1038/ncb1508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fncb1508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=17072303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Kju7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=1398-1406&author=J.+I.+Yookauthor=X.-Y.+Liauthor=I.+Otaauthor=C.+Huauthor=H.+S.+Kimauthor=N.+H.+Kimauthor=S.+Y.+Chaauthor=J.+K.+Ryuauthor=Y.+J.+Choiauthor=J.+Kimauthor=E.+R.+Fearonauthor=S.+J.+Weiss&title=A+Wnt-Axin2-GSK3%CE%B2+cascade+regulates+Snail1+activity+in+breast+cancer+cells&doi=10.1038%2Fncb1508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells</span></div><div class="casAuthors">Yook, Jong In; Li, Xiao-Yan; Ota, Ichiro; Hu, Casey; Kim, Hyun Sil; Kim, Nam Hee; Cha, So Young; Ryu, Joo Kyung; Choi, Yoon Jung; Kim, Jin; Fearon, Eric R.; Weiss, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1398-1406</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulating evidence indicates that hyperactive Wnt signaling occurs in assocn. with the development and progression of human breast cancer.  As a consequence of engaging the canonical Wnt pathway, a β-catenin-T-cell factor (TCF) transcriptional complex is generated, which has been postulated to trigger the epithelial-mesenchymal transition (EMT) that characterizes the tissue-invasive phenotype.  However, the mol. mechanisms by which the β-catenin-TCF complex induces EMT-like programs remain undefined.  Here, we demonstrate that canonical Wnt signaling engages tumor cell dedifferentiation and tissue-invasive activity through an Axin2-dependent pathway that stabilizes the Snail1 zinc-transcription factor, a key regulator of normal and neoplastic EMT programs.  Axin2 regulates EMT by acting as a nucleocytoplasmic chaperone for GSK3β, the dominant kinase responsible for controlling Snail1 protein turnover and activity.  As dysregulated Wnt signaling marks a diverse array of cancerous tissue types, the identification of a β-catenin-TCF-regulated Axin2-GSK3β-Snail1 axis provides new mechanistic insights into cancer-assocd. EMT programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrFRj70e-4L7Vg90H21EOLACvtfcHk0lgNvNz7QjCQrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Kju7rE&md5=69da2931ed955a1f458376d8c3682c34</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fncb1508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1508%26sid%3Dliteratum%253Aachs%26aulast%3DYook%26aufirst%3DJ.%2BI.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DOta%26aufirst%3DI.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DN.%2BH.%26aulast%3DCha%26aufirst%3DS.%2BY.%26aulast%3DRyu%26aufirst%3DJ.%2BK.%26aulast%3DChoi%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DFearon%26aufirst%3DE.%2BR.%26aulast%3DWeiss%26aufirst%3DS.%2BJ.%26atitle%3DA%2520Wnt-Axin2-GSK3%25CE%25B2%2520cascade%2520regulates%2520Snail1%2520activity%2520in%2520breast%2520cancer%2520cells%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2006%26volume%3D8%26spage%3D1398%26epage%3D1406%26doi%3D10.1038%2Fncb1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleer, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. J.</span></span> <span> </span><span class="NLM_article-title">Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">16654</span>– <span class="NLM_lpage">16659</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205822109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.1205822109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=16654-16659&author=Z.-Q.+Wuauthor=X.-Y.+Liauthor=C.+Y.+Huauthor=M.+Fordauthor=C.+G.+Kleerauthor=S.+J.+Weiss&title=Canonical+Wnt+signaling+regulates+Slug+activity+and+links+epithelial-mesenchymal+transition+with+epigenetic+Breast+Cancer+1%2C+Early+Onset+%28BRCA1%29+repression&doi=10.1073%2Fpnas.1205822109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205822109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205822109%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.-Q.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DHu%26aufirst%3DC.%2BY.%26aulast%3DFord%26aufirst%3DM.%26aulast%3DKleer%26aufirst%3DC.%2BG.%26aulast%3DWeiss%26aufirst%3DS.%2BJ.%26atitle%3DCanonical%2520Wnt%2520signaling%2520regulates%2520Slug%2520activity%2520and%2520links%2520epithelial-mesenchymal%2520transition%2520with%2520epigenetic%2520Breast%2520Cancer%25201%252C%2520Early%2520Onset%2520%2528BRCA1%2529%2520repression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D16654%26epage%3D16659%26doi%3D10.1073%2Fpnas.1205822109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emami, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibitor of β-catenin/CREB-binding protein transcription</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">12682</span>– <span class="NLM_lpage">12687</span>, <span class="refDoi"> DOI: 10.1073/pnas.0404875101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.0404875101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=15314234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=12682-12687&author=K.+H.+Emamiauthor=C.+Nguyenauthor=H.+Maauthor=D.+H.+Kimauthor=K.+W.+Jeongauthor=M.+Eguchiauthor=R.+T.+Moonauthor=J.-L.+Teoauthor=S.+W.+Ohauthor=H.+Y.+Kimauthor=S.+H.+Moonauthor=J.+R.+Haauthor=M.+Kahn&title=A+small+molecule+inhibitor+of+%CE%B2-catenin%2FCREB-binding+protein+transcription&doi=10.1073%2Fpnas.0404875101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription</span></div><div class="casAuthors">Emami, Katayoon H.; Nguyen, Cu; Ma, Hong; Kim, Dae Hoon; Jeong, Kwang Won; Eguchi, Masakatsu; Moon, Randall T.; Teo, Jia-Ling; Oh, Se Wong; Kim, Hak Yeop; Moon, Sung Hwan; Ha, Jong Ryul; Kahn, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12682-12687</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inherited and somatic mutations in the adenomatous polyposis coli occur in most colon cancers, leading to activation of β-catenin-responsive genes.  To identify small mol. antagonists of this pathway, the authors challenged transformed colorectal cells with a secondary structure-templated chem. library, looking for compds. that inhibit a β-catenin-responsive reporter.  The authors identified ICG-001, a small mol. that down-regulates β-catenin/T cell factor signaling by specifically binding to cAMP response element-binding protein.  ICG-001 selectively induces apoptosis in transformed cells but not in normal colon cells, reduces in vitro growth of colon carcinoma cells, and is efficacious in the Min mouse and nude mouse xenograft models of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6tlzXLGU-rVg90H21EOLACvtfcHk0lgNvNz7QjCQrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D&md5=51d20409871c490734e66d23987348ee</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0404875101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0404875101%26sid%3Dliteratum%253Aachs%26aulast%3DEmami%26aufirst%3DK.%2BH.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DK.%2BW.%26aulast%3DEguchi%26aufirst%3DM.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26aulast%3DTeo%26aufirst%3DJ.-L.%26aulast%3DOh%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DMoon%26aufirst%3DS.%2BH.%26aulast%3DHa%26aufirst%3DJ.%2BR.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520%25CE%25B2-catenin%252FCREB-binding%2520protein%2520transcription%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D12682%26epage%3D12687%26doi%3D10.1073%2Fpnas.0404875101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hageman, M. J.</span></span> <span> </span><span class="NLM_article-title">The expanding role of prodrugs in contemporary drug design and development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1038/nrd.2018.46</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnrd.2018.46" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=29700501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=559-587&author=J.+Rautioauthor=N.+A.+Meanwellauthor=L.+Diauthor=M.+J.+Hageman&title=The+expanding+role+of+prodrugs+in+contemporary+drug+design+and+development&doi=10.1038%2Fnrd.2018.46"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The expanding role of prodrugs in contemporary drug design and development</span></div><div class="casAuthors">Rautio, Jarkko; Meanwell, Nicholas A.; Di, Li; Hageman, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">559-587</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Prodrugs are mols. with little or no pharmacol. activity that are converted to the active parent drug in vivo by enzymic or chem. reactions or by a combination of the two.  Prodrugs have evolved from being serendipitously discovered or used as a salvage effort to being intentionally designed.  Such efforts can avoid drug development challenges that limit formulation options or result in unacceptable biopharmaceutical or pharmacokinetic performance, or poor targeting.  In the past 10 years, the US Food and Drug Administration has approved at least 30 prodrugs, which accounts for more than 12% of all approved small-mol. new chem. entities.  In this Review, we highlight prodrug design strategies for improved formulation and pharmacokinetic and targeting properties, with a focus on the most recently marketed prodrugs.  We also discuss preclin. and clin. challenges and considerations in prodrug design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYKsM1lriJObVg90H21EOLACvtfcHk0lhfELhwjOd8KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgsL0%253D&md5=9dea9fd2f30779f4ce182b822f2c9539</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.46%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DHageman%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520expanding%2520role%2520of%2520prodrugs%2520in%2520contemporary%2520drug%2520design%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26spage%3D559%26epage%3D587%26doi%3D10.1038%2Fnrd.2018.46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teuscher, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">A versatile method to determine the cellular bioavailability of small-molecule inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00923</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00923" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGiur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=157-169&author=K.+B.+Teuscherauthor=M.+Zhangauthor=H.+Ji&title=A+versatile+method+to+determine+the+cellular+bioavailability+of+small-molecule+inhibitors&doi=10.1021%2Facs.jmedchem.6b00923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">A Versatile Method to Determine the Cellular Bioavailability of Small-Molecule Inhibitors</span></div><div class="casAuthors">Teuscher, Kevin B.; Zhang, Min; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The detn. of the cellular bioavailability of small-mol. inhibitors is a crit. step for interpreting cell-based data and guiding inhibitor optimization.  Herein, a HPLC-MS based protocol was developed to det. inhibitor cellular bioavailability.  This generalizable protocol allows detn. of the accurate intracellular concns. and characterization of various properties of inhibitors including the extra- and intracellular stability, the dose- and time-dependence of the intracellular concns., the cell permeability, and the nonspecific binding with the cell culture plates, the extracellular matrixes, and the cell membrane.  The inhibitors of the protein-protein interactions, bromodomains, and the β-catenin/B-cell lymphoma 9 (BCL9) interaction were used to examine the protocol, and the cellular bioavailability of the inhibitors in cancer cells was detd.  High nonspecific binding and low cellular uptake were obsd. for two bromodomain inhibitors.  The two β-catenin/BCL9 inhibitors had low nonspecific binding but different cellular uptake.  These inhibitors exhibited different stability kinetics in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhu8gNo3yDMrVg90H21EOLACvtfcHk0ljGrXnA7H3POA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGiur7P&md5=5aebfe9a1e5dc7b8604e285661dc0041</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00923%26sid%3Dliteratum%253Aachs%26aulast%3DTeuscher%26aufirst%3DK.%2BB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DA%2520versatile%2520method%2520to%2520determine%2520the%2520cellular%2520bioavailability%2520of%2520small-molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D157%26epage%3D169%26doi%3D10.1021%2Facs.jmedchem.6b00923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhiqing Liu, Pingyuan Wang, Eric A. Wold, Qiaoling Song, Chenyang Zhao, Changyun Wang, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4257-4288. <a href="https://doi.org/10.1021/acs.jmedchem.0c01799" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01799%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252BTargeting%252Bthe%252BCanonical%252BWNT%252BSignaling%252BPathway%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DLiu%26aufirst%3DZhiqing%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14102020%26date%3D06042021%26volume%3D64%26issue%3D8%26spage%3D4257%26epage%3D4288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ross S. Mancini, Christopher J. Barden, Donald F. Weaver, <span class="NLM_string-name hlFld-ContribAuthor">Mark A. Reed</span>. </span><span class="cited-content_cbyCitation_article-title">Furazans in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 1786-1815. <a href="https://doi.org/10.1021/acs.jmedchem.0c01901" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01901%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFurazans%252Bin%252BMedicinal%252BChemistry%26aulast%3DMancini%26aufirst%3DRoss%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D03112020%26date%3D11022021%26volume%3D64%26issue%3D4%26spage%3D1786%26epage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Patrick G. Dougherty, Jin Wen, Xiaoyan Pan, Amritendu Koley, Jian-Guo Ren, Ashweta Sahni, Ruchira Basu, Heba Salim, George Appiah Kubi, Ziqing Qian, <span class="NLM_string-name hlFld-ContribAuthor">Dehua Pei</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing the Cell Permeability of Stapled Peptides with a Cyclic Cell-Penetrating Peptide. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (22)
                                     , 10098-10107. <a href="https://doi.org/10.1021/acs.jmedchem.9b00456" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00456%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEnhancing%252Bthe%252BCell%252BPermeability%252Bof%252BStapled%252BPeptides%252Bwith%252Ba%252BCyclic%252BCell-Penetrating%252BPeptide%26aulast%3DDougherty%26aufirst%3DPatrick%2BG.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15032019%26date%3D08112019%26date%3D28102019%26volume%3D62%26issue%3D22%26spage%3D10098%26epage%3D10107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Zilu  Li</span>, <span class="hlFld-ContribAuthor ">Haitao  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Direct targeting of
              β
              ‐catenin in the Wnt signaling pathway: Current progress and perspectives. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (4)
                                     , 2109-2129. <a href="https://doi.org/10.1002/med.21787" title="DOI URL">https://doi.org/10.1002/med.21787</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21787%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DDirect%252Btargeting%252Bof%252B%2525CE%2525B2%252B%2525E2%252580%252590catenin%252Bin%252Bthe%252BWnt%252Bsignaling%252Bpathway%25253A%252BCurrent%252Bprogress%252Band%252Bperspectives%26aulast%3DWang%26aufirst%3DZhen%26date%3D2021%26date%3D2021%26volume%3D41%26issue%3D4%26spage%3D2109%26epage%3D2129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vishalgiri G.  Goswami</span>, <span class="hlFld-ContribAuthor ">Bhumika D.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">Recent updates on Wnt signaling modulators: a patent review (2014-2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1080/13543776.2021.1940138" title="DOI URL">https://doi.org/10.1080/13543776.2021.1940138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1940138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1940138%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRecent%252Bupdates%252Bon%252BWnt%252Bsignaling%252Bmodulators%25253A%252Ba%252Bpatent%252Breview%252B%2525282014-2020%252529%26aulast%3DGoswami%26aufirst%3DVishalgiri%2BG.%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathias  Wendt</span>, <span class="hlFld-ContribAuthor ">Rosa  Bellavita</span>, <span class="hlFld-ContribAuthor ">Alan  Gerber</span>, <span class="hlFld-ContribAuthor ">Nina‐Louisa  Efrém</span>, <span class="hlFld-ContribAuthor ">Thirza  Ramshorst</span>, <span class="hlFld-ContribAuthor ">Nicholas M.  Pearce</span>, <span class="hlFld-ContribAuthor ">Paul R. J.  Davey</span>, <span class="hlFld-ContribAuthor ">Isabel  Everard</span>, <span class="hlFld-ContribAuthor ">Mercedes  Vazquez‐Chantada</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Chiarparin</span>, <span class="hlFld-ContribAuthor ">Paolo  Grieco</span>, <span class="hlFld-ContribAuthor ">Sven  Hennig</span>, <span class="hlFld-ContribAuthor ">Tom N.  Grossmann</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic β‐Sheet Mimetics that Target the Transcriptional Coactivator β‐Catenin and Inhibit Wnt Signaling. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (25)
                                     , 14056-14063. <a href="https://doi.org/10.1002/ange.202102082" title="DOI URL">https://doi.org/10.1002/ange.202102082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202102082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202102082%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DBicyclic%252B%2525CE%2525B2%2525E2%252580%252590Sheet%252BMimetics%252Bthat%252BTarget%252Bthe%252BTranscriptional%252BCoactivator%252B%2525CE%2525B2%2525E2%252580%252590Catenin%252Band%252BInhibit%252BWnt%252BSignaling%26aulast%3DWendt%26aufirst%3DMathias%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D25%26spage%3D14056%26epage%3D14063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mathias  Wendt</span>, <span class="hlFld-ContribAuthor ">Rosa  Bellavita</span>, <span class="hlFld-ContribAuthor ">Alan  Gerber</span>, <span class="hlFld-ContribAuthor ">Nina‐Louisa  Efrém</span>, <span class="hlFld-ContribAuthor ">Thirza  Ramshorst</span>, <span class="hlFld-ContribAuthor ">Nicholas M.  Pearce</span>, <span class="hlFld-ContribAuthor ">Paul R. J.  Davey</span>, <span class="hlFld-ContribAuthor ">Isabel  Everard</span>, <span class="hlFld-ContribAuthor ">Mercedes  Vazquez‐Chantada</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Chiarparin</span>, <span class="hlFld-ContribAuthor ">Paolo  Grieco</span>, <span class="hlFld-ContribAuthor ">Sven  Hennig</span>, <span class="hlFld-ContribAuthor ">Tom N.  Grossmann</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic β‐Sheet Mimetics that Target the Transcriptional Coactivator β‐Catenin and Inhibit Wnt Signaling. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (25)
                                     , 13937-13944. <a href="https://doi.org/10.1002/anie.202102082" title="DOI URL">https://doi.org/10.1002/anie.202102082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202102082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202102082%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DBicyclic%252B%2525CE%2525B2%2525E2%252580%252590Sheet%252BMimetics%252Bthat%252BTarget%252Bthe%252BTranscriptional%252BCoactivator%252B%2525CE%2525B2%2525E2%252580%252590Catenin%252Band%252BInhibit%252BWnt%252BSignaling%26aulast%3DWendt%26aufirst%3DMathias%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D25%26spage%3D13937%26epage%3D13944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaiqing  Ma</span>, <span class="hlFld-ContribAuthor ">Mengchen  Zhang</span>, <span class="hlFld-ContribAuthor ">Xingkang  Wu</span>, <span class="hlFld-ContribAuthor ">Peng  Yang</span>, <span class="hlFld-ContribAuthor ">Caixia  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a potent β-catenin destabilizer for overcoming the resistance of 5-fluorouracil in colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>30 </em>, 115929. <a href="https://doi.org/10.1016/j.bmc.2020.115929" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115929%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bpotent%252B%2525CE%2525B2-catenin%252Bdestabilizer%252Bfor%252Bovercoming%252Bthe%252Bresistance%252Bof%252B5-fluorouracil%252Bin%252Bcolorectal%252Bcancer%26aulast%3DMa%26aufirst%3DKaiqing%26date%3D2021%26volume%3D30%26spage%3D115929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Ke  Deng</span>, <span class="hlFld-ContribAuthor ">Liang  Gong</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Sapna  Sayed</span>, <span class="hlFld-ContribAuthor ">Huan  Li</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Zijie  Su</span>, <span class="hlFld-ContribAuthor ">Zhongyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Shanshan  Liu</span>, <span class="hlFld-ContribAuthor ">Huifang  Zhu</span>, <span class="hlFld-ContribAuthor ">Jiaxing  Song</span>, <span class="hlFld-ContribAuthor ">Desheng  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>159 </em>, 104955. <a href="https://doi.org/10.1016/j.phrs.2020.104955" title="DOI URL">https://doi.org/10.1016/j.phrs.2020.104955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2020.104955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2020.104955%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DChlorquinaldol%252Btargets%252Bthe%252B%2525CE%2525B2-catenin%252Band%252BT-cell%252Bfactor%252B4%252Bcomplex%252Band%252Bexerts%252Banti-colorectal%252Bcancer%252Bactivity%26aulast%3DWang%26aufirst%3DLing%26date%3D2020%26volume%3D159%26spage%3D104955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Wnt-responsive TOPFlash and FOPFlash luciferase reporter assay results of (<b>Et</b>)-<b>15</b> (negative control) and inhibitors <b>55</b> and <b>56</b> in β-catenin activated HEK293 cells. *<i>P</i> < 0.05, **<i>P</i> < 0.01, as determined by the unpaired, two-tailed Student <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Co-IP experiments to evaluate the disruption of the β-catenin/TCF PPI by <b>53</b> in SW480 cell lysate. (B–D) Co-IP experiments to evaluate the disruption of the β-catenin/Tcf PPI by <b>56</b> and the inhibitory selectivity of <b>56</b> between β-catenin/Tcf, β-catenin/E-cadherin, and β-catenin/APC PPIs using HCT116 cells. IP, immunoprecipitation; IB, immunoblotting; input, 10% of cell lysate. Each experiment was performed in duplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Wound-healing assays showed that <b>56</b> (10 μM) inhibited migration of human TNBC MDA-MB-231 cells induced by serum (10% in media). Control, 0.2% dimethyl sulfoxide (DMSO) in 10% fatal bovine serum (FBS). The β-catenin/CBP inhibitor ICG-001 (5 μM) was assessed in parallel. In all experiments, mitomycin (10 μg/mL) was added to inhibit cell proliferation and allow examination of the effects on cell migration. (B) Matrigel invasion assays showed that <b>56</b> (10 μM) inhibited invasion of human TNBC MDA-MB-231 cells. Control, 0.2% DMSO in 10% FBS. ICG-001 (5 μM) was assessed in parallel. **<i>P</i> < 0.01, as determined by the unpaired, two-tailed Student <i>t</i>-test. Each set of data is expressed as mean ± standard deviation (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>20</b>–<b>21</b> and <b>30</b>–<b>38</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>53</b>, <b>56</b>, and <b>57</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/medium/jm-2019-00147n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>55</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.9b00147/20190404/images/large/jm-2019-00147n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00147&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i105">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 73 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span> <span> </span><span class="NLM_article-title">Wnt/β-catenin signaling and disease</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.cell.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=22682243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1192-1205&author=H.+Cleversauthor=R.+Nusse&title=Wnt%2F%CE%B2-catenin+signaling+and+disease&doi=10.1016%2Fj.cell.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling and disease</span></div><div class="casAuthors">Clevers, Hans; Nusse, Roel</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1192-1205</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade controls myriad biol. phenomena throughout development and adult life of all animals.  In parallel, aberrant Wnt signaling underlies a wide range of pathologies in humans.  In this Review, we provide an update of the core Wnt/β-catenin signaling pathway, discuss how its various components contribute to disease, and pose outstanding questions to be addressed in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDPj3TZSiR1rVg90H21EOLACvtfcHk0lg018VX8WiCqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVaktrg%253D&md5=441540f5c9e168b2a4e657a19bbe31c7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DClevers%26aufirst%3DH.%26aulast%3DNusse%26aufirst%3DR.%26atitle%3DWnt%252F%25CE%25B2-catenin%2520signaling%2520and%2520disease%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1192%26epage%3D1205%26doi%3D10.1016%2Fj.cell.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Wnt/β-catenin signaling, disease, and emerging therapeutic modalities</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.cell.2017.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=28575679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2017&pages=985-999&author=R.+Nusseauthor=H.+Clevers&title=Wnt%2F%CE%B2-catenin+signaling%2C+disease%2C+and+emerging+therapeutic+modalities&doi=10.1016%2Fj.cell.2017.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling, disease, and emerging therapeutic modalities</span></div><div class="casAuthors">Nusse, Roel; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">985-999</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade is a main regulator of development throughout the animal kingdom.  Wnts are also key drivers of most types of tissue stem cells in adult mammals.  Unsurprisingly, mutated Wnt pathway components are causative to multiple growth-related pathologies and to cancer.  Here, we describe the core Wnt/β-catenin signaling pathway, how it controls stem cells, and contributes to disease.  Finally, we discuss strategies for Wnt-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnL11nCbSs8LVg90H21EOLACvtfcHk0lg018VX8WiCqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D&md5=869cc558296677481527ac138f68fbb0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DWnt%252F%25CE%25B2-catenin%2520signaling%252C%2520disease%252C%2520and%2520emerging%2520therapeutic%2520modalities%26jtitle%3DCell%26date%3D2017%26volume%3D169%26spage%3D985%26epage%3D999%26doi%3D10.1016%2Fj.cell.2017.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akhmetshina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palumbo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dees, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venalis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zerr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kireva, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwerina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riener, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDougald, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distler, J. H.</span></span> <span> </span><span class="NLM_article-title">Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1038/ncomms1734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fncomms1734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=22415826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A280%3ADC%252BC38zhtVKmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=735-746&author=A.+Akhmetshinaauthor=K.+Palumboauthor=C.+Deesauthor=C.+Bergmannauthor=P.+Venalisauthor=P.+Zerrauthor=A.+Hornauthor=T.+Kirevaauthor=C.+Beyerauthor=J.+Zwerinaauthor=H.+Schneiderauthor=A.+Sadowskiauthor=M.+O.+Rienerauthor=O.+A.+MacDougaldauthor=O.+Distlerauthor=G.+Schettauthor=J.+H.+Distler&title=Activation+of+canonical+Wnt+signalling+is+required+for+TGF-beta-mediated+fibrosis&doi=10.1038%2Fncomms1734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis</span></div><div class="casAuthors">Akhmetshina Alfiya; Palumbo Katrin; Dees Clara; Bergmann Christina; Venalis Paulius; Zerr Pawel; Horn Angelika; Kireva Trayana; Beyer Christian; Zwerina Jochen; Schneider Holm; Sadowski Anika; Riener Marc-Oliver; MacDougald Ormond A; Distler Oliver; Schett Georg; Distler Jorg H W</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">735</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The transforming growth factor-β (TGF-β) signalling pathway is a key mediator of fibroblast activation that drives the aberrant synthesis of extracellular matrix in fibrotic diseases.  Here we demonstrate a novel link between transforming growth factor-β and the canonical Wnt pathway.  TGF-β stimulates canonical Wnt signalling in a p38-dependent manner by decreasing the expression of the Wnt antagonist Dickkopf-1.  Tissue samples from human fibrotic diseases show enhanced expression of Wnt proteins and decreased expression of Dickkopf-1.  Activation of the canonical Wnt pathway stimulates fibroblasts in vitro and induces fibrosis in vivo.  Transgenic overexpression of Dickkopf-1 ameliorates skin fibrosis induced by constitutively active TGF-β receptor type I signalling and also prevents fibrosis in other TGF-β-dependent animal models.  These findings demonstrate that canonical Wnt signalling is necessary for TGF-β-mediated fibrosis and highlight a key role for the interaction of both pathways in the pathogenesis of fibrotic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoEJ29yVOUW02yPDyEFiigfW6udTcc2ea4eD7vDWcEtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zhtVKmuw%253D%253D&md5=9d10b3b0c90e2c1b72b71e43deb93765</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fncomms1734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1734%26sid%3Dliteratum%253Aachs%26aulast%3DAkhmetshina%26aufirst%3DA.%26aulast%3DPalumbo%26aufirst%3DK.%26aulast%3DDees%26aufirst%3DC.%26aulast%3DBergmann%26aufirst%3DC.%26aulast%3DVenalis%26aufirst%3DP.%26aulast%3DZerr%26aufirst%3DP.%26aulast%3DHorn%26aufirst%3DA.%26aulast%3DKireva%26aufirst%3DT.%26aulast%3DBeyer%26aufirst%3DC.%26aulast%3DZwerina%26aufirst%3DJ.%26aulast%3DSchneider%26aufirst%3DH.%26aulast%3DSadowski%26aufirst%3DA.%26aulast%3DRiener%26aufirst%3DM.%2BO.%26aulast%3DMacDougald%26aufirst%3DO.%2BA.%26aulast%3DDistler%26aufirst%3DO.%26aulast%3DSchett%26aufirst%3DG.%26aulast%3DDistler%26aufirst%3DJ.%2BH.%26atitle%3DActivation%2520of%2520canonical%2520Wnt%2520signalling%2520is%2520required%2520for%2520TGF-beta-mediated%2520fibrosis%26jtitle%3DNat.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D735%26epage%3D746%26doi%3D10.1038%2Fncomms1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
de Wetering, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sancho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Lau, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oving, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurlstone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Horn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batlle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudreuse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haramis, A.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjon-Pon-Fong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moerer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Born, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soete, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pals, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medema, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1016/s0092-8674(02)01014-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fs0092-8674%2802%2901014-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=12408868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD38Xotlahsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2002&pages=241-250&author=M.+van%0Ade+Weteringauthor=E.+Sanchoauthor=C.+Verweijauthor=W.+de+Lauauthor=I.+Ovingauthor=A.+Hurlstoneauthor=K.+van+der+Hornauthor=E.+Batlleauthor=D.+Coudreuseauthor=A.-P.+Haramisauthor=M.+Tjon-Pon-Fongauthor=P.+Moererauthor=M.+van+den+Bornauthor=G.+Soeteauthor=S.+Palsauthor=M.+Eilersauthor=R.+Medemaauthor=H.+Clevers&title=The+%CE%B2-catenin%2FTCF-4+complex+imposes+a+crypt+progenitor+phenotype+on+colorectal+cancer+cells&doi=10.1016%2Fs0092-8674%2802%2901014-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells</span></div><div class="casAuthors">Van de Wetering, Marc; Sancho, Elena; Verweij, Cornelis; De Lau, Wim; Oving, Irma; Hurlstone, Adam; Van der Horn, Karin; Batlle, Eduard; Coudreuse, Damien; Haramis, Anna-Pavlina; Tjon-Pon-Fong, Menno; Moerer, Petra; Van den Born, Maaike; Soete, Gwen; Pals, Steven; Eilers, Martin; Medema, Rene; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">241-250</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The transactivation of TCF target genes induced by Wnt pathway mutations constitutes the primary transforming event in colorectal cancer (CRC).  The authors show that disruption of β-catenin/TCF-4 activity in CRC cells induces a rapid G1 arrest and blocks a genetic program that is physiol. active in the proliferative compartment of colon crypts.  Coincidently, an intestinal differentiation program is induced.  The TCF-4 target gene c-MYC plays a central role in this switch by direct repression of the p21CIP1/WAF1 promoter.  Following disruption of β-catenin/TCF-4 activity, the decreased expression of c-MYC releases p21CIP1/WAF1 transcription, which in turn mediates G1 arrest and differentiation.  Thus, the β-catenin/TCF-4 complex constitutes the master switch that controls proliferation vs. differentiation in healthy and malignant intestinal epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVqLagkm3jcLVg90H21EOLACvtfcHk0lh5d9TiZc6eYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xotlahsrg%253D&md5=d3b611aa88ba8ea40d333774f844038e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fs0092-8674%2802%2901014-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0092-8674%252802%252901014-0%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BWetering%26aufirst%3DM.%26aulast%3DSancho%26aufirst%3DE.%26aulast%3DVerweij%26aufirst%3DC.%26aulast%3Dde%2BLau%26aufirst%3DW.%26aulast%3DOving%26aufirst%3DI.%26aulast%3DHurlstone%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BHorn%26aufirst%3DK.%26aulast%3DBatlle%26aufirst%3DE.%26aulast%3DCoudreuse%26aufirst%3DD.%26aulast%3DHaramis%26aufirst%3DA.-P.%26aulast%3DTjon-Pon-Fong%26aufirst%3DM.%26aulast%3DMoerer%26aufirst%3DP.%26aulast%3Dvan%2Bden%2BBorn%26aufirst%3DM.%26aulast%3DSoete%26aufirst%3DG.%26aulast%3DPals%26aufirst%3DS.%26aulast%3DEilers%26aufirst%3DM.%26aulast%3DMedema%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DThe%2520%25CE%25B2-catenin%252FTCF-4%2520complex%2520imposes%2520a%2520crypt%2520progenitor%2520phenotype%2520on%2520colorectal%2520cancer%2520cells%26jtitle%3DCell%26date%3D2002%26volume%3D111%26spage%3D241%26epage%3D250%26doi%3D10.1016%2Fs0092-8674%2802%2901014-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Rourke, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschaharganeh, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Es, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. W.</span></span> <span> </span><span class="NLM_article-title">Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1539</span>– <span class="NLM_lpage">1552</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.05.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.cell.2015.05.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=26091037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Squ7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2015&pages=1539-1552&author=L.+E.+Dowauthor=K.+P.+O%E2%80%99Rourkeauthor=J.+Simonauthor=D.+F.+Tschaharganehauthor=J.+H.+van+Esauthor=H.+Cleversauthor=S.+W.+Lowe&title=Apc+restoration+promotes+cellular+differentiation+and+reestablishes+crypt+homeostasis+in+colorectal+cancer&doi=10.1016%2Fj.cell.2015.05.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer</span></div><div class="casAuthors">Dow, Lukas E.; O'Rourke, Kevin P.; Simon, Janelle; Tschaharganeh, Darjus F.; van Es, Johan H.; Clevers, Hans; Lowe, Scott W.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1539-1552</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The adenomatous polyposis coli (APC) tumor suppressor is mutated in the vast majority of human colorectal cancers (CRC) and leads to deregulated Wnt signaling.  To det. whether Apc disruption is required for tumor maintenance, we developed a mouse model of CRC whereby Apc can be conditionally suppressed using a doxycycline-regulated shRNA.  Apc suppression produces adenomas in both the small intestine and colon that, in the presence of Kras and p53 mutations, can progress to invasive carcinoma.  In established tumors, Apc restoration drives rapid and widespread tumor-cell differentiation and sustained regression without relapse.  Tumor regression is accompanied by the re-establishment of normal crypt-villus homeostasis, such that once aberrantly proliferating cells reacquire self-renewal and multi-lineage differentiation capability.  Our study reveals that CRC cells can revert to functioning normal cells given appropriate signals and provide compelling in vivo validation of the Wnt pathway as a therapeutic target for treatment of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOJhLhIEo70LVg90H21EOLACvtfcHk0lh5d9TiZc6eYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Squ7zF&md5=c5bdedbcfb89050521a0316438327b5a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.05.033%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DL.%2BE.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DK.%2BP.%26aulast%3DSimon%26aufirst%3DJ.%26aulast%3DTschaharganeh%26aufirst%3DD.%2BF.%26aulast%3Dvan%2BEs%26aufirst%3DJ.%2BH.%26aulast%3DClevers%26aufirst%3DH.%26aulast%3DLowe%26aufirst%3DS.%2BW.%26atitle%3DApc%2520restoration%2520promotes%2520cellular%2520differentiation%2520and%2520reestablishes%2520crypt%2520homeostasis%2520in%2520colorectal%2520cancer%26jtitle%3DCell%26date%3D2015%26volume%3D161%26spage%3D1539%26epage%3D1552%26doi%3D10.1016%2Fj.cell.2015.05.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawatao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leoni, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipps, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. A.</span></span> <span> </span><span class="NLM_article-title">Activation of the Wnt signaling pathway in chronic lymphocytic leukemia</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">3118</span>– <span class="NLM_lpage">3123</span>, <span class="refDoi"> DOI: 10.1073/pnas.0308648100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.0308648100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=14973184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlWhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=3118-3123&author=D.+Luauthor=Y.+Zhaoauthor=R.+Tawataoauthor=H.+B.+Cottamauthor=M.+Senauthor=L.+M.+Leoniauthor=T.+J.+Kippsauthor=M.+Corrauthor=D.+A.+Carson&title=Activation+of+the+Wnt+signaling+pathway+in+chronic+lymphocytic+leukemia&doi=10.1073%2Fpnas.0308648100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the Wnt signaling pathway in chronic lymphocytic leukemia</span></div><div class="casAuthors">Lu, Desheng; Zhao, Yandong; Tawatao, Rommel; Cottam, Howard B.; Sen, Malini; Leoni, Lorenzo M.; Kipps, Thomas J.; Corr, Maripat; Carson, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3118-3123</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">B cell chronic lymphocytic leukemia (CLL) is characterized by an accumulation of mature, functionally incompetent B cells.  Wnts are a large family of secreted glycoproteins involved in cell proliferation, differentiation, and oncogenesis.  The classical Wnt signaling cascade inhibits the activity of the enzyme glycogen synthase kinase-3β, augmenting β-catenin translocation to the nucleus, and the transcription of target genes.  Little is known about the potential roles of Wnt signaling in CLL.  In this study, the authors quantified the gene expression profiles of the Wnt family, and their cognate frizzled (Fzd) receptors in primary CLL cells, and detd. the role of Wnt signaling in promoting CLL cell survival.  Wnt3, Wnt5b, Wnt6, Wnt10a, Wnt14, and Wnt16, as well as the Wnt receptor Fzd3, were highly expressed in CLL, compared with normal B cells.  Three lines of evidence suggested that the Wnt signaling pathway was active in CLL.  First, the Wnt/β-catenin-regulated transcription factor lymphoid-enhancing factor-1, and its downstream target cyclin D1, were overexpressed in CLL.  Second, a pharmacol. inhibitor of glycogen synthase kinase-3β, SB-216763, activated β-catenin-mediated transcription, and enhanced the survival of CLL lymphocytes.  Third, Wnt/β-catenin signaling was diminished by an analog of a nonsteroidal antiinflammatory drug (R-etodolac), at concns. that increased apoptosis of CLL cells.  Taken together, these results indicate that Wnt signaling genes are overexpressed and are active in CLL.  Uncontrolled Wnt signaling may contribute to the defect in apoptosis that characterizes this malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpV-46cT9ujIrVg90H21EOLACvtfcHk0lh5d9TiZc6eYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlWhtL8%253D&md5=6cccf8814aa66e9db8ab83e7a11f6553</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0308648100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0308648100%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DTawatao%26aufirst%3DR.%26aulast%3DCottam%26aufirst%3DH.%2BB.%26aulast%3DSen%26aufirst%3DM.%26aulast%3DLeoni%26aufirst%3DL.%2BM.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DCorr%26aufirst%3DM.%26aulast%3DCarson%26aufirst%3DD.%2BA.%26atitle%3DActivation%2520of%2520the%2520Wnt%2520signaling%2520pathway%2520in%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D3118%26epage%3D3123%26doi%3D10.1073%2Fpnas.0308648100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sukhdeo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, Y.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsiades, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, D. R.</span></span> <span> </span><span class="NLM_article-title">Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">7516</span>– <span class="NLM_lpage">7521</span>, <span class="refDoi"> DOI: 10.1073/pnas.0610299104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.0610299104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=17452641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A280%3ADC%252BD2s3nt1Wnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=7516-7521&author=K.+Sukhdeoauthor=M.+Maniauthor=Y.+Zhangauthor=J.+Duttaauthor=H.+Yasuiauthor=M.+D.+Rooneyauthor=D.+E.+Carrascoauthor=M.+Zhengauthor=H.+Heauthor=Y.-T.+Taiauthor=C.+Mitsiadesauthor=K.+C.+Andersonauthor=D.+R.+Carrasco&title=Targeting+the+%CE%B2-catenin%2FTCF+transcriptional+complex+in+the+treatment+of+multiple+myeloma&doi=10.1073%2Fpnas.0610299104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma</span></div><div class="casAuthors">Sukhdeo Kumar; Mani Mala; Zhang Yunyu; Dutta Jui; Yasui Hiroshi; Rooney Melissa D; Carrasco Daniel E; Zheng Mei; He Haiying; Tai Yu-Tzu; Mitsiades Constantine; Anderson Kenneth C; Carrasco Daniel R</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7516-21</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Multiple myeloma (MM) is an invariably fatal form of cancer characterized by clonal proliferation of malignant plasma cells in the bone marrow.  The canonical Wnt signaling pathway is activated in MM cells through constitutively active beta-catenin, a messenger molecule relevant to growth, survival, and migration of MM cells.  The identification of a number of small molecular compounds, such as PKF115-584, which disrupt the interaction of the transcriptionally active beta-catenin/TCF protein complex, provides valuable new therapeutic tools to target an alternative pathway in MM independent of the proteasome.  Here we evaluated the transcriptional, proteomic, signaling changes, and biological sequelae associated with the inhibition of Wnt signaling in MM by PKF115-584.  The compound blocks expression of Wnt target genes and induces cytotoxicity in both patient MM cells and MM cell lines without a significant effect in normal plasma cells.  In xenograft models of human MM, PKF115-584 inhibits tumor growth and prolongs survival.  Taken together, these data demonstrate the efficacy of disrupting the beta-catenin/TCF transcriptional complex to exploit tumor dependence on Wnt signaling as a therapeutic approach in the treatment of MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfuM4ZEOdZFjAyhZbj3lKdfW6udTcc2eYHXGj_6T9OMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3nt1Wnug%253D%253D&md5=6bd5a012f7fdb1227f3042ace84063af</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0610299104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0610299104%26sid%3Dliteratum%253Aachs%26aulast%3DSukhdeo%26aufirst%3DK.%26aulast%3DMani%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDutta%26aufirst%3DJ.%26aulast%3DYasui%26aufirst%3DH.%26aulast%3DRooney%26aufirst%3DM.%2BD.%26aulast%3DCarrasco%26aufirst%3DD.%2BE.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DTai%26aufirst%3DY.-T.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DCarrasco%26aufirst%3DD.%2BR.%26atitle%3DTargeting%2520the%2520%25CE%25B2-catenin%252FTCF%2520transcriptional%2520complex%2520in%2520the%2520treatment%2520of%2520multiple%2520myeloma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D7516%26epage%3D7521%26doi%3D10.1073%2Fpnas.0610299104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bafico, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aaronson, S. A.</span></span> <span> </span><span class="NLM_article-title">An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2004.09.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ccr.2004.09.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=15542433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGlurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=497-506&author=A.+Baficoauthor=G.+Liuauthor=L.+Goldinauthor=V.+Harrisauthor=S.+A.+Aaronson&title=An+autocrine+mechanism+for+constitutive+Wnt+pathway+activation+in+human+cancer+cells&doi=10.1016%2Fj.ccr.2004.09.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells</span></div><div class="casAuthors">Bafico, Anna; Liu, Guizhong; Goldin, Luba; Harris, Violaine; Aaronson, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Autocrine Wnt signaling in the mouse mammary tumor virus model was the first identified mechanism of canonical pathway activation in cancer.  In search of this transformation mechanism in human cancer cells, we identified breast and ovarian tumor lines with upregulation of the uncomplexed transcriptionally active form of β-catenin without mutations afflicting downstream components.  Extracellular Wnt antagonists FRP1 and DKK1 caused a dramatic downregulation of β-catenin levels in these tumor cells assocd. with alteration of biol. properties and increased expression of epithelial differentiation markers.  Colorectal carcinoma cells with knockout of the mutant β-catenin allele retained upregulated β-catenin levels, which also could be inhibited by these Wnt antagonists.  Together, these findings establish the involvement of autocrine Wnt signaling in human cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXPoqwc2vXarVg90H21EOLACvtfcHk0likwTS3mKT1Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGlurjO&md5=d120566809d1ee0f6474a22eff99630d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.09.032%26sid%3Dliteratum%253Aachs%26aulast%3DBafico%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DGoldin%26aufirst%3DL.%26aulast%3DHarris%26aufirst%3DV.%26aulast%3DAaronson%26aufirst%3DS.%2BA.%26atitle%3DAn%2520autocrine%2520mechanism%2520for%2520constitutive%2520Wnt%2520pathway%2520activation%2520in%2520human%2520cancer%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D497%26epage%3D506%26doi%3D10.1016%2Fj.ccr.2004.09.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaffer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhardt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kah, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.04.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.cell.2011.04.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21663795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVOkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2011&pages=926-940&author=C.+Scheelauthor=E.+N.+Eatonauthor=S.+H.-J.+Liauthor=C.+L.+Chafferauthor=F.+Reinhardtauthor=K.-J.+Kahauthor=G.+Bellauthor=W.+Guoauthor=J.+Rubinauthor=A.+L.+Richardsonauthor=R.+A.+Weinberg&title=Paracrine+and+autocrine+signals+induce+and+maintain+mesenchymal+and+stem+cell+states+in+the+breast&doi=10.1016%2Fj.cell.2011.04.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast</span></div><div class="casAuthors">Scheel, Christina; Ng Eaton, Elinor; Li, Sophia Hsin-Jung; Chaffer, Christine L.; Reinhardt, Ferenc; Kah, Kong-Jie; Bell, George; Guo, Wenjun; Rubin, Jeffrey; Richardson, Andrea L.; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">926-940</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The epithelial-mesenchymal transition (EMT) has been assocd. with the acquisition of motility, invasiveness, and self-renewal traits.  During both normal development and tumor pathogenesis, this change in cell phenotype is induced by contextual signals that epithelial cells receive from their microenvironment.  The signals that are responsible for inducing an EMT and maintaining the resulting cellular state have been unclear.  We describe three signaling pathways, involving transforming growth factor (TGF)-β and canonical and noncanonical Wnt signaling, that collaborate to induce activation of the EMT program and thereafter function in an autocrine fashion to maintain the resulting mesenchymal state.  Downregulation of endogenously synthesized inhibitors of autocrine signals in epithelial cells enables the induction of the EMT program.  Conversely, disruption of autocrine signaling by added inhibitors of these pathways inhibits migration and self-renewal in primary mammary epithelial cells and reduces tumorigenicity and metastasis by their transformed derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQlb4blu5l8rVg90H21EOLACvtfcHk0likwTS3mKT1Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVOkt7s%253D&md5=b3478b773e87b5b98ace6f6172cbfa29</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.04.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.04.029%26sid%3Dliteratum%253Aachs%26aulast%3DScheel%26aufirst%3DC.%26aulast%3DEaton%26aufirst%3DE.%2BN.%26aulast%3DLi%26aufirst%3DS.%2BH.-J.%26aulast%3DChaffer%26aufirst%3DC.%2BL.%26aulast%3DReinhardt%26aufirst%3DF.%26aulast%3DKah%26aufirst%3DK.-J.%26aulast%3DBell%26aufirst%3DG.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DRubin%26aufirst%3DJ.%26aulast%3DRichardson%26aufirst%3DA.%2BL.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DParacrine%2520and%2520autocrine%2520signals%2520induce%2520and%2520maintain%2520mesenchymal%2520and%2520stem%2520cell%2520states%2520in%2520the%2520breast%26jtitle%3DCell%26date%3D2011%26volume%3D145%26spage%3D926%26epage%3D940%26doi%3D10.1016%2Fj.cell.2011.04.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brack, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conboy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rando, T. A.</span></span> <span> </span><span class="NLM_article-title">Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1126/science.1144090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1126%2Fscience.1144090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=17690295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVWjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=807-810&author=A.+S.+Brackauthor=M.+J.+Conboyauthor=S.+Royauthor=M.+Leeauthor=C.+J.+Kuoauthor=C.+Kellerauthor=T.+A.+Rando&title=Increased+Wnt+signaling+during+aging+alters+muscle+stem+cell+fate+and+increases+fibrosis&doi=10.1126%2Fscience.1144090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Wnt Signaling During Aging Alters Muscle Stem Cell Fate and Increases Fibrosis</span></div><div class="casAuthors">Brack, Andrew S.; Conboy, Michael J.; Roy, Sudeep; Lee, Mark; Kuo, Calvin J.; Keller, Charles; Rando, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5839</span>),
    <span class="NLM_cas:pages">807-810</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The regenerative potential of skeletal muscle declines with age, and this impairment is assocd. with an increase in tissue fibrosis.  We show that muscle stem cells (satellite cells) from aged mice tend to convert from a myogenic to a fibrogenic lineage as they begin to proliferate and that this conversion is mediated by factors in the systemic environment of the old animals.  We also show that this lineage conversion is assocd. with an activation of the canonical Wnt signaling pathway in aged myogenic progenitors and can be suppressed by Wnt inhibitors.  Furthermore, components of serum from aged mice that bind to the Frizzled family of proteins, which are Wnt receptors, may account for the elevated Wnt signaling in aged cells.  These results indicate that the Wnt signaling pathway may play a crit. role in tissue-specific stem cell aging and an increase in tissue fibrosis with age.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1GnKCzo1JrVg90H21EOLACvtfcHk0liB4jxl5ik1yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVWjt7g%253D&md5=59532d0206c12d84177212acee85dbe3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.1144090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1144090%26sid%3Dliteratum%253Aachs%26aulast%3DBrack%26aufirst%3DA.%2BS.%26aulast%3DConboy%26aufirst%3DM.%2BJ.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DKuo%26aufirst%3DC.%2BJ.%26aulast%3DKeller%26aufirst%3DC.%26aulast%3DRando%26aufirst%3DT.%2BA.%26atitle%3DIncreased%2520Wnt%2520signaling%2520during%2520aging%2520alters%2520muscle%2520stem%2520cell%2520fate%2520and%2520increases%2520fibrosis%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D807%26epage%3D810%26doi%3D10.1126%2Fscience.1144090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lancaster, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silhavy, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sintasath, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decambre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nigam, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleeson, J. G.</span></span> <span> </span><span class="NLM_article-title">Impaired Wnt-β-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1046</span>– <span class="NLM_lpage">1054</span>, <span class="refDoi"> DOI: 10.1038/nm.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnm.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=19718039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKhs7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=1046-1054&author=M.+A.+Lancasterauthor=C.+M.+Louieauthor=J.+L.+Silhavyauthor=L.+Sintasathauthor=M.+Decambreauthor=S.+K.+Nigamauthor=K.+Willertauthor=J.+G.+Gleeson&title=Impaired+Wnt-%CE%B2-catenin+signaling+disrupts+adult+renal+homeostasis+and+leads+to+cystic+kidney+ciliopathy&doi=10.1038%2Fnm.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired Wnt-β-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy</span></div><div class="casAuthors">Lancaster, Madeline A.; Louie, Carrie M.; Silhavy, Jennifer L.; Sintasath, Louis; DeCambre, Marvalyn; Nigam, Sanjay K.; Willert, Karl; Gleeson, Joseph G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1046-1054</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cystic kidney disease represents a major cause of end-stage renal disease, yet the mol. mechanisms of pathogenesis remain largely unclear.  Recent emphasis has been placed on a potential role for canonical Wnt signaling, but investigation of this pathway in adult renal homeostasis is lacking.  Here we provide evidence of a previously unidentified canonical Wnt activity in adult mammalian kidney homeostasis, the loss of which leads to cystic kidney disease.  Loss of the Jouberin (Jbn) protein in mouse leads to the cystic kidney disease nephronophthisis, owing to an unexpected decrease in endogenous Wnt activity.  Jbn interacts with and facilitates β-catenin nuclear accumulation, resulting in pos. modulation of downstream transcription.  Finally, we show that Jbn is required in vivo for a Wnt response to injury and renal tubule repair, the absence of which triggers cystogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr717LRBx5i1bVg90H21EOLACvtfcHk0liB4jxl5ik1yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKhs7jI&md5=a4bd6a8cd2af68f2aa7ad8143603a78f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2010%26sid%3Dliteratum%253Aachs%26aulast%3DLancaster%26aufirst%3DM.%2BA.%26aulast%3DLouie%26aufirst%3DC.%2BM.%26aulast%3DSilhavy%26aufirst%3DJ.%2BL.%26aulast%3DSintasath%26aufirst%3DL.%26aulast%3DDecambre%26aufirst%3DM.%26aulast%3DNigam%26aufirst%3DS.%2BK.%26aulast%3DWillert%26aufirst%3DK.%26aulast%3DGleeson%26aufirst%3DJ.%2BG.%26atitle%3DImpaired%2520Wnt-%25CE%25B2-catenin%2520signaling%2520disrupts%2520adult%2520renal%2520homeostasis%2520and%2520leads%2520to%2520cystic%2520kidney%2520ciliopathy%26jtitle%3DNat.%2520Med.%26date%3D2009%26volume%3D15%26spage%3D1046%26epage%3D1054%26doi%3D10.1038%2Fnm.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malanchi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peinado, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussenet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huelsken, J.</span></span> <span> </span><span class="NLM_article-title">Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>452</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1038/nature06835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnature06835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=18385740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktFCgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2008&pages=650-653&author=I.+Malanchiauthor=H.+Peinadoauthor=D.+Kassenauthor=T.+Hussenetauthor=D.+Metzgerauthor=P.+Chambonauthor=M.+Huberauthor=D.+Hohlauthor=A.+Canoauthor=W.+Birchmeierauthor=J.+Huelsken&title=Cutaneous+cancer+stem+cell+maintenance+is+dependent+on+%CE%B2-catenin+signalling&doi=10.1038%2Fnature06835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cutaneous cancer stem cell maintenance is dependent on β-catenin signaling</span></div><div class="casAuthors">Malanchi, Ilaria; Peinado, Hector; Kassen, Deepika; Hussenet, Thomas; Metzger, Daniel; Chambon, Pierre; Huber, Marcel; Hohl, Daniel; Cano, Amparo; Birchmeier, Walter; Huelsken, Joerg</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">452</span>
        (<span class="NLM_cas:issue">7187</span>),
    <span class="NLM_cas:pages">650-653</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Continuous turnover of epithelia is ensured by the extensive self-renewal capacity of tissue-specific stem cells.  Similarly, epithelial tumor maintenance relies on cancer stem cells (CSCs), which co-opt stem cell properties.  For most tumors, the cellular origin of these CSCs and regulatory pathways essential for sustaining stemness have not been identified.  In murine skin, follicular morphogenesis is driven by bulge stem cells that specifically express CD34.  Here we identify a population of cells in early epidermal tumors characterized by phenotypic and functional similarities to normal bulge skin stem cells.  This population contains CSCs, which are the only cells with tumor initiation properties.  Transplants derived from these CSCs preserve the hierarchical organization of the primary tumor.  We describe β-catenin signaling as being essential in sustaining the CSC phenotype.  Ablation of the β-catenin gene results in the loss of CSCs and complete tumor regression.  In addn., we provide evidence for the involvement of increased β-catenin signaling in malignant human squamous cell carcinomas.  Because Wnt/β-catenin signaling is not essential for normal epidermal homeostasis, such a mechanistic difference may thus be targeted to eliminate CSCs and consequently eradicate squamous cell carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrZ5OBtyG5wrVg90H21EOLACvtfcHk0liB4jxl5ik1yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktFCgsLY%253D&md5=39a4f10d273ba7dd51b507365bf15ff0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature06835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06835%26sid%3Dliteratum%253Aachs%26aulast%3DMalanchi%26aufirst%3DI.%26aulast%3DPeinado%26aufirst%3DH.%26aulast%3DKassen%26aufirst%3DD.%26aulast%3DHussenet%26aufirst%3DT.%26aulast%3DMetzger%26aufirst%3DD.%26aulast%3DChambon%26aufirst%3DP.%26aulast%3DHuber%26aufirst%3DM.%26aulast%3DHohl%26aufirst%3DD.%26aulast%3DCano%26aufirst%3DA.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DHuelsken%26aufirst%3DJ.%26atitle%3DCutaneous%2520cancer%2520stem%2520cell%2520maintenance%2520is%2520dependent%2520on%2520%25CE%25B2-catenin%2520signalling%26jtitle%3DNature%26date%3D2008%26volume%3D452%26spage%3D650%26epage%3D653%26doi%3D10.1038%2Fnature06835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridgway, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Es, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Wetering, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begthel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Born, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansom, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Crypt stem cells as the cells-of-origin of intestinal cancer</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>457</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">611</span>, <span class="refDoi"> DOI: 10.1038/nature07602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnature07602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=19092804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=457&publication_year=2009&pages=608-611&author=N.+Barkerauthor=R.+A.+Ridgwayauthor=J.+H.+van+Esauthor=M.+van+de+Weteringauthor=H.+Begthelauthor=M.+van+den+Bornauthor=E.+Danenbergauthor=A.+R.+Clarkeauthor=O.+J.+Sansomauthor=H.+Clevers&title=Crypt+stem+cells+as+the+cells-of-origin+of+intestinal+cancer&doi=10.1038%2Fnature07602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Crypt stem cells as the cells-of-origin of intestinal cancer</span></div><div class="casAuthors">Barker, Nick; Ridgway, Rachel A.; van Es, Johan H.; van de Wetering, Marc; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; Clarke, Alan R.; Sansom, Owen J.; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">457</span>
        (<span class="NLM_cas:issue">7229</span>),
    <span class="NLM_cas:pages">608-611</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Intestinal cancer is initiated by Wnt-pathway-activating mutations in genes such as adenomatous polyposis coli (APC).  As in most cancers, the cell of origin has remained elusive.  In a previously established Lgr5 (leucine-rich-repeat contg. G-protein-coupled receptor 5) knockin mouse model, a tamoxifen-inducible Cre recombinase is expressed in long-lived intestinal stem cells.  Here it is shown that deletion of Apc in these stem cells leads to their transformation within days.  Transformed stem cells remain located at crypt bottoms, while fueling a growing microadenoma.  These microadenomas show unimpeded growth and develop into macroscopic adenomas within 3-5 wk.  The distribution of Lgr5+ cells within stem-cell-derived adenomas indicates that a stem cell/progenitor cell hierarchy is maintained in early neoplastic lesions.  When Apc is deleted in short-lived transit-amplifying cells using a different cre mouse, the growth of the induced microadenomas rapidly stalls.  Even after 30 wk, large adenomas are very rare in these mice.  It is concluded that stem-cell-specific loss of Apc results in progressively growing neoplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6qLpNRIIFTbVg90H21EOLACvtfcHk0lh_4SaXYN-w8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOmsbg%253D&md5=2e0febacce6faf1eeafea138c22be101</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature07602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07602%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DN.%26aulast%3DRidgway%26aufirst%3DR.%2BA.%26aulast%3Dvan%2BEs%26aufirst%3DJ.%2BH.%26aulast%3Dvan%2Bde%2BWetering%26aufirst%3DM.%26aulast%3DBegthel%26aufirst%3DH.%26aulast%3Dvan%2Bden%2BBorn%26aufirst%3DM.%26aulast%3DDanenberg%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DA.%2BR.%26aulast%3DSansom%26aufirst%3DO.%2BJ.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DCrypt%2520stem%2520cells%2520as%2520the%2520cells-of-origin%2520of%2520intestinal%2520cancer%26jtitle%3DNature%26date%3D2009%26volume%3D457%26spage%3D608%26epage%3D611%26doi%3D10.1038%2Fnature07602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esposito, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandillet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeisig, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griessinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, C. W. E.</span></span> <span> </span><span class="NLM_article-title">β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2010.10.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ccr.2010.10.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21156284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=606-618&author=J.+Yeungauthor=M.+T.+Espositoauthor=A.+Gandilletauthor=B.+B.+Zeisigauthor=E.+Griessingerauthor=D.+Bonnetauthor=C.+W.+E.+So&title=%CE%B2-Catenin+mediates+the+establishment+and+drug+resistance+of+MLL+leukemic+stem+cells&doi=10.1016%2Fj.ccr.2010.10.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">β-catenin mediates the establishment and drug resistance of MLL leukemic stem cells</span></div><div class="casAuthors">Yeung, Jenny; Esposito, Maria Teresa; Gandillet, Arnaud; Zeisig, Bernd B.; Griessinger, Emmanuel; Bonnet, Dominique; So, Chi Wai Eric</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">606-618</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Identification of mol. pathways essential for cancer stem cells is crit. for understanding the underlying biol. and designing effective cancer therapeutics.  Here, we demonstrated that β-catenin was activated during development of MLL leukemic stem cells (LSCs).  Suppression of β-catenin reversed LSCs to a pre-LSC-like stage and significantly reduced the growth of human MLL leukemic cells.  Conditional deletion of β-catenin completely abolished the oncogenic potential of MLL-transformed cells.  In addn., established MLL LSCs that have acquired resistance against GSK3 inhibitors could be resensitized by suppression of β-catenin expression.  These results unveil previously unrecognized multifaceted functions of β-catenin in the establishment and drug-resistant properties of MLL stem cells, highlighting it as a potential therapeutic target for an important subset of AMLs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Xe1nJS3857Vg90H21EOLACvtfcHk0lh_4SaXYN-w8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGhsbvF&md5=22f418917d697374b30bec1d91dffbfc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.10.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.10.032%26sid%3Dliteratum%253Aachs%26aulast%3DYeung%26aufirst%3DJ.%26aulast%3DEsposito%26aufirst%3DM.%2BT.%26aulast%3DGandillet%26aufirst%3DA.%26aulast%3DZeisig%26aufirst%3DB.%2BB.%26aulast%3DGriessinger%26aufirst%3DE.%26aulast%3DBonnet%26aufirst%3DD.%26aulast%3DSo%26aufirst%3DC.%2BW.%2BE.%26atitle%3D%25CE%25B2-Catenin%2520mediates%2520the%2520establishment%2520and%2520drug%2520resistance%2520of%2520MLL%2520leukemic%2520stem%2520cells%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D18%26spage%3D606%26epage%3D618%26doi%3D10.1016%2Fj.ccr.2010.10.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spranger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, T. F.</span></span> <span> </span><span class="NLM_article-title">Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>523</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1038/nature14404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnature14404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=25970248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFaitrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=523&publication_year=2015&pages=231-235&author=S.+Sprangerauthor=R.+Baoauthor=T.+F.+Gajewski&title=Melanoma-intrinsic+%CE%B2-catenin+signalling+prevents+anti-tumour+immunity&doi=10.1038%2Fnature14404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity</span></div><div class="casAuthors">Spranger, Stefani; Bao, Riyue; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">523</span>
        (<span class="NLM_cas:issue">7559</span>),
    <span class="NLM_cas:pages">231-235</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanoma treatment is being revolutionized by the development of effective immunotherapeutic approaches.  These strategies include blockade of immune-inhibitory receptors on activated T cells; for example, using monoclonal antibodies against CTLA-4, PD-1, and PD-L1 (refs 3, 4, 5).  However, only a subset of patients responds to these treatments, and data suggest that therapeutic benefit is preferentially achieved in patients with a pre-existing T-cell response against their tumor, as evidenced by a baseline CD8+ T-cell infiltration within the tumor microenvironment.  Understanding the mol. mechanisms that underlie the presence or absence of a spontaneous anti-tumor T-cell response in subsets of cases, therefore, should enable the development of therapeutic solns. for patients lacking a T-cell infiltrate.  Here the authors identify a melanoma-cell-intrinsic oncogenic pathway that contributes to a lack of T-cell infiltration in melanoma.  Mol. anal. of human metastatic melanoma samples revealed a correlation between activation of the WNT/β-catenin signaling pathway and absence of a T-cell gene expression signature.  Using autochthonous mouse melanoma models the authors identified the mechanism by which tumor-intrinsic active β-catenin signaling results in T-cell exclusion and resistance to anti-PD-L1/anti-CTLA-4 monoclonal antibody therapy.  Specific oncogenic signals, therefore, can mediate cancer immune evasion and resistance to immunotherapies, pointing to new candidate targets for immune potentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXZ3KSCsvVbVg90H21EOLACvtfcHk0lh_4SaXYN-w8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFaitrrL&md5=ff32a95e2614e76cf9f9167e35bf015e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature14404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14404%26sid%3Dliteratum%253Aachs%26aulast%3DSpranger%26aufirst%3DS.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DMelanoma-intrinsic%2520%25CE%25B2-catenin%2520signalling%2520prevents%2520anti-tumour%2520immunity%26jtitle%3DNature%26date%3D2015%26volume%3D523%26spage%3D231%26epage%3D235%26doi%3D10.1038%2Fnature14404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spranger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajewski, T. F.</span></span> <span> </span><span class="NLM_article-title">Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2017.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ccell.2017.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=28486109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsVanurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=711-723&author=S.+Sprangerauthor=D.+Daiauthor=B.+Hortonauthor=T.+F.+Gajewski&title=Tumor-residing+Batf3+dendritic+cells+are+required+for+effector+T+cell+trafficking+and+adoptive+T+cell+therapy&doi=10.1016%2Fj.ccell.2017.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy</span></div><div class="casAuthors">Spranger, Stefani; Dai, Daisy; Horton, Brendan; Gajewski, Thomas F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">711-723.e4</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Effector T cells have the capability of recognizing and killing cancer cells.  However, whether tumors can become immune resistant through exclusion of effector T cells from the tumor microenvironment is not known.  By using a tumor model resembling non-T cell-inflamed human tumors, we assessed whether adoptive T cell transfer might overcome failed spontaneous priming.  Flow cytometric assays combined with intra-vital imaging indicated failed trafficking of effector T cells into tumors.  Mechanistically, this was due to the absence of CXCL9/10, which we found to be produced by CD103+ dendritic cells (DCs) in T cell-inflamed tumors.  Our data indicate that lack of CD103+ DCs within the tumor microenvironment dominantly resists the effector phase of an anti-tumor T cell response, contributing to immune escape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7fiCVbCdG17Vg90H21EOLACvtfcHk0lhGv2vLTePs1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsVanurY%253D&md5=dec11abf8411306202decf48235b2eac</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2017.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2017.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DSpranger%26aufirst%3DS.%26aulast%3DDai%26aufirst%3DD.%26aulast%3DHorton%26aufirst%3DB.%26aulast%3DGajewski%26aufirst%3DT.%2BF.%26atitle%3DTumor-residing%2520Batf3%2520dendritic%2520cells%2520are%2520required%2520for%2520effector%2520T%2520cell%2520trafficking%2520and%2520adoptive%2520T%2520cell%2520therapy%26jtitle%3DCancer%2520Cell%26date%3D2017%26volume%3D31%26spage%3D711%26epage%3D723%26doi%3D10.1016%2Fj.ccell.2017.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lino, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curotto de Lafaille, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span> <span> </span><span class="NLM_article-title">β-Catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">162</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1038/nm1707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnm1707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=18246080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1KhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=162-169&author=Y.+Dingauthor=S.+Shenauthor=A.+C.+Linoauthor=M.+A.+Curotto+de+Lafailleauthor=J.+J.+Lafaille&title=%CE%B2-Catenin+stabilization+extends+regulatory+T+cell+survival+and+induces+anergy+in+nonregulatory+T+cells&doi=10.1038%2Fnm1707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells</span></div><div class="casAuthors">Ding, Yi; Shen, Shiqian; Lino, Andreia C.; Curotto de Lafaille, Maria A.; Lafaille, Juan J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">162-169</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Catenin is a central mol. in the Wnt pathway.  Expression of a stable form of β-catenin on CD4+CD25+ regulatory T (Treg) cells resulted in a marked enhancement of survival of these cells in vitro.  Furthermore, stable β-catenin-expressing CD4+CD25+ Treg cells outcompeted control Treg cells in vivo, and the no. of Treg cells necessary for protection against inflammatory bowel disease could be substantially reduced when stable β-catenin-expressing CD4+CD25+ Treg cells were used instead of control Treg cells.  Expression of stable β-catenin on potentially pathogenic CD4+CD25- T cells rendered these cells anergic, and the β-catenin-mediated induction of anergy occurred even in Foxp3-deficient T cells.  Thus, through enhanced survival of existing regulatory T cells, and through induction of unresponsiveness in precursors of T effector cells, β-catenin stabilization has a powerful effect on the prevention of inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUx840IceVx7Vg90H21EOLACvtfcHk0lhGv2vLTePs1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1KhsLk%253D&md5=6f7c3c53195015f78e01057f16fb1940</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnm1707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1707%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DS.%26aulast%3DLino%26aufirst%3DA.%2BC.%26aulast%3DCurotto%2Bde%2BLafaille%26aufirst%3DM.%2BA.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26atitle%3D%25CE%25B2-Catenin%2520stabilization%2520extends%2520regulatory%2520T%2520cell%2520survival%2520and%2520induces%2520anergy%2520in%2520nonregulatory%2520T%2520cells%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26spage%3D162%26epage%3D169%26doi%3D10.1038%2Fnm1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keerthivasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghajani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkateswaran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmanuel, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentrem, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keshavarzian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khazaie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gounari, F.</span></span> <span> </span><span class="NLM_article-title">β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">225ra28</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3007607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1126%2Fscitranslmed.3007607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=24574339" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=225ra28&author=S.+Keerthivasanauthor=K.+Aghajaniauthor=M.+Doseauthor=L.+Molineroauthor=M.+W.+Khanauthor=V.+Venkateswaranauthor=C.+Weberauthor=A.+O.+Emmanuelauthor=T.+Sunauthor=D.+J.+Bentremauthor=M.+Mulcahyauthor=A.+Keshavarzianauthor=E.+M.+Ramosauthor=N.+Blatnerauthor=K.+Khazaieauthor=F.+Gounari&title=%CE%B2-Catenin+promotes+colitis+and+colon+cancer+through+imprinting+of+proinflammatory+properties+in+T+cells&doi=10.1126%2Fscitranslmed.3007607"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3007607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3007607%26sid%3Dliteratum%253Aachs%26aulast%3DKeerthivasan%26aufirst%3DS.%26aulast%3DAghajani%26aufirst%3DK.%26aulast%3DDose%26aufirst%3DM.%26aulast%3DMolinero%26aufirst%3DL.%26aulast%3DKhan%26aufirst%3DM.%2BW.%26aulast%3DVenkateswaran%26aufirst%3DV.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DEmmanuel%26aufirst%3DA.%2BO.%26aulast%3DSun%26aufirst%3DT.%26aulast%3DBentrem%26aufirst%3DD.%2BJ.%26aulast%3DMulcahy%26aufirst%3DM.%26aulast%3DKeshavarzian%26aufirst%3DA.%26aulast%3DRamos%26aufirst%3DE.%2BM.%26aulast%3DBlatner%26aufirst%3DN.%26aulast%3DKhazaie%26aufirst%3DK.%26aulast%3DGounari%26aufirst%3DF.%26atitle%3D%25CE%25B2-Catenin%2520promotes%2520colitis%2520and%2520colon%2520cancer%2520through%2520imprinting%2520of%2520proinflammatory%2520properties%2520in%2520T%2520cells%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D225ra28%26doi%3D10.1126%2Fscitranslmed.3007607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foxworth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldman, T.</span></span> <span> </span><span class="NLM_article-title">Proof-of-principle: oncogenic β-catenin is a valid molecular target for the development of pharmacological inhibitors</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=12516970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFaksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=1355-1359&author=J.+S.+Kimauthor=H.+Crooksauthor=A.+Foxworthauthor=T.+Waldman&title=Proof-of-principle%3A+oncogenic+%CE%B2-catenin+is+a+valid+molecular+target+for+the+development+of+pharmacological+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Proof-of-principle: oncogenic β-catenin is a valid molecular target for the development of pharmacological inhibitors</span></div><div class="casAuthors">Kim, Jung-Sik; Crooks, Heather; Foxworth, Aaron; Waldman, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1355-1359</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Activation of β-catenin is a crit. step in the pathogenesis of many common human cancers and is the initiating event in adenocarcinoma of the colon.  Because activation of β-catenin provides a gain-of-function, it is tempting to speculate that specific pharmacol. inhibition of activated β-catenin might reverse the tumorigenic properties of human cancer cells and therefore form the basis of an effective anticancer strategy.  In an effort to provide proof-of-principle for such a strategy, we used a novel clonal growth assay based on human somatic cell gene targeting to det. whether activated β-catenin remains a necessary oncogenic stimulus in advanced human cancer cells.  Using this approach, we demonstrate that β-catenin is a necessary oncogene in human SW48 and DLD1 colon cancer cells but not in HCT116 cells.  These data indicate that activated β-catenin can remain a crit. oncogenic stimulus throughout the progression of human colon cancer and suggest that the small mol. inhibitors of activated β-catenin currently under development will be effective anticancer therapeutics in a subset of malignant colon cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXo_mVzWbq8bVg90H21EOLACvtfcHk0lhGv2vLTePs1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFaksA%253D%253D&md5=59287e5934c147053f390b147e9df20d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DCrooks%26aufirst%3DH.%26aulast%3DFoxworth%26aufirst%3DA.%26aulast%3DWaldman%26aufirst%3DT.%26atitle%3DProof-of-principle%253A%2520oncogenic%2520%25CE%25B2-catenin%2520is%2520a%2520valid%2520molecular%2520target%2520for%2520the%2520development%2520of%2520pharmacological%2520inhibitors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2002%26volume%3D1%26spage%3D1355%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashihara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimazaski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamitsuji, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inaba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniwaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maekawa, T.</span></span> <span> </span><span class="NLM_article-title">β-Catenin small interfering RNA successfully suppressed progression of multiple myeloma in a mouse model</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2731</span>– <span class="NLM_lpage">2738</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-08-1350</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1158%2F1078-0432.ccr-08-1350" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=19351774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksV2nsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=2731-2738&author=E.+Ashiharaauthor=E.+Kawataauthor=Y.+Nakagawaauthor=C.+Shimazaskiauthor=J.+Kurodaauthor=K.+Taniguchiauthor=H.+Uchiyamaauthor=R.+Tanakaauthor=A.+Yokotaauthor=M.+Takeuchiauthor=Y.+Kamitsujiauthor=T.+Inabaauthor=M.+Taniwakiauthor=S.+Kimuraauthor=T.+Maekawa&title=%CE%B2-Catenin+small+interfering+RNA+successfully+suppressed+progression+of+multiple+myeloma+in+a+mouse+model&doi=10.1158%2F1078-0432.ccr-08-1350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">β-Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse Model</span></div><div class="casAuthors">Ashihara, Eishi; Kawata, Eri; Nakagawa, Yoko; Shimazaski, Chihiro; Kuroda, Junya; Taniguchi, Kyoko; Uchiyama, Hitoji; Tanaka, Ruriko; Yokota, Asumi; Takeuchi, Miki; Kamitsuji, Yuri; Inaba, Tohru; Taniwaki, Masafumi; Kimura, Shinya; Maekawa, Taira</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2731-2738</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: β-catenin is the downstream effector of the Wnt signaling pathway, and it regulates cell proliferation. β-catenin overexpression correlates pos. with prognosis in several types of malignancies.  We herein assessed its effects on growth of multiple myeloma cells using a xenograft model.  Exptl. Design: We first investigated the expression of β-catenin in multiple myeloma cell lines and multiple myeloma cells obtained from patients.  Next, we investigated the growth inhibitory effects of β-catenin small interfering RNA on the growth of multiple myeloma cells in vivo.  Six-week-old male BALB/c nu/nu mice were inoculated s.c. in the right flank with 5 x 106 RPMI8226 cells, followed by s.c. injections of β-catenin small interfering RNA, scramble small interfering RNA, or PBS/atelocollagen complex twice a week for a total of eight injections.  RESULTS: Significantly higher levels of β-catenin expression were obsd. in multiple myeloma cell lines and in samples from patients with multiple myeloma than those found in mononuclear cells obtained from healthy volunteers.  In in vivo expts., no inhibitory effects were obsd. following treatment with scramble small interfering RNA or PBS/atelocollagen complexes, whereas treatment with β-catenin small interfering RNA/atelocollagen complex significantly inhibited growth of multiple myeloma tumors (P < 0.05).  CONCLUSIONS: β-catenin small interfering RNA treatment inhibited the growth of multiple myeloma tumors in a xenograft model.  To our knowledge, this is the first report showing that the treatment with β-catenin small interfering RNA produces an inhibitory effects on growth of hematol. malignancies in vivo.  Because treatment with β-catenin small interfering RNA inhibited growth of multiple myeloma cells, β-catenin is the attractive novel target for treating multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqizwMA0oxKDrVg90H21EOLACvtfcHk0ljWuCCup_2G_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksV2nsbs%253D&md5=4d277be3cf4990ad216b725fc302e60f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.ccr-08-1350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.ccr-08-1350%26sid%3Dliteratum%253Aachs%26aulast%3DAshihara%26aufirst%3DE.%26aulast%3DKawata%26aufirst%3DE.%26aulast%3DNakagawa%26aufirst%3DY.%26aulast%3DShimazaski%26aufirst%3DC.%26aulast%3DKuroda%26aufirst%3DJ.%26aulast%3DTaniguchi%26aufirst%3DK.%26aulast%3DUchiyama%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DYokota%26aufirst%3DA.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DKamitsuji%26aufirst%3DY.%26aulast%3DInaba%26aufirst%3DT.%26aulast%3DTaniwaki%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DS.%26aulast%3DMaekawa%26aufirst%3DT.%26atitle%3D%25CE%25B2-Catenin%2520small%2520interfering%2520RNA%2520successfully%2520suppressed%2520progression%2520of%2520multiple%2520myeloma%2520in%2520a%2520mouse%2520model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D2731%26epage%3D2738%26doi%3D10.1158%2F1078-0432.ccr-08-1350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scholer-Dahirel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlabach, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagdasarian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolfenden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markovits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonkin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosher, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, M. E.</span></span> <span> </span><span class="NLM_article-title">Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/β-catenin signaling</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">17135</span>– <span class="NLM_lpage">17140</span>, <span class="refDoi"> DOI: 10.1073/pnas.1104182108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.1104182108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=17135-17140&author=A.+Scholer-Dahirelauthor=M.+R.+Schlabachauthor=A.+Looauthor=L.+Bagdasarianauthor=R.+Meyerauthor=R.+Guoauthor=S.+Woolfendenauthor=K.+K.+Yuauthor=J.+Markovitsauthor=K.+Killaryauthor=D.+Sonkinauthor=Y.-M.+Yaoauthor=M.+Warmuthauthor=W.+R.+Sellersauthor=R.+Schlegelauthor=F.+Stegmeierauthor=R.+E.+Mosherauthor=M.+E.+McLaughlin&title=Maintenance+of+adenomatous+polyposis+coli+%28APC%29-mutant+colorectal+cancer+is+dependent+on+Wnt%2F%CE%B2-catenin+signaling&doi=10.1073%2Fpnas.1104182108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1104182108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1104182108%26sid%3Dliteratum%253Aachs%26aulast%3DScholer-Dahirel%26aufirst%3DA.%26aulast%3DSchlabach%26aufirst%3DM.%2BR.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DBagdasarian%26aufirst%3DL.%26aulast%3DMeyer%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DWoolfenden%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DK.%2BK.%26aulast%3DMarkovits%26aufirst%3DJ.%26aulast%3DKillary%26aufirst%3DK.%26aulast%3DSonkin%26aufirst%3DD.%26aulast%3DYao%26aufirst%3DY.-M.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DSchlegel%26aufirst%3DR.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMosher%26aufirst%3DR.%2BE.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BE.%26atitle%3DMaintenance%2520of%2520adenomatous%2520polyposis%2520coli%2520%2528APC%2529-mutant%2520colorectal%2520cancer%2520is%2520dependent%2520on%2520Wnt%252F%25CE%25B2-catenin%2520signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D17135%26epage%3D17140%26doi%3D10.1073%2Fpnas.1104182108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lepourcelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruseo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivdasani, R. A.</span></span> <span> </span><span class="NLM_article-title">Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/s1535-6108(03)00334-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fs1535-6108%2803%2900334-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=14749129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFGrsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=91-102&author=M.+Lepourceletauthor=Y.-N.+P.+Chenauthor=D.+S.+Franceauthor=H.+Wangauthor=P.+Crewsauthor=F.+Petersenauthor=C.+Bruseoauthor=A.+W.+Woodauthor=R.+A.+Shivdasani&title=Small-molecule+antagonists+of+the+oncogenic+Tcf%2F%CE%B2-catenin+protein+complex&doi=10.1016%2Fs1535-6108%2803%2900334-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex</span></div><div class="casAuthors">Lepourcelet, Maina; Chen, Ying-Nan P.; France, Dennis S.; Wang, Huisheng; Crews, Phillip; Petersen, Frank; Bruseo, Charles; Wood, Alexander W.; Shivdasani, Ramesh A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-102</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Key mol. lesions in colorectal and other cancers cause β-catenin-dependent transactivation of T cell factor (Tcf)-dependent genes.  Disruption of this signal represents an opportunity for rational cancer therapy.  To identify compds. that inhibit assocn. between Tcf4 and β-catenin, we screened libraries of natural compds. in a high-throughput assay for immunoenzymic detection of the protein-protein interaction.  Selected compds. disrupt Tcf/β-catenin complexes in several independent in vitro assays and potently antagonize cellular effects of β-catenin-dependent activities, including reporter gene activation, c-myc or cyclin D1 expression, cell proliferation, and duplication of the Xenopus embryonic dorsal axis.  These compds. thus meet predicted criteria for disrupting Tcf/β-catenin complexes and define a general std. to establish mechanism-based activity of small mol. inhibitors of this pathogenic protein-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGHpdE0U0vA7Vg90H21EOLACvtfcHk0ljWuCCup_2G_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFGrsbw%253D&md5=ddf90ca6f63e3d11421138f5e2bccc17</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fs1535-6108%2803%2900334-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1535-6108%252803%252900334-9%26sid%3Dliteratum%253Aachs%26aulast%3DLepourcelet%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.-N.%2BP.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCrews%26aufirst%3DP.%26aulast%3DPetersen%26aufirst%3DF.%26aulast%3DBruseo%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DA.%2BW.%26aulast%3DShivdasani%26aufirst%3DR.%2BA.%26atitle%3DSmall-molecule%2520antagonists%2520of%2520the%2520oncogenic%2520Tcf%252F%25CE%25B2-catenin%2520protein%2520complex%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D91%26epage%3D102%26doi%3D10.1016%2Fs1535-6108%2803%2900334-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trosset, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veronesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantegani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gianellini, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stouten, P. F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moll, J. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of protein-protein interactions: the discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1002/prot.20955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1002%2Fprot.20955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=16568448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFahs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2006&pages=60-67&author=J.-Y.+Trossetauthor=C.+Dalvitauthor=S.+Knappauthor=M.+Fasoliniauthor=M.+Veronesiauthor=S.+Manteganiauthor=L.+M.+Gianelliniauthor=C.+Catanaauthor=M.+Sundstr%C3%B6mauthor=P.+F.+W.+Stoutenauthor=J.+K.+Moll&title=Inhibition+of+protein-protein+interactions%3A+the+discovery+of+druglike+%CE%B2-catenin+inhibitors+by+combining+virtual+and+biophysical+screening&doi=10.1002%2Fprot.20955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of protein-protein interactions: the discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening</span></div><div class="casAuthors">Trosset, Jean-Yves; Dalvit, Claudio; Knapp, Stefan; Fasolini, Marina; Veronesi, Marina; Mantegani, Sergio; Gianellini, Laura M.; Catana, Cornel; Sundstrom, Michael; Stouten, Pieter F. W.; Moll, Jurgen K.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-67</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The interaction between β-catenin and Tcf family members is crucial for the Wnt signal transduction pathway, which is commonly mutated in cancer.  This interaction extends over a very large surface area (4800 Å2), and inhibiting such interactions using low mol. wt. inhibitors is a challenge.  However, protein surfaces frequently contain "hot spots," small patches that are the main mediators of binding affinity.  By making tight interactions with a hot spot, a small mol. can compete with a protein.  The Tcf3/Tcf4-binding surface on β-catenin contains a well-defined hot spot around residues K435 and R469.  A 17,700 compds. subset of the Pharmacia corporate collection was docked to this hot spot with the QXP program; 22 of the best scoring compds. were put into a biophys. (NMR and ITC) screening funnel, where specific binding to β-catenin, competition with Tcf4 and finally binding consts. were detd.  This process led to the discovery of three druglike, low mol. wt. Tcf4-competitive compds. with the tightest binder having a KD of 450 nM.  Our approach can be used in several situations (e.g., when selecting compds. from external collections, when no biochem. functional assay is available, or when no HTS is envisioned), and it may be generally applicable to the identification of inhibitors of protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDI5V3CAoiWLVg90H21EOLACvtfcHk0lg_xq5JmtW41g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFahs7k%253D&md5=eb5afb4ac9d4f2be85fec32de9e95c26</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fprot.20955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.20955%26sid%3Dliteratum%253Aachs%26aulast%3DTrosset%26aufirst%3DJ.-Y.%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DFasolini%26aufirst%3DM.%26aulast%3DVeronesi%26aufirst%3DM.%26aulast%3DMantegani%26aufirst%3DS.%26aulast%3DGianellini%26aufirst%3DL.%2BM.%26aulast%3DCatana%26aufirst%3DC.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DStouten%26aufirst%3DP.%2BF.%2BW.%26aulast%3DMoll%26aufirst%3DJ.%2BK.%26atitle%3DInhibition%2520of%2520protein-protein%2520interactions%253A%2520the%2520discovery%2520of%2520druglike%2520%25CE%25B2-catenin%2520inhibitors%2520by%2520combining%2520virtual%2520and%2520biophysical%2520screening%26jtitle%3DProteins%26date%3D2006%26volume%3D64%26spage%3D60%26epage%3D67%26doi%3D10.1002%2Fprot.20955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gonsalves, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekas, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagourney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardozo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DasGupta, R.</span></span> <span> </span><span class="NLM_article-title">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">5954</span>– <span class="NLM_lpage">5963</span>, <span class="refDoi"> DOI: 10.1073/pnas.1017496108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.1017496108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21393571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5954-5963&author=F.+C.+Gonsalvesauthor=K.+Kleinauthor=B.+B.+Carsonauthor=S.+Katzauthor=L.+A.+Ekasauthor=S.+Evansauthor=R.+Nagourneyauthor=T.+Cardozoauthor=A.+M.+C.+Brownauthor=R.+DasGupta&title=An+RNAi-based+chemical+genetic+screen+identifies+three+small-molecule+inhibitors+of+the+Wnt%2Fwingless+signaling+pathway&doi=10.1073%2Fpnas.1017496108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway</span></div><div class="casAuthors">Gonsalves, Foster C.; Klein, Keren; Carson, Brittany B.; Katz, Shauna; Ekas, Laura A.; Evans, Steve; Nagourney, Robert; Cardozo, Timothy; Brown, Anthony M. C.; Das Gupta, Ramanuj</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5954-5963, S5954/1-S5954/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Misregulated β-catenin responsive transcription (CRT) has been implicated in the genesis of various malignancies, including colorectal carcinomas, and it is a key therapeutic target in combating various cancers.  Despite significant effort, successful clin. implementation of CRT inhibitory therapeutics remains a challenging goal.  This is, in part, because of the challenge of identifying inhibitory compds. that specifically modulate the nuclear transcriptional activity of β-catenin while not affecting its cytoskeletal function in stabilizing adherens junctions at the cell membrane.  Here, we report an RNAi-based modifier screening strategy for the identification of CRT inhibitors.  Our data provide support for the specificity of these inhibitory compds. in antagonizing the transcriptional function of nuclear β-catenin.  We show that these inhibitors efficiently block Wnt/β-catenin-induced target genes and phenotypes in various mammalian and cancer cell lines.  Importantly, these Wnt inhibitors are specifically cytotoxic to human colon tumor biopsy cultures as well as colon cancer cell lines that exhibit deregulated Wnt signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr94ZMZYTd807Vg90H21EOLACvtfcHk0lg_xq5JmtW41g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVymt70%253D&md5=566aa3c22ccee9ae88aeda4e523699db</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1017496108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1017496108%26sid%3Dliteratum%253Aachs%26aulast%3DGonsalves%26aufirst%3DF.%2BC.%26aulast%3DKlein%26aufirst%3DK.%26aulast%3DCarson%26aufirst%3DB.%2BB.%26aulast%3DKatz%26aufirst%3DS.%26aulast%3DEkas%26aufirst%3DL.%2BA.%26aulast%3DEvans%26aufirst%3DS.%26aulast%3DNagourney%26aufirst%3DR.%26aulast%3DCardozo%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DA.%2BM.%2BC.%26aulast%3DDasGupta%26aufirst%3DR.%26atitle%3DAn%2520RNAi-based%2520chemical%2520genetic%2520screen%2520identifies%2520three%2520small-molecule%2520inhibitors%2520of%2520the%2520Wnt%252Fwingless%2520signaling%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D5954%26epage%3D5963%26doi%3D10.1073%2Fpnas.1017496108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duggineni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, J.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1021/bi201428h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi201428h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1OjtLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=724-731&author=W.+Tianauthor=X.+Hanauthor=M.+Yanauthor=Y.+Xuauthor=S.+Duggineniauthor=N.+Linauthor=G.+Luoauthor=Y.+M.+Liauthor=X.+Hanauthor=Z.+Huangauthor=J.+An&title=Structure-based+discovery+of+a+novel+inhibitor+targeting+the+%CE%B2-catenin%2FTcf4+interaction&doi=10.1021%2Fbi201428h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of a Novel Inhibitor Targeting the β-Catenin/Tcf4 Interaction</span></div><div class="casAuthors">Tian, Wang; Han, Xiaofeng; Yan, Maocai; Xu, Yan; Duggineni, Srinivas; Lin, Nan; Luo, Guifen; Li, Yan Michael; Han, Xiaobing; Huang, Ziwei; An, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">724-731</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overactivation or overexpression of β-catenin in the Wnt (wingless) signaling pathway plays an important role in tumorigenesis.  Interaction of β-catenin with T-cell factor (Tcf) DNA binding proteins is a key step in the activation of the proliferative genes in response to upstream signals of this Wnt/β-catenin pathway.  Recently, we identified a new small mol. inhibitor, named BC21 (C32H36Cl2Cu2N2O2), which effectively inhibits the binding of β-catenin with Tcf4-derived peptide and suppresses β-catenin/Tcf4 driven reporter gene activity.  This inhibitor decreases the viability of β-catenin overexpressing HCT116 colon cancer cells that harbor the β-catenin mutation, and more significantly, it inhibits the clonogenic activity of these cells.  Down-regulation of c-Myc and cyclin D1 expression, the two important effectors of the Wnt/β-catenin signaling, is confirmed by treating HCT116 cells with BC21.  This compd. represents a new and modifiable potential anticancer candidate that targets β-catenin/Tcf-4 interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64BkaTOeZErVg90H21EOLACvtfcHk0lg_xq5JmtW41g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1OjtLfM&md5=21392f27d240f4625f2ff0e77b1afe30</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fbi201428h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201428h%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DDuggineni%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DN.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%2BM.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAn%26aufirst%3DJ.%26atitle%3DStructure-based%2520discovery%2520of%2520a%2520novel%2520inhibitor%2520targeting%2520the%2520%25CE%25B2-catenin%252FTcf4%2520interaction%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D724%26epage%3D731%26doi%3D10.1021%2Fbi201428h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span> <span> </span><span class="NLM_article-title">A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis</span>. <i>Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">740</span>, <span class="refDoi"> DOI: 10.1038/cr.2011.30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fcr.2011.30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21321609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVGjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=730-740&author=W.+Wangauthor=H.+Liuauthor=S.+Wangauthor=X.+Haoauthor=L.+Li&title=A+diterpenoid+derivative+15-oxospiramilactone+inhibits+Wnt%2F%CE%B2-catenin+signaling+and+colon+cancer+cell+tumorigenesis&doi=10.1038%2Fcr.2011.30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis</span></div><div class="casAuthors">Wang, Wei; Liu, Haiyang; Wang, Sheng; Hao, Xiaojiang; Li, Lin</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">730-740</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">NPG Nature Asia-Pacific</span>)
        </div><div class="casAbstract">The Wnt/β-catenin signaling pathway is a highly conserved pathway in organism evolution and regulates many biol. processes.  Aberrant activation of the Wnt/β-catenin signaling pathway is closely related to tumorigenesis.  In order to identify potent small mols. to treat the over-activated Wnt signaling-mediated cancer, such as colon cancer, we established a mammalian cell line-based reporter gene screening system.  The screen revealed a diterpenoid deriv., 15-oxospiramilactone (NC043) that inhibits Wnt3a or LiCl-stimulated Top-flash reporter activity in HEK293T cells and growth of colon cancer cells, SW480 and Caco-2.  Treatment of SW480 cells with NC043 led to decreases in the mRNA and/or protein expression of Wnt target genes Axin2, Cyclin D1 and Survivin , as well as decreases in the protein levels of Cdc25c and Cdc2.  NC043 did not affect the cytosol-nuclear distribution and protein level of sol. β-catenin, but decreased β-catenin/TCF4 assocn. in SW480 cells.  Moreover, NC043 inhibited anchorage-independent growth and xenograft tumorigenesis of SW480 cells.  Collectively these results demonstrate that NC043 is a novel small mol. that inhibits canonical Wnt signaling downstream of β-catenin stability and may be a potential compd. for treating colorectal cancer.  Cell Research (2011) 21:730-740. doi:10.1038/cr.2011.30; published online 15 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMfekvifh107Vg90H21EOLACvtfcHk0lgPhg_V-0O-Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVGjtrk%253D&md5=8bdcb5ea06a60672fc2fd86c76147524</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fcr.2011.30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2011.30%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DA%2520diterpenoid%2520derivative%252015-oxospiramilactone%2520inhibits%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520and%2520colon%2520cancer%2520cell%2520tumorigenesis%26jtitle%3DCell%2520Res.%26date%3D2011%26volume%3D21%26spage%3D730%26epage%3D740%26doi%3D10.1038%2Fcr.2011.30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuenschwander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulf-Goldenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span> <span> </span><span class="NLM_article-title">A small-molecule antagonist of the β-catenin/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">901</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.can-15-1519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1158%2F0008-5472.can-15-1519" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=891-901&author=L.+Fangauthor=Q.+Zhuauthor=M.+Neuenschwanderauthor=E.+Speckerauthor=A.+Wulf-Goldenbergauthor=W.+I.+Weisauthor=J.+P.+von+Kriesauthor=W.+Birchmeier&title=A+small-molecule+antagonist+of+the+%CE%B2-catenin%2FTCF4+interaction+blocks+the+self-renewal+of+cancer+stem+cells+and+suppresses+tumorigenesis&doi=10.1158%2F0008-5472.can-15-1519"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.can-15-1519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.can-15-1519%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DNeuenschwander%26aufirst%3DM.%26aulast%3DSpecker%26aufirst%3DE.%26aulast%3DWulf-Goldenberg%26aufirst%3DA.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DA%2520small-molecule%2520antagonist%2520of%2520the%2520%25CE%25B2-catenin%252FTCF4%2520interaction%2520blocks%2520the%2520self-renewal%2520of%2520cancer%2520stem%2520cells%2520and%2520suppresses%2520tumorigenesis%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D891%26epage%3D901%26doi%3D10.1158%2F0008-5472.can-15-1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malakhova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Z.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibitor of the β-catenin-TCF4 interaction suppresses colorectal cancer growth in vitro and in vivo</span>. <i>EBioMedicine</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1016/j.ebiom.2017.09.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ebiom.2017.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=29033371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A280%3ADC%252BC1M7gvVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=22-31&author=S.+H.+Shinauthor=D.+Y.+Limauthor=K.+Reddyauthor=M.+Malakhovaauthor=F.+Liuauthor=T.+Wangauthor=M.+Songauthor=H.+Chenauthor=K.+B.+Baeauthor=J.+Ryuauthor=K.+Liuauthor=M.-H.+Leeauthor=A.+M.+Bodeauthor=Z.+Dong&title=A+small+molecule+inhibitor+of+the+%CE%B2-catenin-TCF4+interaction+suppresses+colorectal+cancer+growth+in+vitro+and+in+vivo&doi=10.1016%2Fj.ebiom.2017.09.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo</span></div><div class="casAuthors">Shin Seung Ho; Bode Ann M; Lim Do Young; Reddy Kanamata; Malakhova Margarita; Chen Hanyong; Bae Ki Beom; Ryu Joohyun; Liu Fangfang; Song Mengqiu; Wang Ting; Lee Mee-Hyun; Liu Kangdong; Dong Zigang</div><div class="citationInfo"><span class="NLM_cas:title">EBioMedicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Colorectal cancer is associated with aberrant activation of the Wnt pathway. β-Catenin plays essential roles in the Wnt pathway by interacting with T-cell factor 4 (TCF4) to transcribe oncogenes.  We synthesized a small molecule, referred to as HI-B1, and evaluated signaling changes and biological consequences induced by the compound.  HI-B1 inhibited β-catenin/TCF4 luciferase activity and preferentially caused apoptosis of cancer cells in which the survival is dependent on β-catenin.  The formation of the β-catenin/TCF4 complex was disrupted by HI-B1 due to the direct interaction of HI-B1 with β-catenin.  Colon cancer patient-derived xenograft (PDX) studies showed that a tumor with higher levels of β-catenin expression was more sensitive to HI-B1 treatment, compared to a tumor with lower expression levels of β-catenin.  The different sensitivities of PDX tumors to HI-B1 were dependent on the β-catenin expression level and potentially could be further exploited for biomarker development and therapeutic applications against colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTqN5OgHz-tvNenUz0lpNqnfW6udTcc2eZntKlNKetTerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7gvVeitQ%253D%253D&md5=c0b3f84100f9d17a0f8df4f5c7f6d0eb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2017.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2017.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DS.%2BH.%26aulast%3DLim%26aufirst%3DD.%2BY.%26aulast%3DReddy%26aufirst%3DK.%26aulast%3DMalakhova%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DSong%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DBae%26aufirst%3DK.%2BB.%26aulast%3DRyu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.-H.%26aulast%3DBode%26aufirst%3DA.%2BM.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520the%2520%25CE%25B2-catenin-TCF4%2520interaction%2520suppresses%2520colorectal%2520cancer%2520growth%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DEBioMedicine%26date%3D2017%26volume%3D25%26spage%3D22%26epage%3D31%26doi%3D10.1016%2Fj.ebiom.2017.09.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catrow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">High-throughput selectivity assays for small-molecule inhibitors of β-catenin/T-cell factor protein-protein interactions</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1021/ml300367f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300367f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=306-311&author=M.+Zhangauthor=J.+L.+Catrowauthor=H.+Ji&title=High-throughput+selectivity+assays+for+small-molecule+inhibitors+of+%CE%B2-catenin%2FT-cell+factor+protein-protein+interactions&doi=10.1021%2Fml300367f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fml300367f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300367f%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DCatrow%26aufirst%3DJ.%2BL.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DHigh-throughput%2520selectivity%2520assays%2520for%2520small-molecule%2520inhibitors%2520of%2520%25CE%25B2-catenin%252FT-cell%2520factor%2520protein-protein%2520interactions%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D306%26epage%3D311%26doi%3D10.1021%2Fml300367f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halbedl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kratzer, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zippert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bräse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel inhibitors blocking Wnt signaling downstream of β-catenin</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>587</i></span>,  <span class="NLM_fpage">522</span>– <span class="NLM_lpage">527</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2013.01.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.febslet.2013.01.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=2013&pages=522-527&author=S.+Halbedlauthor=M.-C.+Kratzerauthor=K.+Rahmauthor=N.+Crostaauthor=K.-S.+Mastersauthor=J.+Zippertauthor=S.+Br%C3%A4seauthor=D.+Gradl&title=Synthesis+of+novel+inhibitors+blocking+Wnt+signaling+downstream+of+%CE%B2-catenin&doi=10.1016%2Fj.febslet.2013.01.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2013.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2013.01.034%26sid%3Dliteratum%253Aachs%26aulast%3DHalbedl%26aufirst%3DS.%26aulast%3DKratzer%26aufirst%3DM.-C.%26aulast%3DRahm%26aufirst%3DK.%26aulast%3DCrosta%26aufirst%3DN.%26aulast%3DMasters%26aufirst%3DK.-S.%26aulast%3DZippert%26aufirst%3DJ.%26aulast%3DBr%25C3%25A4se%26aufirst%3DS.%26aulast%3DGradl%26aufirst%3DD.%26atitle%3DSynthesis%2520of%2520novel%2520inhibitors%2520blocking%2520Wnt%2520signaling%2520downstream%2520of%2520%25CE%25B2-catenin%26jtitle%3DFEBS%2520Lett.%26date%3D2013%26volume%3D587%26spage%3D522%26epage%3D527%26doi%3D10.1016%2Fj.febslet.2013.01.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, J. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moellering, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdine, G. L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">17942</span>– <span class="NLM_lpage">17947</span>, <span class="refDoi"> DOI: 10.1073/pnas.1208396109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.1208396109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=23071338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsl2ktbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=17942-17947&author=T.+N.+Grossmannauthor=J.+T.+H.+Yehauthor=B.+R.+Bowmanauthor=Q.+Chuauthor=R.+E.+Moelleringauthor=G.+L.+Verdine&title=Inhibition+of+oncogenic+Wnt+signaling+through+direct+targeting+of+%CE%B2-catenin&doi=10.1073%2Fpnas.1208396109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin</span></div><div class="casAuthors">Grossmann, Tom N.; Yeh, Johannes T.-H.; Bowman, Brian R.; Chu, Qian; Moellering, Raymond E.; Verdine, Gregory L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">17942-17947, S17942/1-S17942/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Aberrant activation of signaling by the Wnt pathway is strongly implicated in the onset and progression of numerous types of cancer.  Owing to the persistent dependence of these tumors on Wnt signaling for growth and survival, inhibition of this pathway is considered an attractive mechanism-based therapeutic approach.  Oncogenic activation of Wnt signaling can ensue from a variety of distinct aberrations in the signaling pathway, but most share the common feature of causing increased cellular levels of β-catenin by interfering with its constitutive degrdn.  β-Catenin serves as a central hub in Wnt signaling by engaging in crucial protein-protein interactions with both neg. and pos. effectors of the pathway.  Direct interference with these protein-protein interactions is a biol. compelling approach toward suppression of β-catenin hyperactivity, but such interactions have proven intransigent with respect to small-mol. targeting.  Hence β-catenin remains an elusive target for translational cancer therapy.  Here the authors report the discovery of a hydrocarbon-stapled peptide that directly targets β-catenin and interferes with its ability to serve as a transcriptional coactivator for T-cell factor (TCF) proteins, the downstream transcriptional regulators of the Wnt pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD9Q6Y8-IAI7Vg90H21EOLACvtfcHk0lhoUy9jiBED5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsl2ktbvI&md5=3f2fc0f4f616ef057317639fe7c465c6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1208396109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1208396109%26sid%3Dliteratum%253Aachs%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26aulast%3DYeh%26aufirst%3DJ.%2BT.%2BH.%26aulast%3DBowman%26aufirst%3DB.%2BR.%26aulast%3DChu%26aufirst%3DQ.%26aulast%3DMoellering%26aufirst%3DR.%2BE.%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26atitle%3DInhibition%2520of%2520oncogenic%2520Wnt%2520signaling%2520through%2520direct%2520targeting%2520of%2520%25CE%25B2-catenin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D17942%26epage%3D17947%26doi%3D10.1073%2Fpnas.1208396109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, E. M.</span></span> <span> </span><span class="NLM_article-title">A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19156</span>– <span class="NLM_lpage">19167</span>, <span class="refDoi"> DOI: 10.1038/srep19156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fsrep19156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=26750754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsFOguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=19156-19167&author=T.-H.+Hsiehauthor=C.+Y.+Hsuauthor=C.+F.+Tsaiauthor=C.+C.+Chiuauthor=S.+S.+Liangauthor=T.+N.+Wangauthor=P.+L.+Kuoauthor=C.+Y.+Longauthor=E.+M.+Tsai&title=A+novel+cell-penetrating+peptide+suppresses+breast+tumorigenesis+by+inhibiting+%CE%B2-catenin%2FLEF-1+signaling&doi=10.1038%2Fsrep19156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling</span></div><div class="casAuthors">Hsieh, Tsung-Hua; Hsu, Chia-Yi; Tsai, Cheng-Fang; Chiu, Chien-Chih; Liang, Shih-Shin; Wang, Tsu-Nai; Kuo, Po-Lin; Long, Cheng-Yu; Tsai, Eing-Mei</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19156</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibition of β-catenin/LEF-1 signaling is an emerging strategy in cancer therapy.  However, clin. targeted treatment of the β-catenin/LEF-1 complex remains relatively ineffective.  Therefore, development of specific mol. targets is a key approach for identifying new cancer therapeutics.  Thus, we attempted to synthesize a peptide (TAT-NLS-BLBD-6) that could interfere with the interaction of β-catenin and LEF-1 at nuclei in human breast cancer cells.  TAT-NLS-BLBD-6 directly interacted with β-catenin and inhibited breast cancer cell growth, invasion, migration, and colony formation as well as increased arrest of sub-G1 phase and apoptosis; it also suppressed breast tumor growth in nude mouse and zebrafish xenotransplantation models, showed no signs of toxicity, and did not affect body wt.  Furthermore, the human global gene expression profiles and Ingenuity Pathway Anal. software showed that the TAT-NLS-BLBD-6 downstream target genes were assocd. with the HER-2 and IL-9 signaling pathways.  TAT-NLS-BLBD-6 commonly down-regulated 27 candidate genes in MCF-7 and MDA-MB-231 cells, which are concurrent with Wnt downstream target genes in human breast cancer.  Our study suggests that TAT-NLS-BLBD-6 is a promising drug candidate for the development of effective therapeutics specific for Wnt/β-catenin signaling inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_8qz-srDyV7Vg90H21EOLACvtfcHk0lhoUy9jiBED5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsFOguw%253D%253D&md5=b1d48f8e3788cd3b4e05601357ce7fa4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fsrep19156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep19156%26sid%3Dliteratum%253Aachs%26aulast%3DHsieh%26aufirst%3DT.-H.%26aulast%3DHsu%26aufirst%3DC.%2BY.%26aulast%3DTsai%26aufirst%3DC.%2BF.%26aulast%3DChiu%26aufirst%3DC.%2BC.%26aulast%3DLiang%26aufirst%3DS.%2BS.%26aulast%3DWang%26aufirst%3DT.%2BN.%26aulast%3DKuo%26aufirst%3DP.%2BL.%26aulast%3DLong%26aufirst%3DC.%2BY.%26aulast%3DTsai%26aufirst%3DE.%2BM.%26atitle%3DA%2520novel%2520cell-penetrating%2520peptide%2520suppresses%2520breast%2520tumorigenesis%2520by%2520inhibiting%2520%25CE%25B2-catenin%252FLEF-1%2520signaling%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D19156%26epage%3D19167%26doi%3D10.1038%2Fsrep19156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rathmer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bange, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrichs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schade, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span> <span> </span><span class="NLM_article-title">Cell permeable stapled peptide inhibitor of Wnt signaling that targets β-catenin protein-protein interactions</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">968</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.06.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.chembiol.2017.06.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=28757184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1CksrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=958-968&author=L.+Dietrichauthor=B.+Rathmerauthor=K.+Ewanauthor=T.+Bangeauthor=S.+Heinrichsauthor=T.+C.+Daleauthor=D.+Schadeauthor=T.+N.+Grossmann&title=Cell+permeable+stapled+peptide+inhibitor+of+Wnt+signaling+that+targets+%CE%B2-catenin+protein-protein+interactions&doi=10.1016%2Fj.chembiol.2017.06.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Cell permeable stapled peptide inhibitor of wnt signaling that targets β-catenin protein-protein interactions</span></div><div class="casAuthors">Dietrich, Laura; Rathmer, Bernd; Ewan, Kenneth; Bange, Tanja; Heinrichs, Stefan; Dale, Trevor C.; Schade, Dennis; Grossmann, Tom N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">958-968.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Wnt signaling pathway plays a crit. role in cell proliferation and differentiation, thus it is often assocd. with diseases such as cancers.  Unfortunately, although attractive, developing anti-cancer strategy targeting Wnt signaling has been challenging given that the most attractive targets are involved in protein-protein interactions (PPIs).  Here, we develop a stapled peptide inhibitor that targets the interaction between β-catenin and T cell factor/lymphoid enhancer-binding factor transcription factors, which are crucially involved in Wnt signaling.  Our integrative approach combines peptide stapling to optimize proteolytic stability, with lessons learned from cell-penetrating peptide (CPP) design to maximize cellular uptake resulting in NLS-StAx-h, a selective, cell permeable, stapled peptide inhibitor of oncogenic Wnt signaling that efficiently inhibits β-catenin-transcription factor interactions.  We expect that this type of integrative strategy that endows stapled peptides with CPP features will be generally useful for developing inhibitors of intracellular PPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4mcl8B_B0B7Vg90H21EOLACvtfcHk0lhoUy9jiBED5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1CksrjK&md5=cbf0b96aab1e21c298b9a6d22b7f05d1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.06.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.06.013%26sid%3Dliteratum%253Aachs%26aulast%3DDietrich%26aufirst%3DL.%26aulast%3DRathmer%26aufirst%3DB.%26aulast%3DEwan%26aufirst%3DK.%26aulast%3DBange%26aufirst%3DT.%26aulast%3DHeinrichs%26aufirst%3DS.%26aulast%3DDale%26aufirst%3DT.%2BC.%26aulast%3DSchade%26aufirst%3DD.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26atitle%3DCell%2520permeable%2520stapled%2520peptide%2520inhibitor%2520of%2520Wnt%2520signaling%2520that%2520targets%2520%25CE%25B2-catenin%2520protein-protein%2520interactions%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D958%26epage%3D968%26doi%3D10.1016%2Fj.chembiol.2017.06.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craven, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugbro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svetlov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nudler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knaut, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garabedian, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirshenbaum, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, S. K.</span></span> <span> </span><span class="NLM_article-title">Design of peptoid-peptide macrocycles to inhibit the β-catenin TCF interaction in prostate cancer</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">4396</span>– <span class="NLM_lpage">4405</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-06845-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fs41467-018-06845-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=30352998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A280%3ADC%252BB3cvisFSlug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=4396-4405&author=J.+A.+Schneiderauthor=T.+W.+Cravenauthor=A.+C.+Kasperauthor=C.+Yunauthor=M.+Haugbroauthor=E.+M.+Briggsauthor=V.+Svetlovauthor=E.+Nudlerauthor=H.+Knautauthor=R.+Bonneauauthor=M.+J.+Garabedianauthor=K.+Kirshenbaumauthor=S.+K.+Logan&title=Design+of+peptoid-peptide+macrocycles+to+inhibit+the+%CE%B2-catenin+TCF+interaction+in+prostate+cancer&doi=10.1038%2Fs41467-018-06845-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer</span></div><div class="casAuthors">Schneider Jeffrey A; Briggs Erica M; Garabedian Michael J; Logan Susan K; Craven Timothy W; Kasper Amanda C; Haugbro Michael; Kirshenbaum Kent; Craven Timothy W; Bonneau Richard; Yun Chi; Knaut Holger; Briggs Erica M; Svetlov Vladimir; Nudler Evgeny; Logan Susan K; Svetlov Vladimir; Nudler Evgeny; Garabedian Michael J</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4396</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">New chemical inhibitors of protein-protein interactions are needed to propel advances in molecular pharmacology.  Peptoids are peptidomimetic oligomers with the capability to inhibit protein-protein interactions by mimicking protein secondary structure motifs.  Here we report the in silico design of a macrocycle primarily composed of peptoid subunits that targets the β-catenin:TCF interaction.  The β-catenin:TCF interaction plays a critical role in the Wnt signaling pathway which is over-activated in multiple cancers, including prostate cancer.  Using the Rosetta suite of protein design algorithms, we evaluate how different macrocycle structures can bind a pocket on β-catenin that associates with TCF.  The in silico designed macrocycles are screened in vitro using luciferase reporters to identify promising compounds.  The most active macrocycle inhibits both Wnt and AR-signaling in prostate cancer cell lines, and markedly diminishes their proliferation.  In vivo potential is demonstrated through a zebrafish model, in which Wnt signaling is potently inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScmbQ8u9AhUDToTC3aBaesfW6udTcc2eaMYgohBzMVrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvisFSlug%253D%253D&md5=1c04088452bbaf704ced21bf03541253</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-06845-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-06845-3%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DCraven%26aufirst%3DT.%2BW.%26aulast%3DKasper%26aufirst%3DA.%2BC.%26aulast%3DYun%26aufirst%3DC.%26aulast%3DHaugbro%26aufirst%3DM.%26aulast%3DBriggs%26aufirst%3DE.%2BM.%26aulast%3DSvetlov%26aufirst%3DV.%26aulast%3DNudler%26aufirst%3DE.%26aulast%3DKnaut%26aufirst%3DH.%26aulast%3DBonneau%26aufirst%3DR.%26aulast%3DGarabedian%26aufirst%3DM.%2BJ.%26aulast%3DKirshenbaum%26aufirst%3DK.%26aulast%3DLogan%26aufirst%3DS.%2BK.%26atitle%3DDesign%2520of%2520peptoid-peptide%2520macrocycles%2520to%2520inhibit%2520the%2520%25CE%25B2-catenin%2520TCF%2520interaction%2520in%2520prostate%2520cancer%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D4396%26epage%3D4405%26doi%3D10.1038%2Fs41467-018-06845-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillard, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Rational design of small-molecule inhibitors for β-catenin/T-cell factor protein-protein interactions by bioisostere replacement</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1021/cb300564v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300564v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=524-529&author=B.+Yuauthor=Z.+Huangauthor=M.+Zhangauthor=D.+R.+Dillardauthor=H.+Ji&title=Rational+design+of+small-molecule+inhibitors+for+%CE%B2-catenin%2FT-cell+factor+protein-protein+interactions+by+bioisostere+replacement&doi=10.1021%2Fcb300564v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcb300564v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300564v%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DDillard%26aufirst%3DD.%2BR.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DRational%2520design%2520of%2520small-molecule%2520inhibitors%2520for%2520%25CE%25B2-catenin%252FT-cell%2520factor%2520protein-protein%2520interactions%2520by%2520bioisostere%2520replacement%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D524%26epage%3D529%26doi%3D10.1021%2Fcb300564v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsakhyan, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Targeting the Tcf4 G<sup>13</sup>ANDE<sup>17</sup> binding site to selectively disrupt β-catenin/T-cell factor protein-protein interactions</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">201</span>, <span class="refDoi"> DOI: 10.1021/cb400795x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400795x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWrtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=193-201&author=Z.+Huangauthor=M.+Zhangauthor=S.+D.+Burtonauthor=L.+N.+Katsakhyanauthor=H.+Ji&title=Targeting+the+Tcf4+G13ANDE17+binding+site+to+selectively+disrupt+%CE%B2-catenin%2FT-cell+factor+protein-protein+interactions&doi=10.1021%2Fcb400795x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Tcf4 G13ANDE17 Binding Site To Selectively Disrupt β-Catenin/T-Cell Factor Protein-Protein Interactions</span></div><div class="casAuthors">Huang, Zheng; Zhang, Min; Burton, Shawn D.; Katsakhyan, Levon N.; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-201</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective disruption of protein-protein interactions by small mols. is important for probing the structure and dynamic aspects of cellular network.  It can also provide new therapeutic targets. β-Catenin of the canonical Wnt signaling pathway uses the same pos. charged groove to bind with T-cell factor (Tcf), cadherin, and adenomatous polysis coli (APC).  The extravagant formation of β-catenin/Tcf interactions drives the initiation and progression of many cancers and fibroses, while β-catenin/cadherin and β-catenin/APC interactions are essential for cell-cell adhesion and β-catenin degrdn.  In this study, a selective binding site that can differentiate β-catenin/Tcf, β-catenin/cadherin, and β-catenin/APC interactions was identified by alanine scanning and biochem. assays.  A new peptidomimetic strategy that incorporates SiteMap and multiple-copy simultaneous search was used to design selective small-mol. inhibitors for β-catenin/Tcf interactions.  A potent inhibitor was discovered to bind with β-catenin and completely disrupt β-catenin/Tcf interactions.  It also exhibits dual selectivity for β-catenin/Tcf over β-catenin/cadherin and β-catenin/APC interactions in both biochem. and cell-based assays.  This study provides a proof of concept for designing selective inhibitors for β-catenin/Tcf interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNcaw5jsvhZbVg90H21EOLACvtfcHk0lj_IgQChf8rvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWrtb%252FN&md5=9f59f92f44e5b6cd486d351bd0bf77c6</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fcb400795x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400795x%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DBurton%26aufirst%3DS.%2BD.%26aulast%3DKatsakhyan%26aufirst%3DL.%2BN.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DTargeting%2520the%2520Tcf4%2520G13ANDE17%2520binding%2520site%2520to%2520selectively%2520disrupt%2520%25CE%25B2-catenin%252FT-cell%2520factor%2520protein-protein%2520interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D193%26epage%3D201%26doi%3D10.1021%2Fcb400795x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Catrow, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective small-molecule inhibitors for the β-catenin/T-cell factor protein-protein interaction through the optimization of the acyl hydrazone moiety</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4678</span>– <span class="NLM_lpage">4692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00223</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00223" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosFakt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4678-4692&author=J.+L.+Catrowauthor=Y.+Zhangauthor=M.+Zhangauthor=H.+Ji&title=Discovery+of+selective+small-molecule+inhibitors+for+the+%CE%B2-catenin%2FT-cell+factor+protein-protein+interaction+through+the+optimization+of+the+acyl+hydrazone+moiety&doi=10.1021%2Facs.jmedchem.5b00223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction through the Optimization of the Acyl Hydrazone Moiety</span></div><div class="casAuthors">Catrow, J. Leon; Zhang, Yongqiang; Zhang, Min; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4678-4692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyl hydrazone is an important functional group for the discovery of bioactive small mols.  This functional group is also recognized as a pan assay interference structure.  In this study, a new small-mol. inhibitor for the β-catenin/Tcf protein-protein interaction (PPI), ZINC02092166, was identified through AlphaScreen and FP assays.  This compd. contains an acyl hydrazone group and exhibits higher inhibitory activities in cell-based assays than biochem. assays.  Inhibitor optimization resulted in chem. stable derivs. that disrupt the β-catenin/Tcf PPI.  The binding mode of new inhibitors was characterized by site-directed mutagenesis and structure-activity relationship studies.  This series of inhibitors with a new scaffold exhibits dual selectivity for β-catenin/Tcf over β-catenin/cadherin and β-catenin/APC PPIs.  One deriv. of this series suppresses canonical Wnt signaling, downregulates the expression of Wnt target genes, and inhibits the growth of cancer cells.  This compd. represents a solid starting point for the development of potent and selective β-catenin/Tcf inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqusdU2c6KIQLVg90H21EOLACvtfcHk0lh6F2w6oxhM7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosFakt7o%253D&md5=11aa0209009144341d692c4cf6966790</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00223%26sid%3Dliteratum%253Aachs%26aulast%3DCatrow%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520selective%2520small-molecule%2520inhibitors%2520for%2520the%2520%25CE%25B2-catenin%252FT-cell%2520factor%2520protein-protein%2520interaction%2520through%2520the%2520optimization%2520of%2520the%2520acyl%2520hydrazone%2520moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4678%26epage%3D4692%26doi%3D10.1021%2Facs.jmedchem.5b00223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Sa Alves, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manssour Fraga, C.</span></span> <span> </span><span class="NLM_article-title">From nature to drug discovery: the indole scaffold as a “privileged structure”</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">793</span>, <span class="refDoi"> DOI: 10.2174/138955709788452649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.2174%2F138955709788452649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=19519503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A280%3ADC%252BD1MvhtlymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=782-793&author=F.+de%0ASa+Alvesauthor=E.+Barreiroauthor=C.+Manssour+Fraga&title=From+nature+to+drug+discovery%3A+the+indole+scaffold+as+a+%E2%80%9Cprivileged+structure%E2%80%9D&doi=10.2174%2F138955709788452649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">From nature to drug discovery: the indole scaffold as a 'privileged structure'</span></div><div class="casAuthors">de Sa Alves Fernando Rodrigues; Barreiro Eliezer J; Fraga Carlos Alberto Manssour</div><div class="citationInfo"><span class="NLM_cas:title">Mini reviews in medicinal chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">782-93</span>
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    </div><div class="casAbstract">The indole scaffold probably represents one of the most important structural subunits for the discovery of new drug candidates.  The demonstration that many alkaloids contain the indole nucleus, the recognition of the importance of essential amino acid tryptophan in human nutrition and the discovery of plant hormones served to bring about a massive search on indole chemistry, giving rise to a vast number of biologically active natural and synthetic products, with a wide range of therapeutic targets, such as anti-inflammatories, phosphodiesterase inhibitors, 5-hydroxytryptamine receptor agonists and antagonists, cannabinoid receptors agonists and HMG-CoA reductase inhibitors.  Many of these target-receptors belong to the class of GPCRs (integral membrane G-protein coupled receptors) and possess a conserved binding pocket that is recognized by the indole scaffold in a "common" complementary binding domain, explaining the great number of drugs that contain the indole substructure, such as indomethacin, ergotamine, frovatriptan, ondansetron, tadalafil, among many others.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTBKUu7YDCtEQWRJ3OJdH_qfW6udTcc2eY4082RIXWug7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvhtlymtQ%253D%253D&md5=34fa9e3785856259b4486d57af2e75ee</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F138955709788452649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955709788452649%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BSa%2BAlves%26aufirst%3DF.%26aulast%3DBarreiro%26aufirst%3DE.%26aulast%3DManssour%2BFraga%26aufirst%3DC.%26atitle%3DFrom%2520nature%2520to%2520drug%2520discovery%253A%2520the%2520indole%2520scaffold%2520as%2520a%2520%25E2%2580%259Cprivileged%2520structure%25E2%2580%259D%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D782%26epage%3D793%26doi%3D10.2174%2F138955709788452649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sravanthi, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manju, S. L.</span></span> <span> </span><span class="NLM_article-title">Indoles - a promising scaffold for drug development</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2016.05.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ejps.2016.05.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=27237590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28Xps1ShsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2016&pages=1-10&author=T.+V.+Sravanthiauthor=S.+L.+Manju&title=Indoles+-+a+promising+scaffold+for+drug+development&doi=10.1016%2Fj.ejps.2016.05.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Indoles - A promising scaffold for drug development</span></div><div class="casAuthors">Sravanthi, T. V.; Manju, S. L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Generally, heterocycles occupy a prominent place in chem. due to their wide range of applications in the fields of drug design, photochem., agrochems., dyes and so on.  Among them, indole scaffolds have been found in most of the important synthetic drug mols. and paved a faithful way to develop effective targets.  Privileged structures bind to multiple receptors with high affinity, thus aiding the development of novel biol. active compds.  Among the indole class of compds., 2-arylindoles appear to be a most promising lead for drug development.  The derivs. of 2-arylindoles exhibits antibacterial, anticancer, anti-oxidants, anti-inflammatory, anti-diabetic, antiviral, antiproliferative, antituberculosis activity, etc.  This article would provide a clear knowledge on the wide-ranging biol. activities of 2-arylindoles over the past two decades, which would be beneficial for the designing of more potent drug targets in order to compete with the existing drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHUcvfxzoNJ7Vg90H21EOLACvtfcHk0lh6F2w6oxhM7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xps1ShsL0%253D&md5=b32d3300238020d5b95dbf5fbcab7509</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2016.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2016.05.025%26sid%3Dliteratum%253Aachs%26aulast%3DSravanthi%26aufirst%3DT.%2BV.%26aulast%3DManju%26aufirst%3DS.%2BL.%26atitle%3DIndoles%2520-%2520a%2520promising%2520scaffold%2520for%2520drug%2520development%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D91%26spage%3D1%26epage%3D10%26doi%3D10.1016%2Fj.ejps.2016.05.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banoglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, R. S.</span></span> <span> </span><span class="NLM_article-title">Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate</span>. <i>Eur. J. Drug Metab. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1007/bf03226377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1007%2Fbf03226377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=11808865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtlKmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2001&pages=235-240&author=E.+Banogluauthor=G.+G.+Jhaauthor=R.+S.+King&title=Hepatic+microsomal+metabolism+of+indole+to+indoxyl%2C+a+precursor+of+indoxyl+sulfate&doi=10.1007%2Fbf03226377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate</span></div><div class="casAuthors">Banoglu, Erden; Jha, Gautam G.; King, Roberta S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Drug Metabolism and Pharmacokinetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-240</span>CODEN:
                <span class="NLM_cas:coden">EJDPD2</span>;
        ISSN:<span class="NLM_cas:issn">0378-7966</span>.
    
            (<span class="NLM_cas:orgname">Medecine et Hygiene</span>)
        </div><div class="casAbstract">The aim of our study was to det. which microsomal cytochrome P 450 isoenzyme(s) were responsible for the microsomal oxidn. of indole to indoxyl, an important intermediate in the information of the uremic toxin indoxyl sulfate.  Indole was incubated together with an NADPH - generating system and rat liver microsomes.  Formation of indigo, an auto-oxidn. product of indoxyl, was used to det. the indole-3-hydroxylation activity.  Apparent Km and Vmax values of 0.85 mM and 1152 pmol min-1 mg-1 were calcd. for the formation of indoxyl from indole using rat liver microsomes.  The effects of various potential inducers and inhibitors on the metab. of indole to indoxyl by rat liver microsomes were studied to elucidate the enzymes responsible for metab.  Studies with general and isoenzyme-specific P 450 inhibitors demonstrated that P 450 enzymes and not FMO are responsible for the formation of indoxyl.  In the induction studies, rate of indoxyl formation in the microsomes from untreated vs. induced rats correlated nearly exactly with the CYP2E1 activity (4-nitrophenol 2-hydroxylation).  These results suggests that CYP2E1 is the major isoform for the microsomal oxidn. of indole to indoxyl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobdrwvJ8pFf7Vg90H21EOLACvtfcHk0lh6F2w6oxhM7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtlKmt7w%253D&md5=b09209999ef01cf1fd48393cb4992119</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1007%2Fbf03226377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fbf03226377%26sid%3Dliteratum%253Aachs%26aulast%3DBanoglu%26aufirst%3DE.%26aulast%3DJha%26aufirst%3DG.%2BG.%26aulast%3DKing%26aufirst%3DR.%2BS.%26atitle%3DHepatic%2520microsomal%2520metabolism%2520of%2520indole%2520to%2520indoxyl%252C%2520a%2520precursor%2520of%2520indoxyl%2520sulfate%26jtitle%3DEur.%2520J.%2520Drug%2520Metab.%2520Pharmacokinet.%26date%3D2001%26volume%3D26%26spage%3D235%26epage%3D240%26doi%3D10.1007%2Fbf03226377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kondreddi, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camacho, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bifani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">8849</span>– <span class="NLM_lpage">8859</span>, <span class="refDoi"> DOI: 10.1021/jm4012774</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4012774" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOisLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8849-8859&author=R.+R.+Kondreddiauthor=J.+Jiricekauthor=S.+P.+S.+Raoauthor=S.+B.+Lakshminarayanaauthor=L.+R.+Camachoauthor=R.+Raoauthor=M.+Herveauthor=P.+Bifaniauthor=N.+L.+Maauthor=K.+Kuhenauthor=A.+Gohauthor=A.+K.+Chatterjeeauthor=T.+Dickauthor=T.+T.+Diaganaauthor=U.+H.+Manjunathaauthor=P.+W.+Smith&title=Design%2C+synthesis%2C+and+biological+evaluation+of+indole-2-carboxamides%3A+a+promising+class+of+antituberculosis+agents&doi=10.1021%2Fjm4012774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides: A Promising Class of Antituberculosis Agents</span></div><div class="casAuthors">Kondreddi, Ravinder Reddy; Jiricek, Jan; Rao, Srinivasa P. S.; Lakshminarayana, Suresh B.; Camacho, Luis R.; Rao, Ranga; Herve, Maxime; Bifani, Pablo; Ma, Ngai Ling; Kuhen, Kelli; Goh, Anne; Chatterjee, Arnab K.; Dick, Thomas; Diagana, Thierry T.; Manjunatha, Ujjini H.; Smith, Paul W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8849-8859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Indole-2-carboxamides have been identified as a promising class of antituberculosis agents from phenotypic screening against mycobacteria.  One of the hits, indole-2-carboxamide analog (I), had low micromolar potency against Mycobacterium tuberculosis (Mtb), high mouse liver microsomal clearance, and low aq. soly.  Structure-activity relationship studies revealed that attaching alkyl groups to the cyclohexyl ring significantly improved Mtb activity but reduced soly.  Furthermore, chloro, fluoro, or cyano substitutions on the 4- and 6-positions of the indole ring as well as Me substitution on the cyclohexyl ring significantly improved metabolic stability.  II and III, the lead candidates, displayed improved in vitro activity compared to most of the current std. TB drugs.  The low aq. soly. could not be mitigated because of the pos. correlation of lipophilicity with Mtb potency.  However, both compds. displayed favorable oral pharmacokinetic properties in rodents and demonstrated in vivo efficacy.  Thus, indole-2-carboxamides represent a promising new class of antituberculosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4KW8om-6fZ7Vg90H21EOLACvtfcHk0lh7DtP_jeoQgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOisLjL&md5=ab732bc84632b1f9f364e45610bcbc1b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm4012774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4012774%26sid%3Dliteratum%253Aachs%26aulast%3DKondreddi%26aufirst%3DR.%2BR.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DCamacho%26aufirst%3DL.%2BR.%26aulast%3DRao%26aufirst%3DR.%26aulast%3DHerve%26aufirst%3DM.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DMa%26aufirst%3DN.%2BL.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGoh%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DDick%26aufirst%3DT.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520indole-2-carboxamides%253A%2520a%2520promising%2520class%2520of%2520antituberculosis%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8849%26epage%3D8859%26doi%3D10.1021%2Fjm4012774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piscitelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligresti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Regina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coluccia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allarà, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestri, R.</span></span> <span> </span><span class="NLM_article-title">Indole-2-carboxamides as allosteric modulators of the cannabinoid CB(1) receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5627</span>– <span class="NLM_lpage">5631</span>, <span class="refDoi"> DOI: 10.1021/jm201485c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201485c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5627-5631&author=F.+Piscitelliauthor=A.+Ligrestiauthor=G.+La+Reginaauthor=A.+Colucciaauthor=L.+Moreraauthor=M.+Allar%C3%A0author=E.+Novellinoauthor=V.+Di+Marzoauthor=R.+Silvestri&title=Indole-2-carboxamides+as+allosteric+modulators+of+the+cannabinoid+CB%281%29+receptor&doi=10.1021%2Fjm201485c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm201485c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201485c%26sid%3Dliteratum%253Aachs%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DLigresti%26aufirst%3DA.%26aulast%3DLa%2BRegina%26aufirst%3DG.%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DMorera%26aufirst%3DL.%26aulast%3DAllar%25C3%25A0%26aufirst%3DM.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DIndole-2-carboxamides%2520as%2520allosteric%2520modulators%2520of%2520the%2520cannabinoid%2520CB%25281%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5627%26epage%3D5631%26doi%3D10.1021%2Fjm201485c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ban, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munuganti, R. S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frewin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rennie, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherkasov, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1H-indole-2-carboxamides as novel inhibitors of the androgen receptor binding function 3 (BF3)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6867</span>– <span class="NLM_lpage">6872</span>, <span class="refDoi"> DOI: 10.1021/jm500684r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500684r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6867-6872&author=F.+Banauthor=E.+Leblancauthor=H.+Liauthor=R.+S.+N.+Munugantiauthor=K.+Frewinauthor=P.+S.+Rennieauthor=A.+Cherkasov&title=Discovery+of+1H-indole-2-carboxamides+as+novel+inhibitors+of+the+androgen+receptor+binding+function+3+%28BF3%29&doi=10.1021%2Fjm500684r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1H-Indole-2-carboxamides as Novel Inhibitors of the Androgen Receptor Binding Function 3 (BF3)</span></div><div class="casAuthors">Ban, Fuqiang; Leblanc, Eric; Li, Huifang; Munuganti, Ravi S. N.; Frewin, Kate; Rennie, Paul S.; Cherkasov, Artem</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6867-6872</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To overcome resistance to conventional antiandrogens of human androgen receptor (AR), the allosteric site of the AR binding function 3 (BF3) was investigated as an alternative target for small mol. therapeutics.  A library of 1H-indole-2-carboxamides were discovered as BF3 inhibitors and exhibited strong antiproliferative activity against LNCaP and enzalutamide-resistant prostate cancer cell lines.  Several of the lead compds. may prove of particular benefit as a novel alternative treatment for castration-resistant prostate cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTICfYB_78jbVg90H21EOLACvtfcHk0lh7DtP_jeoQgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCrtLrN&md5=e19e2284afd93d3957e77a63a8f0f146</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm500684r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500684r%26sid%3Dliteratum%253Aachs%26aulast%3DBan%26aufirst%3DF.%26aulast%3DLeblanc%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DMunuganti%26aufirst%3DR.%2BS.%2BN.%26aulast%3DFrewin%26aufirst%3DK.%26aulast%3DRennie%26aufirst%3DP.%2BS.%26aulast%3DCherkasov%26aufirst%3DA.%26atitle%3DDiscovery%2520of%25201H-indole-2-carboxamides%2520as%2520novel%2520inhibitors%2520of%2520the%2520androgen%2520receptor%2520binding%2520function%25203%2520%2528BF3%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6867%26epage%3D6872%26doi%3D10.1021%2Fjm500684r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stec, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onajole, O. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merenbloom, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishai, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Indole-2-carboxamide-based MmpL3 inhibitors show exceptional antitubercular activity in an animal model of tuberculosis infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6232</span>– <span class="NLM_lpage">6247</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00415</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00415" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsVCltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6232-6247&author=J.+Stecauthor=O.+K.+Onajoleauthor=S.+Lunauthor=H.+Guoauthor=B.+Merenbloomauthor=G.+Vistoliauthor=W.+R.+Bishaiauthor=A.+P.+Kozikowski&title=Indole-2-carboxamide-based+MmpL3+inhibitors+show+exceptional+antitubercular+activity+in+an+animal+model+of+tuberculosis+infection&doi=10.1021%2Facs.jmedchem.6b00415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection</span></div><div class="casAuthors">Stec, Jozef; Onajole, Oluseye K.; Lun, Shichun; Guo, Haidan; Merenbloom, Benjamin; Vistoli, Giulio; Bishai, William R.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6232-6247</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Our team had previously identified certain indolecarboxamides that represented a new chem. scaffold that showed promising anti-TB activity at both an in vitro and in vivo level.  Based on mutational anal. using bacteria found resistant to one of these indolecarboxamides, we identified the trehalose monomycolate transporter MmpL3 as the likely target of these compds.  In the present work, we now further elaborate on the SAR of these compds., which has led in turn to the identification of a new analog, 4,6-difluoro-N-((1R,2R,3R,5S)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl)-1H-indole-2-carboxamide (26), that shows excellent activity against drug-sensitive (MIC = 0.012 μM; SI ≥ 16000), multidrug-resistant (MDR), and extensively drug-resistant (XDR) Mycobacterium tuberculosis strains, has superior ADMET properties, and shows excellent activity in the TB aerosol lung infection model.  Compd. 26 is also shown to work in synergy with rifampin.  Because of these properties, we believe that indolecarboxamide 26 is a possible candidate for advancement to human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg0h9TR-VL5rVg90H21EOLACvtfcHk0lizYGmEYD50Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsVCltb8%253D&md5=f9e3d545a65f85deb3f97054dca77c1f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00415%26sid%3Dliteratum%253Aachs%26aulast%3DStec%26aufirst%3DJ.%26aulast%3DOnajole%26aufirst%3DO.%2BK.%26aulast%3DLun%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DMerenbloom%26aufirst%3DB.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DBishai%26aufirst%3DW.%2BR.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DIndole-2-carboxamide-based%2520MmpL3%2520inhibitors%2520show%2520exceptional%2520antitubercular%2520activity%2520in%2520an%2520animal%2520model%2520of%2520tuberculosis%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6232%26epage%3D6247%26doi%3D10.1021%2Facs.jmedchem.6b00415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">New homogeneous high-throughput assays for inhibitors of β-catenin/Tcf protein-protein interactions</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>424</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2012.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.ab.2012.02.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2012&pages=57-63&author=M.+Zhangauthor=Z.+Huangauthor=B.+Yuauthor=H.+Ji&title=New+homogeneous+high-throughput+assays+for+inhibitors+of+%CE%B2-catenin%2FTcf+protein-protein+interactions&doi=10.1016%2Fj.ab.2012.02.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2012.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2012.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DNew%2520homogeneous%2520high-throughput%2520assays%2520for%2520inhibitors%2520of%2520%25CE%25B2-catenin%252FTcf%2520protein-protein%2520interactions%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D424%26spage%3D57%26epage%3D63%26doi%3D10.1016%2Fj.ab.2012.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liljebris, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazuk, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleasdale, J. E.</span></span> <span> </span><span class="NLM_article-title">Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: identification of a tetrazole-containing inhibitor with cellular activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1785</span>– <span class="NLM_lpage">1798</span>, <span class="refDoi"> DOI: 10.1021/jm011100y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011100y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1785-1798&author=C.+Liljebrisauthor=S.+D.+Larsenauthor=D.+Oggauthor=B.+J.+Palazukauthor=J.+E.+Bleasdale&title=Investigation+of+potential+bioisosteric+replacements+for+the+carboxyl+groups+of+peptidomimetic+inhibitors+of+protein+tyrosine+phosphatase+1B%3A+identification+of+a+tetrazole-containing+inhibitor+with+cellular+activity&doi=10.1021%2Fjm011100y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm011100y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011100y%26sid%3Dliteratum%253Aachs%26aulast%3DLiljebris%26aufirst%3DC.%26aulast%3DLarsen%26aufirst%3DS.%2BD.%26aulast%3DOgg%26aufirst%3DD.%26aulast%3DPalazuk%26aufirst%3DB.%2BJ.%26aulast%3DBleasdale%26aufirst%3DJ.%2BE.%26atitle%3DInvestigation%2520of%2520potential%2520bioisosteric%2520replacements%2520for%2520the%2520carboxyl%2520groups%2520of%2520peptidomimetic%2520inhibitors%2520of%2520protein%2520tyrosine%2520phosphatase%25201B%253A%2520identification%2520of%2520a%2520tetrazole-containing%2520inhibitor%2520with%2520cellular%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1785%26epage%3D1798%26doi%3D10.1021%2Fjm011100y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepourcelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivdasani, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span> <span> </span><span class="NLM_article-title">Structure of a human Tcf4-β-catenin complex</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1053</span>– <span class="NLM_lpage">1057</span>, <span class="refDoi"> DOI: 10.1038/nsb720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnsb720" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=1053-1057&author=F.+Poyauthor=M.+Lepourceletauthor=R.+A.+Shivdasaniauthor=M.+J.+Eck&title=Structure+of+a+human+Tcf4-%CE%B2-catenin+complex&doi=10.1038%2Fnsb720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnsb720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb720%26sid%3Dliteratum%253Aachs%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DLepourcelet%26aufirst%3DM.%26aulast%3DShivdasani%26aufirst%3DR.%2BA.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DStructure%2520of%2520a%2520human%2520Tcf4-%25CE%25B2-catenin%2520complex%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D1053%26epage%3D1057%26doi%3D10.1038%2Fnsb720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Graham, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferkey, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimelman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span> <span> </span><span class="NLM_article-title">Tcf4 can specifically recognize β-catenin using alternative conformations</span>. <i>Nat. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1048</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1038/nsb718</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnsb718" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=1048-1052&author=T.+A.+Grahamauthor=D.+M.+Ferkeyauthor=F.+Maoauthor=D.+Kimelmanauthor=W.+Xu&title=Tcf4+can+specifically+recognize+%CE%B2-catenin+using+alternative+conformations&doi=10.1038%2Fnsb718"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnsb718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb718%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DT.%2BA.%26aulast%3DFerkey%26aufirst%3DD.%2BM.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DKimelman%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DTcf4%2520can%2520specifically%2520recognize%2520%25CE%25B2-catenin%2520using%2520alternative%2520conformations%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D8%26spage%3D1048%26epage%3D1052%26doi%3D10.1038%2Fnsb718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sampietro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlberg, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimelman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a β-catenin/BCL9/Tcf4 complex</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2006.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.molcel.2006.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=17052462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtF2rs7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=293-300&author=J.+Sampietroauthor=C.+L.+Dahlbergauthor=U.+S.+Choauthor=T.+R.+Hindsauthor=D.+Kimelmanauthor=W.+Xu&title=Crystal+structure+of+a+%CE%B2-catenin%2FBCL9%2FTcf4+complex&doi=10.1016%2Fj.molcel.2006.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a β-catenin/BCL9/Tcf4 complex</span></div><div class="casAuthors">Sampietro, James; Dahlberg, Caroline L.; Cho, Uhn Soo; Hinds, Thomas R.; Kimelman, David; Xu, Wenqing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">293-300</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The canonical Wnt pathway plays crit. roles in embryonic development, stem cell growth, and tumorigenesis.  Stimulation of the Wnt pathway leads to the assocn. of β-catenin with Tcf and BCL9 in the nucleus, resulting in the transactivation of Wnt target genes.  We have detd. the crystal structure of a β-catenin/BCL9/Tcf-4 triple complex at 2.6 Å resoln.  Our studies reveal that the β-catenin binding site of BCL9 is distinct from that of most other β-catenin partners and forms a good target for developing drugs that block canonical Wnt/β-catenin signaling.  The BCL9 β-catenin binding domain (CBD) forms an α helix that binds to the first armadillo repeat of β-catenin, which can be mutated to prevent β-catenin binding to BCL9 without affecting cadherin or α-catenin binding.  We also demonstrate that β-catenin Y142 phosphorylation, which has been proposed to regulate BCL9-2 binding, does not directly affect the interaction of β-catenin with either BCL9 or BCL9-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyhIEzcTKHQbVg90H21EOLACvtfcHk0lizYGmEYD50Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtF2rs7%252FF&md5=493e9271912b304915e8371b87d2a9b9</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2006.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2006.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DSampietro%26aufirst%3DJ.%26aulast%3DDahlberg%26aufirst%3DC.%2BL.%26aulast%3DCho%26aufirst%3DU.%2BS.%26aulast%3DHinds%26aufirst%3DT.%2BR.%26aulast%3DKimelman%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DCrystal%2520structure%2520of%2520a%2520%25CE%25B2-catenin%252FBCL9%252FTcf4%2520complex%26jtitle%3DMol.%2520Cell%26date%3D2006%26volume%3D24%26spage%3D293%26epage%3D300%26doi%3D10.1016%2Fj.molcel.2006.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">Biochemical and structural characterization of β-catenin interactions with nonphosphorylated and CK2-phosphorylated Lef-1</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>405</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2010.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.jmb.2010.11.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=405&publication_year=2011&pages=519-530&author=J.+Sunauthor=W.+I.+Weis&title=Biochemical+and+structural+characterization+of+%CE%B2-catenin+interactions+with+nonphosphorylated+and+CK2-phosphorylated+Lef-1&doi=10.1016%2Fj.jmb.2010.11.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DBiochemical%2520and%2520structural%2520characterization%2520of%2520%25CE%25B2-catenin%2520interactions%2520with%2520nonphosphorylated%2520and%2520CK2-phosphorylated%2520Lef-1%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D405%26spage%3D519%26epage%3D530%26doi%3D10.1016%2Fj.jmb.2010.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">391</span>– <span class="NLM_lpage">402</span>, <span class="refDoi"> DOI: 10.1016/s0092-8674(01)00330-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fs0092-8674%2801%2900330-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=11348595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjs1ait74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2001&pages=391-402&author=A.+H.+Huberauthor=W.+I.+Weis&title=The+structure+of+the+%CE%B2-catenin%2FE-cadherin+complex+and+the+molecular+basis+of+diverse+ligand+recognition+by+beta-catenin&doi=10.1016%2Fs0092-8674%2801%2900330-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin</span></div><div class="casAuthors">Huber, Andrew H.; Weis, William I.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">391-402</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">As a component of adherens junctions and the Wnt signaling pathway, β-catenin binds cadherins, Tcf family transcription factors, and the tumor suppressor APC.  We have detd. the crystal structures of both unphosphorylated and phosphorylated E-cadherin cytoplasmic domain complexed with the arm repeat region of β-catenin.  The interaction spans all 12 arm repeats, and features quasi-independent binding regions that include helixes which interact with both ends of the arm repeat domain and an extended stretch of 14 residues which closely resembles a portion of XTcf-3.  Phosphorylation of E-cadherin results in interactions with a hydrophobic patch of β-catenin that mimics the binding of an amphipathic XTcf-3 helix.  APC contains sequences homologous to the phosphorylated region of cadherin, and is likely to bind similarly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3EHT0byAbaLVg90H21EOLACvtfcHk0ljlqTQaRRNavQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjs1ait74%253D&md5=e1264790de237cd912acbece8621c7d0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fs0092-8674%2801%2900330-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0092-8674%252801%252900330-0%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DA.%2BH.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DThe%2520structure%2520of%2520the%2520%25CE%25B2-catenin%252FE-cadherin%2520complex%2520and%2520the%2520molecular%2520basis%2520of%2520diverse%2520ligand%2520recognition%2520by%2520beta-catenin%26jtitle%3DCell%26date%3D2001%26volume%3D105%26spage%3D391%26epage%3D402%26doi%3D10.1016%2Fs0092-8674%2801%2900330-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spink, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of β-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-β-catenin complex</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6203</span>– <span class="NLM_lpage">6212</span>, <span class="refDoi"> DOI: 10.1093/emboj/20.22.6203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1093%2Femboj%2F20.22.6203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=6203-6212&author=K.+E.+Spinkauthor=S.+G.+Fridmanauthor=W.+I.+Weis&title=Molecular+mechanisms+of+%CE%B2-catenin+recognition+by+adenomatous+polyposis+coli+revealed+by+the+structure+of+an+APC-%CE%B2-catenin+complex&doi=10.1093%2Femboj%2F20.22.6203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.22.6203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.22.6203%26sid%3Dliteratum%253Aachs%26aulast%3DSpink%26aufirst%3DK.%2BE.%26aulast%3DFridman%26aufirst%3DS.%2BG.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DMolecular%2520mechanisms%2520of%2520%25CE%25B2-catenin%2520recognition%2520by%2520adenomatous%2520polyposis%2520coli%2520revealed%2520by%2520the%2520structure%2520of%2520an%2520APC-%25CE%25B2-catenin%2520complex%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D6203%26epage%3D6212%26doi%3D10.1093%2Femboj%2F20.22.6203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ha, N.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonozuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">Mechanism of phosphorylation-dependent binding of APC to β-catenin and its role in β-catenin degradation</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2004.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.molcel.2004.08.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=511-521&author=N.-C.+Haauthor=T.+Tonozukaauthor=J.+L.+Stamosauthor=H.-J.+Choiauthor=W.+I.+Weis&title=Mechanism+of+phosphorylation-dependent+binding+of+APC+to+%CE%B2-catenin+and+its+role+in+%CE%B2-catenin+degradation&doi=10.1016%2Fj.molcel.2004.08.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DHa%26aufirst%3DN.-C.%26aulast%3DTonozuka%26aufirst%3DT.%26aulast%3DStamos%26aufirst%3DJ.%2BL.%26aulast%3DChoi%26aufirst%3DH.-J.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DMechanism%2520of%2520phosphorylation-dependent%2520binding%2520of%2520APC%2520to%2520%25CE%25B2-catenin%2520and%2520its%2520role%2520in%2520%25CE%25B2-catenin%2520degradation%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D15%26spage%3D511%26epage%3D521%26doi%3D10.1016%2Fj.molcel.2004.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Trong, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinds, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenkamp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimelman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a β-catenin/APC complex reveals a critical role for APC phosphorylation in APC function</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">533</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2004.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1016%2Fj.molcel.2004.08.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=523-533&author=Y.+Xingauthor=W.+K.+Clementsauthor=I.+Le+Trongauthor=T.+R.+Hindsauthor=R.+Stenkampauthor=D.+Kimelmanauthor=W.+Xu&title=Crystal+structure+of+a+%CE%B2-catenin%2FAPC+complex+reveals+a+critical+role+for+APC+phosphorylation+in+APC+function&doi=10.1016%2Fj.molcel.2004.08.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DY.%26aulast%3DClements%26aufirst%3DW.%2BK.%26aulast%3DLe%2BTrong%26aufirst%3DI.%26aulast%3DHinds%26aufirst%3DT.%2BR.%26aulast%3DStenkamp%26aufirst%3DR.%26aulast%3DKimelman%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DW.%26atitle%3DCrystal%2520structure%2520of%2520a%2520%25CE%25B2-catenin%252FAPC%2520complex%2520reveals%2520a%2520critical%2520role%2520for%2520APC%2520phosphorylation%2520in%2520APC%2520function%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D15%26spage%3D523%26epage%3D533%26doi%3D10.1016%2Fj.molcel.2004.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hulsken, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, J.</span></span> <span> </span><span class="NLM_article-title">E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">2061</span>– <span class="NLM_lpage">2069</span>, <span class="refDoi"> DOI: 10.1083/jcb.127.6.2061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1083%2Fjcb.127.6.2061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1994&pages=2061-2069&author=J.+Hulskenauthor=W.+Birchmeierauthor=J.+Behrens&title=E-cadherin+and+APC+compete+for+the+interaction+with+%CE%B2-catenin+and+the+cytoskeleton&doi=10.1083%2Fjcb.127.6.2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1083%2Fjcb.127.6.2061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.127.6.2061%26sid%3Dliteratum%253Aachs%26aulast%3DHulsken%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DBehrens%26aufirst%3DJ.%26atitle%3DE-cadherin%2520and%2520APC%2520compete%2520for%2520the%2520interaction%2520with%2520%25CE%25B2-catenin%2520and%2520the%2520cytoskeleton%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1994%26volume%3D127%26spage%3D2061%26epage%3D2069%26doi%3D10.1083%2Fjcb.127.6.2061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Omer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kral, A. M.</span></span> <span> </span><span class="NLM_article-title">Identification of Tcf4 residues involved in high-affinity β-catenin binding</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1999.0379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1006%2Fbbrc.1999.0379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10080941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVahurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1999&pages=584-590&author=C.+A.+Omerauthor=P.+J.+Millerauthor=R.+E.+Diehlauthor=A.+M.+Kral&title=Identification+of+Tcf4+residues+involved+in+high-affinity+%CE%B2-catenin+binding&doi=10.1006%2Fbbrc.1999.0379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Tcf4 Residues Involved in High-Affinity β-Catenin Binding</span></div><div class="casAuthors">Omer, Charles A.; Miller, Patricia J.; Diehl, Ronald E.; Kral, Astrid M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">584-590</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The N-termini of members of the T-cell factor (Tcf) and lymphocyte-enhancement factor (Lef) protein families bind to β-catenin, forming bipartite transcription factors which regulate expression of genes involved in organismal development and the growth of normal and malignant colon epithelium.  Elevated levels of Tcf4:β-catenin are found in colon tumor cells with mutations in the adenomatous polyposis coli (APC) gene.  The elevated levels of Tcf4:β-catenin result in increased transcription of genes, including c-myc, important for the growth of these tumor cells.  Here we analyze the interaction between β-catenin and Tcf4 and show that the N-terminal 53 amino acids of Tcf4 bind with high affinity to β-catenin.  We show that this high-affinity interaction involves multiple contact points including Tcf4 Asp-16, which is essential for β-catenin binding.  In addn. to Tcf/Lef family members, β-catenin binds to APC and cadherins.  We found that the binding of β-catenin to Tcf4, APC, or E-cadherin was mutually exclusive.  These results are discussed with regard to how β-catenin interacts with its binding partners and to the potential for identifying specific, small mol. inhibitors of these interactions.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh0x1TFhpevbVg90H21EOLACvtfcHk0linc8B3csiLUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVahurw%253D&md5=fba757520faae5a84dc51abc0baba7e0</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1999.0379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1999.0379%26sid%3Dliteratum%253Aachs%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DMiller%26aufirst%3DP.%2BJ.%26aulast%3DDiehl%26aufirst%3DR.%2BE.%26aulast%3DKral%26aufirst%3DA.%2BM.%26atitle%3DIdentification%2520of%2520Tcf4%2520residues%2520involved%2520in%2520high-affinity%2520%25CE%25B2-catenin%2520binding%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1999%26volume%3D256%26spage%3D584%26epage%3D590%26doi%3D10.1006%2Fbbrc.1999.0379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orsulic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemler, R.</span></span> <span> </span><span class="NLM_article-title">E-cadherin binding prevents β-catenin nuclear localization and β-catenin/LEF-1-mediated transactivation</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1237</span>– <span class="NLM_lpage">1245</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10085258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADyaK1MXjtFGhsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1999&pages=1237-1245&author=S.+Orsulicauthor=O.+Huberauthor=H.+Aberleauthor=S.+Arnoldauthor=R.+Kemler&title=E-cadherin+binding+prevents+%CE%B2-catenin+nuclear+localization+and+%CE%B2-catenin%2FLEF-1-mediated+transactivation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">E-cadherin binding prevents β-catenin nuclear localization and β-catenin/LEF-1-mediated transactivation</span></div><div class="casAuthors">Orsulic, Sandra; Huber, Otmar; Aberle, Hermann; Arnold, Sebastian; Kemler, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1237-1245</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">β-Catenin is a multifunctional protein found in three cell compartments: the plasma membrane, the cytoplasm and the nucleus.  The cell has developed elaborate ways of regulating the level and localization of β-catenin to assure its specific function in each compartment.  One aspect of this regulation is inherent in the structural organization of β-catenin itself; most of its protein-interacting motifs overlap so that interaction with one partner can block binding of another at the same time.  Using recombinant proteins, we found that E-cadherin and lymphocyte-enhancer factor-1 (LEF-1) form mutually exclusive complexes with β-catenin; the assocn. of β-catenin with LEF-1 was competed out by the E-cadherin cytoplasmic domain.  Similarly, LEF-1 and adenomatous polyposis coli (APC) formed sep., mutually exclusive complexes with β-catenin.  In Wnt-1-transfected C57MG cells, free β-catenin accumulated and was able to assoc. with LEF-1.  The absence of E-cadherin in E-cadherin-/- embryonic stem (ES) cells also led to an accumulation of free β-catenin and its assocn. with LEF-1, thereby mimicking Wnt signaling.  β-Catenin/LEF-1-mediated transactivation in these cells was antagonized by transient expression of wild-type E-cadherin, but not of E-cadherin lacking the β-catenin binding site.  The potent ability of E-cadherin to recruit β-catenin to the cell membrane and prevent its nuclear localization and transactivation was also demonstrated using SW480 colon carcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVI5JKvvBRzrVg90H21EOLACvtfcHk0linc8B3csiLUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtFGhsLk%253D&md5=f57e374bf552d6e1d413826e8c5c53b0</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrsulic%26aufirst%3DS.%26aulast%3DHuber%26aufirst%3DO.%26aulast%3DAberle%26aufirst%3DH.%26aulast%3DArnold%26aufirst%3DS.%26aulast%3DKemler%26aufirst%3DR.%26atitle%3DE-cadherin%2520binding%2520prevents%2520%25CE%25B2-catenin%2520nuclear%2520localization%2520and%2520%25CE%25B2-catenin%252FLEF-1-mediated%2520transactivation%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D1999%26volume%3D112%26spage%3D1237%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span> <span> </span><span class="NLM_article-title">Thermodynamics of β-Catenin-Ligand Interactions</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1038</span>, <span class="refDoi"> DOI: 10.1074/jbc.m511338200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1074%2Fjbc.m511338200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=1027-1038&author=H.-J.+Choiauthor=A.+H.+Huberauthor=W.+I.+Weis&title=Thermodynamics+of+%CE%B2-Catenin-Ligand+Interactions&doi=10.1074%2Fjbc.m511338200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m511338200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m511338200%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.-J.%26aulast%3DHuber%26aufirst%3DA.%2BH.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26atitle%3DThermodynamics%2520of%2520%25CE%25B2-Catenin-Ligand%2520Interactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D1027%26epage%3D1038%26doi%3D10.1074%2Fjbc.m511338200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiendlmeyer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabletz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hlubek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, A.</span></span> <span> </span><span class="NLM_article-title">β-Catenin regulates the expression of tenascin-C in human colorectal tumors</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">8200</span>– <span class="NLM_lpage">8204</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1208960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fsj.onc.1208960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=16091738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yktbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=8200-8204&author=K.+Beiterauthor=E.+Hiendlmeyerauthor=T.+Brabletzauthor=F.+Hlubekauthor=A.+Haynlauthor=C.+Knollauthor=T.+Kirchnerauthor=A.+Jung&title=%CE%B2-Catenin+regulates+the+expression+of+tenascin-C+in+human+colorectal+tumors&doi=10.1038%2Fsj.onc.1208960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">β-Catenin regulates the expression of tenascin-C in human colorectal tumors</span></div><div class="casAuthors">Beiter, Katharina; Hiendlmeyer, Elke; Brabletz, Thomas; Hlubek, Falk; Haynl, Angela; Knoll, Claudia; Kirchner, Thomas; Jung, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">55</span>),
    <span class="NLM_cas:pages">8200-8204</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tenascin-C (TN-C) is a component of the extracellular matrix (ECM).  It is expressed during development and re-expressed in many types of cancers, where it is involved in the modulation of adhesion and proliferation.  TN-C expression is esp. high at sites of epithelial mesenchymal transition (EMT), which are found frequently at the invasion front of well-differentiated human colorectal adenocarcinomas.  Tumor cells in this compartment are characterized by a strong nuclear expression of the oncogenic transcription factor β-catenin.  Here, we demonstrate that TN-C is a β-catenin target gene in human colorectal tumors.  Thus, by far the most common mutations in colorectal tumors, found in the Wnt-signaling pathway and leading to the stabilizing of β-catenin, might influence invasion by altering adhesive properties and EMT of tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP7S_zSxaDkLVg90H21EOLACvtfcHk0linc8B3csiLUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yktbfE&md5=cc223d0407d4eaaf3fe23b8c195f71c5</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1208960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1208960%26sid%3Dliteratum%253Aachs%26aulast%3DBeiter%26aufirst%3DK.%26aulast%3DHiendlmeyer%26aufirst%3DE.%26aulast%3DBrabletz%26aufirst%3DT.%26aulast%3DHlubek%26aufirst%3DF.%26aulast%3DHaynl%26aufirst%3DA.%26aulast%3DKnoll%26aufirst%3DC.%26aulast%3DKirchner%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DA.%26atitle%3D%25CE%25B2-Catenin%2520regulates%2520the%2520expression%2520of%2520tenascin-C%2520in%2520human%2520colorectal%2520tumors%26jtitle%3DOncogene%26date%3D2005%26volume%3D24%26spage%3D8200%26epage%3D8204%26doi%3D10.1038%2Fsj.onc.1208960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oskarsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharyya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. H.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanharanta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavazoie, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manova-Todorova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brogi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massagué, J.</span></span> <span> </span><span class="NLM_article-title">Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1038/nm.2379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnm.2379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21706029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotV2hsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=867-874&author=T.+Oskarssonauthor=S.+Acharyyaauthor=X.+H.-F.+Zhangauthor=S.+Vanharantaauthor=S.+F.+Tavazoieauthor=P.+G.+Morrisauthor=R.+J.+Downeyauthor=K.+Manova-Todorovaauthor=E.+Brogiauthor=J.+Massagu%C3%A9&title=Breast+cancer+cells+produce+tenascin+C+as+a+metastatic+niche+component+to+colonize+the+lungs&doi=10.1038%2Fnm.2379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs</span></div><div class="casAuthors">Oskarsson, Thordur; Acharyya, Swarnali; Zhang, Xiang H.-F.; Vanharanta, Sakari; Tavazoie, Sohail F.; Morris, Patrick G.; Downey, Robert J.; Manova-Todorova, Katia; Brogi, Edi; Massague, Joan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">867-874</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report that breast cancer cells that infiltrate the lungs support their own metastasis-initiating ability by expressing tenascin C (TNC).  We find that the expression of TNC, an extracellular matrix protein of stem cell niches, is assocd. with the aggressiveness of pulmonary metastasis.  Cancer cell-derived TNC promotes the survival and outgrowth of pulmonary micrometastases.  TNC enhances the expression of stem cell signaling components, musashi homolog 1 (MSI1) and leucine-rich repeat-contg. G protein-coupled receptor 5 (LGR5).  MSI1 is a pos. regulator of NOTCH signaling, whereas LGR5 is a target gene of the WNT pathway.  TNC modulation of stem cell signaling occurs without affecting the expression of transcriptional enforcers of the stem cell phenotype and pluripotency, namely nanog homeobox (NANOG), POU class 5 homeobox 1 (POU5F1), also known as OCT4, and SRY-box 2 (SOX2).  TNC protects MSI1-dependent NOTCH signaling from inhibition by signal transducer and activator of transcription 5 (STAT5), and selectively enhances the expression of LGR5 as a WNT target gene.  Cancer cell-derived TNC remains essential for metastasis outgrowth until the tumor stroma takes over as a source of TNC.  These findings link TNC to pathways that support the fitness of metastasis-initiating breast cancer cells and highlight the relevance of TNC as an extracellular matrix component of the metastatic niche.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOdMMNxDI7srVg90H21EOLACvtfcHk0lj5_IJhg8kruw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotV2hsLg%253D&md5=eaca74c63536b025cadbbb0a641524d2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnm.2379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2379%26sid%3Dliteratum%253Aachs%26aulast%3DOskarsson%26aufirst%3DT.%26aulast%3DAcharyya%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%2BH.-F.%26aulast%3DVanharanta%26aufirst%3DS.%26aulast%3DTavazoie%26aufirst%3DS.%2BF.%26aulast%3DMorris%26aufirst%3DP.%2BG.%26aulast%3DDowney%26aufirst%3DR.%2BJ.%26aulast%3DManova-Todorova%26aufirst%3DK.%26aulast%3DBrogi%26aufirst%3DE.%26aulast%3DMassagu%25C3%25A9%26aufirst%3DJ.%26atitle%3DBreast%2520cancer%2520cells%2520produce%2520tenascin%2520C%2520as%2520a%2520metastatic%2520niche%2520component%2520to%2520colonize%2520the%2520lungs%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D867%26epage%3D874%26doi%3D10.1038%2Fnm.2379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walther, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertins, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heizmann, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlag, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span> <span> </span><span class="NLM_article-title">The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">1486</span>– <span class="NLM_lpage">1500</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2006.08.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1053%2Fj.gastro.2006.08.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=17101323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlantrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=1486-1500&author=U.+Steinauthor=F.+Arltauthor=W.+Waltherauthor=J.+Smithauthor=T.+Waldmanauthor=E.+D.+Harrisauthor=S.+D.+Mertinsauthor=C.+W.+Heizmannauthor=D.+Allardauthor=W.+Birchmeierauthor=P.+M.+Schlagauthor=R.+H.+Shoemaker&title=The+metastasis-associated+gene+S100A4+is+a+novel+target+of+beta-catenin%2FT-cell+factor+signaling+in+colon+cancer&doi=10.1053%2Fj.gastro.2006.08.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The metastasis-associated gene S100A4 is a novel target of β-catenin/T-cell factor signaling in colon cancer</span></div><div class="casAuthors">Stein, Ulrike; Arlt, Franziska; Walther, Wolfgang; Smith, Janice; Waldman, Todd; Harris, Erik D.; Mertins, Susan D.; Heizmann, Claus W.; Allard, David; Birchmeier, Walter; Schlag, Peter M.; Shoemaker, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1486-1500</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background & Aims: Activation of the Wnt/β-catenin pathway is frequently obsd. in colorectal cancers.  Our aim was to elucidate the impact of gain-of-function β-catenin on the metastasis-assocd. gene S100A4 in human colon cancer cell lines and tumors.  Methods: We analyzed cell lines heterozygous for gain-of-function and wild-type β-catenin, and variants homozygous for gain- or loss-of-function mutation in β-catenin, for S100A4 expression, cell motility, and in vivo metastasis.  β-Catenin-mediated S100A4 promoter activation was tested by reporter assays.  For human colon carcinomas, S100A4 expression, β-catenin genotype, and metachronous metastasis were correlated.  Results: We identified S100A4 as the most regulated gene by gain-of-function β-catenin using a 10K microarray.  Cell lines with gain-of-function β-catenin expressed up to 60-fold elevated S100A4 levels, displayed strongly increased migration and invasion in vitro, and induced metastasis in mice.  S100A4 small interfering RNA, β-catenin small interfering RNA, or dominant neg. T-cell factor (TCF) knocked down S100A4 and blocked biol. effects.  S100A4 complementary DNA transfection increased migration and invasion.  We identified a TCF binding site within the S100A4 promoter and demonstrated the direct binding of heterodimeric β-catenin/TCF complexes.  Reporter assays confirmed the β-catenin-induced S100A4 promoter activity.  Furthermore, S100A4 mRNA expression was increased in primary colon cancers, which later developed distant metastases, compared to non-metastasizing tumors.  Colon tumors heterozygous for gain-of-function β-catenin showed concomitant nuclear β-catenin localization, high S100A4 expression, and metastases.  Conclusions: S100A4 is a direct β-catenin/TCF target, induces migration and invasion in vitro and metastasis in vivo, and has value for prognosis of metastasis formation in colon cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSIYEwlk_9X7Vg90H21EOLACvtfcHk0lj5_IJhg8kruw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlantrfJ&md5=a521ea31e8c81809d09d143991717619</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2006.08.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2006.08.041%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DU.%26aulast%3DArlt%26aufirst%3DF.%26aulast%3DWalther%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DWaldman%26aufirst%3DT.%26aulast%3DHarris%26aufirst%3DE.%2BD.%26aulast%3DMertins%26aufirst%3DS.%2BD.%26aulast%3DHeizmann%26aufirst%3DC.%2BW.%26aulast%3DAllard%26aufirst%3DD.%26aulast%3DBirchmeier%26aufirst%3DW.%26aulast%3DSchlag%26aufirst%3DP.%2BM.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26atitle%3DThe%2520metastasis-associated%2520gene%2520S100A4%2520is%2520a%2520novel%2520target%2520of%2520beta-catenin%252FT-cell%2520factor%2520signaling%2520in%2520colon%2520cancer%26jtitle%3DGastroenterology%26date%3D2006%26volume%3D131%26spage%3D1486%26epage%3D1500%26doi%3D10.1053%2Fj.gastro.2006.08.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barraclough, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudland, P. S.</span></span> <span> </span><span class="NLM_article-title">S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6601483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fsj.bjc.6601483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=14710237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFKntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=253-262&author=S.+R.+Jenkinsonauthor=R.+Barracloughauthor=C.+R.+Westauthor=P.+S.+Rudland&title=S100A4+regulates+cell+motility+and+invasion+in+an+in+vitro+model+for+breast+cancer+metastasis&doi=10.1038%2Fsj.bjc.6601483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis</span></div><div class="casAuthors">Jenkinson, S. R.; Barraclough, R.; West, C. R.; Rudland, P. S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">253-262</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Elevated levels of the calcium-binding protein S100A4 are assocd. with poor patient survival in breast cancer patients and induce metastasis in rodent models.  To investigate the effects of S100A4 on different components of the metastatic process, epithelial cells lines have been isolated from nonmalignant tumors in neu transgenic mice and from malignant tumors in neu/S100A4 double transgenic mice.  Addnl. cell lines expressing both Neu and S100A4 have also been derived by transfection of rat S100A4 cDNA into tumor cell lines cloned from neu single transgenic mice.  Using these cells in transfilter migration assays, it has been shown that increases in either motility or invasive properties correlate with each other and with the level of S100A4 protein.  Injection of three of the cell lines sep. into the mammary fat pads of nude mice showed that elevated levels of S100A4 correlated with the degree of metastasis to the lungs.  In contrast, changes in cell proliferation and cell-substrate adhesion did not correlate with S100A4 levels.  Neither motility nor invasiveness correlated with proteolytic degrdn. of gelatin as measured by zymog.  Thus, the results suggest that the main effect of increases in S100A4 levels in metastasis is to generate increased cell motility and invasion and that this latter change is not dependent upon an increased ability to degrade the intercellular matrix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ_2NcKfUPYrVg90H21EOLACvtfcHk0lj5_IJhg8kruw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFKntA%253D%253D&md5=7cf5ff170472eb292b9ee58a6a18dc57</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601483%26sid%3Dliteratum%253Aachs%26aulast%3DJenkinson%26aufirst%3DS.%2BR.%26aulast%3DBarraclough%26aufirst%3DR.%26aulast%3DWest%26aufirst%3DC.%2BR.%26aulast%3DRudland%26aufirst%3DP.%2BS.%26atitle%3DS100A4%2520regulates%2520cell%2520motility%2520and%2520invasion%2520in%2520an%2520in%2520vitro%2520model%2520for%2520breast%2520cancer%2520metastasis%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D90%26spage%3D253%26epage%3D262%26doi%3D10.1038%2Fsj.bjc.6601483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ambartsumian, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grigorian, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstrøm, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sidenius, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rygaard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiev, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukanidin, E.</span></span> <span> </span><span class="NLM_article-title">Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1621</span>– <span class="NLM_lpage">1630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=8895507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADyaK28XmvVShtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=1621-1630&author=N.+S.+Ambartsumianauthor=M.+S.+Grigorianauthor=I.+F.+Larsenauthor=O.+Karlstr%C3%B8mauthor=N.+Sideniusauthor=J.+Rygaardauthor=G.+Georgievauthor=E.+Lukanidin&title=Metastasis+of+mammary+carcinomas+in+GRS%2FA+hybrid+mice+transgenic+for+the+mts1+gene"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene</span></div><div class="casAuthors">Ambartsumian, Noona S.; Grigorian, Mariam S.; Larsen, Ingrid Fossar; Karlstroem, Olle; Sidenius, Nicolai; Rygaard, Joergen; Georgiev, Georgii; Lukanidin, Eugene</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1621-1630</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">Transgenic mice, carrying the mts1 gene, one of the genes involved in the acquisition of the metastatic phenotype, were generated.  The mts1 gene was placed under the control of the mouse mammary tumor virus (MMTV) long terminal repeat (LTR) promoter leading to overexpression in the lactating mammary gland of transgenic animals.  Animals bearing the transgene appear phenotypically normal.  Animals of two transgenic lines (Tg463 and Tg507) were crossed with the GRS/A mice.  The GRS/A strain is characterized by high incidence of mammary tumors which rarely metastasize.  Some 40% of the tumor bearing hybrid GRS/A mts1 females were found to develop secondary tumors in the lungs.  The Mts1 protein was detected in the transgene primary tumor cells as well as in the corresponding metastases.  Nontransgenic littermates expressed the Mts1 protein only in the stromal cells surrounding the tumor but not in tumor cells by itself.  Thus, overexpression of the mts1 gene in the mouse mammary carcinoma cells gives rise to more aggressive tumors which are able to metastasize.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfG1SSuBCa8rVg90H21EOLACvtfcHk0lj4MpXPpuFaZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVShtr4%253D&md5=57499dec46b70c7389ea2b90f4ed2c6b</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmbartsumian%26aufirst%3DN.%2BS.%26aulast%3DGrigorian%26aufirst%3DM.%2BS.%26aulast%3DLarsen%26aufirst%3DI.%2BF.%26aulast%3DKarlstr%25C3%25B8m%26aufirst%3DO.%26aulast%3DSidenius%26aufirst%3DN.%26aulast%3DRygaard%26aufirst%3DJ.%26aulast%3DGeorgiev%26aufirst%3DG.%26aulast%3DLukanidin%26aufirst%3DE.%26atitle%3DMetastasis%2520of%2520mammary%2520carcinomas%2520in%2520GRS%252FA%2520hybrid%2520mice%2520transgenic%2520for%2520the%2520mts1%2520gene%26jtitle%3DOncogene%26date%3D1996%26volume%3D13%26spage%3D1621%26epage%3D1630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudland, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolicoeur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barraclough, R.</span></span> <span> </span><span class="NLM_article-title">Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1631</span>– <span class="NLM_lpage">1637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=8895508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADyaK28XmvVShtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=1631-1637&author=M.+P.+Daviesauthor=P.+S.+Rudlandauthor=L.+Robertsonauthor=E.+W.+Parryauthor=P.+Jolicoeurauthor=R.+Barraclough&title=Expression+of+the+calcium-binding+protein+S100A4+%28p9Ka%29+in+MMTV-neu+transgenic+mice+induces+metastasis+of+mammary+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumors</span></div><div class="casAuthors">Davies, Michael P. A.; Rudland, Philip S.; Robertson, Lynne; Parry, E. Wyn; Jolicoeur, Paul; Barraclough, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1631-1637</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">Increased levels of S100A4 (p9Ka) confer metastatic ability on a normally non-metastatic epithelial cell line.  To find out whether S100A4 can induce metastasis in vivo, transgenic mice expressing high levels of S100A4, but which show no phenotypic effect, have been mated with MMTV-neu transgenic mice which succumb to stochastic mammary neoplasia related to expression of the MMTV-neu transgene.  Resulting bitransgenic, multi-parous, female progeny expressing both S100A4 and Neu have a slightly earlier incidence of palpable mammary tumors than the MMTV-neu offspring and specifically exhibit macroscopic metastatic lesions in the lungs.  The S100A4 transgene is expressed in primary and secondary lesions of bitransgenic offspring and its expression its particularly assocd. with regions of invasion of primary lesions and metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWU4IbRc-SmLVg90H21EOLACvtfcHk0lj4MpXPpuFaZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvVShtr8%253D&md5=492ba973da5d85f262547241c75a3d61</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DM.%2BP.%26aulast%3DRudland%26aufirst%3DP.%2BS.%26aulast%3DRobertson%26aufirst%3DL.%26aulast%3DParry%26aufirst%3DE.%2BW.%26aulast%3DJolicoeur%26aufirst%3DP.%26aulast%3DBarraclough%26aufirst%3DR.%26atitle%3DExpression%2520of%2520the%2520calcium-binding%2520protein%2520S100A4%2520%2528p9Ka%2529%2520in%2520MMTV-neu%2520transgenic%2520mice%2520induces%2520metastasis%2520of%2520mammary%2520tumours%26jtitle%3DOncogene%26date%3D1996%26volume%3D13%26spage%3D1631%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platt-Higgins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudland, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barraclough, R.</span></span> <span> </span><span class="NLM_article-title">Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1201948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fsj.onc.1201948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=9696040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVWlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=465-473&author=B.+H.+Lloydauthor=A.+Platt-Higginsauthor=P.+S.+Rudlandauthor=R.+Barraclough&title=Human+S100A4+%28p9Ka%29+induces+the+metastatic+phenotype+upon+benign+tumour+cells&doi=10.1038%2Fsj.onc.1201948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumor cells</span></div><div class="casAuthors">Lloyd, Bryony H.; Platt-Higgins, Angela; Rudland, Philip S.; Barraclough, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-473</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The rodent S100-related calcium-binding protein, S100A4 induces metastasis in non-metastatic rat and mouse benign mammary cells and cooperates with benign-tumor-inducing changes in two transgenic mouse models, to yield metastatic mammary tumors.  Co-transfection of the human gene for S100A4 with pSV2neo into the benign rat mammary cell line, Rama 37, yielded cells which expressed a low level of the endogenous S100A4 mRNA, and either high or undetectable levels of human S100A4 mRNA.  The cells which expressed a high level of human S100A4 mRNA induced metastasis in the benign rat mammary cell line Rama 37 in an in vivo assay, whereas the cells which expressed an undetectable level of human S100A4 did not induce any detectable metastases.  The primary tumors arising from the S100A4-expressing cells contained high levels of immunocytochem.-detected S100A4 and this high level of S100A4 and the metastatic potential were maintained when cells from a metastasis were re-injected into syngeneic rats.  The results show that the human S100A4 possesses metastasis-inducing capabilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa9Fd7JjzxgbVg90H21EOLACvtfcHk0lj4MpXPpuFaZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVWlurY%253D&md5=1fdd72f7d0bfa497abddbce6d62e4c45</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1201948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1201948%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DB.%2BH.%26aulast%3DPlatt-Higgins%26aufirst%3DA.%26aulast%3DRudland%26aufirst%3DP.%2BS.%26aulast%3DBarraclough%26aufirst%3DR.%26atitle%3DHuman%2520S100A4%2520%2528p9Ka%2529%2520induces%2520the%2520metastatic%2520phenotype%2520upon%2520benign%2520tumour%2520cells%26jtitle%3DOncogene%26date%3D1998%26volume%3D17%26spage%3D465%26epage%3D473%26doi%3D10.1038%2Fsj.onc.1201948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravindranath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, H.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grills, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappin, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tanani, M.</span></span> <span> </span><span class="NLM_article-title">Wnt-β-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1038/bjc.2011.269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fbjc.2011.269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=21772333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFygsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2011&pages=542-551&author=A.+Ravindranathauthor=H.-F.+Yuenauthor=K.-K.+Chanauthor=C.+Grillsauthor=D.+A.+Fennellauthor=T.+R.+Lappinauthor=M.+El-Tanani&title=Wnt-%CE%B2-catenin-Tcf-4+signalling-modulated+invasiveness+is+dependent+on+osteopontin+expression+in+breast+cancer&doi=10.1038%2Fbjc.2011.269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt-β-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer</span></div><div class="casAuthors">Ravindranath, A.; Yuen, H.-F.; Chan, K.-K.; Grills, C.; Fennell, D. A.; Lappin, T. R.; El-Tanani, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">542-551</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: We have previously demonstrated that Tcf-4 regulates osteopontin (OPN) in rat breast epithelial cells, Rama37.  In this report, we have examd. the importance of this regulation in human breast cancer.  Methods: The regulatory roles of Tcf-4 on cell invasion and OPN expression were investigated.  The mRNA expression of Tcf-4 and OPN, and survival of breast cancer patients were correlated.  Results: Tcf-4 enhanced cell invasion in both MCF10AT and MDA MB 231 breast cancer cells by transcriptionally activating OPN expression.  Osteopontin was activated by Wnt signaling in MDA MB 231 cells.  Paradoxical results on Tcf-4-regulated OPN expression in MCF10AT (activation) and Rama37 (repression) cells were shown to be a result of differential Wnt signaling competency in MCF10AT and Rama37 cells.  High levels of OPN and Tcf-4 mRNA expression were significantly assocd. with survival in breast cancer patients.  Most importantly, Tcf-4-pos. patients had a poorer prognosis when OPN was overexpressed, while OPN-neg. patients had a better prognosis when Tcf-4 was overexpressed.  Conclusion: Our results suggest that Tcf-4 can act as a repressor or activator of breast cancer progression by regulating OPN expression in a Wnt-dependent manner and that Tcf-4 and OPN together may be a novel prognostic indicator for breast cancer progression.  British Journal of Cancer (2011) 105, 542-551; doi:10.1038/bjc.2011.269 www. bjcancer. com. published online 19 July 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWbYcLI9kxLLVg90H21EOLACvtfcHk0lj4MpXPpuFaZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFygsLs%253D&md5=82407baaedb6d96489723ae8e602320a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2011.269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2011.269%26sid%3Dliteratum%253Aachs%26aulast%3DRavindranath%26aufirst%3DA.%26aulast%3DYuen%26aufirst%3DH.-F.%26aulast%3DChan%26aufirst%3DK.-K.%26aulast%3DGrills%26aufirst%3DC.%26aulast%3DFennell%26aufirst%3DD.%2BA.%26aulast%3DLappin%26aufirst%3DT.%2BR.%26aulast%3DEl-Tanani%26aufirst%3DM.%26atitle%3DWnt-%25CE%25B2-catenin-Tcf-4%2520signalling-modulated%2520invasiveness%2520is%2520dependent%2520on%2520osteopontin%2520expression%2520in%2520breast%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2011%26volume%3D105%26spage%3D542%26epage%3D551%26doi%3D10.1038%2Fbjc.2011.269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howe, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span> <span> </span><span class="NLM_article-title">Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1906</span>– <span class="NLM_lpage">1913</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1906-1913&author=L.+R.+Howeauthor=O.+Watanabeauthor=J.+Leonardauthor=A.+M.+Brown&title=Twist+is+up-regulated+in+response+to+Wnt1+and+inhibits+mouse+mammary+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowe%26aufirst%3DL.%2BR.%26aulast%3DWatanabe%26aufirst%3DO.%26aulast%3DLeonard%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26atitle%3DTwist%2520is%2520up-regulated%2520in%2520response%2520to%2520Wnt1%2520and%2520inhibits%2520mouse%2520mammary%2520cell%2520differentiation%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D1906%26epage%3D1913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yook, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. J.</span></span> <span> </span><span class="NLM_article-title">Wnt-dependent regulation of the E-cadherin repressor snail</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">11740</span>– <span class="NLM_lpage">11748</span>, <span class="refDoi"> DOI: 10.1074/jbc.m413878200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1074%2Fjbc.m413878200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=11740-11748&author=J.+I.+Yookauthor=X.-Y.+Liauthor=I.+Otaauthor=E.+R.+Fearonauthor=S.+J.+Weiss&title=Wnt-dependent+regulation+of+the+E-cadherin+repressor+snail&doi=10.1074%2Fjbc.m413878200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m413878200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m413878200%26sid%3Dliteratum%253Aachs%26aulast%3DYook%26aufirst%3DJ.%2BI.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DOta%26aufirst%3DI.%26aulast%3DFearon%26aufirst%3DE.%2BR.%26aulast%3DWeiss%26aufirst%3DS.%2BJ.%26atitle%3DWnt-dependent%2520regulation%2520of%2520the%2520E-cadherin%2520repressor%2520snail%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D11740%26epage%3D11748%26doi%3D10.1074%2Fjbc.m413878200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yook, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fearon, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. J.</span></span> <span> </span><span class="NLM_article-title">A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1398</span>– <span class="NLM_lpage">1406</span>, <span class="refDoi"> DOI: 10.1038/ncb1508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fncb1508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=17072303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Kju7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=1398-1406&author=J.+I.+Yookauthor=X.-Y.+Liauthor=I.+Otaauthor=C.+Huauthor=H.+S.+Kimauthor=N.+H.+Kimauthor=S.+Y.+Chaauthor=J.+K.+Ryuauthor=Y.+J.+Choiauthor=J.+Kimauthor=E.+R.+Fearonauthor=S.+J.+Weiss&title=A+Wnt-Axin2-GSK3%CE%B2+cascade+regulates+Snail1+activity+in+breast+cancer+cells&doi=10.1038%2Fncb1508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells</span></div><div class="casAuthors">Yook, Jong In; Li, Xiao-Yan; Ota, Ichiro; Hu, Casey; Kim, Hyun Sil; Kim, Nam Hee; Cha, So Young; Ryu, Joo Kyung; Choi, Yoon Jung; Kim, Jin; Fearon, Eric R.; Weiss, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1398-1406</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulating evidence indicates that hyperactive Wnt signaling occurs in assocn. with the development and progression of human breast cancer.  As a consequence of engaging the canonical Wnt pathway, a β-catenin-T-cell factor (TCF) transcriptional complex is generated, which has been postulated to trigger the epithelial-mesenchymal transition (EMT) that characterizes the tissue-invasive phenotype.  However, the mol. mechanisms by which the β-catenin-TCF complex induces EMT-like programs remain undefined.  Here, we demonstrate that canonical Wnt signaling engages tumor cell dedifferentiation and tissue-invasive activity through an Axin2-dependent pathway that stabilizes the Snail1 zinc-transcription factor, a key regulator of normal and neoplastic EMT programs.  Axin2 regulates EMT by acting as a nucleocytoplasmic chaperone for GSK3β, the dominant kinase responsible for controlling Snail1 protein turnover and activity.  As dysregulated Wnt signaling marks a diverse array of cancerous tissue types, the identification of a β-catenin-TCF-regulated Axin2-GSK3β-Snail1 axis provides new mechanistic insights into cancer-assocd. EMT programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrFRj70e-4L7Vg90H21EOLACvtfcHk0lgMLurMDLZmVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Kju7rE&md5=69da2931ed955a1f458376d8c3682c34</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fncb1508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1508%26sid%3Dliteratum%253Aachs%26aulast%3DYook%26aufirst%3DJ.%2BI.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DOta%26aufirst%3DI.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DN.%2BH.%26aulast%3DCha%26aufirst%3DS.%2BY.%26aulast%3DRyu%26aufirst%3DJ.%2BK.%26aulast%3DChoi%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DFearon%26aufirst%3DE.%2BR.%26aulast%3DWeiss%26aufirst%3DS.%2BJ.%26atitle%3DA%2520Wnt-Axin2-GSK3%25CE%25B2%2520cascade%2520regulates%2520Snail1%2520activity%2520in%2520breast%2520cancer%2520cells%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2006%26volume%3D8%26spage%3D1398%26epage%3D1406%26doi%3D10.1038%2Fncb1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleer, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, S. J.</span></span> <span> </span><span class="NLM_article-title">Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">16654</span>– <span class="NLM_lpage">16659</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205822109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.1205822109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=16654-16659&author=Z.-Q.+Wuauthor=X.-Y.+Liauthor=C.+Y.+Huauthor=M.+Fordauthor=C.+G.+Kleerauthor=S.+J.+Weiss&title=Canonical+Wnt+signaling+regulates+Slug+activity+and+links+epithelial-mesenchymal+transition+with+epigenetic+Breast+Cancer+1%2C+Early+Onset+%28BRCA1%29+repression&doi=10.1073%2Fpnas.1205822109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205822109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205822109%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.-Q.%26aulast%3DLi%26aufirst%3DX.-Y.%26aulast%3DHu%26aufirst%3DC.%2BY.%26aulast%3DFord%26aufirst%3DM.%26aulast%3DKleer%26aufirst%3DC.%2BG.%26aulast%3DWeiss%26aufirst%3DS.%2BJ.%26atitle%3DCanonical%2520Wnt%2520signaling%2520regulates%2520Slug%2520activity%2520and%2520links%2520epithelial-mesenchymal%2520transition%2520with%2520epigenetic%2520Breast%2520Cancer%25201%252C%2520Early%2520Onset%2520%2528BRCA1%2529%2520repression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2012%26volume%3D109%26spage%3D16654%26epage%3D16659%26doi%3D10.1073%2Fpnas.1205822109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emami, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, M.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibitor of β-catenin/CREB-binding protein transcription</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">12682</span>– <span class="NLM_lpage">12687</span>, <span class="refDoi"> DOI: 10.1073/pnas.0404875101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1073%2Fpnas.0404875101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=15314234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=12682-12687&author=K.+H.+Emamiauthor=C.+Nguyenauthor=H.+Maauthor=D.+H.+Kimauthor=K.+W.+Jeongauthor=M.+Eguchiauthor=R.+T.+Moonauthor=J.-L.+Teoauthor=S.+W.+Ohauthor=H.+Y.+Kimauthor=S.+H.+Moonauthor=J.+R.+Haauthor=M.+Kahn&title=A+small+molecule+inhibitor+of+%CE%B2-catenin%2FCREB-binding+protein+transcription&doi=10.1073%2Fpnas.0404875101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription</span></div><div class="casAuthors">Emami, Katayoon H.; Nguyen, Cu; Ma, Hong; Kim, Dae Hoon; Jeong, Kwang Won; Eguchi, Masakatsu; Moon, Randall T.; Teo, Jia-Ling; Oh, Se Wong; Kim, Hak Yeop; Moon, Sung Hwan; Ha, Jong Ryul; Kahn, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12682-12687</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inherited and somatic mutations in the adenomatous polyposis coli occur in most colon cancers, leading to activation of β-catenin-responsive genes.  To identify small mol. antagonists of this pathway, the authors challenged transformed colorectal cells with a secondary structure-templated chem. library, looking for compds. that inhibit a β-catenin-responsive reporter.  The authors identified ICG-001, a small mol. that down-regulates β-catenin/T cell factor signaling by specifically binding to cAMP response element-binding protein.  ICG-001 selectively induces apoptosis in transformed cells but not in normal colon cells, reduces in vitro growth of colon carcinoma cells, and is efficacious in the Min mouse and nude mouse xenograft models of colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6tlzXLGU-rVg90H21EOLACvtfcHk0lgMLurMDLZmVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVent70%253D&md5=51d20409871c490734e66d23987348ee</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0404875101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0404875101%26sid%3Dliteratum%253Aachs%26aulast%3DEmami%26aufirst%3DK.%2BH.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DJeong%26aufirst%3DK.%2BW.%26aulast%3DEguchi%26aufirst%3DM.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26aulast%3DTeo%26aufirst%3DJ.-L.%26aulast%3DOh%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DMoon%26aufirst%3DS.%2BH.%26aulast%3DHa%26aufirst%3DJ.%2BR.%26aulast%3DKahn%26aufirst%3DM.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520%25CE%25B2-catenin%252FCREB-binding%2520protein%2520transcription%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D12682%26epage%3D12687%26doi%3D10.1073%2Fpnas.0404875101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rautio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hageman, M. J.</span></span> <span> </span><span class="NLM_article-title">The expanding role of prodrugs in contemporary drug design and development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1038/nrd.2018.46</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=10.1038%2Fnrd.2018.46" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=29700501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=559-587&author=J.+Rautioauthor=N.+A.+Meanwellauthor=L.+Diauthor=M.+J.+Hageman&title=The+expanding+role+of+prodrugs+in+contemporary+drug+design+and+development&doi=10.1038%2Fnrd.2018.46"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The expanding role of prodrugs in contemporary drug design and development</span></div><div class="casAuthors">Rautio, Jarkko; Meanwell, Nicholas A.; Di, Li; Hageman, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">559-587</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Prodrugs are mols. with little or no pharmacol. activity that are converted to the active parent drug in vivo by enzymic or chem. reactions or by a combination of the two.  Prodrugs have evolved from being serendipitously discovered or used as a salvage effort to being intentionally designed.  Such efforts can avoid drug development challenges that limit formulation options or result in unacceptable biopharmaceutical or pharmacokinetic performance, or poor targeting.  In the past 10 years, the US Food and Drug Administration has approved at least 30 prodrugs, which accounts for more than 12% of all approved small-mol. new chem. entities.  In this Review, we highlight prodrug design strategies for improved formulation and pharmacokinetic and targeting properties, with a focus on the most recently marketed prodrugs.  We also discuss preclin. and clin. challenges and considerations in prodrug design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYKsM1lriJObVg90H21EOLACvtfcHk0lguaXUVzOdM7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgsL0%253D&md5=9dea9fd2f30779f4ce182b822f2c9539</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2018.46&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2018.46%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DHageman%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520expanding%2520role%2520of%2520prodrugs%2520in%2520contemporary%2520drug%2520design%2520and%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2018%26volume%3D17%26spage%3D559%26epage%3D587%26doi%3D10.1038%2Fnrd.2018.46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teuscher, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span> <span> </span><span class="NLM_article-title">A versatile method to determine the cellular bioavailability of small-molecule inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00923</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00923" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGiur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=157-169&author=K.+B.+Teuscherauthor=M.+Zhangauthor=H.+Ji&title=A+versatile+method+to+determine+the+cellular+bioavailability+of+small-molecule+inhibitors&doi=10.1021%2Facs.jmedchem.6b00923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">A Versatile Method to Determine the Cellular Bioavailability of Small-Molecule Inhibitors</span></div><div class="casAuthors">Teuscher, Kevin B.; Zhang, Min; Ji, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-169</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The detn. of the cellular bioavailability of small-mol. inhibitors is a crit. step for interpreting cell-based data and guiding inhibitor optimization.  Herein, a HPLC-MS based protocol was developed to det. inhibitor cellular bioavailability.  This generalizable protocol allows detn. of the accurate intracellular concns. and characterization of various properties of inhibitors including the extra- and intracellular stability, the dose- and time-dependence of the intracellular concns., the cell permeability, and the nonspecific binding with the cell culture plates, the extracellular matrixes, and the cell membrane.  The inhibitors of the protein-protein interactions, bromodomains, and the β-catenin/B-cell lymphoma 9 (BCL9) interaction were used to examine the protocol, and the cellular bioavailability of the inhibitors in cancer cells was detd.  High nonspecific binding and low cellular uptake were obsd. for two bromodomain inhibitors.  The two β-catenin/BCL9 inhibitors had low nonspecific binding but different cellular uptake.  These inhibitors exhibited different stability kinetics in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhu8gNo3yDMrVg90H21EOLACvtfcHk0lguaXUVzOdM7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGiur7P&md5=5aebfe9a1e5dc7b8604e285661dc0041</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00923%26sid%3Dliteratum%253Aachs%26aulast%3DTeuscher%26aufirst%3DK.%2BB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26atitle%3DA%2520versatile%2520method%2520to%2520determine%2520the%2520cellular%2520bioavailability%2520of%2520small-molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D157%26epage%3D169%26doi%3D10.1021%2Facs.jmedchem.6b00923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i101"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00147">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_56685"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00147">10.1021/acs.jmedchem.9b00147</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Supplemental procedures, chemical stability of <b>1</b> and <b>21</b>, determination of the intracellular concentrations of <b>53</b> and <b>56</b>, FP and MTS cell viability assay curves of β-catenin/Tcf inhibitors, sequences of the fluorescence tracers, SDS-PAGE result of the purified β-catenin (residue 138–781), full western blot images of co-IP experiments, supplementary synthetic schemes S1–S14, HPLC conditions and chromatograms, NMR spectra, and the supplementary references (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_001.pdf">jm9b00147_si_001.pdf (13.74 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00147/suppl_file/jm9b00147_si_002.csv">jm9b00147_si_002.csv (7.7 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00147&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00147%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00147" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995e40fb053cc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
